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Abstract
Reactions with 2-methylenetetrahydropyrans are underutilized in the literature, especially
with respect to general methods demonstrating their nucleophilic nature. This work provides
three general methods toward the synthesis of 2--oxygenated pyranyl substrates, which are key
structural components of many biologically active polyketides and natural products.
The use of exocyclic enol ethers as nucleophiles was first demonstrated as a general
process in three-component coupling reactions with secondary nucleophiles. The 2--hydroxy
tetrahydropyran products were obtained in good to excellent yields through promotion with
stoichiometric levels of titanium(IV) chloride at reduced temperatures. Only activated aldehydes
or ketones worked as efficient coupling partners for this method. The point at which the
secondary nucleophile was added to the reaction in progress was governed by the level of
electrophile activation and in turn the amount of oxonium ion present for immediate capture.
NOE studies determined that cis-tetrahydropyran products are solely formed with C6-substituted
enol ether substrates.
The carbonyl-ene reaction of exocyclic enol ethers provides 2--hydroxy dihydropyrans
in excellent yields at room temperature. This process only requires catalytic levels of zinc
chloride, and both activated and non-activated carbonyl-enophiles act as appropriate coupling
partners. These mild reaction conditions produce dihydropyranyl substrates, which are equipped
for further functionalization through the newly formed olefin. 2-Methylenetetrahydropyrans,
bearing either mono- or di-substitution about the tetrahydropyran ring, were synthesized to
determine if any chiral influence could be channeled to the dihydropyranyl products. The
diastereomeric ratios of resulting products showed that exocyclic enol ethers with C3 mono-

substitution or 2-methylenetetrahydropyrans with di-substitution, where at least one group is held
axial, produced moderate levels of selectivity. Alternatively, the other substrates studied in this
project demonstrated only low levels of chirality induction.
The carbonyl-ene reaction of exocyclic enol ethers has been applied bi-directionally to
iodomethyl-2-methylenetetrahydropyrans to provide bis--hydroxypyrans. Good to excellent
yields were obtained for the initial carbonyl-ene coupling and subsequent iodine elimination.
The second carbonyl-ene coupling of 2-methylenedihydropyran was only effected with highly
activated enophile components with zinc(II) chloride as the promoter. This reaction with ethyl
glyoxylate proceeded in good to excellent yield with catalytic zinc(II) chloride. Only moderate
yields of the pyranyl products were obtained with p-nitrobenzaldehyde and equimolar levels of
zinc chloride.

The bis--hydroxypyran products manufactured from this process are

theoretically furnished for further functionalization into trioxadispiroketal systems. Attempted
cyclization of these substrates under a number of acidic conditions failed to provide the desired
bis-spiroketal systems. Therefore a step-wise approach to their manufacture was attempted,
although this too failed to produce the bis-spirocyclic system due to difficulties experienced with
iodide elimination.
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Chapter 1. The Synthesis and Reactivity of 2-Methylenetetrahydropyrans
1.1 Overview
-Hydroxytetrahydropyrans and their derivatives are present in a number of biologically
active natural products. Organic synthesis is used to manufacture natural products, because often
these molecules are not isolated from nature in reasonable yields.

Therefore the synthesis of

tetrahydropyrans is of importance to the synthetic organic community and beyond.

-

Hydroxytetrahydropyran functionalities like 1 can be accessed through reactions of 2methylenetetrahydropyrans (2).

These exocyclic enol ethers can be synthesized by one of

several methods (Scheme 1.1).
Scheme 1.1
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This chapter will examine the different methods of exocyclic enol ether synthesis, which
includes the elimination of alkyl halides (3), cyclization of acetylenic alcohols (4), and direct
methylenation and alkylidenation of the corresponding lactone (5). Secondly, the reactivity of
exocyclic enol ethers is addressed. Exocylic enol ethers have been reported to undergo a number
of processes, including their use as substrates in addition reactions, rearrangements, pericyclic
reactions, and radical reactions, and their use as electrophiles and nucleophiles. The reactions of
greatest significance in organic chemistry are those involving new carbon-carbon bonding.
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Therefore, the primary focus will be on these transformations and the use of exocyclic enol
ethers as nucleophiles.
1.2 Background and Significance
-Hydroxytetrahydropyrans and their derivatives are common moieties found in many
natural products.

These natural products are of synthetic interest because of their varied

biological activities, which makes them effective drugs or worthy drug candidates. There are a
number of interesting tetrahydropyranyl ketide derivative-containing natural products, which
include, but are not limited to popular synthetic targets such as leucascandrolide A (6),1
diospongin A (7) and B (8),2 amphotericin B (9),3 spiroketal-containing natural product
spirangian A (10)4 and rapamycin (11)5 (Figure 1.1).
Leucascandrolide A (6) contains within it a cis-1,6-substituted tetrahydropyranyl diketide.
This natural product has a remarkable set of biologically active properties, making it a potential
drug candidate. Leucascandrolide A shows marked cytotoxicity against human KB tumor cell
lines and P388 leukemia cell lines, displaying IC50 values of 0.05 and 0.25 g/mL respectively.
Leucascandrolide A also shows antifungal inhibition against Candida albicans, a pathogenic
yeast that attacks immune-compromised individuals including AIDs patients.6

The natural

product is theorized to inhibit the cytochrome bc1 complex, which is used by cells to make ATP,
an important source of a cell’s energy. Blocking ATP formation triggers the cell to undergo
apoptosis and eventually die.7
Leucascandrolide A was isolated in 1996 from the calcareous sponge Leucascandra
caveolata, however attempts at re-isolation were unsuccessful.8 The natural product is believed
to originate from a microbial colony present on the sponge rather than the sponge itself.
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The high biological activity of leucascandrolide A, coupled with the inability to re-isolate the
natural product, has led to a variety of synthetic approaches.9

3

Diospongin A (7) and B (8) are simple examples of tetrahydropyranyl ketide-containing
natural products that differ only in the stereochemistry at the C3 position of the tetrahydropyranyl
ring. Both natural products were isolated from Dioscorea spongiosa in 2004,10 and since then a
number of syntheses have been reported.11 Diaspongin B has displayed anti-osteoporotic activity
similar to the clinically used drug elcitionin.12 Interest in the diospongins stems from the
observed bioactivity and their relatively simple structure.

Since diospongin is not an

overwhelmingly complex molecule, it can be synthesized in a minimal number of steps. This
makes diospongin B a synthetic target of possible pharmacological use, since fewer synthetic
steps would reduce production costs and consequently cost to consumers.
Amphotericin B (9) was isolated from Streptomyces nodosus and is used as an antifungal
and antiprotazoal agent.13 Oral preparations of this drug have been used to treat thrush, and it is
also administered intravenously as a last resort to treat systematic fungal infections (cryptococcal
meningitis)

and

parasitic

protozoan

infections

(leishmaniasis

and

amoebic

meningoencephalitis).14 Additionally, inoculation of amphotericin B to tissue cultures prevents
fungal contamination.

Amphotericin B causes cell death by associating with ergosterol, a

component of the cellular membrane, forming trans-membrane channels that cause monovalent
ion leakage. Because mammalian membranes contain similar sterols, toxicity can occur in
amphotericin-treated patients.15

Thus Amphotericin is used as a last resort in critically ill

patients. The structure of amphotericin B was fully established via X-ray crystallographic
analysis,16 and both the total synthesis17 and biosynthesis18 of this molecule have been reported.
Spirangien A (6) is another example of a tetrahydropyranyl spiroketal-containing natural
product of recent interest that was isolated from the Sorangium cellulosum strain of
myxobacteria.19 Spirangien A exhibits both antifungal and cytotoxic biological activities, with

4

IC50 values of 1.0 x 10-9 M against a L929 mouse fibroblast cell line.20 This level of cytotoxicity
is comparable to the popular anticancer drug Taxol,® which also exhibits nanomolar cytoxicity
against human cancer lines.21 Hence, spirangien A is a potential drug target for cancer treatment.
To date, the mechanism of action that gives rise to the promising anticancer activity has not yet
been determined. Total syntheses have been published by the Paterson22 and Ley23 groups.
Rapamycin (5), also known as sirolimus, is a tetrahydropyranyl polyketide-containing
natural product that is used in treatment of a multitude of diseases. Within this macrolide there
exists a cis-tetrahydropyranyl ketide unit. This natural product was isolated from the bacterium
Streptomyces hygroscopicus, which was found in a soil sample local to Easter Island in 1975.24
Originally developed as an antifungal treatment, rapamycin is currently marketed by Wyeth
(Rapamune) as a highly effective immunosuppressant amongst other uses.

The drug is

biosynthesized through the use of polyketide synthase and additional enzyme modifications.25
Although quite similar in structure to tacrolimus, a tetrahydropyranyl ketide-containing,
immunosuppressive, calcineurin-inhibiting drug,26 rapamycin works by a different mode of
action. Rapamycin binds to the cytosolic protein, FK-binding protein 12 (FKBP12), and inhibits
the mammalian target of rapamycin (mTOR) pathway by directly binding to mTOR complex 1.
Thus rapamycin inhibits the response to interleukin-2 and blocks the activation of T and Bcells.27
The use of rapamycin as an immunosuppressant is preferred over other drugs because
lower toxicities to the liver are observed.28 Alternatively, internal use of tacrolimus has lead to
impaired kidney function and even chronic renal failure in patients. This makes rapamycin an
especially effective drug for preventing organ rejection in kidney transplantations.
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Not only is rapamycin a great drug candidate for immunosuppressive therapy, but it has
also found use in a number of other treatments.

Rapamycin has been found to exhibit

antiproliferative properties and has been used in conjunction with coronary stents to prevent
restenosis in coronary arteries following balloon angioplasty. This natural product is marketed
as a sirolimus-eluting coronary stent (Cypher) by Cordis, a sub-division of Johnson and Johnson.
In studies of patients with tuberous sclerosis complex (TSC), a disease marked by benign
tumor growth in various organs, inhibitory effects were observed, diminishing the reoccurrence
of tumor formation in these patients. As part of this study researchers also discovered that
symptoms of attention deficit hyperactive disorder (ADHD) and autism decreased. In fact
autistic mice treated with rapamycin demonstrated marked increases in intellect within three
days.29 A treatment for autism would be especially valuable, with no current available treatment.
Additional studies have shown rapamycin to be an effective treatment toward autosomal
dominant polycystic kidney disease,30 decreasing cancer risk in patients with renal failure,31 and
inhibiting HIV replication via downregulation of coreceptor CCR532 and inhibition of the
induction of autophagy.33 Rapamycin’s demonstrated bioactivity against a wide variety of highimpact diseases and disorders is convincing evidence that tetrahydropyranyl ketide-containing
natural products are of value to the world.
These natural products are a small selection of biologically active tetrahydropyranylcontaining synthetic targents that attract interest. Not only are these tetrahydropyranyl ketides
and derivatives interesting synthetic targets, but they also are prepared for use in the medical
field. Our interest in these functional groups stems from the desire to showcase the nucleophilic
nature

of

neutral

exocyclic

enol

ethers.

The

approach

focuses

on

utilizing

2-

methylenetetrahydropyrans (2) as synthetic precursors (Scheme 1.2). The combination of these
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exocyclic enol ethers with aldehydes under Lewis acid conditions yields tetrahydropyran 1. This
approach provides a highly convergent synthetic approach toward these tetrahydropyranyl
moieties. We expect a broad application of our methodology to synthetic organic chemistry
based on the varied interest in synthesizing tetrahydropyranyl ketide subunits.
Scheme 1.2
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Exocyclic enol ethers have been underutilized in synthetic organic transformations,
especially as nucleophiles. The limited study of these exocyclic enol ether substrates is possibly
due to the tendency of these systems to undergo isomerization and hydrolysis in the presence of
trace acid or heat.34 These substrates, however, can be manufactured and successfully applied in
organic transformations. In fact the manufacture and use of these substrates has sparked some
interest in the field and has lead to the publication of two review articles.35 The synthesis and
subsequent chemistry of exocyclic enol ethers is discussed herein.
1.3 Synthesis of Exocyclic Enol Ethers
The synthesis of 2-methylene tetrahydropyrans has been achieved using several different
strategies: two-step addition/elimination processes, cyclization of alkynyl alcohols, and direct
methylenation of the corresponding lactone. In all cases their synthesis is not trivial. The
synthesis and subsequent chemistry of exocyclic enol ethers is complicated by their possible
hydrolysis (Scheme 1.3),36 and the propensity of these systems to undergo isomerization to the
Scheme 1.3
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endocyclic isomer, dihydropyran 14, in the presence of trace acid or excessive heat (Scheme
1.4).37

Use of appropriate reaction conditions and proper handling, however, makes these

moieties accessible through a number of reactions.
Scheme 1.4
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2-Methylenetetrahydropyran 2 can isomerize to dihydropyran 14 with trace acid or heat
because the later heterocycle is stabilized by three factors: increased hyperconjugative effects,38
decreased steric repulsions,39 and increases in favorable orbital overlap between the ring oxygen
and pi electrons.40 The transition from exocyclic enol ether 2 to endocyclic enol ether 14
involves an increase in olefin substitution. The increase in substitution is associated with greater
hyperconjugative effects, which stabilize the olefin through delocalization of alkyl bonding
electrons with the double bond pi electrons.41

Isomerization studies of the corresponding

carbocycles, however, indicates that the stability of endocyclic over exocyclic olefins involves
more than just hyperconjugative effects.
The heats of hydrogenation for ethylidenecyclohexane (15) and ethyl cyclohexenes (16)
were compared (Figure 1.2).42

In this system the exo and endo olefins possess similar

conjugative effects due to equivalent substitution, but an energy gap between the isomers still
exists, favoring the endocyclic double bond. The energy difference between isomers 15 and 16
is 1.2 Kcal/mol, favoring the endocyclic olefin, as opposed to 2.4 Kcal/mol for the corresponding
methylene/methyl derivatives (17 and 18) where the degree of hyperconjugation differs. The
energy values for the carbocycles can be related to the corresponding heterocyclic olefins 2 and
14. In fact studies have shown exocyclic enol ether 2 is stabilized (4.3 kJ/mol) when a methyl

8

group

is

attached

to

the

exocyclic

olefin

like

the

stabilization

seen

for

(Z)-

ethylidenetetrahydropyran.40 Nonetheless, an energy difference still exists between isomers 15
and 16 and indicates that stabilizing effects beyond hyperconjugation are responsible for
thermodynamically-favored endocyclic enol ether formation.
Figure 1.2

15

16

18

17

Steric factors also contribute to energy differences between exo and endo isomers.
Methylenecyclohexane 17 experiences steric repulsion between equatorial hydrogens (Hb and
Hd) and hydrogens Ha and Hc of the exocyclic methylene unit respectively (Figure 1.3).43 These
non-bonding interactions are not present in the endocyclic system 18.

Between hyperconjug

Figure 1.3
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-ative effects and steric repulsions there exists an enthalpy difference of 8.7 kJ/mol between
isomers 17 and 18, with 18 existing as the lower energy isomer. Alternatively, the energy
difference between corresponding enol ethers 2 and 14 was calculated to be 15.1-16.8 kJ/mol.40
By subtracting the calculated hyperconjugative effects observed in the tetrahydropyranyl system
(4.3 kJ/mol)40 a large energy difference is still observed, greater than that of the carbocyclic
system.
The difference in energy between the two systems cannot be based solely on non-bonding
repulsions. In fact the heterocyclic system should have less steric repulsion between hydrogens

9

because a ring methylene group is replaced by an oxygen atom (Figure 1.4). With one less steric
effect, the energy difference between the two heterocyclic isomers should be less than that
between the carbocycles. However this is not observed, indicating that another factor contributes
to dihydropyran 14’s stability over exo enol ether 2.
Figure 1.4
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The third contributing factor towards endocyclic stability is the increased orbital overlap
between the ring oxygen lone pairs and the olefin pi electrons.40 If the ring oxygen is sp3
hybridized, endo enol ether 14 can orient the oxygen lone pairs so that they fully overlap with the
double bond’s pi electrons (Figure 1.5). The steric arrangement of oxygen lone pairs and pi
Figure 1.5

O
Me

O

14

2

electrons yields an enol ether conformation that is analogous to the most stable methyl vinyl
ether conformation. This orientation of orbitals causes endo enol ether 14 to have low energy
because of the increased degree of resonance stabilization that can occur. Exo enol ether 2,
however, is forced to hold one of the lone pair of electrons equatorial and out of plane with the
olefin’s pi electrons (Figure 1.5). This steric arrangement does not result in an enol ether
conformation with maximum orbital overlap, and hence lower resonance stabilization results.
Isomerization is thermodynamically favored in exo enol ether 2. The isomerization is
also kinetically driven by formation of the oxonium cation intermediate. The oxonium ion
10

intermediate 19 is more readily formed than the less stable carbocation intermediate 20 of the
analogous all carbon system (Scheme 1.5).40 Because exo enol ethers are prone to isomerization
and hydrolysis, conditions employed toward their manufacture or subsequent chemistry must be
carried out carefully without protic acids. However, exocyclic enol ether synthesis is routinely
performed via elimination, cyclization or direct olefination.
Scheme 1.5
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Synthesis of Exocyclic Enol Ethers via Elimination
One of the most traditional routes for synthesizing exocyclic enol ethers involves the
elimination of a leaving group, typically a halide, sulfonate,44 or selenoxide,45 (Scheme 1.6).
Scheme 1.6
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21
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Leaving group installation occurs at the exocyclic methylene position, adjacent to the
anomeric center.

A number of elimination conditions have proven successful in this

transformation, however elimination can be accompanied with the formation of water and
isomerization to the endocyclic enol ether 14.46 Use of elimination conditions in exocyclic enol
ether formation is advantageous compared to other techniques in that often the reagents used are
relatively inexpensive.
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Commonly, thionyl chloride is used to prepare tetrahydropyranyl chloride 3 from 2(hydroxymethyl) tetrahydropyran 22 (Scheme 1.7). Chloride 3 is transformed to desired exo
Scheme 1.7
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enol ether 2 through elimination using KOH.47 Similar reactions, involving the elimination of a
methylene halide at the anomeric position of a tetrahydropyran have been successfully performed
through application of the following common bases: tBuOK48, NaOH,49 KOH,50 NaH,51
NaOMe,52 DBU,53 and K2CO3.54 Silver fluoride has also facilitated elimination in a number of
these systems.55
Exo enol ethers have also been synthesized through base-induced elimination of
mesylates (Scheme 1.8).44 Mesylate 23 was formed via the corresponding primary alcohol.
Addition of the sulfonate group aids in activating this group towards elimination. Subjection of
mesylate 23 to potassium tert-butoxide gives rise to the exocyclic enol ether 24 in good yield.
Scheme 1.8
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Phenyl selenides can be transformed into exocyclic enol ethers through oxidation and
subsequent elimination of the selenoxide.

This reaction is not as common as the related

elimination of halogens because it involves formation of selenium byproducts and involves more
synthetic steps. Enol ether 27 has been synthesized for use in the total synthesis of bioactive
alkaloid (+)-K252a.45
12

Intermediate enol ether 27 was synthesized from iodide 25 in three steps (Scheme 1.9).
Initial attempts and dehydroiodination failed to yield the desired enol ether, instead
Scheme 1.9
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resulting in an unwanted byproduct. Therefore a second route was employed for conversion of
iodide 25 to the exo enol ether 27. Iodide 25 was converted to phenyl selenide 26 with diphenyl
selenide and sodium borohydride.56 Selenide 26 was subsequently oxidized to the selenoxide,
which was directly subjected to heat-induced elimination conditions.57

Exo enol ether 27

resulted without byproduct formation.
Epoxy-2-methylenetetrahydrofurans 29 have been effectively synthesized from
corresponding glycals 28 in a one-pot synthesis (Scheme 1.10).58 First dihydrofuran 28 was
subjected to bromination. Basic conditions effect concurrent epoxide formation, and elimination
to produce epoxide target 29. This exo enol ether could subsequently be used as an electrophile,
and produced alcohol 30 after palladium catalyzed (20 mol %) addition of dimethyl malonate.
Scheme 1.10
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Exocyclic enol ethers have been selectively formed from anomeric bromides.
Bromoketose 31 was converted to the corresponding exocyclic enol ether by modified FisherZanch conditions (Scheme 1.11).59 Bromide 31 was reductively eliminated with zinc dust and
Scheme 1.11
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N-methyl-imidazole (MIM) to provide enol ether 33 in 79% yield along with 11% of the
endocyclic isomer. Exocyclic enol ether 32 predominates because the terminal hydrogens (Ha)
are more accessible towards elimination than the secondary cyclic proton (Hb). The kinetic
conditions of this reaction favor the exo enol ether formation and little isomerization occurs.
Alternatively, the use of Zn/Cu and acetic acid on a similar substrate favored endo product 34
under thermodynamic conditions (Scheme 1.12).
Scheme 1.12

The Ramberg-Backlund rearrangement has been used effectively to form exocyclic enol
ethers from sulfones (Scheme 1.13).60 Methylsulfone 35 can be subjected to either standard
Scheme 1.13
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Meyer conditions61 or milder Chan conditions62 to provide enol ether 36. In both cases halogen
transfer is followed by deprotonation. The carbanion that results arranges into an unstable
thiirane dioxide that decomposes through elimination of sulfur dioxide (Scheme 1.14). The same
conditions have been applied to enantiopure sulfones bearing longer carbon chains to yield
substituted enol ethers with some E:Z selectivity.60a
Scheme 1.14

Synthesis of Exocyclic Enol Ethers via Intramolecular Cyclization
Exocyclic enol ethers have been synthesized via intramolecular cyclization of alkynyl
alcohols, alkynyl carboxylic acids, vinyl halides, and hydroxy alkenes via metal and lanthanide
catalysts. This technique involves both cyclization and the formation of an exo double bond in
one step. A number of elements have been utilized for these cyclization reactions including
catalysts containing mercury, silver, palladium, copper, gold, rhodium, and various lanthanides.
The cyclizations prove to be useful methods for exo enol ether synthesis, especially from linear
precursors.
Alkynyl carboxylic acids and alcohols were first cyclized through the use of mercury
catalysts.63

Katzenellenbogen created simple and substituted exocyclic enol ether lactones 38

and 40 and halo enol ether lactones 41 via corresponding acetylenic acids 37, 39, and 41 using
catalytic Hg(OTFA)2 (Scheme 1.15).64 Use of mercury acetate in the same reaction was less
effective, resulting in lower yields and longer reaction times. The lower yield observed for the
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reaction involving carboxylic acid 41 is most likely due to a lack of positive charge stabilization
at the  carbon. Halogenated acetylenic acids experience inductive destabilization of the
intermediate cation created after mercury addition. Additionally, dehalogenation accompanies
the reaction which substantially lowered yield.
Scheme 1.15
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Schwartz demonstrated the manufacture of exocyclic enol ethers though mercury
activation (Scheme 1.16).65

A variety of mercury species effected cyclization including HgCl2,

Hg(OAc)2, and Hg(OCOCF3)2 although mercury acetate provided the best yields. Enol ether 43
Scheme 1.16
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was created from the cyclization of alkynyl alcohol 44. Interception of the organomercury
intermediate by NBS yielded bromo enol ether 45 from alcohol 44. Similarly, Villemin utilized
HgO and BF3Et2O to transform internal alkynes into substituted enol ethers.66
The cyclization of alkynyl alcohols and acids under silver catalysis has received little
study. Silver carbonate (10 mol %) has induced cyclization of both acetylenic alcohol 46 and
acids 48 and 50 to the corresponding exocyclic enol ethers 47, 49, and 51 (Scheme 1.17).67 The
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reactions involving terminal alkynes 46 and 47 reached near quanitative yields of the desired
products. Cyclization of acid 50 was less effective and resulted in a 1:1 mixture of E:Z isomers.
Silver oxide and silver acetate also facilitated the conversion of acetylenic alcohol 46 to enol
ether 47, albeit in lower yields and over a longer period of time (80%, 40 min and 80%, 30 min
respectively as compared to 98%, 15 min for silver carbonate).
Scheme 1.17
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Cyclizations involving copper catalysis have also been studied.

Vinyl bromides were

coupled, intramolecularly, to alcohols using copper iodide to form 6, 5, and 4-membered
exocyclic enol ethers (Scheme 1.18).68 Hexene 52 was cyclized to 2- methylenetetrahydropyran
Scheme 1.18
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53 in modest yields. 2-Methylenetetrahydrofuran 55 was formed from alkenyl bromide 54, and
even strained four-membered ring 57 was successfully manufactured from butene 56. In fact the
four-membered exo enol ethers were created preferentially (Scheme 1.19).
Scheme 1.19
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Cyclization to form four-membered exocyclic enol ethers was preferred over formation
of the six and five-membered rings.

All of the ring closure reactions are permissible by

Baldwin’s rules,69 however, the 4-exo-trig cyclization is sterically favored.

This preferred

cyclization involves a 5-membered transition state that is thermodynamically favored and more
sterically attainable than either the 5-exo-trig or 6-exo-trig cyclizations. If a palladium catalyst
(Pd(OAc)2/BINAP) is used as a catalyst in place of copper iodide, formation of the 5-exo
products was preferred over the 4-exo products. Thus, tetrahydropyran 58 and tetrahydrofuran
61 were alternatively formed from dibromodienes 59 and 62 respectively. A Pd(0) 5-membered
transition state is not sterically preferred in these reactions because Pd(0) is much larger than
Cu(I), which effects the transition state geometry.
Copper iodide has also induced formation of enol lactones from carboxylic acids.70 Two
methods were used to form the enol lactones: cyclization of bromoenoic acids and
cycloisomerizations of alkynoic acids. The first method utilizes copper iodide as a crosscoupling catalyst in a modified Ullmann coupling.

Best yields were obtained using a N,N’-

dimethylcyclohexane-1,2-diamine (DMCHDA) ligand. Both 6-exo (65) and 5-exo (67) products
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were synthesized in good yields (Scheme 1.20). 4-Exo products like 69 were not isolated, but
instead provided ketone 71. Presumably the strained enol lactone undergoes ring-opening and
subsequent decarboxylation, leading instead to the isolation of ketone 71.
Application of the modified Ullman conditions to alkynoic acids provided enol lactones
in good yields without any further optimization. Pent-4-ynoic (72) and hex-5-ynoic (73) acids
were successfully cyclized to enol lactones 67 and 74. Similarly, Mindt and Schibli discovered
that amine-containing alkynoic acids like 75 were capable of cycloisomerization to enol lactones
76 using CuBr in aqueous media (Scheme 1.21).71
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Gold catalysts have recently received attention for their ability to induce alkyne
cyclization reactions. AuCl was used to cyclize acetylenic acids to form exocyclic enol lactones
(Table 1.1).72 5, 6, and 7-membered enol lactones were synthesized. Electrophilic activation of
the alkyne by AuCl facilitates intramolecular cycloaddition of the deprotonated lactone. Acids 48
and 37 were successfully converted to enol lactones
Table 1.1: Gold Catalyzed Cyclization of Acetylenic Acids
10 mol % of AuCl
n

Entry

O
CO2H

10 mol % K2CO3
MeCN, 20oC, 2hr

Acetylenic acid

O
n

Lactone

Yield

O
1

OH
48

O
49

O

O
38

O

O
78

O

96

O
97

2

OH
37
O

3

25

OH
77

49 and 38 in near quantitative yields. The reaction of acetylenic acid 77 with AuCl, alternatively
afforded enol lactone 78 in low yield over a longer period of time (48 h). Nonetheless the exo
products were always preferentially formed instead of endo cyclization products.
Cyclization of diacetylenic alcohols with AuCl and AgBF4 have provided 5-(80) and 6membered (82) exocyclic enol ethers in good yields (Scheme 1.22).73 Because the enol ethers
are sensitive to acidic conditions, the catalyst loading of AgBF4 was kept below that of the gold
catalyst.

The gold catalyst coordinates to the alkyne, forming

metallacyclopropene 84.

Intramolecular attack of the propene by the alcohol yields a vinyl gold intermediate that is
protodeaurated to form enol ether 86 (Scheme 1.23).
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Rhodium metal has facilitated cyclization of hydroxy alkene 88 to exo enol ether 90
(Scheme 1.24).74 This example differs from others because an olefin is acting as the cyclic
precursor. Coordination of alkene 88 with rhodium complex 87 yielded rhodium alkoxide 89.
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The coordination results in the loss of the silylamide ligand. After isolation of intermediate 89,
excess triethylphosphine is added and facilitates oxidative insertion of the hydroxyl group into
the double bond. Insertion is followed by reductive elimination of the rhodium catalyst to yield
the 2-methylenetetrahydrofuran 90.
Lanthanide catalysis has been used to transform alkynyl alcohols into enol ethers.
Exocyclic enol ethers 92 and 2 were formed from the cyclization of alcohols 91 and 93 in the
presence of lanthanide amide complexes {Ln[N(SiMe3)2]3, Ln = La, Nd, Sm, Y, and Lu (Scheme
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1.25).75 Quantitative yields of enol ethers 92 and 2 were obtained by 1H NMR analysis. The
mechanism of the reaction involves slow alkyne insertion followed by rapid substrate
protonolysis.
Scheme 1.25
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Synthesis of Exocyclic Enol Ethers via Direct Methylenation
The most direct method for exo enol ether synthesis involves the direct methylenation of
the corresponding lactones with phosphorus-based or organometallic reagents. Typically Wittigtype reactions are not effective at this transformation, although trisubstituted exocyclic enol
ethers and dihaloolefins76 can be prepared in this way.

Lactones 94 react with stabilized

phosphoranes to form trisubstituted, conjugated products 95 and 96 (Scheme 1.26).77 Elevated
temperatures or microwave irradiation was required to facilitate these reactions and little to no
Z/E selectivity was observed.
Generally, methylene enol ethers 2 are better prepared using organometallic reagents.
The Tebbe78 and Petasis79 reagents are most commonly used in these organometallic olefination
Scheme 1.26
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processes.

Limited examples also make use of zinc/titanium(I) chloride mixtures,80

triethylphosphine-based

titanium

reagents,81

and

titanium(IV)

chloride/magnesium

combinations.82 The advantage of using these titanium-based reagents is that aqueous work-ups
are not required, which is important in avoiding hydrolysis and possible isomerization in these
labile enol ethers.
The first use of organotitanium complexes was reported using the Tebbe reagent (98).83
Initially the Tebbe reagent was applied to esters as a new method for synthesizing enol ethers
from esters.78 A protocol had not previously been devised for the direct olefination of esters.
Thereafter the Tebbe reagent was applied toward 5 and 6-membered exocyclic enol ether
synthesis (Scheme 1.27).84 Wilcox manufactured exocyclic enol ethers for use in C-glycoside
synthesis. Wilcox used Tebbe’s reagent (98) to convert lactone 97 into exocyclic enol ether 99
in high yield, thus validating use of the Tebbe reagent towards the synthesis of these moieties.
Scheme 1.27
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Use of Tebbe reagent towards the synthesis of enol ether 101 however, resulted in
unwanted, hydrolyzed products. Application of Tebbe reagent to bicyclic -lactone 100 yielded
unexpected products 102 and 103 (Scheme 1.28).85 Here, initial formation of the enol ether 101
was quickly followed by hydrolysis to give alcohol 102. Ring-opening of bicycle 102 leads to
ketone 103, which subsequently undergoes a second methylenation to provide biproduct 104.
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The Tebbe reagent has generally been effective toward the synthesis of exo enol ether,
however there are several drawbacks of this method. The Tebbe reagent is relatively unstable
and must be synthesized just prior to use from trimethyl aluminum and titanocene dichloride.
The reagent also contains aluminum resulting in manufacture of aluminum salts after product
synthesis. These aluminum salts can be difficult to remove from the product mixture, resulting
in lower yields.
An alternative protocol for lactone olefination was developed by Petasis. This method
employed the use of dimethyltitanocene (106), which can be easily prepared from
titanocenedichloride (105) and methyllithium in either diethylether or toluene (Scheme 1.29).86
Benefits of using the Petasis reagent over Tebbe’s reagent include a shorter, less expensive
preparation, longer shelf life (when stored as a solution in THF or toluene), enhanced stability,
and a lack of residual aluminum reagents.
Scheme 1.29
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Like Tebbe, the Petasis olefination has been used successfully for the conversion of
aldehydes, ketones, esters, and lactones to their corresponding olefins. Because lactones and
esters are less reactive than ketones or aldehydes, the olefination of these functional groups
occurred over a longer period of time. Petasis discovered that methylenation of lactones and
esters was optimized by using two equivalents of dimethyltitanocene.
A number of different types of lactones are capable of undergoing Petasis olefination.
Examples of 5, 13, and 6-membered lactones that have been converted to exo enol ethers using
the Petasis olefination method are shown in Table 1.2.86 Lactone 107 was converted to exo enol
Table 1.2: Petasis Olefination of Lactones
O

Cp2TiMe2

O
n
Entry

toluene
24h, reflux

O
n
Product

Lactone

Yield

O
O

O

Ph
107

Ph
108

1

41%

O
O

O

2

70%

110

109
O

O

O

3

80%
112

111
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ether 108 in moderate yield while the 13-membered lactone 109 provided enol ether 110 in fairly
good yield. Petasis olefination was also effective in converting aromatic-containing lactone,
dihydrocoumarin 111, to exocyclic enol ether 112.
The mechanism of the Petasis reaction was first proposed by Petasis.87 Petasis proposed
that olefination occurred through a mechanism involving acyclic intermediates (Scheme 1.30). It
was theorized that dimethyl titanocene 106 complexes with the ester carbonyl. Complexation is
Scheme 1.30
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followed by migratory insertion of the ester into the titanium complex, which provides acyclic
intermediate 113. This insertion involves methyl transfer from dimethyl titanocene 106 to the
ester.

Reductive elimination of titanium complex 113 results in the loss of methane and

production of enol ether 114 and titanoceneoxide 115. By this mechanism, complexation is
viewed to be the rate-determining step. Therefore the reaction kinetics should be second order
and based on both the concentration of ethyl acetate and titanocene dichloride.
Petasis based his mechanistic hypothesis on his deuterium labeling studies.
Hydrogen/deuterium scrambling occurred both in reactions of protio dodecyl acetate with
Cp2Ti(CD3)2 and dodecyl acetate-d3 with Cp2Ti(CH3)2.

In both cases, Petasis’s proposed

mechanism accounts for deuterium incorporation into the product or methane biproduct
respectively. In either deuterium experiment, once methyl transfer is complete and intermediary
complex 113 is formed, there is a 50% chance that the deuterated methyl group is transferred to
the enol ether product or methane biproduct.
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Hughes88 and Eberlin89 have each performed additional experiments that refute Petasis’s
proposed olefination mechanism.

Hughes proposed that enol ether 114 was formed through

titanium carbene intermediate 116 (Scheme 1.31). Reductive elimination of methane from
dimethyl titanocene 106 results in formation of titanium carbene species 116. Addition of an
ester to carbene 116 yields oxatitanocycle 117.

Subsequent retrocyclization of

cyclic

intermediate 117 provides enol ether 114 and titanoceneoxide 115. Research performed by
Eberlin supported the Hughes mechanism by detecting protonated versions of oxatitanacyclo 117
using tandem mass spectrometry.90
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Both isotopic labeling studies and kinetic experiments provided evidence for the revised
Petasis mechanism. The reaction of ethyl acetate,

13

C labeled at the C2 position, with dimethyl

titanocene yielded products that did not incorporate

13

C at the methylene carbon.89

This

evidence supports the Hughes’ methylenation mechanism. Via the Petasis mechanism there
should be a fifty percent incorporation of the labeled carbon in the newly formed olefin. Both
methyl groups of intermediate 113 are equivalent and are equally likely to form the methylene
carbon of enol ether 114.

The Hughes’ proposed mechanism, alternatively, should not

incorporate 13C into the methylene position of enol ether 114 because the labeled carbon is never
part of oxatitanocycle intermediate 117. The

13

C labeling study is a more reliable method for

mechanistic study than the deuterium labeling used by Petasis because carbon labeling avoids
potential deuterium/hydrogen exchanges with cyclopentyl dienyl hydrogens.90
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Furthermore, kinetic studies proved that the reaction is zero order in ethyl acetate,
indicating that ethyl acetate is not involved in the rate-determining step.89 This observation is
consistent with a mechanism involving a carbene intermediate (Scheme 1.31), but again does not
agree with the Petasis mechanism, which involves both dimethyltitanocene and ethyl acetate in
the rate-determining step. For the methyl addition mechanism (Scheme 1.30) the reaction is
expected to be first order both in dimethyltitanocene and the ester. Secondly, if the ratedetermining step of Petasis olefination is independent of the ester, as proposed by Hughes,
reactions of electronically and sterically diverse esters should result in similar reaction rates.
The similarity of olefination reaction rates observed by combining both ethyl acetate and phenyl
methyl ester with dimethyltitanocene verified that esters aren’t involved in the rate-determining
step.
Hughes’ third set of experiments showed a large primary kinetic isotope effects when
Cp2Ti(CD3)2 was used in a reaction with both dodecyl acetate and ethyl acetate. The primary
kinetic isotope effect that is observed indicates loss of a methyl group in the rate-determining
step of the reaction. The carbene olefination mechanism, opposed to the Petasis mechanism,
involves the loss of methane from dimethyltitanocene in the rate-determining step. Only a small
secondary isotope effect would be expected by the Petasis mechanism. Additionally,
observations from this deuterium study did not demonstrate hydrogen/deuterium scrambling,
which is consistent with the 13C isotope studies.
Finally, the regiochemical outcome of the exo enol ether products is inconsistent with the
Petasis mechanism.

In this proposed mechanism titanocene intermediate 119 is formed and

subsequently eliminated (Scheme 1.32). In theory elimination should occur to form the more

28

Scheme 1.32
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stable trisubstituted endocyclic enol ether 120 as a major product. In practice, little endocyclic
enol ether is formed in these reactions, and seems to arise from isomerization of the exocyclic
product. A regiospecific carbene-mediated mechanism is more consistent with this observation.
A third titanium catalyzed protocol for one-step olefination was reported using 1,1dibromoalkanes, zinc, titanium(IV)chloride, and TMEDA (Takai-Lombardo reagent) (Scheme
1.33).80 In this process the catalyst is generated in situ from commercially available starting
Scheme 1.33
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materials, which is a major advantage. This method is useful for the conversion of esters to enol
ethers, but less so for the olefination of lactones. Interestingly ester 122 was converted to enol
ether 123 by Takai-Lombardo olefination, but application of the Tebbe reagent to the same
system was unsuccessful.91 A number of different esters could be converted to enol ethers
through Takai alkylidenation (Table 1.3).80 The reaction provided a mixture of Z-selective
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Table 1.3: Manufacture of E versus Z Isomers with Takai-Lombardo Olefination
O
+
R

R''

TiCl4, TMEDA

R''CHBr2

Zn

OR'

R

124

OR'
125

Entry

R

R'

R''

Yield (%)

Z/E

1

Ph

Me

Me

86

92/8

2

Ph

Me

i-Bu

79

96/4

3

Ph

t-Bu

Me

81

71/29

stereoisomers. The Z-isomer formed preferentially to minimize the steric repulsion between R
and R’ groups n olefin 125. As the size of the R or R’’ groups increase, the selectivity increases,
which is observed when the R’’ group is changed from a methyl to a iso-butyl group (Table 1.3,
entries 1 and 2). The opposite affect occurs when the size of the R’ group is increased. When
R’ is changed from methyl to tert-butyl the Z/E selectivity decreased because a competing steric
repulsion exists between the R’’ and R’ groups, increasing the formation of the E isomer (Table
1.3, entries 1 and 3).
Use of this methodology toward exo enol ether synthesis is complicated by hydroloysis.
Significant amounts of hydrolysis products 128 were formed in addition to the desired,
substituted exocyclic enol ethers 127 (Scheme 1.34).80 The Z/E stereoselectivity of this process
Scheme 1.34
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is similar to that seen for the Takai alkylidenation of esters (Table 5.1). Currently there are no
reports of simple methylenetetrahydropyran preparation using the Takai-Lombardo protocol.
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In a related process, Takeda reported the synthesis of substituted enol ethers from
thioacetals (Scheme 1.35).81 In this olefination process, titanium species 130 was synthesized
from triethyl phosphite and titanocene dichloride.

Complex 130 was combined with

dithioacetals and carbonyl-containing compounds to yield the corresponding olefins.
This methodology proved useful with transforming aldehydes, ketones, esters, and
lactones into olefins and is effective for synthesizing conjugated dienes with modest selectivity
based on steric repulsion, similar to the Takai examples.80 Only the synthesis of tri- (131 and
132) and tetra-substituted (133) exocyclic enol ethers were demonstrated. This process was also
used to prepare geminally disubstituted alkenes 135 from ketone 134. The formation of simple
enol ethers like 2 was not reported in the communication.
Scheme 1.35
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This reaction could proceed though one of two pathways. The first proposed mechanism
(Path A, Scheme 1.36) involves the addition of dithiane 136 to the phosphate-titanium complex,
which is accompanied with sulfur-titanium complex removal, resulting in formation of intermed31

Scheme 1.36
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iate 137. Addition of complex 137 with a carbonyl creates oxatitanocyclobutane intermediate
138. Intermediate 138 undergoes anti 2+2 addition to yield olefin 139 and titanocene oxide. An
alternate proposed pathway (Path B, Scheme 1.36) proceeds through insertion of two equivalents
of the titanium complex into the carbon sulfur bonds of dithiane 136. Addition of this gemdimetallic species to a carbonyl yields intermediate 140, which undergoes elimination to olefin
139.
More recently, a CH2Cl2-Mg-TiCl4-THF system has been devised for the conversion of
esters into their corresponding olefinated products.82 This process involves a dichloromethanederived methylene transfer to an ester through use of a bimetallic complex (Mg-TiCl4).
Although this process has not been thoroughly studied for its use on lactones, dihydrocoumarin
111 was successfully converted to the corresponding exocyclic enol ether 112 by this method
(Scheme 1.37). Initially, only a 40% yield of enol ether 112 was isolated due to unwanted
isomerization. Altering the solvent system from THF to 50% THF and 50% toluene, however,
produced desired product 112 in good yield.
Scheme 1.37
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The synthesis of exo enol ethers is key towards our methodology studies. The synthetic
methods used by our group focus mainly on elimination and titanium-mediated olefination
processes. Elimination is used as one of the methods, because access to the corresponding
precursors is fairly straightforward and works with our synthetic strategy. Petasis olefination is
also applied to a number of lactones, providing exo-enol ethers for the methodology studies.
Petasis olefination is utilized for several reasons: The process can be applied to a wide variety of
lactones without altering reaction kinetics, the methylenating reagent is relatively stable when
properly stored, and the lactone precursors are generally stable intermediates.
1.4 Reactions of 2-Methylenetetrahydropyrans
Although exocyclic enol ethers are portrayed as labile functional groups that are prone to
isomerization and hydrolysis, a wide variety of reactions have been applied to these moieties.
Often these enol ethers act as alkenes in addition reactions, but have been reported in a number
of other bond-forming reactions as well. Exo enol ethers have been repeatedly used as substrates
in rearrangements, pericyclic reactions, radical reactions, and have been used as both
electrophiles and nucleophiles. The carbon-carbon bond forming techniques of these enol ethers
is of special interest to organic chemists, because of the application toward natural product
synthesis. The use of 2-methylenetetrahydropyrans as nucleophiles, especially in carbon-carbon
bond forming processes, has received limited attention. The research focus in our group is to
demonstrate the inherent ability of 2-methylenetetrahydropyrans as nucleophiles in carboncarbon bond forming reactions.
Addition Reactions
Many of the addition reactions of alkenes can be applied to exocyclic enol ethers.
Addition reactions on chiral substrates like exo-glycals can yield stereoselective products due to

33

chiral induction from the substrate. Addition reactions of enol ethers include hydrogenation,
oxidative additions, carbene addition processes, and hydroboration.

The addition of carbenes

and boron to the enol ether are the most meaningful transformations because these processes
facilitate the manufacture of new carbon-carbon bonds.
The addition of hydrogen to exo enol ethers results in formation of the corresponding
tetrahydropyrans. Hydrogenation proceeds stereoselectively from the less hindered face of the 2methylenetetrahydropyran.92

Typical reduction conditions are suitable for exo enol ether

hydrogenation and include the use of palladium,93 rhodium,94 platinum,95 nickel,96 and
enationselective ruthenium binol-derived catalysts.97
Oxidative additions to exo enol ethers include epoxidation and dihydroxylation
processes. Exo enol ether derived epoxides are synthesized using standard conditions (mCPBA98
or dimethyldioxirane99) and can be subsequently subjected to nucleophilic attack, affording the
corresponding alcohols. An intramolecular example of this process involves epoxidation of enol
ether 142 (Scheme 1.38).100 Epoxidation occurs via in situ formation of
Scheme 1.38
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methyl(trifluoromethyl) dioxirane from oxone and 1,1,1-trifluoroacetone to afford epoxide
147.101 Subsequent hydrolysis of oxonium ion 144, resulting from the opening of epoxide 143
yields diol 145.

Concomitant oxonium ion formation and methanol elimination provides
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intermediate 146. Intramolecular attack of the oxonium ion by the primary alcohol provided
bicycle 147.
Metal-mediated dihydroxylations of exo enol ethers have been reported using osmium
and ruthenium metals. Osmylation of exo-glycal 148 yielded epimeric diol 149, which was
isolated as the hemiketal rather than the ring-opened ketone isomer (Scheme 1.39).102 Use of
ruthenium(III) chloride and sodium periodate also provided dihydroxylated products. Under
Scheme 1.39
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these oxidative conditions, enol ether 150 was converted to diol 151.

(Scheme 1.40).103

Addition occurred to the top face of 2-methylenetetrahydropyran 150, opposite to the axial C6
Scheme 1.40
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Cyclization by silica gel chromatography, and DBU-induced

rearrangement afforded bicycle 153, which could be used as a synthetic precursor to zaragozic
acid natural products.
Carbene additions to exocyclic enol ethers are effective methods of carbon-carbon bond
formation. Simmons-Smith conditions,104 addition of dihalocarbenes derived from chloroform or
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bromoform,105 and metal-mediated carbene additions106 all afforded the corresponding
cyclopropanes which were studied for their biological activity or could be carried on to more
complex natural products. Robinson et al. seeked the discovery of new SGLT2 inhibitors that
prevent re-uptake of filtered glucose from pro-urine and therefore aid in the treatment and
prevention of diabetes.105

The researchers made modifications to the glycoside portion of

dapagliflozin, a diabetes drug candidate in phase 3 clinical trials, hoping to discover additional
drug targets. As part of this effort, spirocyclopropyl tetrahydropyran 155 was synthesized from
enol ether 154 under standard Simmons-Smith conditions (Scheme 1.41). Although no yield
Scheme 1.41
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was reported for this step, the biological activity of spirocyclopropane 155 was evaluated.
Spirocyclopropane 155 displayed potent activity against SGLT2 with an IC50 value of 3.0 nM.
In spite of the high bioactivity, the short half-life of this molecule, when applied to live rat
models, prevented further advancement of this molecule as a drug target.
Metal-catalyzed cyclopropanation of exo enol ethers results in formation of spiro 5,6-ring
systems after subsequent modification.

Cyclopropanation of enol ether 142 with ethyl

diazoacetate and catalytic copper afforded cyclopropane 156 as a mixture of 4 diastereomers
(Scheme 1.42).107 Cyclopropane 156 was subsequently converted to 5,6 spiroketal 160 through
reduction, oxidation, and Lewis acid-induced ring enlargement.

LiAlH4 reduction of

cyclopropane 156 led to the corresponding primary alcohol 157. Oxidation of alcohol 157
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Scheme 1.42

yielded aldehyde 158, which was treated in situ with a Lewis acid catalyst [Yb(OTf)3] to provide
the linear, zwitterionic intermediate 159. Intramolecular addition of the enolate from the less
hindered, top face solely produced spiroketal 160 as the product. This methodology proved to be
an effective way to make various 5,6-spiroketals from exo enol ethers via the formation of new
carbon-carbon bonds.

This study is an important entry towards the manufacture of 5,6-

spiroketals, which are functional groups prevalent in many natural products.
Addition of boron to exocyclic enol ethers is a highly versatile addition process. Not
only can these boron species be oxidized to primary alcohols, but they can also be used as
coupling partners in metal-mediated coupling reactions. Hydroboration and oxidative workup of
enol ether 161 resulted in alcohol 162 (55%) (Scheme 1.43).55 Tetrahydropyranyl alcohol 162
resulted as the major product because boron approached the tetrahydropyranyl double bond from
the opposite face of the adjacent methyl group.
Exocyclic enol ethers are hydroborated and used as coupling partners in Suzuki
coupling.107

This is an effective carbon bond forming process that extends the utility of

exocyclic enol ethers. Enol ethers are readily used to couple fragments together, to make larger,
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more complex molecules. Thus, the hydroboration and subsequent Suzuki coupling of enol
ethers has proven to be a very convergent synthetic process toward natural product synthesis.
Scheme 1.43
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Suzuki-Miyaura cross coupling of an exocyclic enol ether was utilized in the first reported
synthesis of brevisin (Scheme 1.44).108 Hydroboratation of 2-methylenetetrahydropyran 163
with 9-BBN gave the corresponding alkylborane, which was treated with phosphonate 164 in the
presence of catalytic palladium and cesium carbonate in situ to provide tetrahydropyran 165.
Tetrahydropyranyl intermediate 165 was later carried on to form the ABC ring system of
Brevisin.
Scheme 1.44

Suzuki coupling of an enol ether to a vinyl triflate was used as a key step in Nicalou’s
synthesis of the GHIJKLMNO ring domain of maitotoxin (Scheme 1.45).109 Maitotoxin is a very
large secondary metabolite possessing high levels of toxicity.110

Exo enol ether 166 was

hydroborated and subsequently coupled to vinyl triflate 167 under palladium catalysis. Suzukicoupled product 168 was produced, which formed the carbon framework for the GIJ ring system
of maitotoxin.
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Scheme 1.45
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Work towards the manufacture of gambierol has utilized B-alkyl Suzuki coupling of exo
enol ethers in the synthetic approach. Gambierol is a marine polyether toxin isolated from
dinoflagellate Gambierdiscus toxicus.111

This tetrahydropyranyl-containing natural product

demonstrates toxicity against mice with LD50 values of 50 g/kg. Sasaki et al. stereoselectively
synthesized the FGH ring system of this natural product (172), using a Suzuki coupling to obtain
the required carbon framework (Scheme 1.46).112

Hydroboration of enol ether 169 was
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followed by palladium catalyzed addition of enol phosphonate 170 to afford cross coupledproduct 171 in excellent yield. Thus, the Suzuki coupling of fragments 169 and 170 successfully
formed the cyclization precursor 172 of the FGH ring system of gambierol.
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Rearrangements
Enol ethers have been used in several types of rearrangement reactions. Although the
reported rearrangements do not directly create new carbon-carbon bonds or couple large carbon
fragments together, they serve as methods to make alternative functional groups from 2methylenetetrahydropyrans.

Rearrangements of 2-methylenetetrahydropyrans are used to

synthesize functionalized cyclohexanones, cyclohexenes, tetrahydropyrans, and tetrahydrofurans
through Ferrier carbocyclic rearrangements, metal catalyzed rearrangement, olefin metathesis,
and hydrolysis/rearrangement reactions.
Ferrier carbocyclic rearrangement of exocyclic enol ethers provides substituted
cyclohexenones. Ferrier rearrangement involves the coordination of the exo enol ether to a
mercury salt, which is followed by ring-opening and ring-closing processes to afford -ketols. A
proposed mechanism for this reaction is shown in Scheme 1.47. Hemiacetal 174 is formed
through hydoxymercuration of olefin 173. Loss of methanol is followed by intramolecular
cyclization of diketone intermediate 176 to provide -hydroxy ketone 177.
Scheme 1.47
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This process was first used toward the manufacture of cyclitols from carbohydrates
(Scheme 1.48).113 Treatment of enol ether 142 with mercury(II) chloride in aqueous acetone
afforded cyclohexanone 178 as a mixture of epimeric diastereomers (3:1) in 80% yield. This
reaction yielded low diastereoselective formation of the new alcohol chiral center. Elimination
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of the -hydroxyl group to form the corresponding enone avoids the formation of diastereomeric
mixtures while maintaining a reactive functionality.
Scheme 1.48
OBn
BnO

OBn
OBn

HgCl2, acetone, H2O

BnO

OBn

80%
MeO

O

HO

O
dr 3:1
178

142

Ferrier carbocyclization followed by -elimination is used towards the manufacture of

,-unsaturated cyclohexanones. The transformation of exo enol ethers to enones has been
utilized toward the manufacture of bioactive substrates such as PIMs (a glycolipid component of
cell walls)114 and aminoglycosides (a large family of molecules with antibiotic activities)115 as
well as bioactive natural products. A formal synthesis of paniculide A, a highly oxygenated
bisabolene that was isolated from the culture broth of Andrographis paniculata,116 involves the
formation of enone 180 from exo enol ether 179. After Ferrier carbocyclion, -elimination of
the intermediary alcohol afforded enone 180, which was further manipulated to provide a formal
synthesis of paniculide A (181) (Scheme 1.49).117
Ferrier rearrangement has also been used towards a formal synthesis of (-)-morphine, a wellknown pharmaceutical alkaloid isolated from opium poppy (Scheme 1.50).118 Mercury-metal
catalyzed cyclization of enol ether 182 followed by mesylation
Scheme 1.49
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Scheme 1.50
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of the newly formed -hydroxy alcohol yielded cyclohexenone 183. Enone 183 provided (-)dihydroisocodeine (184), a known morphine precursor,119 after subsequent synthetic
manipulations.
Substituted enol ethers have undergone palladium-catalyzed rearrangements.

5-

membered exocyclic enol ethers, stabilized by pendant electron-withdrawing groups were
converted to cyclopentanone products.120 The reaction involves coordination of the palladium
catalyst to the pendant vinyl group of stabilized enol ether 185. Intramolecular, back-side attack
of the -allyl palladium species by the enolate provides the expected stereochemistry at the C3
position of cyclopentanone 187 (Scheme 1.51).
Ionization of 185b is favored over the ionization of 185a due to unfavorable eclipsing
interactions associated with complex 186a. Therefore ionization of 185b leads to the more
favorable intermediate 186b with an inversion of the stereochemistry. At this point palladiumallyl complex 186b can either undergo bond rotations to form compounds 188, 189, and 190 via
complex 186c or ring closure to afford cyclopentanone 187. Since enolate addition to the
palladium complex is faster than syn-anti conversions, production of cyclopentanone 187
predominates.
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More recently, 6-membered enol ethers have been employed in this reaction (Scheme
1.52).121 Cyclohexanone 193 was prepared stereoselectively from exocyclic enol ethers using
palladium acetate (10 mol%) and tributyl phosphine via a [1,3]-O-to-C rearrangement. The
observed trans-relative stereochemistry arises from chair transition state 192 where the phenyl
and allyl groups are held in equatorial positions.
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Scheme 1.52
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Exocyclic enol ethers containing electron-withdrawing groups at the C6 position have
been cyclized using Lewis acids to form hydroxy-cyclohexanes. Alcohols 196 and 197 are
formed as a diastereomeric mixture from enol ether 194 (Scheme 1.53).122 This reaction occurs
Scheme 1.53
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by transposition of the exocyclic carbon atom with the enol ether oxygen followed by hydride
delivery to afford the cyclohexanyl products with retention of stereochemistry. By a similar
process, enol ethers can also be converted to linear alcohols. Enol ether 198 was
hydroaluminated and subsequently eliminated to yield alcohol 199 using tri-isobutyl aluminum
(Scheme 1.54).123
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Ring closing metathesis of exocyclic enol ethers using Grubbs first generation catalyst
yields fused ether ring systems like 201 from corresponding dienes 200 (Scheme 1.55).124 This
methodology, is very effective at synthesizing 7 and 8-membered rings, which otherwise are
difficult to access.
Scheme 1.55
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Exo enol ethers containing C3 alcohols can undergo rearrangement to the corresponding
keto-tetrahydrofurans (Scheme 1.56).125 Enol ether 202, after subjection to acidic conditions,
produced furanose 203 as an anomeric mixture via hydrolysis and subsequent rearrangement.
This ring contraction was effective in manufacturing a precursor toward the synthesis of
hygromycin A (204).
Scheme 1.56
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Pericyclic Reactions
Exocyclic enol ethers are used as partners in pericyclic reactions such as the Hetero-Diels
Alder, Povarov, [3+2], and 1,3 dipolar cycloadditions. These carbon bond-forming processes are
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principally used toward spiroketal synthesis. Claisen rearrangements of exo enol ethers have
also been reported and are effective methods toward the manufacture of dihydropyrans and
cyclooctanes.
The Inverse electron demand Hetero-Diels-Alder reaction of exo enol ethers is effective
for the production of spirocyclic tetrahydropyrans. These subunits are present in a variety of
polyether antibiotics and their analogs.

Ireland first described the use of 2-methylene

tetrahydropyrans 2 and tetrahydrofurans 92 as dienophile substrates.126 The cycloaddition of
these enol ethers with acrolein 205 yielded the corresponding spiroketals 206 and 207 in good
yields (Scheme 1.57).

Use of heat or Lewis acid catalysis in this reaction rapidly led to

isomerization of the exo enol ethers to the endocyclic enol ethers, however, reaction at room
temperature over a number of days with 1 mol % hydroquinone yielded the desired spiroketals
206 and 207 in large scale.

Oxidative ring contraction of spiroketal 207 and successive

manipulations yielded racemic chalcogran 208, the principal aggregation pharmone of the L.
chalcographus beetle, a known pest of the Norway spruce.
Scheme 1.57
O
+

H

O
2

rt, 4-6 days

205
O

O
92

O

72%

+

O
206

rt, 4-6 days
H

O

82%

205

O

207

O

O
208

The Hetero-Diels-Alder reaction of exo enol ethers has been well utilized in the literature
because it is an effective method for stereoselective spiroketal synthesis that tolerates a variety of
different dienes, including those that are hindered. Palasz demonstrated that many hindered
dienes work well in this reaction, and the application of diene 209 to the Diels-Alder reaction
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proved interesting because two spiro centers could be stereoselectively made in one step
(Scheme 1.58).127 One diastereomer was isolated in 89% yield, however the stereochemistry of
that product could not be identified. Fused uracil-spirotetrahydropyranyl products like 210 were
manufactured because they are reported to have a wide range of biological properties and are
otherwise challenging to synthesize.
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Hetero-Diels-Alder reactions have also been performed on sulfur-containing dienes. The
reaction of exo-glycal 36 with diketone 212 resulted in spiroketals 213 and 214 as a 2.5 to 1
mixture of diastereomers (Scheme 1.59).128 Pyridine was used to form the intermediate 212 from
diketone 211 in-situ. This diene was then reacted with exo enol ether 36 to yield the inverseelectron demand hetero-Diels Alder products.
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Exo enol ethers can also be used as partners in the Povarov reaction, which is a [4+2]
cycloaddition between an aromatic Schiff base and an activated olefin.129 The Pavarov reaction
of exo enol ethers was used to synthesize sugar-quinoline adducts that could potentially have
high biological activity. The sugar portion could facilitate drug delivery and aid in DNA
intercalation of the quinoline ring. The Pararov reaction between exo-glycal 36 and imine 215,
under Lewis acid conditions, provided spiro-intermediate 216 (Scheme 1.60).130 Subsequent
oxidation with manganese oxide resulted in cleavage of the spiro-ring and forms quinoline 217.
This process was driven by the aromatization of the tetrahydroquinoline portion of intermediate
216.
Synthetic efforts towards the rubromycins was performed using a [3+2] cycloaddition of
exo enol ethers and a -hydroxy enone. The rubromycins represent an interesting class of
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bioactive spiroketal natural products that are found to inhibit Gram-positive bacteria.131 The
Pettus group employed the cyclization of dihydrocoumarin-derived enol ether 112 and hydroxy enone 218 towards a model system study of the rubromycins (Scheme 1.61).132 A
zwitterion is formed from enone 218, which successively adds to enol ether 112 via a [3+2]
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cycloaddition to provide spiroketal 219 with no mention of diastereoselectivity.

Further

elaboration of spiroketal 219 provided naphthoquinone 220, which completed the model-system
study for -rubromycin (221).
Scheme 1.61
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The [1,3]-dipolar cycloaddition is a synthetically useful method toward carbon-carbon
bond formation. This cycloaddition has been applied to exo enol ethers toward the formation of
spiroisoxazolines, which are biologically active substrates. Spiroisoxazolines 223 were made
from exo-glycal 222 through a [1,3]-dipolar cycloaddition with arylnitrideoxides (Table 1.4).133
Table 1.4: [1,3]-Dipolar Cycloaddition of Enol Ether 222
OAc

OAc
AcO
AcO

OAc

Ar(Cl)C NOH
Et3N, CH2Cl2

O
222

AcO
AcO

OH
OAc

O

O N
223

NaOMe, MeOH

HO
HO

Ar

OH
O

O N
224

Entry

Ar

Yield of 224 (%)

Yield of 225 (%)

Ki of 225 (M)

1

p-MeO-Ph

83

98

6.6

2

p-Me-Ph

95

93

7.9

3

Ph

99

97

19.6

4

p-NO2-Ph

94

99

92.5
`

5

2-Naphthyl

94

78

1.7
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Ar

The anomerically stabilized sprioisoxazoline isomers were exclusively produced in
excellent yields. Deprotection of the alcohols yielded triols 224, which were subsequently
evaluated for their biological activity against glycogen phosphorylase. Inhibitors of glycogen
phosphorylase are possible drug candidates toward glycemic control in type-2 diabetes. The
biological activity was measured by Ki values, and the 2-naphthyl derivative was found to have
very high inhibitory effects toward glycogen phosphorylase, making it a likely drug candidate
(entry 5, Table 1.4).
The [1,3] dipolar cycloaddition of bis-arylnitride oxides have also been reported to form
bi-directional bis-spiroketal adducts for use as possible ligands in enantioselective catalyzed
reactions (Scheme 1.62).134

Two equivalents of enol ether 222 were combined with bis-

arylnitrile oxide 225 to provide bis-isoxazoline 226 as one diastereomer. A pyridine version of
Scheme 1.62
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the bis-isoxazoline was successfully synthesized as well, in 71% yield. Application of bisisoxazoline 226 as a ligand in the Cu(I)-catalyzed imine alkynylation reaction of imine 227 with
phenyl acetylene 228 provided the desired alkyne products, but with poor enantioselectivity
(Scheme 1.63).
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Claisen rearrangements have been performed on olefin-containing enol ethers to form
cyclooctenes (Scheme 1.64). This [3,3] sigmatropic rearrangement proceeds under Lewis acid
Scheme 1.64
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catalysis,135 upon heating,136 or by microwave irradation.137 This method was used to form the 78 fused ring system in micrandilactone A when ring-closing metathesis proved unsuccessful.
Lewis acid addition to exo enol ether 230 yielded 7-8 ring system 232 as a single diastereomer
after undergoing chair-like transition state 231. Subsequent oxidation of alcohol 232 yielded
ketone 233 in 71% over two steps.
Claisen-Ireland rearrangements have been carried out using sugar derivatives (Scheme
1.65).138 Exocyclic enol ether 234 was transformed under basic conditions to enol ether 235 with
little diastereoselectivity. This served as a method for the construction of -C-glycosides.
Scheme 1.65

Radical Reactions
Exocyclic enol ethers can react with radicals to give sulfides and create carbon-carbon
bonds in a synthetically convergent manner. Typically, radical donors 237 react with an enol
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ether 236 to form anomeric radicals 238. The anomeric radical will perform an axial capture of a
hydrogen to yield diastereoselective tetrahydropyranyl products at that center (Scheme 1.66).139
The stereochemical outcome of the newly formed radical donor stereocenter is not always as
straightforward.
Scheme 1.66

The coupling of exocyclic enol ethers to thiols has been reported using a radical process.
This chemistry was used to manufacture carbohydrate mimics for biological studies and leads for
new therapeutics. Exo enol ethers were coupled to anomeric sugar thiols 241 (Scheme 1.67).140
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This light-induced radical reaction, utilizing 2,2-dimethoxy-2-phenylacetophenone (242) as
photoinitiator,

provided

1,6-linked

S-disaccharide

243

in

good

yield

with

high

diastereoselectivity at the newly formed anomeric carbon. Addition of thiol 241 to exo-glycal
240 resulted in formation of radical intermediate 243. Addition of hydrogen from the less
hindered, bottom face of the intermediate is favorable, producing diastereomer 244.
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The coupling of thiols to enol ethers has also been reported by AIBN initiation.
Exocyclic glycal 36 and thoilacetate produced thiolacetate 245 (Scheme 1.68).141
Tetrahydropyran 245 was exclusively isolated as one isomer, based on the previously described
steric argument.
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Exocyclic enol lactones have been transformed into alkylated lactones through reactions
mediated by triphenylsilane and thiol catalysts (Scheme 1.69).142

Racemic products were

produced with triphenylsilanethiol as the catalyst (5 mole %) and di-tbutyl hyponitrate acting as
the radical initiator. Stereoselective products were created with chiral catalyst 248 (10 mol%)
and radical initiator dilauroyl peroxide.
Scheme 1.69
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The proposed propagation cycle is outlined in Scheme 1.70.

CO2Et

O

O

249

The tbutyoxy radical

abstracts a hydrogen from triphenylsilane to produce a chain-carrying silyl radical. Abstraction
of a halide by the silyl radical produces an intermediate that adds to an electron-rich alkene.
Subsequent hydrogen abstraction from a thiol produces the alkene addition product and a sulfide
radical. The sulfide radial then facilitates manufacture of the initial silyl catalyst. Absence of the
thiol catalyst caused little to no product formation.
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Scheme 1.70
RHal

R'3SiHal

R'3Si

R
EDG

XSH

R'3SiH

EDG

XS
R
XSH

EDG
R

Intramolecular radical addition has been facilitated by silane tethers to make carboncarbon bonds. The use of a silane tether aids in the formation of the new carbon-carbon bond
because the reaction proceeds through an intramolecular process rather than an unfavorable
intermolecular nucleophilic addition. Myers reported this methodology in the synthesis of the
antibiotic tunicaminyluracil (252) (Scheme 1.71).143 The carbon-selenium bond of enol ether
250 underwent radical cleavage. Subsequent addition of the carbon radical to the enol ether
Scheme 1.71

provided tetrahydropyran 251 after axial, anomeric hydrogen capture. C5’ stereocenter formation
was controlled by the reaction solvent system. Toluene provided the undesired C5’ diastereomer,
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while acetonitrile solvent produced tetrahdropyran 251 in 62% yield. Successive deprotection of
the amine and hydroxyl functional groups rendered tunicaminyluracil. This sequence proved to
be a highly convergent method for natural product synthesis.
Silyl tethers have been similarly used towards disaccharide synthesis. This cyclization
reaction was used to manufacture bioactive disaccharides (Scheme 1.72).144 In this transition, an
alkyl iodide is used as a progenitor of a radical donor. Alcohol 254 is coupled to enol ether 253
through a silyl tether.

A 8-endo-trig cyclization is mediated by tributyltinhydride to form

tetrahydropyran 256, in 37% yield from iodide 254, after de-tethering. The stereochemistry of
the C4 stereocenter is expected on a steric basis because cyclohexyl and non-anomeric
hexopyranosyl radicals prefer equatorial addition when there are adjacent equatorial
substituents.145
Scheme 1.72

Silyl-tethered radical processes have been used towards -hydroxy tetrahydropyran
synthesis.146

Enol ether 257 was converted to Diol 261, albeit in low yield, through

hydrohydroxymethylation, a process initially applied to allylic alcohols by Nishiyama147 and
Stork,148 (Scheme 1.73). Hydroxy-exo enol ether 257 is transformed into silyl ether 258 and
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subsequently treated with tributylstananne to yield intermediate 259. The silylmethylene radical
successively cyclizes to the 5-membered siloxy ring 260. Tetrahydropyranyl diol 261 resulted
from oxidative cleavage via a Tamao-Kumada process.149
Scheme 1.73
OBn
BnO
MeO

Br
Si(Me)2Cl, Et3N, CH2Cl2

OH
O
257

MeO

OBn
BnO
MeO

OBn
BnO

O

Si

Br

Bu3SnH, AIBN, PhH

O
258

OBn
O

Si

CH2

O
259

BnO

OBn
O
Si

MeO

MeOH, THF, H2O2, Na2CO3
13%

O
260

BnO
MeO

OH
O
261

OH

Use as Electrophiles
Amongst the uses of exocyclic enol ethers is their role as electrophiles. Nitrogen and
oxygen nucleophilic additions occur at the anomeric carbon of exocyclic enol ethers. Both
indole and ketal products have been synthesized by this method. The manufacture of these
functional groups is important toward the synthesis of biologicalically active substrates.
Exocyclic enol ethers are assumed to be intermediates in the hydrohydrazination-Fisher
indolization tandem reaction of arylhydrazines with acetylenic alcohols (Scheme 1.74).150 A
general method for the fabrication of these moieties is important towards the synthesis of indolebased pharmaceuticals like serotonin, indomethacin, and sumitraptan. The mechanism of this
hydrohydrazination-Fisher indolization proceeds through an exo-enol ether intermediate. This
reaction pathway is confirmed by using the corresponding exo enol ethers as reaction
components rather than acetylenic alcohols.

56

Scheme 1.74
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Acetylenic alcohol 262 forms a complex with a gold catalyst, which is subsequently
cyclized, resulting in in-situ exo enol ether formation. Nucleophilic addition of hydrazine 263 to
the enol ether intermediate is followed by p-toluenesulfonic acid induced hydration and
subsequent Fisher indolization to yield indole 264. This nucleophilic addition of hydrazine
demonstrates the use of exocyclic enol ethers as electrophiles for nitrogen addition.
To determine the plausibility of an exocyclic enol ether intermediate, 2methylenetetrahydropyran 2 was subjected to only Fisher-indolization conditions. Addition of
hydrazine 263 to enol ether 2 produced indole 264. The creation of the same indole product
from either addition of an exo enol ether or acetylenic alcohol indicates that the exo enol ether is
indeed the Fisher-indolization precursor in this reaction, whether it is added directly or made insitu. By using acetylenic alcohols as reactants, the enol ether is made and used within the
reaction, circumventing the need for isolation of this labile product.
Exo enol ethers have been coupled with numerous alcohols through nucleophilic addition
to the anomeric center. In particular, enol ethers have been used for carbohydrate synthesis. The
synthesis of carbohydrates and carbohydrate analogs is important because they are biologically
active components that mediate cell-cell recognition and moderate behavior of enzymes.
Glucose, galactose, and mannose-derived disaccharides have been synthesized by the O57

glycosidations of exo-glycals with protected glycosides (Scheme 1.75).151 Exclusive formation
of the O-glycosylation product 266 results from combining exo-glycal 36 with alcohol 265 under
acid catalyzed conditions.

Under these thermodynamic conditions, the -glucoside 266 is

formed preferentially.
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Use as Nucleophiles
Exo enol ethers have developed as effective nucleophiles and are similar in their
reactivity to alkenes. Nucleophilic reactions of the exo olefin include the formation of halonium
ions that are successively opened by secondary nucleophile addition and protic or Lewis acid
hydrolysis. Less common is the use of exocyclic enol ethers in nucleophilic carbon-carbon bond
formation. Examples of these types of transformations include exo-glycal dimerization and
addition to an episulfonium ion.
Nucleophilic attack of an electrophilic halogen species by an exo enol ether produces
intermediate halonium ions, which undergo nucleophilic attack to yield enol ether addition
products. Bromoetherification152 or iodoetherification153 of exo enol ethers 267 and 269 formed
racemic ketals 268 and 270 (Scheme 1.76). Similarly, secondary nucleophilic attack of an
iodonium ion by azide resulted in the formation of iodide 272 with high levels of regio and
stereoselectivity (Scheme 1.77).154

The observed stereoselectivity is due to preferential

iodonium ion formation on the -face of the molecule. In the absence of the C3 hydroxy group,
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no selectivity was observed. Other conditions used to manufacture iodides from exo enol ethers
include NaNH3, I2, and [Bn(Et)3N]Cl,155 I2, MeCN,156 and NIS, H2O.157
Scheme 1.76
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Elimination of halides formed from exo enol ethers yields haloalkenes. Bromination of
enol ether 273 in the presence of Hunig’s base produced allyl bromo-enol ether 275 (Scheme
1.78).158 Formation of dibromide intermediate 274 was followed by -elimination of the tertiary
bromide to provide bromide 275. The more stable, internal olefin is produced rather than the
exocyclic olefin.
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Iodo-enol ethers can also be synthesized through the nucleophilic attack of a halogen by
an exo enol ether followed by elimination (Scheme 1.79). Iodonium intermediate 277 is directly
eliminated as compared to the secondary bromide addition and subsequent elimination of
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dibromide 274. Treatment of enol ether 276 with iodonium dicollidine perchlorate leads to
oxionium ion intermediate 277. Elimination of a proton from the exocyclic carbon provided
iodoenol ether 278 as a mixture of stereoisomers in low yield.
Scheme 1.79
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Halo-enol ethers can be prepared by selective iodonium addition/elimination of exo enol
ethers using iodonium dicollidinium triflate (Scheme 1.80).159 Exo-glycal 36 is transformed into
iodo enol ether 280 through elimination of oxonium intermediate 279. Stereoselectivity is
derived from the conformational preference of the intermediate oxonium ion 279. Abstraction of
a proton that is aligned parallel to the oxonium ion pi bonds then provides halo enol ether 280.
This proves to be an effective method for synthesizing iodo-enol ether substrates
stereoselectively from the corresponding sugar derivatives. Iodo-enol ethers are used as partners
in Sonogoshira,160 Suzuki,159 and Stille161 cross coupling reactions.
Scheme 1.80
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Addition of water to exocyclic enol ether nucleophiles can be effected under both protic
and Lewis acid conditions to yield both hemiketals and keto-products. Treatment of enol ether
281 with p-toluenesulfonic acid provided the expected Markovnikov product 282 (Scheme
1.81).162 Subjection of exo-glycal 283 with a lanthanum reagent system led to ring-opened
60

Scheme 1.81
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product 285 (Scheme 1.82).163

OH

282

Hydration of the exocyclic double bond was followed by

successive ring opening of hemiketal 284. Hemiketal cleavage proceeds with concomitant loss
of methoanol to provide keto-aldehyde 285.
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The use of exocyclic enol ethers as nucleophiles in carbon-carbon bond forming reactions
is limited.

Dimerization of exoglycal 36 in the presence of a Lewis acid provided bis-

tetrahydropyran 287 (Scheme 1.83).164 In this reaction one molecule of the enol ether is acting
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as a nucleophile while the other is an electrophile. One equivalent of exocyclic enol ether 36
attacks oxonium species 286 formed in-situ from another molecule of the enol ether 36 and the
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Lewis acid. Water workup leads to the anomeric dimer 287. Schroder’s group detected exo enol
ether dimerization products in their research of acid-promoted 1,5-diene cyclizations.165

A

mixture of isomers 289, 290, and 291 resulted upon subjection of pseudo-georgywood (288) to
Lewis acidic conditions (Scheme 1.84). Typically the isomer mixture was converted to the most
Scheme 1.84

O
288
Lewis
Acid
H

H
O

O

289

290

O
georgywood (291)

stable constituent, georgywood (291), through addition of catalytic p-toluenesulfonic acid.
However, upon standing at room temperature for several weeks the product mixture also
produces dimer 293 as a crystalline solid (Scheme 1.85). Addition of enol ether 290 to ketone
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289 results in formation of oxonium ion intermediate 292.

Subsequent elimination and

cyclization generates dimer 293 as a 1:1 mixture of E:Z stereoisomers.
The Smoliakova research group demonstrated the nucleophilic properties of exo-glycals
for the preparation of -C-glycosides.166 Nucleophilic addition of Exo-glycal 36 to episulfonium
ion 294 yields oxonium ion 295 (Scheme 1.86). Intermediate 295 was quenched with water to
Scheme 1.86
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provide hemiketal 296. Other external nucleophiles used in this process included methanol and
sodium cyanoborohydride. The observed stereoselectivity of the secondary nucleophilic addition
is based upon steric and electronic factors.167

Nucleophilic addition occurs from the face

opposite that of the C6 substituent to afford the anomerically-stabalized thermodynamic product.
This example of exo-glycal nucleophilic addition to episulfonium ions demonstrates exocyclic
enol ethers as viable nucleophiles when added to activated, electrophilic systems. The resulting
products formed are -oxygenated tetrahydropyrans, which are useful functional groups toward
tetrahydropyranyl natural product synthesis.
With the exception of the dimerization and Smoliakova examples, the research utilizing
exocyclic enol ethers as carbon-carbon nucleophiles is nearly non-existent. The research in our
group is geared toward showcasing these nucleophilic nature of exocyclic olefins, namely in
carbon-carbon bond forming reactions.

The research method involves the synthesis of -

hydroxytetrahydropyrans and dihydropyrans through coupling of 2-methylenetetrahydropyrans
with aldehydes and ketones. Not only do these reactions demonstrate the use of exo enol ethers
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as nucleophiles, but the products produced could also be used as key tetrahydropyranyl ketide
intermediates in natural product synthesis.
Two different reactions were studied in order to demonstrate the nucleophilic character of
exo enol ethers and their ability to create new carbon bonds: three component coupling (Scheme
1.87) and carbonyl-ene reactions (Scheme 1.86) of 2-methylenetetrahydropyrans. The threecomponent coupling reaction involves formation of oxonium ion intermediate 297 after
nucleophilic attack of the enol ether to an activated aldehyde or ketone. Secondary nucleophile
trapping of oxonium ion 297 provided -hydroxy tetrahydropyrans 298 as diastereomeric
mixtures in good yield.
Scheme 1.87
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Use of exo enol ethers in the carbonyl ene reaction provided dihydropyrans 299 in
excellent yields (Scheme 1.88). Activation of aldehydes and ketones by catalytic zinc(II)
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chloride (5-20 mol %) and subsequent addition to exo enol ethers produced racemic mixtures of
-hydroxy dihydropyrans. Chiral induction studies have been performed as an extension of this
carbonyl-ene reaction. Through examination of chiral exo enol ethers, preferential stereoisomer
formation can be determined (Scheme 1.89). Bi- directional studies were also carried out to
assess if bis--hydroxypyrans 304 and trioxadispiroketals 305 could be manufactured from the
carbonyl-ene methodology (Scheme 1.90).
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Chapter 2: Three-Component Coupling Reactions of 2-Methylenetetrahydropyrans
2.1 Overview
Tetrahydropyranyl ketides are present in biologically active natural products. Therefore,
new methodologies toward the synthesis of tetrahydropyrans and their analogs are synthetically
significant. Our synthetic efforts toward -hydroxy tetrahydropyrans include the use of exo enol
ethers as neutral nucleophiles in a three component coupling reaction (Scheme 2.1). General
methods utilizing exocyclic enol ethers as nucleophiles have not been published outside of our
reports. Endo enol ethers have been more extensively studied as nucleophiles in carbon-carbon
bond-forming reactions and lend argument to the use of enol ethers as neutral nucleophiles. This
chapter reviews the use of endocyclic enol ethers as nucleophiles in coupling reactions and
discusses the development of our three-component coupling reaction of exocyclic enol ethers.
The three component coupling reaction between 2-methylenetetrahydropyrans 2 and
aldehydes or ketones occurs under Lewis acid activation (Scheme 2.1).

-Hydroxy-

tetrahydropyrans 298 are produced through addition of nucleophiles to oxonium ion
intermediates 297. This reaction demonstrates the nucleophilic nature of exocyclic enol ethers.
Reaction conditions that were screened for this process include use of alternative Lewis acids,
variation of the reaction stoichiometry, and evaluation of reagent addition times. The scope of
the reaction was evaluated by screening different types of 2-methylenetetrahydropyrans and
electrophiles.
Scheme 2.1
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2.2 Background and Significance
Exocyclic enol ethers have been scarcely used as nucleophiles in carbon-carbon bondforming reactions, most likely due to the tendency of these systems to undergo isomerization and
hydrolysis in the presence of trace acid or heat.1 Nonetheless chemical transformations can be
successfully applied to these moieties as previously discussed. Endocyclic enol ethers have been
more extensively studied as nucleophiles in carbon-carbon bond forming processes. These aldollike reactions typically involve the Lewis-acid catalyzed addition of an endocyclic enol ether to
an acetal or aldehyde, followed by secondary nucleophilic attack of the resulting oxonium ion.
Such processes have been studied by Mukiyama,2 Sugimura,3 and Ghosh.4 Ghosh later applied
three-component coupling strategies towards the synthesis of natural products and biologically
active substrates.5
Mukiyama initially reported the use of endocyclic enol ethers as nucleophiles in carboncarbon bond-forming transformations.2 This methodology employed acetals as electrophiles,
which were coupled to electron rich olefins under mild conditions. Olefin substrates included
both endocyclic and vinyl ethers, as well as styrene. In most cases the best results were obtained
using tin chloride and trimethylsilylchloride as an activator (Table 2.1, entries 1-4, and 6).
Yields were optimized for the reaction between enol ether 315 and acetal 307 through use of a
different activator, tin trifilate and trityl chloride (entry 5). In the case of tetrahydropyran 306,
three adjacent stereocenters were created, giving rise to a complex mixture of diastereomeric
products.
Styrene 317 provided a mixture of the desired aldol-like product along with chloride 318.
When conditions were modified such that one equivalent of trimethylsilylchloride was used, the
corresponding chloride 318 was isolated in 80% yield as the sole product (Table 2.1, entry 6).
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Table 2.1: Mukiyama Electrophilic Addition to Dihydropyrans
OMe
+
RO

Entry

Olefin

H

R

OMe
H
R

activator

OMe

0oC, CH2Cl2
RO

OMe

Activator

Acetal

Product

a

SnCl2 + TMSCl

Ph

Ph

OMe
307

O
306

dr

84

70:14:13:3

55

75:25

OMe

OMe
1

Yield

O

OMe
308
OMe

H

2
O
306

OMe
OMe
OMe

a

SnCl2 + TMSCl

OMe
O

309

OMe
310
OMe

OMe
a

3
O
306

Ph

OMe

SnCl2 + TMSCl

a

O
306

Ph

OMe

70b

-

74c

60:40

80

55:45

OMe

OMe
4

-

OMe
312

O

311

Ph 64b

SnCl2 + TMSCl

Ph
OMe
314

O

313

OMe
OMe
Sn(OTf)2 + TrCla

Ph

5

Ph
OMe
OMe
316

OMe
307

OMe
315

OMe
6

a

Ph
317

Cl

SnCl2 + TMSCld

Ph

OMe

Ph

OMe
307

Ph
318

1 eq of SnCl2 used with 10 mol % TMSCl or TrCl

b

mixture of diastereomers

c

Quenched with NaOMe

d

1 eq of both SnCl2 and TMSCl used

These results suggest the chloride as a key intermediate in the reaction path (Scheme 2.2). The
first step in the reaction mechanism is the activation of acetal 307 by the tin catalyst, resulting in
oxonium ion 319. Generation of oxonium intermediate 319 is followed by nucleophilic addition
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of dihydropyran 306, and provides the intermediate chloride 321 after chlorine addition.
Chloride 321 is in turn replaced by methoxide to provide tetrahydropyran 308.
Scheme 2.2
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TMSCl SnCl2
Ph

OMe
Ph

307

OMe
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O
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Ph
O
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OMe
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O
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Ph
O

Cl

+ TMSCl

OMe
308

321

A similar methodology was developed by Sugimura whereby enol ethers were combined
with aldehydes to yield oxetane substrates.3 Lewis acid activation of aldose aldehyde derivates
322 was followed by nucleophilic attack of enol ether 323, resulting in zwitterion 324 (Scheme
2.3). Intramolecular addition of the oxide into the oxonium ion provided oxetane 325.
Scheme 2.3

Reaction yields and the extent of Lewis acid loading varied based on substrate. The
reaction proceeded in moderate to high yields with enol ethers 326 and 329 and aldehyde 327
(Table 2.2, entries 1 and 2). Use of both cis and trans enol ethers 329 and 331 resulted in similar
yields of the same cis product 330 (entries 2 and 3). The reaction yield dropped dramatically
with dihydropyran 306 acting as the olefin despite equimolar addition of Lewis acid (entry 4).
Aldehydes 333 and 336 were examined for use in the
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Table 2.2: Formation of Oxetanes from Enol Ethers
OR'

O
O
O
Olefin

Entry

1

H2C CHOEt

BF3-OE2
H

+

OR'

R

O
O

CH2Cl2, -78oC

O
Eneophile
O

CHO

O

O

BF3-OEt2 (eq)

Product
OEt

0.1

2

PhHC

CHOMe

O

O

329
327

O

3

PhHC

CHO

O

O

CHOMe
331

4

O

CHO

O

O

O
306

327
O

5

H2C CHOEt
326

OMe
0.1

O
R
330

OMe
O
0.1

O

75%

Ph

O

R
330
O

O

O

1.0

O

O

39%
R
332
OEt

CHO

OEt

O
0.05

O

80%

Ph

O

O

327

R
328
O

O

O

94%

O

327 O
CHO

Yield

O

326

O

R

333 OTBS

O
+

O
O

64%

O
O

R
334

27%
R
335

OMe
6

PhHC

CHOMe
329

O

O

CHO
0.1

21%

O

O
336

O

337

coupling reaction. Aldehyde 333 resulted in a diastereomeric mixture of products and aldehyde
336 produced desired cycloadduct 337 in low yield (entries 5 and 6).
The stereoselective outcome is consistent with Cram’s cyclic chelation model where the
nucleophile adds from the less hindered side. Additionally, the same oxetane product 330 was
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formed with both the E and Z enol ethers 329 and 331. Both E and Z enol ethers 329 and 331
result in similar reaction intermediates 340 and 341.

The reaction proceeds preferentially

through intermediate 341 to produce the observed cis product 330. Most likely the
stereoselective outcome is based on reducing the steric and electronic repulsion between the
methoxy group and the sugar side-chain (Scheme 2.4).
Scheme 2.4

In 1999, Ghosh reported a three-component coupling methodology towards the synthesis
of 2,3-disubstituted tetrahydropyrans and tetrahydrofurans.4a This reaction employed enol ethers
and ethyl glyoxylate (343) in an efficient, high yielding, and one-pot aldol-type reaction.
Titanium(IV) chloride activates glyoxylate 343, leading to formation of oxonium species 344,
which can be trapped with secondary nucleophiles (Table 2.3). Ethyl glyoxylate was exclusively
used as the electrophilic component in this reaction. These aldehydes possess high reactivity and
form bidentate coordination complexes with Lewis acids.
The three-component coupling products were formed in good yield from vinyl enol ethers
345 (Table 2.3, entry 1), 347 (entry 2), and 306 (entries 3, 4, and 5). Allyltrimethylsilane (entries
1 and 4), triethyl silane (entries 2 and 3), and methanol (entry 5) all effectively trapped oxonium
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species 344 to yield coupled products 346 and 348-351. These products were all formed in good
yield with little to no diastereoselectivity.
Table 2.3: Three-Component Coupling of Enol Ethers with Ethyl Glyoxylate
R'

TiCl4

O
+
H

RO

CO2Et CH Cl , -78oC
2 2
343

Enol ether

Entry

O

LA

R'

O

RO

OEt
344

Nucleophile

OH
Nucleophile

R'
RO

Product

CO2Et
Nu

Yield

dr

83

1:1

88

1:1

95

1:1

85

1:1

65

2:1

HO
CO2Et

1

Me3Si

EtO
345

EtO

H
346

HO
2

CO2Et

Et3SiH

O
347

O

H
348
OH

Et3SiH

3
O
306

CO2Et
O

H
349
OH

4

CO2Et

Me3Si

O
306

O
350
OH
MeOH

5
O
306

CO2Et
O

OMe
351

Modification of reaction conditions, whereby the reaction is run at 0oC, led to the
isolation of elimination products 352 (Scheme 2.5).4a Optimization of the reaction
Scheme 2.5
OH
1. TiCl4, CH2Cl2, 0oC

O
O
306

H

CO2Et

2. Et3SiH

O

O

343

349, 10%

82

CO2Et

CO2Et +

+

352, 77%

conditions resulted in exclusive formation of elimination products 352 (Table 2.4). This reaction
provides an entry into the synthesis of functionalized 3-methylene tetrahydropyrans, a less
common type of tetrahydropyranyl derivative. A number of different secondary nucleophiles
were effective in trapping the tetrahydropyranyl alkenes including silanes (Table 2.4, entries
Table 2.4: Competing Elimination in the Three-Component Coupling of Dihydropyran
O
O
306

H

H

TiCl4

+
CO2Et
343

o

0 C
O

O

TiCl3

O
O

OEt
353

Entry

Nucleophile

1

Et3SiH

Product
CO2Et
O

2

CO2Et

nucleophile

O

O

Yield

Ratio (E:Z)a

95

1:2

83

1:2

84

7:1

74b

3:2

46b

3:2

35b

3:2

Nuc
355

H
CO2Et

Me3Si

OEt
354

O
3

CO2Et

Me3SiCN
O

4

CO2Et

MeOH
O

5

OMe
CO2Et

EtSH
O

6

CN

SEt
CO2Et

PhSH
O

SPh

a

ratio determined from 1H NMR
With addition of 2 equiv of ipr2NEt

b

1, 2 and 3), methanol (entry 4), and thiols (entries 5 and 6). Yields for this process were good
except for the use of thiols as secondary nucleophiles. Subjection of dihydrofurans to the same
reaction conditions did not provide the elimination products solely, but produced poor reaction
mixtures of the 3-methylenetetrahydrofurans and corresponding hydroxy three-component
coupling products.
Interestingly, the corresponding hydroxy tetrahydropyranyl three-component coupling
products are not prone to elimination.

Both subjection of tetrahydropyran 349 to
83

camphorsulfonic acid and p-toluenesulfonic acid in refluxing benzene as well as the application
of basic elimination conditions to the corresponding mesylate (DBU and triethylamine) did not
yield eliminated product 352 (Scheme 2.6). The lack of elimination in the hydroxide product
indicates that it is the oxonium ion-titanium complex 353 that is prone towards elimination. The
same oxonium ion intermediate presumably forms, however elimination of the titanium as
titanium dioxide yields ,-unsaturated ester 352 after secondary nucleophile addition.
Scheme 2.6
OH
CSA or pTsOH

1. MsCl
CO2Et

No Reaction
PhH, 80oC

O

2. DBU or Et3N

No Reaction

349

TiCl4
-78oC - 23oC

No Reaction

When pyruvates were employed in place of glyoxylates the three-component coupling
reaction occurred with good to excellent levels of diastereoselectivity (Table 2.5).4b This process
results in the stereoselective preparation of quaternary centers. Excellent diastereoselectivity
resulted for the three component coupling reaction of dihydropyran 306 (entries 1 and 2) and
dihydrofuran 347 (entry 3) using both methyl and phenyl pyruvates 356 and 358 with
triethylsilane. A lower yield and diastereoselectivity was observed for chiral enol ether 361
(entry 4). Diastereomer ratios were determined by 1HNMR and relative stereochemistry was
determined by X-ray crystallography.
The observed diastereoselectivity can be explained by consideration of the following
transition state (Scheme 2.7). The proposed transition state correctly predicts that the major
diastereomer is formed preferentially. Both transition state 363a and 363b are stabilized by the
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Table 2.5: Three-Component Coupling of Enol Ethers with Pyruvates
1. TiCl4, CH2Cl2, 0oC

O

Enol ether

CO2Et

+

RO

Entry

R

CO2Et

2. nucleophile

RO

Nucleophile

Pyruvate

H

Me

CO2Et
356

H
Et3SiH

2
Ph

O
306

CO2Et
357

O

O
CO2Et
358

O

OH
Ph
CO2Et
359

O
347

Me
356

CO2Et

Et3SiH

CO2Et

O
360

O
361

Me
358

CO2Et

Et3SiH

CO2Et

82%

>99:1

77%

>99:1

83%

>99:1

65%

1:1

OH

O
4

dr

OH

O
3

Yield

OH

Et3SiH

1

nuc

Product

O
O
306

OH

R'

O
362

lone-pair donation of the ethoxy oxygen into the C2 portion of the carbenium ion, yielding a ringlike transition state. Transition state 363a experiences an unfavorable interaction between the H4
axial hydrogen with the chelated titanium species. When the stereochemistry on the side chain is
switched, as is the case for transition-state 363b, the titanium species resides on the top-face
where steric crowding is avoided.
Scheme 2.7
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Since the initial investigation of the three-component coupling methodology, this
transformation has been applied to a number of systems including the synthesis of amine
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derivatives,5b substituted pyrrolidines and prolines,5c modified nucleosides,5e cyclopentenoids,5d
and the natural product eburnamonine.5a

Aminotetrahydropyrans were created using N-

tosyliminoesters as partners in the three-component coupling with dihydropyran 306 (Scheme
2.8).5b N-tosyliminoesters 364 acted as good electrophilic components in this reaction and gave
the

corresponding

tetrahydropyranyl

products

365

in

good

to

excellent

yields.

Diastereoselectivity varied with substrate and secondary nucleophile used.
Scheme 2.8
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Ghosh later applied the three-component coupling methodology towards the manufacture
of biologically significant substrates. The coupling of dihydrofurans, ethyl glyoxylate, and
purine or pyrimidine bases resulted in formation of modified nucleosides with excellent
diastereoselectivites.

The synthesis of modified nucleosides is valuable because of their

widespread applications as antiviral, antitumor, and antibacterial agents.6 Furthermore modified
nucleosides have been used as treatments for AIDS, herpes, hepatitis, and cancer.7 In particular,
AZT (366) and floxuridine (367) have been synthesized and used in treatments for HIV/AIDS
and cancer respectively (Figure 2.1).
Figure 2.1
H
N

O
O

N

HO

H
N

O

O
O
Me

HO

N

O
F

HO

N3

floxuridine (367)

AZT (366)

Ghosh utilized the three component coupling methodology designed in his lab to
synthesize modified nucleosides (Scheme 2.9).5e Lewis acid activation of ethyl pyruvate 369 and
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subsequent attack by dihydrofuran 268 yielded oxonium ion 370.

Subsequent attack of

intermediate 370 with a purine or pyrimidine nucleophile furnished modified nucleosides 371
and 372.
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Ghosh extended the three-component coupling research to natural product synthesis.
Eburnamonine (375) was synthesized in four steps from dihydropyran 306 (Scheme 2.10). Three
component coupling of dihydropyran 306 with ethyl glyoxylate 343 and equimolar amounts of
titanium(IV) chloride provided oxonium intermediate 354. Secondary nucleophilic addition of
tryptamine yielded imine 373 as a mixture of diastereomers (E:Z = 1.2:1). Because separation of
the imines led to decomposition, subsequent cyclization was performed on the diastereomeric
mixture in aqueous acid, providing amine 374 as the only diastereomer over two steps, albeit in
low yield. Attempts at improving the 25% yield using different acids resulted in similar yields.
Presumably cyclization only occurred on the E-isomer, while the Z-isomer decomposed under
the reaction conditions.

The natural product was obtained from intermediate 374 in two

successive steps.
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The interest in natural product synthesis led our group towards the development of a mild
reaction protocol between exocyclic enol ethers and electrophiles. Spirastrellolide A is a potent
and selective inhibitor of Ser/Thr protein phosphatase 2A and thus a potential anticancer agent of
synthetic interest (Figure 2.2).8 Initially, relative configurations were determined for three
Figure 2.2
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segments (C3-C7, C9-C24, and C27-C38), however, the stereochemical relationships between
segments was not discovered until spirastrellolide B furnished structural insight.9 The lack of
known relative stereochemistry led us to disconnect spirastrellolide at the C8-C9 bond (Scheme
2.11). The creation of the C8-C9 bond of spirastrellolide requires mild reaction conditions that do
not result in -elimination of the C9 oxygen. Addition of a neutral nucleophile to an aldehyde
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may be the best method for attaining the desired coupling, because anion addition to an aldehyde
would undoubtedly yield elimination products. Therefore we sought to develop an aldol-like
process with aldehydes using neutral exo enol ethers as nucleophilic substrates.
Scheme 2.11
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As described, dihydropyrans and dihydrofurans are known to act as neutral nucleophiles
in carbon-carbon bond-forming reactions with acetals or aldehydes. Similar application of
exocyclic substrates to these aldol-like reactions has not been studied. The advantage of using 2methylenetetrahydropyrans over endocyclic systems is that these groups possess higher levels of
steric strain10 and a lower degree of stereoelectronic stability,

11,12

resulting in a more highly

activated nucleophile, although they are consequently prone to olefin isomerization. Our aim
was to develop a coupling methodology between exo enol ethers and electrophiles such that
addition will occur faster than double bond isomerization. The goal is to develop a general
process that can be applied to a wide range of substrates using mild reaction conditions, all while
yielding synthetically valuable tetrahydropyranyl ketides as products.
2.3 Results and Discussion
Because tetrahydropyranyl ketide moieties are present in bioactive natural products, new
methods toward the synthesis of their analogs are synthetically significant. Our synthetic efforts
toward -hydroxy tetrahydropyrans include the use of exo enol ethers as neutral nucleophiles in
a

three

component

coupling

reaction.

The
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three-component

coupling

of

2-

methylenetetrahydropyrans was developed through synthesis of the exocyclic enol ether
components, and then subjection of these substrates to various Lewis acid conditions in
conjunction with electrophilic components and secondary nucleophiles. After optimization of
reaction conditions, the substrate scope of the reaction was evaluated through evaluation of
different exo enol ethers and electrophiles.
Synthesis of Exocyclic Enol Ethers
Earlier reports have suggested the feasibility of exo enol ethers acting as nucleophiles in
three-component coupling.13,14 Appropriate exo enol ethers were prepared to explore their
possible use in three component coupling with electrophiles. Exo enol ethers 2, 112, and 378
were synthesized (Figure 2.3). Exo enol ether 2 was used to screen suitable reaction conditions.
The other enol ethers allowed us to evaluate scope of the reaction, including the use of less
electron rich enol ethers (112).
Figure 2.3
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Preparation of enol ether 378 provided an opportunity to evaluate how a preexisting stereocenter
affects the diastereoselectivity of the three component coupling reaction.

Enol ether 2 is

synthesized through dehydrohalogenation whereas enol ethers 112 and 378 are prepared from
corresponding lactones using Petasis olefination.15

The synthesis of these enol ethers is

discussed herein.
2-Methylenetetrahydropyran 2 was prepared from 2-(hydroxymethyl) tetrahydropyran
379 using a two-step literature procedure (Scheme 2.12).16,17,18 Alcohol 379 was converted to
the corresponding alkyl chloride 3 upon treatment with thionyl chloride. Subsequent elimination
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was achieved upon heating halide 3 in the presence of powdered KOH. Resulting enol ethers 2
and 14 were isolated by distillation from the reaction mixture as, at best, a 38:1 ratio, with the
exocyclic isomer predominating.
Scheme 2.12
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Dehydrohalogenation proved to be a successful method toward synthesis of enol ether 2.
The volatility of this enol ether makes its preparation from -valerolactone difficult using
Petasis’s olefination methodology.

However, dehydrohalogenation is problematic in that a

mixture of isomers results in the distilled product. The ratio of exo to endo enol ethers deviated
considerably, from 3:1 to 38:1 with no discernable reason for the variation.

Unwanted

isomerization could be somewhat minimized through use of base-washed glassware.

The

minimum ratio of exo to endo cyclic enol ether used for the three-component coupling project
was 10:1.

Although a minimal amount of endocyclic enol ether is present in the three-

component reaction mixture, and endocyclic enol ethers have been shown to participate in three
component coupling reactions,4a it is believed to have little effect on the reaction. The exo enol
ethers should be much more reactive towards the three component coupling reaction because of
their high steric strain10 and low stereoelectronic stability.11,12
Preparation of the exo enol ether was further complicated by its co-distallation with
water.

The presence of water is problematic in the subsequent three-component coupling

reaction because isomerization of the exocyclic enol ether to the endo enol ether proceeds with
the production of protic acid from Lewis acid and water. Hydrolysis of the resulting threecomponent coupled product is also possible. A number of desiccants were used to eliminate the
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excess water from the distilled product, KOH, CaH, P2O5, and K2CO3, however addition of solid
sodium metal yielded the best results.
Enol ethers 378 and 112 were both synthesized from commercially available
octanolactone 380 and dihydrocoumarin 111 respectively through direct olefination (Scheme
2.13).19 The synthesis of enol ether 378 was achieved upon treatment of octanolactone 380 with
Scheme 2.13
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freshly prepared dimethyl titanocene (Petasis reagent) in refluxing THF.

Purification of the

enol ether was achieved through triteration with hexanes and subsequent flash column
chromatography using a 5% solution of Et3N in hexanes. Addition of Et3N to the column is
essential to avoid isomerization of the exo enol ether on the acidic silica. By this method, enol
ether 378 was isolated in 68% yield as a single regioisomer. Enol ether 112 was prepared
similarly from dihydrocoumarin 111. Exo enol ether 112 was isolated in good yield as a single
regioisomer. Without the need for a water work-up, Petasis olefination repeatedly provided exo
enol ethers without competing endocyclic enol ether formation. With the exo enol ethers in
hand, we next evaluated their utility as nucleophiles in the three-component coupling reaction.
Three-Component Coupling of 2-Methylenetetrahydropyrans
To demonstrate the feasibility of the three component coupling reaction of exo enol
ethers, we first looked at the reaction of 2-methylenetetrahydropyran with ethyl glyoxylate and
triethylsilane (Table 2.6). Preliminary studies included screening Lewis acids and identifying
suitable reaction conditions to effect the transformation and optimize yield.20
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Initial efforts focused on screening Lewis acids (Table 2.6). The reaction was carried out
by combining equal amounts of the enol ether and electrophile in dichloromethane at –78oC.
Addition of Lewis acid immediately followed. After the reaction had stirred for an hour, three
equivalents of triethylsilane were added and the reaction was left to stir at –78oC for an
additional five hours. Work up conditions included addition of aqueous sodium bicarbonate at –
78oC, isolation of the organic layer, and flash column chromatography.21
Table 2.6: Initial Conditions for Three-Component Coupling of Exo Enol Ethers
1. Lewis acid, 1 hr
-78oC, CH2Cl2

O
+
O
2

H

CO2Et
343

OH
O

2. Et2SiH, 5 hr

Entry

Lewis acid

Yield (%)

1

SnCl4

0

2

BF3 Et2O

·

0

3

ZnCl2

0

4

EtAlCl2

0

5

Et2AlCl

0

6

TiCl4

48

H

CO2Et
381

Prior work by Mukaiyama2 and Ghosh4a suggests the need for a strong Lewis acid to
effect an aldol-like addition of enol ethers to electrophiles. Therefore we began our study by
looking at relatively strong Lewis acids. Use of tin chloride (entry 1, Table 2.6) did not produce
the desired tetrahydropyranyl product, although this Lewis acid was successfully used in
Mukaiyama’s transformations. BF3Et2O (entry 2) was also unsuccessful in generating the
reaction.

Zinc chloride (entry 3), a weaker Lewis acid, was also evaluated.

Rather than

producing the desired tetrahydropyranyl product, a dihydropyranyl ene adduct was formed.
Ethyl aluminum dichloride and diethyl aluminum chloride (entries 4 and 5) both did not yield the
desired product.21
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Finally, titanium(IV) chloride was examined. This Lewis acid was previously reported
by Ghosh to transform dihydropyrans to three component coupled products. Alas titanium(IV)
chloride produced our coupled product 381, albeit in modest yield, and this success encouraged
us to continue our studies. This data demonstrated the feasibility of the three component
coupling reaction of exocyclic enol ethers with ethyl glyoxylate and the use of exo enol ethers as
neutral nucleophiles.
In an effort to optimize yield, the time between the addition of titanium(IV) chloride to
the reaction mixture and addition of the secondary nucleophile, triethylsilane, was evaluated
(Table 2.7). Initial reaction conditions involved stirring enol ether 2 with Lewis acid an hour
prior to triethylsilane addition (entry 1, Table 2.7). There was effectively no change in reaction
yield when the stirring time between the enol ether and Titanium(IV) chloride was reduced to
twenty minutes (entry 2). A modest increase in
Table 2.7: Evaluation of Reaction Time in The Three-Component Coupling Reaction
1. TiCl4, -78oC
CH2Cl2

O
+
H

O
2

a

OH

CO2Et
343

2. Et2SiH, 5 hr

Entry

Timea

Yield (%)

1

1 hr

48

2

20 min

45

3

10 min

59

4

0 min

86

O

H

CO2Et
381

Time reaction stirred before triethylsilane addition
1:1 mixture of 2 and 343

yield was observed when the time was further reduced to 10 minutes (entry 3). The best results
were obtained when triethylsilane was added to the enol ether prior to the Lewis acid (entry 4).
The best yields were obtained with instant access to the reducing agent, indicating that
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immediate reduction of the oxonium ion intermediate was key in production of the coupled
product. Instant reduction of the oxonium intermediate following its formation could prevent the
decomposition of this reaction intermediate and the production of other side-products.21
Finally, changes to the reaction stoichiometry were evaluated, whereby the relative
amounts of enol ether, electrophile, and Lewis acid were varied. The ratio of exocyclic enol
ether to ethyl glyoxylate was determined to be of little consequence to the reaction yield. Use of
either reactant in modest excess gave comparable yields of the tetrahydropyranyl ketide 381
(entries 1 and 2, Table 2.8). Again, the best yields for the three-component coupling reaction
Table 2.8: Study of Reaction Equivalents in Three-Component Coupling Reaction
1. TiCl4, -78oC,
CH2Cl2

O
+
H

O
2

CO2Et
343

OH
O

2. Et2SiHa, 5 hr

H

CO2Et
381

Timeb

Yield (%)

1

1 hr

48

1.5:1

1

1 hr

56

3

1:1.2

1

0 min

86

4

1:1.2

1

0 min

86

5

1.2:1

1

0 min

84

6

1:1.2

0.5

0 min

45

7

1:1.2

0.2

0 min

23

8

1:1.2

0.1

0 min

10

Entry

Ratio 1:18

1

1:1.2

2

Lewis Acid eq.

a

Three equivalents used except entry 4 where amount of triethylsilane
was reduced to 1 equivalent
b
Time reaction stirred before addition of triethylsilane

were observed when the triethylsilane was added prior to Lewis acid addition, however the ratio
of enol ether to aldehyde still had little consequence on the reaction yield (entries 3 and 5).
Nonetheless ethyl glyoxylate was used in slight excess for the remainder of the experiments
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because it was more difficult to accurately determine the exact amount utilized in the reaction
due to its tendency towards polymerization.21
Both excess and equimolar amounts of triethylsilane were equally effective in the three
component coupling transformation (entries 3 and 4).

Therefore only one equivalent of

triethylsilane was used in the reactions that followed these experiments. Reducing the amount of
triethylsilane in the reaction mixture not only increases the reaction economy, but also reduces
any unwanted reduction in the products.21
Of greater significance was the quantity of titanium(IV) chloride used. The best yields
for the three-component coupling reaction were obtained using equimolar amounts of the Lewis
acid (entry 3, Table 2.7). When the amount of titanium(IV) chloride was reduced, there was a
proportional decrease in the reaction yield. An 84% yield was achieved with a full equivalent of
Lewis acid (entry 3). The yield was nearly cut in half (45%) with use of half an equivalent of
Lewis acid (entry 5), and likewise yields of 23% and 10% were observed when the Lewis acid
was reduced to 20 and 10 mole percent respectively (entries 6 and 7).21
The preliminary experiments demonstrated the feasibility of the three component reaction
of exo enol ethers with ethyl glyoxylate. The best results were obtained using equimolar
amounts of the aldehyde in the presence of a full equivalent of titanium(IV) chloride when time
between oxonium ion intermediate formation and addition of the secondary nucleophile is
minimized.
Once the basic reaction was demonstrated, studies were expanded to evaluate the scope
and stereoselectivity of the three component coupling reaction (Table 2.9). Of particular interest
was the range of electrophiles that could be used for this transformation. For these studies both
triethylsilane and allyltrimethylsilane were used effectively at secondary nucleophiles. First
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Table 2.9: Three-Component Coupling of Enol Ether 2 with Various Electrophiles

explored was the range of electrophiles that could be used for this tranformation. Electron
deficient aldehydes and ketones worked well in this reaction whereas simple aromatic and
aliphatic aldehydes were unreactive under the reaction conditions.

Excellent results were

obtained with ethyl glyoxylate 343 and 2,3-butane dione 382, using trimethylsilane as the
secondary nucleophile (entires 1 and 3, Table 2.9). Product yields were slightly lower using
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allyltrimethylsilane as the secondary nucleophile, but nonetheless resulted in synthetically useful
quantities of the desired products (entries 2 and 4). The reaction was found to be efficient when
triethylsilane and allyltrimethylsilane were both added to the reaction mixtures five minutes after
the other components. A slight delay in reducing agent addition provided quick access of the
secondary nucleophile to the oxonium ion intermediate, while avoiding direct reduction of the
aldehyde.
The examples utilizing a ketone as the electrophile (entries 3 and 4, Table 2.9) are
intriguing because an oxygen-containing quaternary center is formed. If allyltrimethylsilane is
used as the secondary nucleophile two adjacent quaterinary centers are formed. Secondly the
aldol-like transformation with 2,3-butane dione proceeds fairly rapidly in good to excellent yield
whereas most reversible aldol transformations involving ketones favor the reverse reaction and
fail to produce products in appreciable yields.
The reaction of enol ether 2 with p-nitrobenzaldehyde 383 was less successful and
resulted in production of byproduct 396 along with low yields of the three-component coupled
products 390 and 391 (entries 5 and 6, Table 2.9) Upon formation of oxonium ion intermediate
395, a competing reaction transpires with unreacted p-nitrobenzaldehyde 383 to give spiroketal
product 396 (Scheme 2.14). No reaction was observed using unactivated aliphatic and aromatic
aldehydes such as octyl aldehyde 384 (entry 7), benzaldehyde 386 (entry 8), and trifluoroacetone
387 (entry 9).
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Scheme 2.14

The three component coupled products were isolated as mixtures of diastereomers
because they were inseparable by chromatographic methods.

Diastereomer ratios were

determined from 1H NMR integrations of purified products, however the relative stereochemistry
of the products was not determined. Generally, little diastereoselectivity was observed for this
process, resulting in stereoisomers that were isolated in ratios of 1-3:1 with the exception of
tetrahydropyran 388. Tetrahydropyran 388 was produced as a 4:1 ratio of diastereomers.
The initial addition of the enol ether to the electrophile almost certainly proceeds
unselectively. The addition of the secondary nucleophile to the oxonium intermediate is what
gives rise to the observed diastereomeric ratios. The oxonium ion intermediate formed is likely
stabilized through addition of a lone pair from an ethoxy or carbonyl oxygen into the pseudoaxial vacant orbital (Figure 2.4). Based on this conformation, the direction of secondary
nucleophile addition into the oxo carbenium ion most likely occurs from the non-hindered
bottom face, although a higher energy, boat-like transition state is required. Note that a simple
chair flip would give rise to the opposite stereoisomer in equal amounts. Thus a 1:1 ratio of
diastereomers is expected and addition from either face does not preferentially correlate with the
initial hydroxy stereocenter formed.
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Figure 2.4
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Although a 1:1 mixture of diastereomers is predicted, higher ratios are experimentally
obtained. Most noteworthy is the addition of 2-methylenetetrahydropyran to 2,3-butanedione,
which yields a 1:4 diastereomeric ratio. There is no discernable reason that ketones should
produce higher isomer ratios. Application of 2,3-butanedione to Figure 2.4 does not increase the
facial preference towards secondary nucleophile addition. It must be noted that diastereomer
ratios were obtained through 1H NMR integrations for products purified by flash column
chromatography.

Although diastereomer ratios are typically measured from crude spectra,

impurities present in the product mixtures made these measurements difficult. Even though a
majority of the column fractions were collected, combined, and tested for diastereomer ratios, the
ratios could be affected from this purification process.
Previous studies (Table 2.7) suggested the need to minimize the time between oxonium
ion formation and addition of the secondary nucleophile. In practice, however, the optimum
time before addition of the secondary nucleophile (“pre-stir” time) had to be carefully balanced
against the reactivity of the electrophile to avoid direct addition of triethylsilane to the carbonyl
instead of the oxonium ion intermediate. The reaction pre-stir times varied based on the degree
of electrophile activation. As activation increased, oxonium ion formation proceeded more
quickly. Therefore secondary nucleophiles were introduced to the reaction mixture sooner when
more highly activated electrophiles were used. In the case of ethyl glyoxylate 343, a pre-stir
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time of only five minutes was required (entries 1,2, Table 2.9). With less activated enophiles
pre-stir times of one hour were required (entries 3-6).
After study of 2-methylenetetrahydropyran in the three component reaction, we sought to
extend the scope of enol ether used by evaluating dihydrocoumarin-derived enol ether 112
(Table 2.10). Enol ether 112 was expected to be less reactive than 2-methylenetetrahydropyran
since the lone pair on oxygen is tied up in resonance with the aromatic ring. Nonetheless, the
desired three component coupling resulted with excellent yields in the presence of electron
deficient electrophiles and both triethylsilane and allyltrimethylsilane as secondary nucleophiles.
Table 2.10: Three-Component Coupling of Enol Ether 112 with Various Electrophiles
1. TiCl4, -78oC,
CH2Cl2

O
+
H

O
112
Entry

Enol Ether

O

1
2

O
112

H

4

CO2Et
343

O

3
O
112

R
12

Electrophile

O
382

Timea

6

a

O
112

O

Product

5 min

Et3SiH

OH

5 min

CH2=CHCH2TMS

1 hour

Et3SiH

1 hour

CH2=CHCH2TMS

1 hour

Et3SiH

O

NO2

1 hour

CH2=CHCH2TMS

398c

Nu

H

Yield
97%b

399d CH2=CHCH2

97%b

OH

400e

87%

O

401f CH2=CHCH2

97%b

402g

95%

OH
O

383

Nu

CO2Et

Nu

O

R

Nuc

2. Nucleophile, 5 hr
Nucleophile

O
5

OH

Nu
NO2

H

H

403h CH2=CHCH2

97%

Time before nucleophile addition; bReaction performed by Dr. G. Liang; cdr 1:1; ddr 1:1; edr 1:5; fdr 1:1; gdr 1:2; hdr 1:1

Reaction of enol ether 112 with ethyl glyoxylate provided high yields of tetrahydropyran
products with both triethylsilane and allyltrimethylsilane as secondary nucleophiles (entries 1
and 2, Table 2.10). Similar to the reaction of ethyl glyoxylate with enol ether 2, the high
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reactivity of ethyl glyoxylate necessitated only five minutes of pre-stir time between enol ether
112, aldehyde, and Lewis acid before secondary nucleophile addition. Although less activated
than ethyl glyoxylate, 2,3-Butanedione 382 (entries 3 and 4) and p-nitrobenzaldehyde 383
(entries 5 and 6) were successfully coupled with enol ether 112 in excellent yields.
The high yields observed for enol ether 112 are most likely attributed to the greater
stability of this enol ether as compared to 2-methylenetetrahydropyran. The olefin owes its
stability to the resonance it experiences with the aromatic ring. By having a greater level of
stability, enol ether 112 is less likely to isomerize or decompose in solution. Secondly, enol
ether 112 successfully produced product 402, whereas addition of enol ether 2 to the same
aldehyde, p-nitrobenaldehyde 383, failed as previously discussed (Scheme 2.9). The increased
steric bulk enol ether 112 experiences is enough to hinder approach of a second pnitrobenzaldehyde molecule towards the oxonium ion intermediate. Therefore product 402 could
be isolated in 95% yield.
Like the 2-methylenetetrahydropyran examples (Table 2.9), the three component coupled
products of enol ether 112 were isolated as mixtures of diastereomers. Diastereomer ratios were
determined from the 1H NMR integrations of purified products, and the relative stereochemistry
was not determined. Here too the reaction generally proceeded with little diastereoselectivity
except for the reaction with 2,3-butanedione and triethylsilane (entry 3).
The study of 6-propyl-2-methylenetetrahydropyran 378 provides an opportunity to
explore the diastereoselectivity of the reaction when the enol ether bears a substituent at C6. This
system is similar to how the A-ring of spirastrellolide would be approached using this
methodology. The reaction of 2-methylenetetrahydropyran 378 with ethyl glyoxylate provided
desired -hydroxytetrahydropyrans 404 and 405 in good to excellent yields with both
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triethylsilane and allyltrimethylsilane as secondary nucleophiles (entries 1 and 2, Table 2.11)
Use of 2,3-butanedione 382 as the electrophilic component also provided the desired coupled
product in moderate yield (entry 3).
The three component coupled products of enol ether 378 have three stereocenters and
thus four diastereomer products could result.

Figure 2.5 indicates the two different types of

relationships that exist between the stereocenters. If the C2’ hydroxy substituent and secondary
nucleophile are on the same or opposite faces of the molecule they are said to be either syn or
anti respectively. The other stereochemical relationship relates to the C2 and C6 ring substituents
Table 2.11: Three-Component Coupling of Enol Ether 378 with Various Electrophiles
1. TiCl4, -78oC,
CH2Cl2

O
+
2

Entry

Enol Ether

Electrophile
O

1
2

O
378

2

O
378

H

CO2Et
369

H

OH

R
2

2. Nucleophile, 5 hr
Timea

O

Nuc

Nucleophile

Product

5 min

Et3SiH

OH

5 min

CH2=CHCH2TMS

1 hour

Et3SiH

O

2

Nu

R

404b

CO2Et

Nu

Yield

H

77%

405c CH2=CHCH2

67%

406d
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These substituents are either cis or trans. Therefore the following four diastereomers could
result: cis, syn; cis, anti; trans, syn; trans, anti.
Figure 2.5
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Results from the three component coupling of enol ether 378 indicated that only two
diastereomers were formed. The diastereomeric ratios of tetrahydropyranyl products obtained are
most likely derived from syn/anti relationships, because as previously discussed with the three
component couplings of 2-methylenetetrahydropyrans, little to no stereoselectivity is expected at
the newly generated C2’ stereocenter.

Secondary nucleophile addition, however, is highly

controlled by the pre-existing C6 stereocenter on the enol ether. Nuclear Overhauser effect (nOe)
studies of the resulting products confirmed this hypothesis by detecting only cis-configured
products. Therefore only cis, syn and cis, anti products were obtained.
A 1:1 ratio of diastereomers results from the three component coupling of enol ether 378
to 2,3-butanedione (entry 2, Table 2.11), demonstrating the lack of stereoselective addition to the
electrophile. The diastereomeric ratios of products 404 and 406 were 1:5 and 1:2 respectively
(entries 1 and 3). Unlike previous examples where enol ethers 2 and 112 showed increased
diastereomeric ratios for the 2,3-butanedione products, (entry 3, Table 2.9 and entry 3, Table
2.10), these results show an enhanced ratio for ethyl glyoxylate product 404 (entry 1). Again
there exists no stereochemical model that would explain such a significant deviation from the
expected 1:1 ratio of diastereomers. As previously discussed, purification of the crude product
mixtures was necessary to determine diastereomer ratios. The diastereomer ratios could have
been altered as a result of purification process.
All three component coupled products of enol ether 378 yielded only cis-2,6-substituted
products, as was determined through nOe studies. In all cases the trans diastereomer was not
observed. Oxidation of alcohol 405 was performed to simplify the 1H NMR spectrum for nOe
analysis (Scheme 2.15). Alcohol oxidation reduced the number of diastereomers from two to
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one, proving that the observed diastereoselectivity stems from the syn/anti selectivity, while also
eliminating overlapping proton NMR signals.
Scheme 2.15
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Dess-Martin Periodinane
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CH2Cl2, NaHCO3, 24 h, 66%
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CO2Et
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The individual resonances for the protons adjacent to the tetrhydropyranyl oxygen on
product 404 were identified in the 1H NMR on the basis of chemical shift. These two protons are
also differentiated from the ethoxy protons, which integrate for two and have a quartet
multiplicity. The relative stereochemistry at C2 and C6 was established by nOe experiments
(Figure 2.6). Irradiation of Ha resulted in the enhancement of resonances due to Hb. A nOe was
Figure 2.6
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not observed between either Ha or Hb and the C2 or C6 side chains. The nOe between Ha and Hb
of alcohol 404 is only expected when the protons are on the same face of the tetrahydropyranyl
ring.
Study of ketone 407 through nOe experiements also proved the preferential formation of
2,6-cis-products from the three component coupling of enol ether 378. The proton resonance for
Ha was determined by chemical shift, multiplicity, and integration. Ha was differentiated from
the ethoxy protons, which integrate for two and display a quartet splitting pattern. The allyl
proton resonances in the 1H NMR spectrum derived from Hb were identified by chemical shift,
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and were the only signals present in the 2.10-2.80 ppm range. The resonances due to Hc were
identified by chemical shift and integration. Irradiation of Ha on tetrahydropyran 407 caused a
strong enhancement in the resonances associated with Hb and Hc, but not with any signals
associated with the C2 sidechain. The nOe between Ha, Hb, and Hc of product 407 is expected
only when the ring junction proton and allyl sidechain are on the same face of the
tetrahydropyranyl ring.
The relative stereochemistry about the tetrahydropyranyl ring of alcohol product 406 was
determined similarly through nOe experiments, by separately irradiating both C2 and C6 protons.
Both resonances associated with Ha and Hb were determined by chemical shift, and are the only
two in the 3.10-3.50 ppm range. Upon irradiation of Ha, which resulted in the enhancement of
resonances due to Hb. Likewise, irradiation of Hb caused enhancement in resonances due to Ha.
A nOe was not observed between either irradiated protons and the C2 or C6 side chains. The nOe
between Ha and Hb is only expected when these protons are on the same face of the
tetrahydropyranyl ring. The three nOe experiments of products 404, 407, and 406 indicate that
secondary nucleophile addition to the C2 tetrahydropyranyl carbon is trans selective relative to
the C6 side chain. The 2,6-cis products result without detection of the 2,6-trans products.
The observed preference for formation of 2,6-cis-tetrahydropyranyl derivatives stems
from both steric and stereoelectronic factors.22 The initial, nucleophilic attack by enol ether 378
results in formation of the oxonium ion intermediate. Subsequent attack of the oxonium ion
intermediate by the secondary nucleophile is anticipated through one of two half-chair
conformations (408 and 409, Scheme 2.16). Attack of these half-chairs from the top or bottom
face through pathways a-d provides tetrahydropyrans 410-413.
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Half-chair conformers 408 and 409 exist in equilibrium, favoring half-chair 408, which
orients the propyl side chain pseudo equatorially. Addition of the secondary nucleophile through
both pathways a and d (Scheme 2.16) is disfavored based on stereoelectronic grounds. The
transition state for equatorial attack by the nucleophile requires a higher activation energy than
the transition state for axial attack. The increased activation energy is derived from the highenergy, boat-like transition state.
Both pathways b and c proceed through more favorable, lower energy chair-like
transition states. Of these pathways, c is disfavored on steric grounds. This transition state,
which orients the n-propyl group pseudo axially, develops a severe 1,3-diaxial interaction
Scheme 2.16

between the C6 substituent and the incoming nucleophile. Therefore b is the kinetically favored
pathway by which the selective secondary nucleophilic addition occurs.

The secondary

nucleophile preferentially adds trans to the C6 substituent, resulting in 2,6-cis-tetrahydropyran
product formation in reference to the propyl and -hydroxy side chains. These are also the
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thermodynamically favored products where both tetrahydropyranyl substituents occupy
equatorial positions.
Related trans-selective additions of nucleophiles to C6 substituted tetrahydropyranyl
oxocarbenium ions have been previously reported. Acetal 414 was treated with propargyl
trimethylsilane and Me3SiOTf to yield allene 416 diastereoselectively as the trans product
(Scheme 2.17).23 Lewis acid activation of the methoxy group leads to formation of oxonium ion
intermediate 415. Preferential, axial propargyl addition to the oxocarbenium ion from the top
face leads to allene 416 where the nucleophile has added trans to the C6 pentyl substituent. As
was explained in Scheme 2.16, this reaction proceeds through chair-like transition state 415 due
to its lower activation energy. This transition state also minimizes 1,3-diaxial interactions
between the C6 substituent and the incoming nucleophile.
Scheme 2.17
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Likewise, Lucero and Woerpel discovered that allyltrimethylsilane addition to a similar
oxonium intermediate formed from acetal 417 resulted in trans-selective tetrahydropyranyl
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product 78.24 Note the similarity of these examples to our transition state 408, which also favors
trans addition of the nucleophile in relation to pre-existing C6 substitutants.
Addition of silyl enol ethers to 6-substituted tetrahydropyranyl 2-benzenesulfones
preferentially produced the trans 2,6-products.25 Ley demonstrated that addition of sulfone 420
to a silyl enol ether generates solely trans product 421 under Aluminum trichloride promotion
(Scheme 2.18). Addition of the same sulfone to a trisubstituted silyl enol ether under the same
conditions produced solely the cis product 424. Ley also demonstrated the addition of other
nucleophiles to tetrahydropyranyl benzenesulfones including addition of trimethyl aluminum to
sulfone 420 to produce product 425.
Scheme 2.18
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Cis product 424 arises from the equilibration of ring-opened intermediate 423, which
originates from kinetic trans product 422. Ring opening followed by recyclization leads to
thermodynamic 2,6-cis product 424. Product 421 is not prone to isomerization because a methyl
group is substituted for the acidic proton, which resided on intermediate 422. The lack of acidic
proton prevents ring opening and isomerization, providing solely the kinetic product. In all cases
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production of the trans product predominates followed in some cases by thermodynamic
equilibration to the more stable 2,6-cis product.
Both

Ley26

Rovis27

and

groups

demonstrated

related

trans-selective

rearrangement/additions of C6 substituted tetrahydropyranyl acetals (Scheme 2.19). Acetal 427
Scheme 2.19
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was converted to the corresponding oxonium ion intermediate under Lewis acid catalysis.
Subsequent addition from the opposite face of the pendant C6 hexyl group resulted in the
expected trans-selective product 426. What all of these processes have in common is that they
are kinetically controlled, giving rise to the trans product. Under thermodynamic conditions the
cis-selective addition product predominates.15 We observed formation of the kinetically driven
trans-addition product.

This product is also the 2,6-cis-substituted product, which is

thermodynamically favored.
2.4 Conclusions
Our lab has developed the three component coupling of exo enol ethers and activated
electrophiles. This process is the first general method demonstrating the use of the exo enol
ethers as nucleophiles. The reaction proceeds in good to excellent yield with both aromatic and
aliphatic substituted enol ethers. The use of a highly activated electrophile is required, however,
which limits the reaction scope. Use of substoichiometric levels of Lewis acid led to low
product yields.

Titanium(IV) chloride produced the best results when used in equimolar

amounts, however, the need for stoichiometric quantities of Lewis acid is not ideal for
developing related asymmetric processes which typically utilize expensive substrates.
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The three component coupling process developed has demonstrated both a hydride and a
carbon nucleophile to act as secondary nucleophiles toward the intermediate oxonium ion.
Careful timing of secondary nucleophile addition to the oxonium ion intermediate formed is
important so as to avoid byproduct formation. Typically the time required to add the secondary
nucleophile is short. Presence of a preexisting C6 substituent caused for diastereoselective
addition the nucleophile. Overall this new method proved to be a useful way to synthesize
tetrahydropyranyl ketides, containing up to two new quaternary oxygenated centers, from
exocyclic enol ethers and activated electrophiles. This methodology we developed may have a
broad impact on natural product synthesis and is most useful in creating new bonds from two
carbon fragments.
2.5 Experimental
General Methods
All air sensitive reactions were performed in oven dried glassware under an atmosphere
of argon. Reaction solvents were dried over CaH2 (dichloromethane and pyradine) or
sodium/benzophenone ketyl (tetrahydrofuran) and were distilled just prior to use. Ethyl
glyoxylate and 2,3-butanedione were distilled just prior to use. Ethyl glyoxylate was distilled
according to the procedure of Evans.28 All other reagents were reagent grade and were purified
as necessary. Analytical thin layer chromatography was performed on EM silica gel 60 F254 glass
plates (0.25 mm). Flash column chromatography was performed using SiliaFlash P60 silica gel
(40-63 m) from SiliCycle, Inc. 1H NMR spectra were recorded on a Bruker Avance DPX-300
(300 MHz) spectrometer. Chemical shifts are reported in ppm, downfield from tetramethylsilane
using residual CHCl3 ( 7.27 ppm) as the internal standard. 13C NMR spectra were recorded on a
Bruker Avance DPX-300 (75 MHz) spectrometer with complete proton decoupling. Chemical
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shifts are reported in ppm, downfield from tetramethylsilane using residual CHCl3 as the internal
standard ( 77.0 ppm). IR spectra were obtained with a Thermo Nicolet IR-100 spectrometer on
NaCl plates. Elemental analyses were performed by Complete Analysis Laboratories, Inc.;
Parsippany, NJ. High resolution mass spectra were obtained using the positive ion electrospray
mode on a 3-Tesla FT mass spectrometer at The Ohio State University, Columbus, OH.

Experimental Procedures:
SOCl2
OH

O

pyridine

O
36

35

2-(Chloromethyl)tetrahydropyran 3.

Cl

Chloride 3 was prepared by a known literature

procedure,17 using 2-(hydroxymethyl) tetrahydropyran 379 (10.0 g, 86.2 mmol), pyridine (8.6
ml, 106 mmol), and thionyl chloride (7.6 ml, 103 mmol). The product was purified via
distillation (760mmHg, 70-75oC ) to give 7.26 g of chloride 3 as a colorless liquid (72% yield).
The identity of this compound was established by comparing 1H NMR data with that previously
reported.22 TLC: Rf = 0.61 (hexanes: EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz): δ 4.05 (1H, m),
δ 3.50 (4H, m), δ 1.90 (1H, m), δ 1.75-1.61 (5H, m).

KOH
O
36

Cl

+

reflux

O
24

38 : 1

O
37

2-Methylene tetrahydropyran 2. Enol ether 2 was formed by known literature procedure,29
using chloride 3 (3.86 g, 135 mmol), crushed potassium hydroxide (3.22 g, 57.3 mmol), and
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oven dried, base-washed glassware. Distillation (760 mmHg, 100-110oC) yielded the desired
enol ether (1.67 g) in a 60% yield in a ratio of 38:1 of 2 to 14. The resulting product was dried
over a minimal amount of sodium metal (0.10 g). The identity of enol ether 2 was established by
comparing 1H NMR data with that previously reported.28 TLC: Rf = 0.81 (hexanes: EtOAc, 2:1).
1

H NMR (CDCl3, 300 MHz): δ 4.31 (1H, s), δ 4.04 (1H, s), δ 3.88 (2H, m), δ 2.25 (1H, m) 1.72

(4H, m).

Cp2TiMe2
O
O
380

THF

O
378

Enol Ether 378: To a solution of -octanolactone 380 (1.38g, 9.7 mmol) in 70 mL THF was
added Cp2TiMe2 (39 mL of a 0.5M solution in THF, 19.5 mmol). The resulting mixture was
warmed to reflux and stirred for 24 h in the dark. The solution was then cooled to room
temperature, concentrated in vacuo, and the resulting residue was triturated with hexanes. (100
mL). The hexanes solution was filtered through celite and concentrated again. The residue was
purified via flash chromatography (SiO2; hexanes:triethylamine, 19:1) to afford the exocyclic
enol ether 378 as a yellow oil (0.82 g, 68%). TLC: Rf = 0.84 (hexanes: EtOAc, 10:1). 1H NMR
(CDCl3, 300 MHz):  4.30 (1H, d, J = 1.4 Hz), 4.04 (1H, d, J = 1.4 Hz), 3.59 (1H, m), 2.25 (1H,
dt, J = 14.0, 3.8 Hz), 2.12 (1H, m), 1.82 (1H, m), 1.74-1.32 (7H, m), 0.93 (3H, t, J = 6.9 Hz). 13C
NMR (CDCl3, 300 MHz):  160.6, 90.8, 78.9, 38.1, 30.3, 29.0, 22.7, 18.5, 14.0. IR (film): 3110,
2938, 2870, 1649 cm-1. HRMS (ESI) Calcd for C9H16O ([2M+Na]+): 303.2294, found 303.2288.
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O

THF
63%

113

O
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3,4-Dihydro-2-methylene-2H-1-benzopyran 112.

Enol ether 112 was prepared by known

literature procedure using dihydrocumarin 111 (0.96 g, 6.5mmol) and Cp2TiMe2 (0.5 M, 26ml).15
Purification via column chromatography (SiO2: 95% hexanes, 5% triethylamine) afforded the
product as a colorless oil (0.60 g) in a yield of 63 %. TLC: Rf = 0.80 (Hexanes: ethyl acetate;
10:1). The identity of enol ether 112 was established by comparing 1H NMR data with that
previously reported.30 1H NMR (CDCl3, 300 MHz): 7.17 (1H, m), 7.08 (1H, m), 6.91 (2H, m),
4.59 (1H, s), 4.17 (1H, s), 2.82 (2H, t, J = 5.1 Hz), 2.59 (2H, t, J = 5.1 Hz).

General Procedure for Three Component Coupling: To a stirred solution of the enol ether
(1.00 mmol) in 5 mL CH2Cl2 was added the carbonyl derivative (1.20 mmol). The resulting
mixture was cooled to -78°C and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2,
1.0 mmol) was added dropwise. After 5-60 minutes, triethylsilane or allyltrimethylsilane (1.00
mmol) was added dropwise and stirring continued for 5 hours at -78oC. Saturated NaHCO3 (2
mL) was then added carefully and the mixture was warmed to room temperature. The layers
were separated and the aqueous layer was extracted with additional CH2Cl2 (3x). The organic
layers were combined, dried over MgSO4, filtered, and concentrated in vacuo.
O
O
2

H

OH

TiCl4

+
CO2Et

triethylsilane

343

O

CO2Et

H
381

Tetrahydropyran 381: Production of tetrahydropyran 381 was conducted according to the
general procedure. Ethyl glyoxylate (0.12g, 1.20 mmol), 2-methylenetetrahydropyran (0.098g,
1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2, 1.0 mmol) were
combined in CH2Cl2 (5 mL) at –78oC. After stirring five minutes, triethylsilane (0.12g, 1.00
mmol) was added and stirring continued five more hours at –78oC. Upon workup, the residue
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was purified by flash chromatography (SiO2; hexanes:ethyl acetate, 10:1  5:1) to afford
tetrahydropyran 381 (0.17g, 86%) as a colorless oil (1:1 mixture of diastereomers). TLC: Rf =
0.46 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  4.40 (0.5H, m), 4.32 (0.5H, m), 4.24
(1H, dq, J = 7.0, 2.4 Hz), 4.23 (1H, q, J = 7.1 Hz), 3.99 (1H, dm, J = 11.2 Hz), 3.92 (1H, dm, J =
11.2 Hz), 3.56 (1H, m), 3.55 (0.5H, d, J = 3.3 Hz), 3.44 (0.5H, br s), 3.42 (1H, m), 1.97 (0.5H,
ddd, J = 14.4, 10.2, 3.2 Hz), 1.90 (1H, m), 1.82 (1H, m), 1.72 (0.5H, ddd, J = 14.4, 8.2, 2.6 Hz),
1.49 (3.5, m), 1.36 (0.5, m), 1.30 (3H, t, J = 7.1 Hz). 13C NMR (CDCl3, 75 MHz):  175.0, 174.3,
75.5, 74.8, 69.2, 68.5, 68.4, 68.2, 61.3, 61.2, 40.4, 40.1, 32.0, 31.7, 25.8, 25.7, 23.2, 23.2, 14.2,
14.1. IR (film): 3460, 2935, 2856, 1735 cm-1. Anal. Calcd for C10H18O4: C, 59.39%; H, 8.97%.
Found: C, 59.36%; H, 8.99%.
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Tetrahydropyran 387: Production of tetrahydropyran 387 was conducted according to the
general procedure. Ethyl glyoxylate (0.12g, 1.20 mmol), 2-methylenetetrahydropyran (0.098g,
1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2, 1.0 mmol) were
combined in CH2Cl2 (5 mL) at –78oC. After stirring five minutes, allyltrimethylsilane (0.11g,
1.00 mmol) was added and stirring continued five more hours at –78oC. Upon workup, the
residue was purified by flash chromatography (SiO2; hexanes:ethyl acetate, 15:1  8:1) to afford
tetrahydropyran 387 (0.13g, 55%) as a yellow oil (2:1 mixture of diastereomers). TLC: Rf = 0.53
(hexanes:EtOAc, 1:2).  5.78 (1H, m), 5.13 (2H, m), 4.52 (1H, m), 4.23 (0.7H, m), 4.23 (1.3H, q,
J = 7.1 Hz), 4.04 (0.3H, d, J = 2.8 Hz), 3.93 (0.7H, d, J = 2.9 Hz), 3.73 (2H, m), 2.62 (1H, dd, J
= 14.2, 6.6 Hz), 2.47 (0.3H, dd, J = 14.0, 7.2 Hz), 2.31 (0.7H, dd, J = 14.2, 7.9), 1.96 (2H, m),
1.78 (2H, m), 1.63 (1H, m), 1.53 (3H, m), 1.30 (2H, t, J = 7.1 Hz), 1.29 (1H, t, J = 7.1 Hz). 13C
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NMR (CDCl3, 75 MHz):  174.5, 133.2, 118.6, 118.3, 75.5, 68.5, 68.2, 61.5, 61.3, 41.1, 40.6,
39.4, 38.2, 33.0, 31.4, 29.7, 25.4, 18.8, 18.6, 14.2. IR: 3479, 3075, 2936, 2868, 1730, 1640 cm-1.
HRMS (ESI) Calcd for C13H22O4 ([M+Na]+): 265.1410, found 265.1405.
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Tetrahydropyran 388: Production of tetrahydropyran 388 was conducted according to the
general procedure. 2,3-Butanedione (0.10g, 1.20 mmol), 2-methylenetetrahydropyran (0.098g,
1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2, 1.0 mmol) were
combined in CH2Cl2 (5 mL) at –78oC. After stirring sixty minutes, triethylsilane (0.12g, 1.00
mmol) was added and stirring continued five more hours at –78oC. Upon workup, the residue
was purified by flash chromatography (SiO2; hexanes:ethyl acetate, 15:1  10:1) to afford
tetrahydropyran 388 (0.147g, 79%) as a yellow oil (4:1 mixture of diastereomers). TLC: Rf =
0.47 (hexanes:EtOAc, 3:1). 1H NMR (CDCl3, 300 MHz):  4.85 (0.2H, s), 4.36 (0.8H, s), 3.98
(0.2H, dm, J = 11.0 Hz), 3.80 (0.8H, dm, J = 10.8 Hz), 3.44 (0.8H, m), 3.37 (0.2H, m), 3.24 (1H,
m), 2.29 (0.6H, s), 2.22 (2.4H, s), 2.03 (0.2H, dd, J = 14.6, 2.0 Hz), 1.98 (0.8H, dd, J = 14.6,
10.1 Hz), 1.80 (1H, m), 1.75 (0.8H, dd, J = 14.6, 2.0 Hz), 1.71 (0.2H, dd, J = 14.4, 10.5 Hz),
1.48 (4H, m), 1.31 (2.4H, s), 1.27 (1H, m), 1.26 (0.6H, s). 13C NMR (CDCl3, 75 MHz):  212.1,
73.5, 68.3, 68.0, 45.7, 44.5, 32.3, 31.9, 29.7, 26.5, 26.2, 26.0, 25.7, 24.1, 23.4, 22.9. IR (film):
3462, 2931, 2857, 1710 cm-1. HRMS (ESI) Calcd for C10H18O3 ([M+Na]+): 209.1148, found
209.1145.
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Tetrahydropyran 389: Production of tetrahydropyran 389 was conducted according to the
general procedure. 2,3-Butanedione (0.10g, 1.20 mmol), 2-methylenetetrahydropyran (0.098g,
1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2, 1.0 mmol) were
combined in CH2Cl2 (5 mL) at –78oC. After stirring sixty minutes, allyltrimethylsilane (0.11g,
1.00 mmol) was added and stirring continued five more hours at –78oC. Upon workup, the
residue was purified by flash chromatography (SiO2; hexanes:ethyl acetate, 15:1  8:1) to afford
tetrahydropyran 389 (0.12g, 51%) as a colorless oil (2:1 mixture of diastereomers). TLC: Rf =
0.46 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  5.77 (1H, m), 5.10 (2H, m), 4.99
(0.7H, s), 4.63 (0.3H, s), 3.68 (1.4H, m), 3.60 (0.6H, m), 2.59 (0.7H, dd, J = 14.1, 6.4 Hz), 2.42
(0.3H, dd, J = 14.2, 6.1 Hz), 2.32 (2.1H, s), 2.31 (0.7H, dd, J = 14.1, 8.0 Hz), 2.31 (0.3H, d, J =
14.9 Hz), 2.23 (0.9H, s), 2.22 (0.3H, dd, J = 14.4, 5.3 Hz), 2.20 (0.7H, d, J = 14.7 Hz), 1.98
(0.3H, m), 1.95 (0.7H, d, J = 14.7 Hz), 1.79 (0.3H, d, J = 14.9 Hz), 1.60 (2H, m), 1.45 (3.7H, m),
1.26 (0.9H, s), 1.22 (2.1H, s). 13C NMR (CDCl3, 75 MHz):  215.7, 133.6, 133.4, 118.3, 118.1,
79.3, 78.7, 76.2, 75.0, 61.3, 61.3, 47.0, 45.9, 38.8, 37.8, 33.2, 32.1, 28.5, 28.4, 25.4, 25.2, 24.6,
18.9, 18.7. IR (film): 3445, 3075, 2933, 2863, 1711, 1639 cm-1. Anal. Calcd for C13H22O3: C,
68.99%; H, 9.80%. Found: C, 68.92%; H, 10.02%.
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Tetrahydropyran 391: Production of tetrahydropyran 391 was conducted according to the
general procedure. p-Nitrobenzaldehyde (0.18g, 1.20 mmol), 2-methylene-tetrahydropyran
(0.098g, 1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2, 1.0
mmol) were combined in CH2Cl2 (5 mL) at –78oC.

After stirring sixty minutes,

allyltrimethylsilane (0.11g, 1.00 mmol) was added and stirring continued five more hours at –
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78oC. Upon workup, the residue was purified by flash chromatography (SiO2; hexanes:ethyl
acetate, 15:1  8:1) to afford tetrahydropyran 391 (0.095g, 38%) as a colorless oil (1:1 mixture
of diastereomers). TLC: Rf = 0.44 (hexanes:EtOAc, 3:1). 1H NMR (CDCl3, 300 MHz):  8.91
(2H, dd, J = 8.9, 0.7 Hz), 7.54 (2H, m), 5.77 (1H, m), 5.18 (3H, m), 4.92 (0.4H, s), 4.87 (0.6H,
s), 3.81 (2H, m), 2.59 (2H, m), 1.72 (8H, m).

13

C NMR (CDCl3, 75 MHz):  152.6, 152.5, 147.0,

133.4, 132.7, 126.5, 126.2, 123.5, 118.8, 118.6, 77.2, 76.7, 76.6, 70.3, 70.0, 61.6 (2), 47.9, 46.3,
38.5, 37.3, 33.8, 30.4, 25.4, 25.3, 18.8, 18.4. IR (film): 3438, 2943, 1520, 1346 cm-1. HRMS
(ESI) Calcd for C16H21NO4 ([M+H]+): 314.1363, found 314.1361.
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Dihydrobenzopyran 398: Production of dihydrobenzopyran 398 was conducted according to the
general procedure. Ethyl glyoxylate (0.12g, 1.20 mmol), 5,6-benzo-2-methylenetetrahydropyran
(0.146g, 1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2, 1.0
mmol) were combined in CH2Cl2 (5 mL) at –78oC. After stirring five minutes, triethylsilane
(0.12g, 1.00 mmol) was added and stirring continued five more hours at –78oC. Upon workup,
the residue was purified by flash chromatography (SiO2; hexanes:ethyl acetate, 9:1  4:1) to
afford dihydrobenzopyran 398 (0.24g, 97%) as a colorless oil (1.5:1 mixture of diastereomers).
TLC: Rf = 0.41 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  7.08 (2H, m), 6.84 (1.4H,
m), 6.72 (0.6H, d, J = 8.1 Hz), 4.59 (0.4H, ddd, J = 9.9, 6.0, 2.9 Hz), 4.41 (0.6H, J = 9.8, 5.2
Hz), 4.35 (1H, m), 4.28 (2H, q, J = 7.2 Hz), 3.33 (0.6H, d, J = 4.5 Hz), 3.17 (0.4H, d, J = 6.0
Hz), 2.84 (2H, m), 2.18 (1.6H, m), 2.02 (1H, m), 1.82 (1.4H, m), 1.32 (1.2H, t, J = 7.4 Hz), 1.30
(1.8H, t, J = 7.1 Hz).

13

C NMR (CDCl3, 75 MHz):  175.0, 174.7, 154.3, 154.2, 129.4, 127.0,

121.8, 121.7, 120.1, 116.7, 116.5, 72.0, 71.6, 67.6, 67.5, 61.6, 40.0, 38.8, 27.8, 27.1, 24.6, 24.3,
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14.1, 14.0. IR (film): 3500, 3039, 2930, 2850, 1731, 1582, 755 cm-1. Anal. Calcd for C14H18O4:
C, 67.18%; H, 7.25%. Found: C, 66.97%; H, 7.12%.
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Dihydrobenzopyran 399: Production of dihydrobenzopyran 399 was conducted according to the
general procedure. Ethyl glyoxylate (0.12g, 1.20 mmol), 5,6-benzo-2-methylenetetrahydropyran
(0.146g, 1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2, 1.0
mmol) were combined in CH2Cl2 (5 mL) at –78oC.

After stirring five minutes,

allyltrimethylsilane (0.11g, 1.00 mmol) was added and stirring continued five more hours at –
78oC. Upon workup, the residue was purified by flash chromatography (SiO2; hexanes:ethyl
acetate, 9:1  5:1) to afford dihydrobenzopyran 399 (0.28g, 96%) as a colorless oil (1:1 mixture
of diastereomers). TLC: Rf = 0.59 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  7.09
(2H, m), 6.83 (2H, m), 5.88 (1H, m), 5.16 (2H, m), 4.52 (1H, m), 4.23 (1H, q, J = 7.1 Hz), 4.20
(1H, m), 3.30 (0.5H, dd, J = 14.7 Hz), 3.26 (0.5H, d, J = 4.8 Hz), 2.84 (2H, m), 2.60 (0.5H, dd, J
= 14.2, 6.7 Hz), 2.54 (1H, d, J = 7.5 Hz), 2.45 (0.5H, dd, J = 14.1, 8.0 Hz), 2.22 (0.5H, dd, J =
14.8, 2.9 Hz), 2.16 (0.5H, dd, J = 14.7, 2.9 Hz), 1.97 (3H, m), 1.28 (1.5H, t, J = 7.1 Hz), 1.26
(1.5H, t, J = 7.1 Hz).

13

C NMR (CDCl3, 75 MHz):  174.9, 174.6, 152.9, 132.8, 132.7, 129.3,

127.3, 127.2, 121.0, 120.8, 120.1, 118.9, 118.6, 117.2, 117.1, 77.4, 77.2, 67.8, 67.6, 61.5, 41.2,
41.0, 40.9, 40.7, 28.7, 28.3, 21.5, 21.4, 14.0. IR: 3524, 3076, 2932, 2855, 1730, 1640, 1582, 755
cm-1. Anal. Calcd for C17H22O4: C, 70.32%; H, 7.64%. Found: C, 70.41%; H, 7.59%.
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Dihydrobenzopyran 400: Production of dihydrobenzopyran 400 was conducted according to the
general procedure. 2,3-Butanedione (0.10g, 1.20 mmol), 5,6-benzo-2-methylenetetrahydropyran
(0.146g, 1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2, 1.0
mmol) were combined in CH2Cl2 (5 mL) at –78oC. After stirring sixty minutes, triethylsilane
(0.12g, 1.00 mmol) was added and stirring continued five more hours at –78oC. Upon workup,
the residue was purified by flash chromatography (SiO2; hexanes:ethyl acetate, 9:1  4:1) to
afford dihydrobenzopyran 400 (0.22g, 95%) as a yellow oil (5:1 mixture of diastereomers). TLC:
Rf = 0.52 (ethyl acetate: hexanes, 1:3). 1H NMR (CDCl3, 300 MHz):  7.07 (2H, m), 6.83 (1H,
m), 6.65 (1H, d, J = 8.1 Hz), 4.38 (1H, br s), 4.23 (1H, tt, J = 10.3, 2.1 Hz), 2.86 (1H, m), 2.74
(1H, m), 2.35 (0.5H, s), 2.34 (2.5H, s), 2.30 (0.83H, dd, J = 14.7, 10.3 Hz), 2.18 (0.17H, dd, J =
14.5, 3.3 Hz), 2.03 (0.17H, dd, J = 14.5, 9.1 Hz), 2.00 (0.83H, dd, J = 14.7, 2.0 Hz), 1.94 (1H,
m), 1.78 (1H, m), 1.40 (3H, s).

13

C NMR (CDCl3, 300 MHz):  214.3, 211.2, 154.1, 153.6,

129.7, 129.5, 127.2, 127.1, 121.8, 121.6, 120.8, 120.3, 116.4, 116.2, 79.2, 76.7, 74.2, 71.1, 45.2,
43.8, 28.1, 27.6, 26.8, 26.1, 24.8, 24.5, 24.0. IR (film): 3464, 3022, 2928, 1710, 1582, 755 cm-1.
Anal. Calcd for C14H18O3: C, 71.77%; H, 7.74%. Found: C, 71.83%; H, 7.82%.
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Dihydrobenzopyran 401: Production of dihydrobenzopyran 401 was conducted according to the
general procedure. 2,3-Butanedione (0.10g, 1.20 mmol), 5,6-benzo-2-methylenetetrahydropyran
(0.146g, 1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2, 1.0
mmol) were combined in CH2Cl2 (5 mL) at –78oC.
120

After stirring sixty minutes,

allyltrimethylsilane (0.11g, 1.00 mmol) was added and stirring continued five more hours at –
78oC. Upon workup, the residue was purified by flash chromatography (SiO2; hexanes:ethyl
acetate, 12:1  5:1) to afford dihydrobenzopyran 401 (0.27g, 97%) as a yellow oil (1:1 mixture
of diastereomers). TLC: Rf = 0.46 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  7.07
(2H, m), 6.84 (0.5H, m), 6.72 (0.5H, d, J = 8.1 Hz), 6.65 (1H, d, J = 8.2 Hz), 5.82 (1H, m), 5.14
(2H, m), 4.32 (0.5H, s), 4.19 (0.5H, s), 2.72 (2.5H, m), 2.53 (0.5H, d, J = 15.2 Hz), 2.38 (1.5H,
s), 2.33 (3H, m), 2.22 (1.5H, s), 2.10 (0.5H, d, J = 15.2 Hz), 1.89 (0.5H, ddd, J = 13.8, 5.8, 4.4
Hz), 1.76 (0.5H, ddd, J = 14.1, 6.0, 2.3 Hz), 1.66 (0.5H, m), 1.36 (1.5H, s), 1.34 (1.5H, s).

13

C

NMR (CDCl3, 75 MHz):  212.3, 211.2, 152.6, 152.5, 133.3, 132.8, 129.5, 129.4, 127.4, 127.2,
121.0, 120.9, 120.3, 120.2, 118.9, 118.8, 116.9, 116.6, 78.3, 78.0, 77.6, 77.3, 46.5, 45.9, 41.5,
39.6, 30.0, 28.4, 27.6, 24.4, 24.3, 21.6, 21.3. IR (film): 3458, 3075, 2930, 1709, 1583, 755 cm-1.
Anal. Calcd for C17H22O3: C, 74.42%; H, 8.08%. Found: C, 74.62%; H, 8.18%.
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Dihydrobenzopyran 402: Production of dihydrobenzopyran 402 was conducted according to the
general

procedure.

p-Nitrobenzaldehyde

(0.18g,

1.20

mmol),

5,6-benzo-2-

methylenetetrahydropyran (0.146g, 1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M
solution in CH2Cl2, 1.0 mmol) were combined in CH2Cl2 (5 mL) at –78oC. After stirring sixty
minutes, triethylsilane (0.12g, 1.00 mmol) was added and stirring continued five more hours at –
78oC. Upon workup, the residue was purified by flash chromatography (SiO2; hexanes:ethyl
acetate, 7:1  3:1) to afford dihydrobenzopyran 402 (0.26g, 87%) as a yellow oil (1:1 mixture of
diastereomers). TLC: Rf = 0.26 (hexanes:EtOAc, 3:1). 1H NMR (CDCl3, 300 MHz):  8.23 (2H,
121

d, J = 8.8 Hz), 7.60 (1H, d, J = 8.8 Hz), 7.59 (1H, d, J = 8.8 Hz), 7.11 (2H, m), 6.88 (2H, m),
5.29 (0.5H, m), 5.22 (0.5H, dd, J = 8.9, 3.8 Hz), 4.27 (1H, m), 3.66 (0.5H, d, J = 1.4 Hz), 3.06
(0.5H, d, J = 4.8 Hz), 2.85 (2H, m), 2.03 (4H, m). 13C NMR (CDCl3, 75 MHz):  154.0, 153.6,
152.0, 151.4, 147.2, 129.7, 129.7, 127.4, 127.3, 126.6, 126.4, 123.7, 121.8, 121.7, 120.9, 120.7,
116.6, 77.2, 75.9, 72.9, 72.8, 70.2, 44.8, 44.0, 28.0, 27.6, 24.6, 24.4. IR (film): 3564, 3077, 2925,
1606 , 1582, 1519, 1348 cm-1. HRMS (ESI) Calcd for C17H17NO4 ([M+Na]+): 322.1050, found
322.1049.
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Dihydrobenzopyran 403: Production of dihydrobenzopyran 403 was conducted according to the
general

procedure.

p-Nitrobenzaldehyde

(0.18g,

1.20

mmol),

5,6-benzo-2-

methylenetetrahydropyran (0.146g, 1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M
solution in CH2Cl2, 1.0 mmol) were combined in CH2Cl2 (5 mL) at –78oC. After stirring sixty
minutes, allyltrimethylsilane (0.11g, 1.00 mmol) was added and stirring continued five more
hours at –78oC.

Upon workup, the residue was purified by flash chromatography (SiO2;

hexanes:ethyl acetate, 12:1  5:1) to afford dihydrobenzopyran 403 (0.33g, 97%) as a yellow oil
(1:1 mixture of diastereomers). TLC: Rf = 0.52 (hexanes:EtOAc, 3:1). 1H NMR (CDCl3, 300
MHz):  8.21 (1H, d, J = 8.9 Hz), 8.20 (1H, d, J = 8.9 Hz), 7.56 (1H, d, J = 8.9 Hz), 7.14 (2H,
m), 6.92 (1H, m), 6.86 (1H, d, J = 8.0 Hz); 5.80 (1H, m), 5.24 (3H, m), 4.09 (0.5H, d, J = 0.8
Hz), 3.81 (0.5H, d, J = 1.4 Hz), 2.81 (3H, m), 2.45 (1H, m), 2.36 (1H, m), 1.94 (3H, m).
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C

NMR (CDCl3, 75 MHz):  152.3, 152.1, 152.1, 152.0, 132.3, 132.2, 129.7, 129.7, 127.7, 127.6,
126.5, 126.3, 123.7 123.7, 121.1, 121.0, 119.7, 119.4, 117.5, 117.1, 79.1, 78.7, 70.1, 70.0, 47.2,
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46.2, 41.2, 39.3, 30.0, 27.4, 21.5, 21.2. IR (film): 3564, 3077, 2855, 1640, 1583, 1518, 1347 cm1

. Anal. Calcd for C20H21NO4: C, 70.78%; H, 6.24%. Found: C, 71.07%; H, 6.44%.
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Tetrahydropyran 404: Production of tetrahydropyran 404 was conducted according to the
general procedure. Ethyl glyoxylate (0.12g, 1.20 mmol), 2-methylene-6-propyltetrahydropyran
(0.140g, 1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2, 1.0
mmol) were combined in CH2Cl2 (5 mL) at –78oC. After stirring five minutes, triethylsilane
(0.12g, 1.00 mmol) was added and stirring continued five more hours at –78oC. Upon workup,
the residue was purified by flash chromatography (SiO2; hexanes:ethyl acetate, 15:1  8:1) to
afford tetrahydropyran 404 (0.19g, 77%) as a colorless oil (5:1 mixture of diastereomers).
Relative stereochemistry about the tetrahydropyran was determined by NOE. TLC: Rf = 0.41
(hexanes:EtOAc, 3:1).

1

H NMR (CDCl3, 300 MHz):  4.42 (0.83H, dt, J = 7.4, 3.2 Hz), 4.36

(0.17H, m), 4.23 (2H, m), 3.94 (0.17H, d, J = 2.8 Hz), 3.72 (0.83H, d, J = 7.4 Hz), 3.62 (0.17H,
m), 3.57 (0.83H, m), 3.31 (1H, m), 1.96 (1H, m), 1.80 (2H, m), 1.62-1.25 (9H, m), 1.30 (3H, t, J
= 7.1 Hz), 0.91 (3H, t, J = 7.3 Hz). 13C NMR (CDCl3, 300 MHz):  174.9, 77.8, 77.8, 76.4, 75.3,
70.2, 69.2, 61.2, 39.8, 39.8, 38.5, 38.5, 31.7, 31.6, 31.4, 31.2, 23.4, 23.4, 18.8, 18.7, 14.2, 14.2,
14.1. IR (film): 3480, 2932, 2863, 1733 cm-1. HRMS (ESI) Calcd for C13H24O4 ([M+Na]+):
267.1567, found 267.1563.
Key NOE Enhancements:
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Tetrahydropyran 405: Production of tetrahydropyran 405 was conducted according to the
general procedure. Ethyl glyoxylate (0.12g, 1.20 mmol), 2-methylene-6-propyltetrahydropyran
(0.140g, 1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2, 1.0
mmol) were combined in CH2Cl2 (5 mL) at –78oC.

After stirring five minutes,

allyltrimethylsilane (0.11g, 1.00 mmol) was added and stirring continued five more hours at –
78oC. Upon workup, the residue was purified by flash chromatography (SiO2; hexanes:ethyl
acetate, 15:1  8:1) to afford tetrahydropyran 405 (0.19g, 67%) as a yellow oil (1:1 mixture of
diastereomers). Relative stereochemistry about the tetrahydropyran ring was determined by NOE
studies on the corresponding ketone. TLC: Rf = 0.46 (hexanes:EtOAc, 3:1). 1H NMR (CDCl3,
300 MHz):  5.73 (1H, m), 5.12 (2H, m), 4.68 (0.5H, d, J = 1.3 Hz), 4.58 (1.5H, m), 4.22 (1H,
dq, J = 7.1, 0.7 Hz), 4.21 (1H, q, J = 7.1 Hz), 3.60 (1H, m), 2.71 (1H, m), 2.45 (0.5H, ddd, J =
14.1, 6.9, 1.2 Hz), 2.18 (0.5H, dd, J = 14.5, 8.1 Hz), 2.08 (1H, m), 1.75 (3H, m), 1.62 (3H, m),
1.36 (4H, m), 1.30 (1.5H, t, J = 7.1 Hz), 1.29 (1.5H, t, J = 7.1 Hz), 1.16 (1H, m), 0.88 (1.5H, t, J
=7.1 Hz), 0.87 (1.5H, t, J =7.1 Hz). 13C NMR (CDCl3, 75 MHz):  173.7, 133.2, 132.9, 118.5,
118.4, 77.1, 70.4, 70.1, 69.0, 68.7, 61.0, 61.0, 43.3, 42.2, 39.0, 38.8, 38.5, 35.7, 32.7, 31.1, 31.0,
30.2, 19.1, 19.0, 18.7, 18.6, 14.2, 14.1, 14.0. IR (film): 3468, 3075, 2934, 2871, 1732 cm-1.
HRMS (ESI) Calcd for C16H28O4 ([M+Na]+): 307.1880, found 307.1878.
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Tetrahydropyran 406: Production of tetrahydropyran 406 was conducted according to the
general procedure. 2,3-Butanedione (0.10g, 1.20 mmol), 2-methylene-6-propyltetrahydropyran
(0.140g, 1.00 mmol), and titanium(IV) chloride (1.0 mL of a 1.0 M solution in CH2Cl2, 1.0
mmol) were combined in CH2Cl2 (5 mL) at –78oC. After stirring sixty minutes, triethylsilane
(0.12g, 1.00 mmol) was added and stirring continued five more hours at –78oC. Upon workup,
the residue was purified by flash chromatography (SiO2; hexanes:ethyl acetate, 15:1  8:1) to
afford tetrahydropyran 406 (0.13g, 56%) as a colorless oil (2:1 mixture of diastereomers).
Relative stereochemistry about the tetrahydropyran ring was determined by NOE. TLC: Rf =
0.65 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  5.16 (0.3H, s), 4.45 (0.7H, s), 3.50
(1H, m), 3.28 (0.3H, m), 3.15 (0.7H, m), 2.30 (1H, s), 2.24 (2H, s), 2.01 (1H, m), 1.77 (1H, dd
14.6, 1.9 Hz), 1.70 (1H, m), 1.57-1.08 (9H, m), 1.31 (2H, s), 1.25 (1H, s), 0.90 (1H, t, J = 7.3
Hz), 0.88 (2H, t, J = 7.2 Hz). 13C NMR (CDCl3, 75 MHz):  216.5, 212.0, 80.3, 77.9, 77.6, 77.1,
76.7, 73.3, 45.4, 44.2, 38.4, 38.3, 32.0, 31.7, 31.2, 31.1, 26.3, 26.1, 24.6, 24.2, 23.5, 23.1, 18.9,
18.6, 14.2, 14.0. IR (film): 3463, 2932, 2862, 1711, cm-1 HRMS (ESI) Calcd for C13H24O3
([M+Na]+): 251.1618, found 251.1614.
Key NOE enhancements:
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Tetrahydropyran 407: To a solution of alcohol 405 (0.020g, 0.070 mmol) in CH2Cl2 (0.35 mL)
was added Dess-Martin periodinane (0.034g, 0.081 mmol) and solid NaHCO3 (0.029g, 0.350
mmol). The reaction mixture was stirred at rt for two hours, after which time the reaction was
shown to be complete by TLC. Hexane (4 mL) was added and the resulting solution was gravity
filtered to remove precipitates. The filtrate was concentrated in vacuo, and the residue was
purified by flash column chromatography (SiO2; 50:1, hexanes:EtOAc) to provide
tetrahydropyran 407 (0.013 g, 66%) as a colorless oil. TLC: Rf = 0.79 (hexanes:ethyl acetate,
3:1). 1H NMR (CDCl3

5.79 (1H, m), 5.12 (2H, m), 4.25 (2H, dq, J = 7.2, 1.8 Hz),

3.50 (1H, m), 3.43 (1H, d, J = 12.6 Hz), 2.69 (1H, ddt, J = 14.4, 6.1, 1.4 Hz), 2.44 (1H, d, J =
12.6 Hz), 2.27 (1H, dd, J = 14.4, 8.3 Hz), 1.66 (2H, m), 1.56 (2H, m), 1.50 (1H, dm, J = 14.0
Hz), 1.38 (1H, m), 1.36 (3H, t, J = 7.2 Hz), 1.25 (3H, m), 1.09 (1H, m), 0.87 (3H, t, J = 7.0 Hz).
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C NMR (CDCl3

195.4, 162.2, 133.2, 118.5, 76.5, 69.9, 61.9, 47.8, 38.8, 37.3,

31.6, 30.9, 19.2, 18.5, 14.1. 13.9. IR (film): 3077, 2937, 2871, 1728, 1640 cm-1. HRMS (ESI)
Calcd for C16H26O4 ([M+Na] +): 305.1723, found 305.1718.
Key NOE enhancements:
O
O
H
H
H
H
NOE
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Chapter 3: Carbonyl-Ene Reactions of Exocyclic Enol Ethers: Chiral Induction Studies
3.1 Overview
Since its discovery nearly seventy years ago, the ene reaction has found abundant utility
in making carbon-carbon bonds. Carbonyl-ene reactions are one segment of this chemistry and
combine olefins with oxygenated double bonds. Herein we discuss the carbonyl-ene reaction of
exocyclic enol ethers, again demonstrating their inherit nucleophilicity.

Specifically chiral

induction from substrate to ene product is studied on 2-methylenetetrahydropyrans with one or
two pre-existing stereocenters.
This chapter will briefly review carbonyl-ene chemistry, focusing on diastereoselective
processes. Previous research in this field focused on the production of racemic mixtures of hydroxydihydropyrans from carbonyl-ene reactions of exocyclic enol ethers and a variety of
aldehydes and ketones. The utility of this carbon-carbon bond forming transformation would be
enhanced through control of the newly formed stereocenter. Chiral induction from the enol ether
to the resulting product is discussed here. Seven new substituted 2-methylenetetrahydropyrans
were synthesized, three enol ethers containing one chiral center and four possessing two
stereocenters. These exo enol ethers were subsequently subjected to carbonyl-ene conditions,
which involved catalytic zinc chloride and aldehydes with a range of reactivity (Scheme 3.1).
The extent of chiral induction these enol ethers have on the resulting -hydroxydihydropyran
products is discussed.
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3.2 Background and Significance
Previous work in our lab demonstrated the inherent nucleophilic nature of 2-methylenetetrahydropyrans through their use in the three component coupling with electron deficient
aldehydes and secondary nucleophiles.

This coupling reaction successfully produced

synthetically useful -hydroxy-tetrahydropyranyl ketides, but only with the use of titanium(IV)
chloride as the Lewis acid. Other Lewis acids were screened, but failed to yield the desired
tetrahydropyran product.

Although this is a useful method for the introduction of

tetrahydropyran moieties, the reaction is somewhat limited in scope and utility for natural
product synthesis.

Ultimately, the goal was to find a more general method towards

tetrahydropyranyl ketide synthesis that would take place under mild conditions.
Further evaluation of reaction conditions associated with the three component coupling
reaction led to the discovery that zinc chloride promoted a similar process, the ene reaction of 2methylenetetrahydropyrans with aldehydes and activated ketones.

Even in the presence of

triethylsilane, carbonyl-ene products were formed, which upon treatment with BF3OEt2 and
triethylsilane, provided tetrahydropyran products (Scheme 3.2). This transformation holds
Scheme 3.2
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advantage over the three component coupling reaction in that milder reaction conditions are
used.

Zinc(II) chloride, a mild Lewis acid, promoted minor carbonyl activation without

decomposition of the labile exo enol ether. The use of a mild Lewis acid allows the carbonyl to
participate in the reaction and abstract a hydrogen, six atoms away, thus leading to the carbonyl131

ene product. A strong Lewis acid like titanium(IV) chloride binds tightly to the carbonyl oxygen
and prevents oxo-addition until work-up. The formation of these ene adducts inspired further
investigation.
The Carbonyl-Ene Reaction: Mechanism and Transition States of Thermal and Lewis
Acid Promoted Processes
The ene reaction has proven to be a valuable carbon-carbon bond-forming technique
since Alder highlighted it in his 1943 publication1 and has been studied on a wide variety of
substrates.2 Ene reactions are defined as pericyclic processes between an olefin possessing an
allylic hydrogen 429 and an enophile 430 that contains an electron deficient multiple bond
(Scheme 3.3). This reaction involves the transfer of the allylic hydrogen to the enophile oxygen,
an allylic shift of the ene olefin, and bonding between the two alkenyl termini.
Scheme 3.3
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Although mechanistically similar to the Diels-Alder reaction, the ene reaction possesses a
higher activation energy when comparing bond dissociation energies between the two systems.
The Diels-Alder mechanism requires breakage of only pi bonds. On the other hand, two of the
electrons involved in the ene pericyclic process originate from a sigma bond. Sigma bonds
possess higher bond dissociation energies than pi bonds, resulting in higher overall reaction
activation energies. These two reactions are nonetheless mechanistically similar and with use of
certain substrates ene byproducts can be detected in the Diels-Alder reaction and vice versa.
The ene reaction mechanism ranges from a concerted (432) to a zwitterionic (434)
process based on the substrates at hand (Scheme 3.4). If simultaneous bond making at both ends
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of the ene terminus is geometrically unfavorable and to a lesser extent if radical intermediates
can be stabilized, a stepwise radical mechanism can also prevail (433).2a

In the stepwise

biradical approach radical intermediates like 436 are formed, which inevitably leads to some
cyclobutane
Scheme 3.4
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438 formation (Scheme 3.5).3 Thus the presence of cyclobutane derivatives indicates a radical
stepwise mechanism. Ene reactions of substrates without strained transition states, however,
typically follow a truly concerted course in the case of thermal, all carbon systems, or a partial
ionic mechanism.
Scheme 3.5
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Whether the mechanism is concerted, stepwise, or somewhere in-between, ene reactions
involving Lewis acids undoubtedly develop a positive charge to some extent on the ene
component.4 Ene reactions that exhibit any level of concerted mechanism, proceed through a
single-barrier process, which can yield products with good stereoselectivity. The purely stepwise cationic method, on the other hand, proceeds through a cationic intermediate. Either
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formation of the cationic intermediate or the secondary hydride transfer can be rate determining.
In the latter case, creation of the cationic intermediate is reversible.
Deuterium isotope effects can aid in determining the type of mechanism the ene reaction
proceeds through. Ene reactions of deuterated ene 439 and oxomalonate 440 were studied under
both thermal and Lewis acid catalyzed conditions (Scheme 3.6).5 A primary deuterium isotope
Scheme 3.6
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effect was observed for the thermal reaction. This result arises from CH bond-breakage in the
transition state, indicating a concerted mechanism. The minimal primary isotope effect observed
for the Lewis acid catalyzed ene reaction, however, indicates a concerted mechanism in which
CH bond breakage has only minimally progressed in the transition state. The transition state
would possess a partial cationic charge associated with the ene component. If a truly cationic
mechanism prevailed no primary isotope effect would be expected.

Without these kinetic

studies, however, it is not always clear exactly what mechanism the ene reaction follows for
different substrates.
A number of different enophiles have been utilized in ene reactions (Scheme 3.7). These
include substrates from four different groups: carbon-carbon multiple bonds (olefinic,6
acetylenic,7 an benzyne8), carbon-hetero multiple bonds (C=O,9 C=N,10 C=S,11 and CP12),
hetero-hetero multiple bonds (N=N,13 O=O,14 Si=Si,15 N=O,16 and S=O17), cumulene systems
(N=S=O,18 N=S=N,19 C=C=O,20 C=C=S,8 and O=S=O21), as well as other charged pi systems
(C=N+,22 C=S+,23 CN+,24 and CO+25).
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Aldehydes, ketones, and glyoxylates are commonly used in carbonyl-ene reactions and
will be the only substrates examined in any detail due to their relevance to the reactions
discussed herein. The carbonyl enophiles are more reactive than olefins in the ene reaction, and
these types of reactions are effectively promoted by Lewis acids. The advantages to Lewis acid
catalyzed processes over thermal are two fold, and the differences associated with these two
processes are discussed herein. The use of a metal catalyst provides possible asymmetric control
over the reaction, while avoiding undesired byproduct formation often accompanied with high
temperatures.
Scheme 3.7
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Alcohols 444 are exclusively produced from carbonyl-ene reactions rather than the
corresponding ethers based on thermodynamic and stereoelectronic grounds. Ether 445
formation is avoided due to the greater gain in bond energy for the reaction (Scheme 3.8).26 The
carbon-oxygen double bond is also naturally polarized such that the carbon is electrophilic and
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set up to accept a bond from the electron-rich ene. Coordination of Lewis acids to the oxygen
portion of the carbonyl further polarizes the carbon-oxygen bond and activates the carbon center
for nucleophilic addition, thus avoiding the need for a thermal process.
Scheme 3.8
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The large activation energy associated with the ene reaction lends to its facilitation with
either thermal or Lewis acid conditions. The two processes differ in mechanism, transition state,
and the major diastereomer products formed. As previously mentioned, the mechanism of the
ene reaction may differ for thermal based processes versus Lewis acid promoted ones. The
thermal reaction typically undergoes a completely concerted mechanism while the Lewis acidpromoted reaction contains a partial cationic intermediate or transition state.
Based upon their mechanistic differences, the thermal ene reactions generally produce
products that stem from sterically accessible olefins and allyic hydrogens whereas Lewis acidpromoted processes produce products based on reaction intermediate stability. For example,
when diene 446 is added to dimethyl oxomalonate 447 under thermal conditions, product 448
prevails (Scheme 3.9).27 The more sterically accessible terminal olefin preferentially reacts.
Alternatively, the same reactants produce primarily product 449 under Lewis acid catalyzed
conditions. Here, a partial positive charge develops on the ene reactant. Progression to this
intermediate is rate determining and therefore addition occurs from the tri-substituted olefin,
preferentially producing product 449 as a result.
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Scheme 3.9
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The thermal ene reaction develops an early envelope-like transition state structure 450
between the ene and enophile substrates (Figure 3.1).28 Although planar in both the reactants
and products, in this transition state C5 distorts slightly from planarity to maximize p orbital
overlap between the C5 carbon and those p or slightly hybridized p orbitals of C6 and C4.
Through this orientation, the C5 carbon is able to maximize its pi overlap with C6 until the pi
bond between C5 and C4 has significantly developed. Notably, substitution of formaldehyde for
ethylene resulted in little change in this transition state conformation. Alternatively, in the case
of carbonyl-ene reactions, Lewis acid promotion results in chair-like late transition states 451,
which minimize torsional and steric strain in six-membered processes.29
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The difference in transition state between the two ene reactions lends to variations in their
diastereocontrol. The thermal carbonyl-ene reaction of 2-methyl-2-butene 452 with chloral 453
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results in production of anti isomer 455 (84%) versus production of primarily the syn isomer 454
(85%) under Lewis acid catalysis (Scheme 3.10).30 The thermal reaction proceeds through either
envelope-like transition state 456 or 457 (Scheme 3.11). Transition state 456
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predominates due to the steric repulsion experienced between the methyl and trichloro groups
within transition state 457, therefore favoring formation of the anti ene diastereomer. The Lewis
Scheme 3.11
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acid catalyzed reaction, which undergoes a chair-like transition state, favored syn product
formation because 1,3-diaxial steric repulsions are avoided. Thus, thermal and Lewis acid
catalyzed processes have been proven to preferentially produce products of opposite
stereochemistry based solely upon the transition state geometry.
Furthermore internal asymmetric induction may be observed in ene systems where
favorable secondary orbital overlap can occur in the transition state. Berson demonstrated the
thermal ene reaction between maleic anhydride and cis-2-butene to proceed preferentially
through endo transition state 462 (Scheme 3.12).31 Like the Diels Alder reaction, the activation
Scheme 3.12
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energy of the endo transition state is reduced by secondary p-orbital overlap between the ene and
enophile. The exo transition state does not experience the same stabilization and leads to a
product with the opposite relative stereochemistry. The reaction of malic anhydride with cis-2butene resulted in production of products 463 and 465 in a 85:15 ratio, in favor of the endo
product. Trans-2-butene, on the other hand, resulted in a 43:57 ratio of products. A decrease in
selectivity is observed due to competing steric influences associated with the trans methyl group.
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Ene reactions of cis and trans decanes delivered similar results, indicating again that the endo
transition state can be sensitive to steric effects.32
The carbonyl-ene reactions of ethyl glyoxylate 343 were studied under both thermal and
Lewis-acid catalysis to determine endo/exo transition state bias.33

The reaction of ethyl

glyoxylate and cis-2-butene at 200oC resulted in a 88:12 diastereomeric mixture of products
favoring anti isomer 466, which resulted from the endo transition state (Scheme 3.13). The
reaction of trans-2-butene again resulted in lower product selectivity (36:64) due to competing
steric interactions, but nonetheless produced endo, syn product 467 as the major isomer.
Promotion of the carbonyl-ene reaction of cis-2-butene with Fe(III) chloride produced the
desired ene adducts, favoring the anti isomer, but with much lower selectivity (58:42) than the
thermal reaction.
Scheme 3.13
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Carbonyl-Ene Reactions of Enol Ethers
Ene reactions of enol ethers are limited in the literature to the asymmetric work of
Careirra34 and Jacobsen.35 Careirra combined aldehydes and 2-methoxypropene 468 along with
a chiral titanium(IV) binol complex to provide the -hydroxyketones 470 in good to excellent
yields after aqueous acidic workup (Scheme 3.14). Similarly, Jacobsen demonstrated both 2methoxypropene and the TMS equivalent to react with aldehydes under chromium(III) complex
catalysis (Scheme 3.15). The work of these two authors focuses specifically on enantioselective
examples and will be discussed later in this work (Tables 3.6 and 3.7).
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Carbonyl-ene reactions involving exocyclic enol ethers, the focus of this chapter, are
underutilized in the literature. Only one general method has been established,36 and other
examples are restricted to one report where product formation is driven by aromatization37 and
an instance of byproduct formation from a Diels-Alder reaction.38
In 2005 Miles et al. 39 developed a strategy towards the synthesis of -hydroxy furans via
the carbonyl-ene reaction of 2-methylene-2,5-dihydrofuran 474 with various enophiles.
selection of their results is included in Table 3.1. The reaction with highly activated enophile
Table 3.1: Carbonyl Ene Reactions of 2-Methylene-2,5-dihydrofuran
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A

ethyl glyoxylate 343 proceeded in excellent yield without Lewis acid activation (entry 1).
Good to excellent yields were obtained for non-activated enophiles 477 and 479 as well through
Lewis acid catalysis with both zinc(II) chloride and Yb(fod)3 (entries 2 and 3). Although this
methodology presents an efficient method toward stereoselective -hydroxy furan synthesis, it
varies greatly from the carbonyl-ene methodology of simple exo enol ethers in that aromatization
drives the reaction forward.
Rizzacasa has demonstrated the formation of -hydroxy dihydropyran 484 as a byproduct
of the Diels Alder reaction.40

Combination of enol ether 481 with enone 482 resulted in

formation of hetero-Diels Alder product 483 and ene biproduct 484 (Table 3.2). Under purely
Table 3.2: Pericyclic Reaction Conditions of Enol Ether 481

thermal conditions only the desired Diels Alder product was detected albeit in low yield (entry
1). A slight improvement in yield was obtained by performing the reaction neat (entry 2). The
authors then turned to Lewis acid catalyzation with lanthanide catalyst Eu(fod)3 to improve the
yield of Diels Alder adduct 483, however ene adduct 484 also resulted as a mixture of
diastereomers in a 1:1.3 ratio respectively (entry 3). Again performing this reaction neat resulted
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in a reasonable yield of Diels Alder adduct 483 such that it could be later transformed into
reveromycin A.
Recently, a general method has been developed in the Totah group that demonstrates the
ability of exocyclic enol ethers to undergo the carbonyl-ene reaction.41 This research combined
exocyclic enol ethers with a variety of enophile substrates to provide -hydroxy dihydropyrans
in excellent yields under zinc(II) chloride catalysis. The reaction benefits from low catalyst
loading, use of equimolar quantities of enol ether and enophile, and wide enophile substrate
scope as depicted in Table 3.3.
Highly activated aldehyde ethyl glyoxylate 343 reacted quickly in excellent yield with
low catalyst loading (entry 1). Likewise, the activated ketone ethyl pyruvate 369 resulted in
excellent yields of product 488, although longer reaction time (15 h) was required (entry 2).
Aromatic aldehydes bearing both electron withdrawing (383, entry 3) and electron donating
(491, entry 5) groups worked well as enophile components, although the non-activated aromatic
aldehydes 479 and 491 required longer reaction times and higher catalyst loadings (entries 4 and
5). Only moderate yields were obtained with conjugated aldehyde 493 (entry 6). Excellent
yields were obtained for the carbonyl-ene reaction with aliphatic aldehydes octyl aldehyde 496
and cyclohexylaldehyde 497 (entries 7 and 8).
As demonstrated, reactive enophile components range from highly activated (343) to
somewhat deactivated aldehydes (491) and include activated ketones (369). Secondarily, other
aromatic and C3-substituted exocyclic enol ethers were screened for use in the carbonyl-ene
reaction and the results are shown in Tables 3.4 and 3.5. Both the dihydrocoumarin derived enol
ether 112 and the 6,6-diphenyl exocyclic enol ether 499 reacted quickly to produce ene adducts
in excellent yields with the use of highly activated ethyl glyoxylate 343 (entries 1 and 2).
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Table 3.3: Carbonyl-Ene Reactions of 2-Methylenetetrahydropyran
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Coupling with p-nitrobenzaldehyde, a lesser activated enophile component, resulted in high yield
for enol ether 499 (entry 4), however enol ether 112 required a longer reaction time and higher
catalyst loading to produce moderate yields of the desired ene adduct (entry 3).
Enol ether 112 suffers from deactivation by the aromatic ring, which pulls electron
density from the ene component through resonance (Scheme 3.16).

With highly activated

enophile substrates, use of deactivated exocyclic enol ether 112 had little effect on yield. The
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Table 3.4: Carbonyl-Ene Reactions of Substituted Exocyclic Enol Ethers
O
H

O

Entry

ZnCl2

+

R

R'

O

0.5M, THF, rt

Enophile

Enol Ether

OH

R

R'

Time

mole % ZnCl2

Yield

1 hr

5

91%

1 hr

5

90%

72 hr

20

48%

6 hr

5

99%

O
1
H

O
112

CO2Et
343
O

2

Ph
Ph

H

O
499

CO2Et
343

O
H

3
O
112

383

NO2

O
4

Ph
Ph

H
O
383

499

NO2

reaction of enol ether 112 with less reactive enophiles resulted in lower product yields, in the
case of p-nitrobenzaldehyde 383 (entry 3), or no product production in the case of non-activated
octyl aldehyde 495.
Scheme 3.16
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Exo enol ethers bearing C3 substitution increase the steric bulk at the reaction center.
Therefore these enol ethers were studied to determine the effect of C3 substitution on the
carbonyl-ene reaction rate. Reaction of the C3-substituted enol ethers 503 and 504 resulted in the
desired ene adducts in moderate to excellent yields (Table 3.5). Combination with highly
activated ethyl glyoxylate 343 resulted in excellent yields (entries 1 and 2). However, the
reaction rate of C3-substituted enol ethers 503 and 504 decreased upon subjection to p-nitrobenz145

Table 3.5: Carbonyl-Ene Reactions of C3-Substituted 2-Methylenetetrahydropyrans
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aldehyde 383. Both enol ethers required longer reaction times (entries 3 and 4) compared to 2methylenetetrahydropyran 2 (Table 3.3, entry 3) and in the case of enol ether 503, a higher
catalyst loading.
The decrease in reaction rate indicates that the carbonyl-ene mechanism is concerted. As
previously discussed,27 the rate of the concerted ene reaction is affected by sterics at the reaction
center. Therefore the decrease in reaction rate seen going from 2-methylenetetrahydropyran,
which is an unhindered substrate, to 3-methyl or 3-allyl-2-methylenetetrahydropyran, sterically
hindered substrates, indicates a concerted reaction mechanism. To support this data, exo enol
ether 504 was additionally studied with non-activated octyl aldehyde 495 (Table 3.5, entry 5).
Again this reaction demonstrates a decrease in the reaction rate using C3-substituted enol ethers.
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Both longer reaction time and a higher catalyst loading were required for modest yields of the
ene adduct as compared to the 2-methylenetetrahydropyran example (Table 3.3, entry 7).
This carbonyl-ene reaction of exocyclic enol ethers yields similar products as the threecomponent coupling methodology outlined in chapter 2. The dihydropyran products of the
carbonyl-ene reaction, however, are prone to hydrolysis, and therefore the best reaction yields
were obtained when purification via column chromatography immediately followed reaction
completion. An aqueous workup was avoided because the addition of water facilitates the
production of open-chain hydrolyzed byproduct 505 (Scheme 3.17).42

Nonetheless the

advantages of the carbonyl-ene methodology over the three component coupling reaction include
the use of catalytic amounts of a mild Lewis acid (5-20 mol%), a wider substrate scope (use of
non-activated aldehydes and ketones), and room temperature reaction conditions.
Scheme 3.17

The carbonyl-ene reaction of enol ethers results in formation of a new stereogenic center
at the hydroxy carbon.

Control of this newly formed chiral center has importance in the

reaction’s application to natural product synthesis. Methods to induce stereocontrol in the ene
reaction include enantioselective chiral catalysis and diastereoselective chiral induction derived
from chiral reactants. The latter is the focus of this work.
Asymmetric Carbonyl-Ene Reactions of Enol Ethers
Enantioselective carbonyl-ene reactions have been extensively studied through use of
chiral catalysis.43 These asymmetric ene reactions represent a large topic that lies outside of the
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scope of the current discussion, therefore this discussion will be restricted to enantioselective
carbonyl-ene reactions of enol ethers.
Careirra first demonstrated the use of enol ethers in carbonyl-ene reactions toward the
manufacture of -hydroxy ketones.44 Catalyzation of this process by titanium(IV) complex 506
(Figure 3.2) led to the desired chiral enol ether intermediates 507, which upon aqueous acidic
workup produced the -hydroxyketone products in good to excellent yields (Table 3.6). The 2methoxypropene enol ether was used as solvent in these cases as the reaction would not proceed
Figure 3.2

upon dilution. Excellent enantioselectivities were obtained with use of non-hindered enophiles
such as acetylenic and aliphatic aldehydes (Table 3.6, entries 1 and 2). Lower selectivities were
observed using aromatic aldehydes (entries 3 and 4).
Table 3.6: Carreira Carbonyl-Ene Reactions of Enol Ethers
O
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Jacobsen later developed an ene methodology utilizing chiral tridentate schiff base
chromium(III) complexes 509 and 510 (Figure 3.3) as catalysts in the ene reaction of both enol
Figure 3.3

tBu

N OH2 O
Cr
X

O

Cl

Cl

O

X

Cr
O

OH2 N

t

Bu

X = Br (509)
X = OTIPS (510)

ethers and silyl enol ethers.45 Pre-stirring the catalyst with desiccant barium oxide for five hours
maximized enantioselectivites for this reaction. The reaction of 2-methoxypropene 468 was
successful in producing carbonyl-ene products with aromatic aldehydes as enophile components
(Table 3.7, entries 1 and 2) although somewhat long reaction times were required. Slight
activation of the aromatic aldehyde with electron withdrawing groups (entry 1) rather than
electron donating groups (entry 2) increased product yields.
Ene reactions of 2-trimethylsilyloxypropene provided products in good to excellent yields
with excellent enantioselectivity (entries 3-5) without any evidence of silyl transfer to the
products. The scope of this reaction was broadened to include not only aromatic aldehydes
(entry 3), but also aliphatic aldehydes (entries 4 and 5). Furthermore, Jacobsen demonstrated
that this reaction could be carried out without solvent (entries 4 and 5). The use of chiral
chromium complexes as catalysts in the carbonyl-ene reaction of enol ethers offers an alternative
to Carreira’s method and in contrast can produce excellent enantioselectivities with aromatic
aldehydes.
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Enantioselective studies of exocyclic enol ethers with chiral catalysts has been restricted
to research done by Miles46 and the Totah research group.47 Miles demonstrated the
Table 3.7: Jacobsen Carbonyl-Ene Reactions of Enol Ethers
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nucleophilic nature of 2-methylenedihydrofuran 474 in ene reactions with aldehydes.

By

utilizing chiral titanium BINOL catalyst, non-racemic mixtures of ene adducts resulted. Use of
decanal 477 produced furan 511 in moderate yield with excellent enantioselectivity (Table 3.8,
entry 1). Contrarily, benzaldehyde 479 provided furan 512 in excellent yield with only moderate
selectivity (entry 2).

Although these systems are driven by aromatization, this study

substantiates that exocyclic enol ethers can deliver enantioselective products through chiral
catalysis.
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Table 3.8: Asymmetric Carbonyl-Ene Reactions of 2-Methylene-2,5-dihydrofuran

The Totah group has demonstrated degrees of stereoselective -hydroxydihydropyran
formation through chiral catalysis of the carbonyl-ene reaction of 2-methylenetetrahydropyrans.
Catalyst 510, previously discoverd by Jacobsen to induce asymmetry in carbonyl-ene products of
enol ethers,35 was used to catalyze the reaction between exocyclic enol ether 2 and benzaldehyde
(Scheme 3.18). This reaction provided -hydroxydihydropyran 490 in near quantitative yield
with moderate enantioselectivity.

The barium oxide additive acted as a desiccant in the

reaction.35 The drawback of this reaction with 2-methylenetetrahydropyran is that determining
the enantiomeric excess of the resultant products proved challenging. Decomposition of ene
adducts resulted on HPLC chiral columns, and conversion to the Mosher ester caused elimination
of the chiral center. These difficulties in judging stereoselectivity lead to another approach.
Scheme 3.18

Alternatively, C6-substituted 2-methylenetetrahydropyran 513 was examined in the
asymmetric carbonyl-ene reaction. This substrate was chosen so that the stereoselectivity of the
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reaction could be judged through 1H NMR integrations of diastereomeric products.

The

carbonyl-ene reaction of exocyclic enol ether 513 with titanium(IV) BINOL catalyst 514 and pnitrobenzaldehyde 383 produced the desired dihydropyran 515, but with yields and selectivities
based on catalyst preparation (Scheme 3.19). In situ generation of the catalyst led to a moderate
Scheme 3.19

yield of product 515 with modest selectivity. Isolation of the catalyst prior to the reaction caused
lower yields, but good diastereoselectivity was achieved. Although the C6-stereocenter could
plausibly contribute to the observed selectivity, it is the chiral catalyst that is believed to induce
generation of this new chiral center. The study of 2-methylenetetrahydropyrans bearing C6stereocenters, which will be discussed later in this work, argues that chiral induction derived
from the C6 site is minimal.
Although the Totah group had moderate success at stereoselectively synthesizing 2methylenetetrahydropyran ene adducts, that work concentrated on enantioselective processes
utilizing chiral catalysis. The aim of this research is to determine the level of diastereoselective
induction from substrate to product. Diastereofacial selection involves the preferential creation
of a stereogenic center relative to a preexisting chiral center. Previous work in the field has
demonstrated chiral induction to occur from both chiral enophiles and chiral enes. Although
both types of research will be discussed, the latter is the focus of this paper.
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Stereoinduction from Enophile Components of the Carbonyl-Ene Reaction
Ene reactions that derive diastereoselectivity from chiral aldehydes primarily involve
chelation of alpha or beta heteroatom-substituted aldehydes48 and stereoinduction through
glyoxylate chiral auxiliaries.49,50,51

-Oxygenated chiral aldehydes govern stereoselective

product formation in the carbonyl-ene reaction based upon chelation control and Cram chelation
models.

This trend was first reported by Mikami through use of aldehyde 517 (Scheme

3.20).48a,48b
Scheme 3.20

The ene reaction of 2-methylpropene 516 with alkoxy-aldehyde 517, in the presence of tin(IV)
chloride, resulted solely in the formation of ene adduct 518. The presence of the -alkoxy
substituent on the enophile allows for chelation between it and the carbonyl with the Lewis acid.
The preferred approach of the incoming olefin from the less hindered si face of this complex is
presumably the basis for the observed stereoselectivity. Syn diol 518 resulted as the sole
product.
Within the same work, Mikami also demonstrated diastereoselective preference for
product 522 through use of chiral aldehyde 521 (Scheme 3.21). As discussed above, transition
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state structure 523 predominated through cram chelation of enophile 521. Nucleophilic attack
from the less hindered re face results in production of ene adduct 522 in excellent yield. Thus
Scheme 3.21

the work of Mikami demonstrated that both alpha and beta-alkoxy aldehydes can
diastereoselectively control formation of the new stereocenter formed in the carbonyl-ene
reaction.
The diastereoselective production of ene adducts stemming from chiral -amino
aldehydes is dependant upon both the type of Lewis acid and choice of amino protecting group.
The use of bidentate Lewis acids like Tin(IV) chloride (Table 3.9, entry 1) and titanium(IV)
chloride (entry 4) provided the syn products through the cram chelation model as discussed
above.48a Substitution of N-Boc protecting groups for benzyl caused a decrease in yield along
with an increase in diastereoselectivity (entry 2). More pertinent to our current study, silyl enol
ether 531 also provided reasonable yields of the syn product under Tin(IV) chloride catalysis
(entry 3). Thus, in the case of these bidentate Lewis acids, the alteration of either ene or
enophile did not change the observed stereoselectivity.
Mikami discovered that use of monodentate Lewis acids like EtAlCl2 in this reaction
provided both syn and anti ene adducts based on the enophile’s protecting group.
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Dibenzylaminoaldehyde 525 resulted in production of syn product 532 (entry 5), while chiral NBoc-aminoaldehyde 527 produced the anti ene adduct 533 (entry 6). The stereoselectivity of
these reactions is best explained in terms of the Curtain-Hammett principal.52

The

predominantly monodentate Lewis acids like EtAlCl2 prefer to react through the non-chelation
complex 535 (Scheme 3.22). This intermediate is much less reactive towards the ene reaction,
however, than chelation complex 534.

When benzyl protecting groups are present on the

enophile, the reaction proceeds through the chelation complex because the potential energy of
Table 3.9: Carbonyl-Ene Reactions of -Aminoaldehydes
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the system is too low to react through complex 535. The syn products preferentially form in
these cases (entry 5). Substitution of enophile 527 for 525 provides anti products, presumably
due to the higher reactivity of N-BOC amino aldehyde 527. The dependence of
diastereoselectivity on the protective groups used demonstrates the sensitivity of these systems to
changes in substrate.
In a similar study of N-trityl aziridine-2-(S)-carboxaldehyde 537, anti ene adducts
predominated with use of Lewis acids capable of bidentate chelation, versus the syn products,
which resulted from the use of monodentate Lewis acids.53 The reaction of olefin 536 with
Scheme 3.22

aldehyde 537 produced ene adduct 538 in good yield, favoring the anti diastereomer (Scheme
3.23). Bidentate chelation of the aldehyde to tin(IV) chloride results in complex 540 where
Scheme 3.23
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nucleophile addition is favored from the less hindered re face (Figure 3.4). The large size of the
N-trityl group blocks attack of the nucleophile from the si face. Alternatively, use of
Figure 3.4

monodentate Lewis acid borontrifluoride etherate predominately produced the syn product 539.
This reaction proceeds through complex 541 according to the Felkin-Ahn model. This research
corroborates that research done by Mikami,Error!
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which demonstrated how

diastereoselectivity depended on substrates and Lewis acids used.
The ene reactions of glyoxylates bearing chiral auxiliaries are alternative types of
diastereoselective processes that involves chiral aldehydes. These examples benefit in that the
auxiliary can be added and removed, making these reactions applicable to many different types
of glyoxylate-ene syntheses. Camphorpyrazolidinone49 and 8-phenylmenthol50,51 have both been
used as chiral auxiliaries for glyoxylate-ene reactions. Chen et al. discovered that N-glyoxyloyl
camphorpyrazolidinone 542 effectively produced glyoxylate-ene adducts with moderate to high
yields in the presence of Lewis acid catalyst scantium triflate.49 Olefin 2-phenylpropene was
found to achieve the best yield and diastereoselectivity for this reaction because of the pi overlap
between the phenyl groups on both the enophile and incoming ene component (Scheme 3.24).
This reaction provided ene adduct 544 as the major isomer.

The observed

diastereoselectivity arises from preferred transition state 543. The glyoxylate portion of enophile
542 complexes to the bidentate scantium trifoliate Lewis acid. This glyoxylate portion aligns
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Scheme 3.24

parallel to the plane of the N-benzyl ring to optimize stabilizing pi orbital overlap
between the two groups. The olefin component attacks from the less sterically hindered back
face of this complex to provide product 544. Although this reaction provided the best yields and
diastereoselectivity, the authors demonstrated a range of 2-substituted propenes to work in this
study.
In a similar reaction, glyoxylate 545 produced ene adduct 546 when combined with 1hexene in the presence of equimolar amounts of tin(IV) chloride (Scheme 3.25).50 Unlike the
camphor derived auxiliary, glyoxylate 545 is not locked into a rigid structure. Nonetheless the
chair conformation shown is highly favored from an all-equitorial arrangement of substituents.
The glyoxylate portion of the structure aligns with the phenyl pi electron cloud to optimize
stabalizing pi orbital overlap. Attack of 1-hexene from the front, si face, which is not blocked by
the aromatic ring, then affords alcohol 546 as the predominant isomer.
Scheme 3.25

Examples of chiral induction derived from stereogenic aldehydes and their application to
exocyclic enol ethers are scarce.

Miles demonstrated that -hydroxyfuran 548 could be

produced in excellent yield with moderate diastereoselectivity from chiral aldehyde 547 (Scheme
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3.26).46

The observed diastereoselectivity is derived from Felkin-Ahn model 549 (Scheme

3.27). Conformer 549 is preferred over conformation 550 due to minimization of torsional strain
Scheme 3.26

Attack of the incoming nucleophile occurs from the most accessible si face, resulting in major
diastereomer 548.
Scheme 3.27

The Totah research group also demonstrated chiral aldehyde 548 to induce diastereoselectivity
in -hydroxydihydropyran products (Table 3.10).47 Chiral aldehyde 547 was combined with 2methylenetetrahydropyran 2 to produce carbonyl-ene adduct 552 as a mixture of diastereomers.
The best yields were obtained after 24 hours (entry 2), and the products were obtained as a
modest 2.4:1 ratio of diastereomers. The identity of the major diastereomer could not be
identified through Mosher ester modification because of the propensity of these systems toward
elimination. Both shorter (entry 1) and longer (entry 2) reaction times resulted in decreased
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product yields, but had little to no effect on stereoinduction. Increasing catalyst loading caused
reduction in yields and little effect on diastereoselectivity (entry 4).
Table 3.10: Carbonyl-Ene Reactions of Exocyclic Enol Ether 2 with Chiral aldehyde 547

Stereoinduction and Transfer from Ene Components of the Carbonyl-Ene Reaction
The olefin component of the ene reaction has been shown to demonstrate chiral induction in
resulting products. Types of influences derived from chiral ene constituents include those from
substituted olefins, olefins possessing allyl hydroxyl groups, and ene components that contain
large facial preferences. Choice of Lewis acid with enes possessing E or Z olefin geometry will
influence the stereochemical outcome of products. Subjection of (E) and (Z)-2-butenes produced
both erythro and threo products depending on the type of Lewis acid employed.48a,54 Use of
equimolar quantities of bidentante tin(IV) chloride preferentially produced threo product 553
(Table 3.11, entries 1 and 2). The observed stereochemistry is based from chair transition states
555 and 556 (Figure 3.5).

Chair transition states 555 and 556 correspond toward the

manufacture of threo product 553. The bidentate metal promoter binds to both carbonyls of the
glyoxylate enophile. Both models minimize unfavorable steric interactions between the olefin
methyl group and the relatively large Lewis acid metal as opposed to transition state 557 which
gives rise to erythro isomer 554.
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Table 3.11: Carbonyl-Ene Reactions of (E) and (Z)-2-Butenes

Figure 3.5

Figure 3.6 alternatively shows the chair transition states associated with manufacture of
threo isomer 554 through use of monodentate aluminum Lewis acids. The aluminum Lewis acid
complexes anti to the glyoxylate, and as a result transition state 558 predominates for the Z
Figure 3.6

isomer to avoid steric repulsion between the pendant methyl group and bulky Lewis acid.
Similarly, (E)-2-butene proceeds through transition state 560 as opposed to model 561, which
experiences steric repulsion between these two groups. In conclusion, this research demonstrates
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how bidentate and monodenate Lewis acids demonstrate preference toward eryrthro and threo
isomers respectively with E and Z olefins based on steric repulsions in their respective transition
states.
The research of Wovkulich55 demonstrates how chiral, tri-substituted olefins transpose
selectivity onto corresponding products through a combination of steric effects. The ene reaction
of enol ethers 562 and 562b (Z and E isomers) with formaldehyde resulted in production of
alcohol isomers 563, 564, and 565 with ratios 86:10:4 and 5:7:88 respectively (Scheme 3.28).
While the reaction of Z olefin 562 occurred regio and stereoselectively, primarily creating isomer
563, the reaction of E olefin 562b predominantly produced regioisomer 565.
Scheme 3.28

The high relative stereoselectivity associated with the E olefin results through the
unification of two steric models where effects originate from both the olefinic and cyclic methyl
groups. Firstly, the aldehyde-Lewis acid complex is favored to attack from the  face, opposite
the cyclic methyl group due to steric interactions, which would preferentially lead to isomer 563
production. Secondly, the aldehyde complex prefers to attack the  face of the ring based on
steric interactions that arise between the olefinic and cyclic methyl groups (Scheme 3.29). As
the formaldehyde complex attacks the olefin, the olefinic carbon is bent out of plane with the
ring. This forces a steric interaction between the olefinic methyl and the cyclopentyl ring.
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Transition state 566 predominates, because methyl-methyl non-bonding interactions are
minimized as compared to transition state 567. In effect ene adduct 563 is produced and the
cumulative combination of both types of steric influence gives rise to the good selectivity
observed for this reaction.
Scheme 3.29

The reaction of E isomer 562b, on the other hand, results in minor selectivity between
isomers 563 and 564. In fact, isomer 565 was primarily produced since the C4 hydrogen is more
sterically accessible towards abstraction than the C7 hydrogens.

The only source of

stereochemical preference in this reaction is the favored addition of the formaldehyde complex
from the face opposite the cyclic methyl group.

The E isomer does not experience methyl-

methyl interactions as the enophile enters, thus lowering the effective stereoselectivity of this
system as compared to the Z isomer.

Nonetheless these examples demonstrate the strong

directing capabilities of chiral ene substrates toward their products.
The ene reaction of chiral allylic alcohols with singlet oxygen,56 triazolinediones,57 and
p-nitronitrosobenzene58 leads predominantly to threo ene adducts due to hydroxyl steering
effects. For example, chiral alcohol 568 yielded products 569 and 570 as a 91:9 ratio of
diastereomers when subjected to phenyltriazolinedione (Scheme 3.30). The pi facial selectivity
of this reaction and that of singlet oxygen is derived from the pendant alcohol, which is shown in
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transition state models 571 and 572 (Scheme 3.31). Masking of the hydroxyl or replacement of
the alcohol moiety by an alkyl group results in significantly lower stereoselectivity.
Scheme 3.30

1,3-Allylic strain plays a role in the stability of the transition states. The chiral methyl
group adopts an orientation that minimizes non-bonding interactions with the syn allylic methyl
group. The incoming enophile is then directed through hydrogen bonding with the alcohol.
Abstraction of the syn-hydrogen (transition state 571) is slightly favored over the anti-hydrogen
(transition state 572), but nonetheless both models result in formation of the threo product.
Choice of solvent affects these systems in that nonpolar solvents like dichloromethane and
benzene deliver great threo selectivity, while polar solvents like acetone and methanol produce
poor diastereoselectivity. The production of erythro products in these cases accompanies the
threo product, because directive hydrogen bonding is blocked by solvent interactions.
Scheme 3.31

Olefins which possess a face with considerable steric bulk have demonstrated chiral
induction in the carbonyl-ene reaction, affecting the stereochemistry of the alkoxy carbon
formed. The ene reaction of ring system 573 with aryl nitroso compounds produced aromatic
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ene adducts as single diastereomers (Scheme 3.32).59

In these examples no Lewis acid

catalyzation is required due the aromatization driving force. The steric influence is based
entirely on the structure of the nucleophilic ene component, where addition of the enophile
Scheme 3.32

comes from the top face. The three-ringed system of olefin 573 possesses a convex and concave
face where the top, convex face has less steric interference with the incoming enophile thus
leading to structure 575.
-Pinene derived enes 576 have produced carbonyl-ene products with considerable
selectively about the new hydroxyl center.

60,61

Use of a ruthenium salen catalyst produced

alcohols 577 as a mixture of isomers in a 81:19 ratio (Scheme 3.33). The isomers were not
assigned to the ratios obtained, however, approach of the aldehyde theoretically occurs from
Scheme 3.33

opposite the bridged system. A chair transition state results, where the aldehyde approaches such
that the aromatic ring is held equatorial to avoid steric strain (Scheme 3.34). From this transition
state alcohol 578 is predicted to predominate over isomer 579. This stereochemical model is
purely steric based on the ene substrate and not the ruthenium catalyst used. Reactions of olefins
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possessing sterically equivalent faces with the same catalyst did not result in selective product
formation.
Scheme 3.34

Chirality transfer from ene components has been studied both in thermal and Lewis acid
catalyzed systems. Chirality transfer occurs through destruction of the original stereocenter with
concomitant creation of a new one. Study of this subject pertaining to the thermal ene reaction
demonstrated that stereoselectivity was based entirely on steric considerations. The thermal
reaction of (R)-3-phenyl-1-butene 580 with maleic anhydride 581 produced ene adduct 582 as
the major isomer (Scheme 3.35).62 Either exo or endo transition states (Figure 3.7) lead to
Scheme 3.35

production of the R enantiomer. The observed selectivity is based on the steric argument that the
larger phenyl group orients away from the maleic anhydride as the two molecules approach.
Chirality transfer in Lewis acid catalyzed systems has produced products with good
selectivity.

Kuwajima demonstrated that allylic silyl ether 583 formed ene product 587

asymmetrically (Scheme 3.36).43b The reaction proceeds through a chair transition state where
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Figure 3.7

the large Lewis acid avoids steric interactions by chelating anti to the aromatic group on the
aldehyde. An equatorial orientation of the Lewis acid and phenyl group as the two molecules
come into proximity avoids unwanted 1,3-diaxial interactions with the ene substituents.
Furthermore the reaction proceeds through transition state 585 opposed to 586 to avoid the steric
interactions of the ene methyl substituent.
Scheme 3.36

The intermolecular carbonyl-ene reactions discussed have demonstrated high levels of
stereoselectivity through chiral catalysis and stereo induction or transfer from both enophile and
ene components. Chirality induction from ene components has shown to be somewhat substrate
dependent. Chirality induction studies of exocyclic enol ethers have only been evaluated with
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octanolactone-derived enol ether 588 in the Totah research group (Scheme 3.37). The study of
enol ether 588 with ethyl glyoxylate 343 resulted in a 1:1 diastereomeric mixture of products at
the alcohol center, which indicates little to no chiral induction from the C6 stereocenter in the
starting enol ether. Therefore the objective is to explore the influence of stereocenters at other
positions about the tetrahydropyranyl ring of exocyclic enol ethers.
Scheme 3.37

3.3 Results and Discussion
As

described,

the

non-stereoselective

carbonyl-ene

reaction

of

2-

methylenetetrahydropyrans has been studied to provide the corresponding ene adducts in good
yield with aldehydes that range in reactivity. Addition of functionality to the tetrahydropyran
ring is anticipated to impact the stereoselectivity of this reaction through influence of the ring
conformation. The presence of ring substituents would also create new steric interactions with
the incoming enophile, resulting in proximity effects that influence product stereochemistry.
The goal of this research is to explore how substituted 2-methylenetetrahydropyrans
could induce stereoselectivity into the resulting carbonyl-ene products. To reach this end, we
sought to study exocyclic enol ethers that contained one or more stereocenters at positions 3, 4,
5, and 6 about the ring (Figure 3.8). Although the implication for this research is the asymmetric
Figure 3.8
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preparation of functionalized tetrahydropyrans, the substrates are prepared as racemic mixtures.
This allows for measure of the carbonyl-ene reaction’s diastereoselectivity through 1H NMR
integration of the resulting products.
Synthesis of 2-Methylenetetrahydropyrans
Initial work was aimed toward the stereoselective synthesis of enol ethers for use in the
diastereoselective carbonyl-ene study of 2-methylenetetrahydropyrans. These substrates were
generally synthesized through conversion of the corresponding lactone via methylenation
(Scheme 3.38).
Scheme 3.38

Initial studies focused on the preparation of exocyclic enol ethers containing a single
substituent about the ring. These enol ethers were synthesized so the extent of chiral induction
of one pendant group in relation to its proximity to the site of proton abstraction could be
examined. The exocyclic enol ethers prepared contained a benzyl substituent at the C6 (590), C5
(591), or C4 (592) position on the 2-methylenetetrahydropyranyl ring (Figure 3.9).
Figure 3.9

Although chiral induction has been studied from C6 substituents on octanolactone derived
enol ethers to the corresponding carbonyl-ene products, enol ether 590 was synthesized to
confirm the lack of diastereoselective product formation.

This enol ether was prepared in 4

linear steps (48%) from cyclopentane oxide 593 (Scheme 3.39). Copper catalyzed ring opening
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of cyclopentane oxide 593 with benzyl Grignard gave alcohol 594 as a single diastereomer.
Swern oxidation63 of the resulting secondary alcohol led to ketone 595, which was readily
converted to lactone 596 via Baeyer-Villiger oxidation.64 Subsequently, lactone 596 yielded
desired enol ether 590 in 84% yield upon treatment with Petasis reagent.65
Scheme 3.39

Synthesis of enol ethers 591 and 592 was achieved according to the method developed by
Gravel. 66 Oxacycloalkane-2-carboxaldehydes were converted to the corresponding lactones by
N-heterocyclic carbene catalyzed ring-expansion/lactonization. Enol ether 591 was synthesized
from hydrocinnamic acid 597 in 6 linear steps (30% overall yield) via the route outlined by
Gravel (Scheme 3.40).66 In this sequence, direct alkylation of hydrocinnamic acid 597 with allyl
bromide afforded carboxylic acid 598.

Reduction of the carboxylic acid 598 with LiAlH4

afforded alcohol 599 in 72% yield as opposed to the 10% reported for this transformation.66
Tetrahydrofuran 600 was then prepared from alkene 599 upon epoxidation with mCPBA and
subsequent epoxide opening under acid catalyzed conditions. A mixture of diastereomers was
obtained (1:1.3) from this reaction, however loss of the -hydroxy chiral center in a subsequent
step makes this poor selectivity of little concern.
From here aldehyde 601 was obtained by Swern oxidation of the primary alcohol.
Though in the original report66 this transformation was achieved with IBX oxidation, we found
Swern conditions to be superior (100% yield with Swern as compared to the reported 84% yield
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with IBX).

Lactone 603 was formed after N-heterocyclic carbine (NHC)-catalyzed ring

expansion-lactonization of aldehyde 601. The proposed mechanism of this reaction is outlined in
Scheme 3.41.
Scheme 3.40

NHC 604 was produced from DBU deprotonation of heterocycle 602. Combination of
the newly formed NHC with 2-carboxaldehyde 601 delivered Breslow intermediate 605, which
was prepared for ring opening. Tautomerization of ring opened intermediate 606 led to ketone
intermediate 607, which upon intramolecular cyclization provided the desired lactone 603 and
the regenerated NHC catalyst. Thereafter, Petasis olefination yielded desired enol ether 591 in
80% yield.
Enol ether 591 was synthesized over 8 linear steps, in 20% overall yield, from
benzeneacetaldehyde

608

(Scheme

3.42).

Horner-Wadsworth-Emmons

reaction

of

benzeneacetaldehyde 608 gave predominantly trans-alkene 609.

Olefination was followed by

DIBAL reduction to afford alcohol 610 in quantitative yield.

Although this reaction was
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performed following the procedure outlined in Gavel’s publication, the obtained yield of alcohol
610 far surpassed the published yield of 76%.66 Upon heating alcohol 610 in the presence of
Scheme 3.41

triethyl orthoacetate, a Johnson- Claisen rearrangement occurred giving ester 611 in 81% yield as
opposed to the 70% published yield.66

Subsequent lithium aluminum hydride reduction

provided alcohol 612 in 98% yield. Again, the obtained yield for this reduction surpasses that
reported (54%).66
Treatment of the resulting alcohol 612 with mCPBA resulted in formation of
tetrahydrofuran 613, as previously discussed (cf. Scheme 3.40).

The poor mixture of

diastereomers obtained (1:1.4) was of little consequence since one stereocenter is destroyed in a
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proceeding step. Oxidation of alcohol 613 provided aldehyde 614. Here too, Swern oxidation
was used rather than the reported66 Dess-Martin Periodinane,67 Subsequent N-heterocyclic
Scheme 3.42

carbene catalyzed ring expansion-lactonization led to lactone 615.

Finally, Petasis

methylenation gave rise to desired enol ether 592 in 84% yield. In general, the routes described
here for the synthesis of enol ethers 591 and 592 proved to be quite efficient, with many of the
yields exceeding those reported.
Mono-substituted 2-methylenetetrahydropyrans bearing substitution at the C3 carbon
were not synthesized for this diastereoselective ene study. Application of this enol ether to the
carbonyl-ene reaction would not provide diasteromer products, because the C3 stereocenter is
lost in the reaction (Scheme 3.43).

This absence of diastereomers causes difficulty in

determining the stereoselectivity of the reaction as previously demonstrated by the Totah
research group.47 Analysis of 2-methylenetetrahydropyran ene adducts by HPLC led to their
decomposition on the chiral column. Addition of shift reagents in the 1H NMR spectra produced
poor results, such that the ratio of enantiomers could not be evaluated. Lastly, derivativization to
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Scheme 3.43

the Mosher ester led to olefin byproducts due to the propensity of ene adducts to undergo
elimination. These difficulties directed us toward the study of 2-methylenetetrahydropyrans with
two substituents about the ring. The ene reaction of these substrates would provide the desired
set of diastereomer products that could be analyzed by 1H NMR analysis (Scheme 3.43). The C6
stereocenter present on these systems was not expected to influence product selectivity as was
previously established.68
Not only were di-substituted 2-methylenetetrahydropyrans synthesized for evaluation of
chirality transfer due to the C3 center, but also for the study of axial versus equatorial effects of
substituents. The substituents on the monosubstituted enol ethers 590, 591, and 592 are expected
to adopt an equatorial configuration the majority of the time. By placing two stereogenic centers
on the ring, two isomers of the same enol ether can be tested, one which has an all-equitorial
conformation (616) and another where one substituent must be axial (619) (Scheme 3.44). Enol
ethers 622/623 and 624/625 were manufactured to study these axial/equatorial substitution
effects of the tetrahydropyran ring (Figure 3.10). The synthesis of these enol ethers allows for
evaluation of C6/C5 and C6/C3-substituted systems. The manufacture of a C6/C4 exocyclic enol
ether system was attempted, however these efforts proved unsuccessful.
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Scheme 3.44

Figure 3.10

Initial studies toward the synthesis of di-substituted 2-methylenetetrahydropyrans,
containing C3 chiral centers, began with the synthesis of enol ether 628. This enol ether was
chosen, because it could be synthesized from commercially available octanolactone in two short
synthetic steps (Scheme 3.45). Lactone 627 was synthesized as a 1:2 mixture of diastereomers
Scheme 3.45

through direct alkylation of commercially available octanolactone 626. At this point, separation
of the two lactone diastereomers was envisioned by column chromatography such that each
could be converted into the corresponding enol ether and then individually studied in the
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carbonyl-ene reaction. Separation of the individual diastereomers, however, proved unsuccessful
by flash column chromatography.
Since separation of lactone 628 diastereomers could not be achieved by silica gel
chromatography, the related benzyl substituted lactone 629 was synthesized to facilitate
separation by HPLC equipped with a UV detector. Lactone 629 was again synthesized through
alkylation of the commercially available octanolactone 626. Unfortunately, here too, neither
flash column chromatography nor HPLC proved successful for separation of the cis and trans
diastereomers of compound 629. Therefore other routes toward the synthesis of di-substituted
enol ethers were investigated.
Enol ethers 622 and 623 were synthesized so that the effects axial substituents have on
chiral induction can be evaluated in a C6/C5 substituted system.

Enol ether 623 has two cis-

related substituents at C5 and C6. Therefore, one of the substituents must lie in equatorial
position while the other is axial (Scheme 3.44).

Alternatively, in enol ether 622, both

substituents are equatorial.
The synthesis of enol ethers 622 and 623 are similar, but differ in the geometry of the
olefin intermediate. Compound 622 is derived from the E-olefin 631, whereas compound 623 is
derived from the Z-alkene 634 (Scheme 3.46). Formation of the trans-C6/C5 substituted
Scheme 3.46
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exocyclic enol ether 622 was accomplished, beginning with 2-butyne-1,4-diol 637 (Scheme
3.47). Diol 637 was monoprotected with benzyl bromide to form alcohol 71,69 which was
Scheme 3.47

selectively reduced to the trans-alkene 631 using Red-Al. Treatment with mCPBA then afforded
epoxide 639 as a single diastereomer.70 Alcohol 639 was subsequently oxidized to the
corresponding aldehyde 640 under Swern conditions.71 Horner Wadsworth Emmons olefination
of aldehyde 640, using freshly prepared carbethoxymethylene triphenylphosphorane,72 led solely
to the trans-epoxy-alkene 641.

Addition of trimethylaluminum and water to epoxide 641

regioselectively produced alcohol 632 as the only isomer.73

The observed regioselective

addition, of the methyl group to the epoxide, which proceeds through a six-membered transition
state, is based on the coordination of the Lewis acid (Me3Al) to the benzyl ether (Figure 3.11).
Figure 3.11

The next step in this sequence, hydrogenation of the double bond, proved difficult.
Nonetheless, reduction of olefin 632 was accomplished, surprisingly, without removal of the
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benzyl protecting group. The difficulty with this reaction occurred as the process was scaled up.
The reaction only proceeded under vigorous stirring with larger proportions of Pd/C as the
amount of substrate increased. In these cases Pd/C was added by increasing the mole percent by
0.2% every 24 h until the reaction was complete. Adding large amounts of Pd/C was avoided to
circumvent concomitant benzyl removal. Reduction of the double bond resulted in partial
cyclization of the ester to afford mixtures of lactone 633 and the corresponding ester (3:1-1:1
respectively). The mixture of compounds was washed with acid to complete the cyclization,
yielding lactone 633. Petasis olefination then provided desired trans-5,6-substituted exocyclic
enol ether 622 in 76% yield.
The synthesis of enol ether 623 is outlined in Scheme 3.48. Monoprotection of 2-butene1,4-diol 642 with benzyl bromide formed alcohol 634.74 Subjection of alcohol 634 to mCPBA
resulted in production of epoxide 643 as a single diastereomer with yields exceeding that
published.70 The resulting alcohol was then oxidized under Swern conditions to aldehyde 644.75
Olefination and subsequent epoxide-opening with trimethyl aluminum led to alcohol 635.76
Scheme 3.48
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Selective hydrogenation of substrate 635 again reduced the olefin without benzyl deprotection to
form a mixture of lactone 636 and the ester (2:1-1:1 respectively). Subjection of this mixture of
compounds to acidic conditions furnished lactone 636 in 67% yield (over two steps). Petasis
olefination of lactone 636 then produced desired 2-methylenetetrahydropyran 623.
The last two substrates prepared were enol ethers 624 and 625. Evaluation of these enol
ethers in the ene reaction may help to determine the influence a C3 substituent has on the
selectivity observed in the carbonyl-ene reaction.

These enol ethers contain a pendent C6

iodomethyl substituent that could subsequently be eliminated to form a second enol ether. These
enol ethers can not only be used in the chiral transfer study, but also used in bi-directional
carbonyl-ene reactions (Scheme 3.49). The iodomethyl group was chosen as the C6 substituent
because diastereomeric mixtures of these lactones are known to be separable77 as opposed to
those that were previously attempted (Scheme 3.45)
Scheme 3.49

Lactones 655 and 656 were prepared as a mixture of diastereomers and subsequently
separated via HPLC. Their synthesis is outlined in Scheme 3.50. Carboxylic acid 651 was
synthesized in quantitative yield from 1-hexen-6-ol 650 via known Jones oxidation.78
Scheme 3.50
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Esterification and subsequent methylation led to ester 653.79 Direct iodocyclization of this
compound failed to produce the desired lactones, in contrast to previously published results of 5carboxy-1-pentenes.80 Therefore hydrolysis of ester 653 was done to provide carboxylic acid
654. Iodocyclization of carboxylic acid 654 then gave lactones 655 and 656 as a 1:2 mixture of
diastereomers respectively.81

The cis and trans stereochemistry was deduced through

interpretation of the 1H NMR spectra of these compounds. The trans isomer demonstrates large
axial-axial coupling for both Ha and Hb (Scheme 3.51). Alternatively, cis isomer 655 only
experiences one of these large couplings. This deduction of stereochemistry agreed with that
cited in the literature.
Scheme 3.51

Although the mixture of diastereomers could not be separated by flash column chromatography,
lactones 655 and 656 were successfully partitioned by semi-preparative HPLC (Scheme 3.52).
The subsequent conversion of these lactones to exocyclic enol ethers 624 and 625 was performed
via Petasis olefination, albeit in moderate to low yield. It should be noted that the reaction of
trans-lactone 656 was performed only once, and optimization of this transformation may lead to
higher yields.

180

Scheme 3.52

Chiral Induction and Transfer Studies
With a variety of 2-methylenetetrahydropyrans in hand, studies were initiated to
determine the effect of ring substitution on the diastereoselectivity of the carbonyl-ene reaction.
All reactions were performed at room temperature with 5 to 20 mol% zinc(II) chloride according
to optimized conditions previously determined for the carbonyl-ene reaction of exocyclic enol
ethers.47 The 2-methylenetetrahydropyran substrates were diluted to 0.5 M in THF, to which
aldehydes (1.2 equivalents) were added. After zinc(II) chloride addition, the reaction was stirred
from 2-12 hours depending on the reactivity of the aldehyde substrate used.

The

diastereoselectivity of each reaction was determined through integration analysis of resonances
arising from either C6 or C2’ hydrogen peaks in the respective product 1H NMRs, although the
major isomer in each case was not assigned.
The aldehyde components for this study were chosen to reflect anticipated differences in
reactivity. These enophiles ranged from highly reactive ethyl glyoxylate 343 to aliphatic octyl
aldehyde 495, which has much less inherent reactivity. The high activation of ethyl glyoxylate
343 stems from the adjacent, strong electron-withdrawing group (CO2Et), which increases the
electrophilic nature of the compound by decreasing electron density at the carbonyl.

The

reduced electron density at this carbon center results in increased activation towards the ene
reaction. p-Nitrobenzaldehyde 383 represents an enophile of intermediary reactivity. This
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aromatic ring also pulls electron density from the carbonyl carbon, due to the presence of an
electron withdrawing group on the aromatic ring, but to a much lesser extent than ethyl
glyoxylate 343.

Octyl aldehyde 495 represents a non-activated aliphatic aldehyde that

consequently has the lowest intrinsic reactivity of the group chosen. Due to these differences in
reactivity, ene processes with activated aldehydes 343 and 383 were performed with 5 mole %
zinc(II) chloride, whereas reactions involving non-activated aldehyde 495 were carried out with
20 mol % of the Lewis acid catalyst.
Initial diastereoselective studies focused on the influence of mono-substituted enol ethers
590-592 (Table 3.12). Enol ether 590 was first examined to evaluate the influence of a C6
stereocenter on the diastereoselectivity of the carbonyl-ene reaction. The reaction of enol ether
590 with ethyl glyoxylate 343 was highly efficient, providing product 657 as a 1:1.1 mixture of
diastereomers in 98% yield within a relatively short period of time (entry 1). The relative
stereochemistry of the resulting isomers here, and in all cases, was not determined. The reaction
with p-nitrobenzaldehyde 383 also provided the corresponding ene adduct in high yield within
two hours, but as a 1:1 mixture of isomers. Lastly, non-activated octyl aldehyde 495 provided
ene adduct 659 as a non-selective (1:1) mixture of diastereomers (entry 3). While all these
reactions of C6-benzyl-substituted 2-methylenetetrahydropyran 590 delivered the desired ene
adducts in high yield, little to no selectivity was observed in each case. These results are in
keeping with earlier studies performed in the Totah group (Scheme 3.37).68
Exocyclic enol ether 591 was evaluated in turn to discover if selectivity can be induced
from a C5 stereocenter on the tetrahydropyran ring. The reaction between substrate 591 and all
three aldehydes also proceeded well with ene adducts isolated in 80-88% yield (entries 4-6).
These reactions showed only modest selectivity, with ratios of about 1:1.3 in each case.
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Table 3.12: Carbonyl Ene Reactions of mono-Substituted 2-Methylenetetrahydropyrans
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The C4-substituted enol ether 592 was finally examined with the same set of aldehydes.
The yields ranged from 74-92% (entries 7-8), with the lowest yield obtained for the least
activated substrate, octyl aldehyde 495 (entry 9). Note that this reaction (entry 9) was run only
once, and the data does not demonstrate optimized yields. In these examples, mixtures of
diastereomers were obtained as a ca. 1:2.5 ratio.
Though the observed selectivity was modest in every case, the higher selectivity
demonstrated by the C4-substituted substrate 592 (entry 7) as opposed to enol ethers 590 (entry
1) and 591 (entry 4) indicates that the proximity of a single pre-existing stereocenter to the site of
hydrogen abstraction may influence reaction diastereoselectivity. Additionally, stereoselectivity
is not dependent of the electronic nature of the aldehyde. For each of the enol ether substrates
evaluated, observed diastereoselectivity remained constant regardless of the aldehyde used in the
reaction (entries 1-3, 4-6, and 7-9).
As discussed earlier in this chapter, the mechanism for the carbonyl-ene reaction can
range from a concerted to stepwise cationic process. Whether the mechanism is concerted,
stepwise, or somewhere in-between, ene reactions involving Lewis acids undoubtedly develop a
positive charge to some extent on the ene component.82 The concerted mechanism is capable of
producing products of good stereoselectivity, since it is a single barrier process. Most carbonylene reactions without large conformational constraints proceed through a mechanism with
appreciable concerted character. If the Lewis acid-catalyzed carbonyl-ene reaction was purely a
cationic process, many of the diastereoselective ene examples presented herein, most of which
involve chair transition states, would not proceed selectively.
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Therefore the carbonyl-ene

reaction of 2-methylenetetrahydropyrans with aldehydes, catalyzed by zinc(II) chloride, is
assumed to proceed in at least a partially concerted manner via chair-like transition states.
The presence of a single stereocenter on the exocyclic enol ether causes the
tetrahydropyran ring to preferentially adopt a conformation favoring equatorial placement of the
substituent. The aldehyde prefers approach from the tetrahydropyran face which bears the axial
hydrogen for abstraction. The axial hydrogen is prone towards this process due to its favorable
orbital alignment with the olefin pi electrons.

Thus high selectivity was expected for the

carbonyl-ene reaction of mono-substituted 2-methylenetetrahydropyrans, dictated by the
conformation of the tetrahydropyran ring system. The low ratio of resulting isomers shows,
however, that this is not the case.
In light of the poor selectivity observed, the transition state models were more closely
examined.

It is the face of the aldehyde approach that is believed to influence the

stereochemistry of these systems. In these models, the Lewis acid can adopt either endo or exo
chelation with the carbonyl oxygen. The endo conformer is predicted to be significantly higher
in energy because of the non-bonding interactions between the relatively large metal and
tetrahydropyran ring (Scheme 3.53). Therefore the transition state models for the ene reaction
between 2-methylenetetrahydropyran and chelated aldehydes is typically expected to occur
through endo transition states.
Approach of the aldehyde toward the 2-methylenetetrahydropyran can occur from either
the re or si face (Scheme 3.53). Exposure of the re face is demonstrated in exo transition state
666. Here, unfavorable, high energy 1,3 diaxial steric interactions (2.4 Kcal/mol) are avoided
that develop between the aldehyde’s R group and the ring oxygen as compared to the 667 endo
transition state (Scheme 3.53). If the interaction between the aldehyde R group and the ring
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oxygen was the only basis for stereochemical preference, high ratios of diastereomer 668 would
prevail in upwards of ca. 98:2 according to equations 3.1-3.2.
(Equation 3.1)

(Equation 3.2)
Scheme 3.53

Clearly the discrepancy between calculated ratios and the low ratio of stereoisomers
obtained for this reaction (Table 3.12, entries 1-3) indicates other steric influences are at hand,
namely non-bonding interactions between the chelated Lewis acid and the pendent aldehyde
group. Therefore when the aldehyde approaches from the re face, this Lewis acid-aldehyde R
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group interaction is the predominant steric influence (666 exo, Scheme 3.53). Conversely, the
transition state where the aldehyde enters from the si face (667 exo) experiences the steric
repulsion between the aldehyde R group and the ring oxygen. The ratio observed (1:1) indicates
that the severity of these steric repulsions is comparable.
Application of these transition state models to the reactions of enol ethers 591 and 592
shows similar analyses (Schemes 3.54 and 3.55 respectively). Ene reactions between 2Scheme 3.54

methylenetetrahydropyran 591 and aldehydes are expected to proceed through either exo
transition state 670 or 671, producing products 672 and 673 respectively. Both transition states
contain the same steric interferences that were exhibited by enol ether 590. In turn, analysis of
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the transition states associated with enol ether 592 (Scheme 3.55) illustrates that the same
stereochemical influences are present in this system.
The transition state structures for enol ethers 590, 591, and 592 all show very similar
energies and as such, low diastereoselectivity is observed for these processes. Although it is true
that selectivity improves as the chiral center nears the site of hydrogen abstraction, a 2.6:1 ratio
Scheme 3.55

(at best) is very modest and only represents a small energy difference between transition state
configurations. Prediction of the major isomer is difficult in these cases based on this transition
state evaluation.
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The

low

level

of

stereoinduction

derived

from

mono-substituted

2-

methylenetetrahydropyrans proved disappointing. The diastereoselectivity of the reaction may
be improved through use of di-substituted exo enol ethers, especially in those substrates with
axial substituents. These groups may have an influence on the enophile approach. Secondly, disubstituted 2-methylenetetrahydropyrans were used to evaluate the extent of chirality transfer
resulting from 2-methylenetetrahydrpyran C3 stereocenters.
The results of the diastereoselective ene reaction with enol ethers 622-625 are shown in
Table 3.13.

Reaction of 2-methylenetetrahydropyran 622 with activated aldehydes ethyl

glyoxylate 343 and p-nitrobenzaldehyde 383 provided the desired ene adducts in high yield
(entries 1 and 2). The diastereomer products produced in these reactions were observed as ca.
1.4:1 ratios, however, as in the mono-substituted 2-methylenetetrahydopyran studies, the identity
of the major and minor isomers was not determined. Reaction of the same enol ether with octyl
aldehyde 495 resulted in moderate yields of corresponding ene adduct 680 (entry 3). Although it
is true that this enophile is less reactive in comparison to ethyl glyoxylate 343 and pnitrobenzaldehyde 383, this reaction was only performed twice and does not represent optimized
yields. Diastereomeric ratios were not obtained for ene product 680, because analysis of the 1H
NMR resonances did not reveal the ratio of isomers. The individual peaks of each diastereomer
could not be resolved, even after altering NMR sample solvent systems. The solvents tested for
peak resolution included CDCl3, C6D6, D-methanol, D-acetonitrile, D-acetone, D-ethanol, and
mixtures thereof.
Examination of exocyclic enol ether 623 demonstrated that high yields of ene adducts
681 and 682 could be obtained with aldehydes 343 and 383 respectively (entries 4 and 5). The
reaction with ethyl glyoxylate 343 produced ene aducts as a 2.6:1 ratio, whereas the reaction

189

Table 3.13: Carbonyl Ene Reactions of di-Substituted 2-Methylenetetrahydropyrans

with p-nitrobenzaldehyde 383 yielded products in a 3.5:1 ratio. Alternatively, the reaction with
octyl aldehyde 495 produced product 683 in moderate yield with relatively low stereoselectivity
(1:1.7 ratio of isomers, entry 6).
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Exocyclic enol ethers 624 and 625 were studied last to determine how both axial or
equatorial substituents and C3 chiral centers affect stereoselectivity.

Subjection of 2-

methylenetetrahydropyrans 625 and 626 to highly activated ethyl glyoxylate 343 resulted in
modest yields of the same carbonyl-ene adduct 684 (entries 7 and 8). The low yields observed
for this process are in keeping with earlier studies performed in the Totah group that
demonstrated how 2-methylenetetrahydropyran C3 substituents can decrease carbonyl-ene
product yields (Table 3.5).68 The ratio of products in each case complimented one another. The
1

H NMR product resonances indicated the given diastereomer ratios through evaluation of the C6

proton integrations.

The 1H NMR spectra of both reactions were the same except the

integrations of the resolved C6 protons were opposite in magnitude. Therefore it is concluded
that both reactions result in the same products, but the major diasteremer produced in each case
was different.
The ene reactions of enol ether 622 only demonstrated low levels of selectivity (1:1.41:1.3 dr, entries 1 and 2, Table 3.13), which was similar to that observed for C5-substituted enol
ether 591 (entries 4-6, Table 3.12). Therefore, the equitorial C5 methyl substituent on enol ether
622 most likely has a similar effect as the equatorial benzyl group on enol ether 591. Review of
exo transition states 685 and 686 (Scheme 3.56) indicate the same steric interactions are at play
as were in the transition states associated with enol ether 591 (Scheme 3.54). Transtion state 685
suffers from steric repulsion between the chelated Lewis acid and pendant aldehyde group,
whereas transition state 686 experiences non-bonding interactions between the aldehyde R group
and the ring oxygen.

It is not clear from the presented transition states which isomer is

preferentially produced or how the C5 chiral center plays part, but as the low selectivity shows,
only a small difference in energy exists between the two transition states.

191

The ene reactions of enol ether 623, on the other hand, shows higher levels of
diastereoselectivity in the resulting products (3.5:1-1.7:1, entries 4-5, Table 3.13).

The

difference in observed selectivity can be rationalized in terms of steric repulsion between the
axial tetrahydropyranyl methyl group and incoming enophile (Scheme 3.57). Thus transition
state 689 only possesses one major non-bonding interaction between the aldehyde group and
Scheme 3.56

Lewis acid, whereas transition state 690 contains two large steric repulsions between the
aldehyde R group and both the axial methyl and ring oxygen. This leads to the prediction of
diastereomer 691 as the major product.
While there is no change in the level of stereoselectivity based on aldehyde
stereoelectronics, a trend in enophile sterics is demonstrated. As the steric bulk of the aldehyde
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substrate increased near to the carbonyl center, the ratio of isomers changed directly. This is
shown by octyl aldehyde 495, the smallest of the aldehydes tested, producing the lowest ratio of
diastereomers (1.7:1, entry 6, Table 3.13). In turn ethyl glyoxylate 343 delivered less selectivity
(2.6:1, entry 4) than the largest aldehyde tested, p-nitrobenzaldehyde 383 (3.5:1, entry 5). This
Scheme 3.57

trend illustrates that as the size of enophile increases, a larger effect is experienced by transition
state 690 versus transition state 689.
Both enol ethers 624 and 625 produce the same product 684 through the carbonyl-ene
reaction with ethyl glyoxylate 343. Similar diastereomer ratios are obtained for both enol ether
624 and 625, however, the major diastereomers formed in each case are different, as was
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indicated in the 1H NMR spectra of each separate reaction. Enol ether 624 is expected to provide
isomer 695 as the major product (Scheme 3.58), while enol ether 625 is anticipated to produce
larger quantities of isomer 696 (Scheme 3.59).
The transition states associated with enol ethers 624 and 625 are perceived to proceed
with the abstractable hydrogen in the axial position due to favorable orbital alignment with the
olefin pi bond. In these systems, the factors associated with selectivity include the face of
enophile approach and exo versus endo chelation of the Lewis acid. Steric influences of axial
versus equatorial substituents on the tetrahydropyran ring are indicated to be of little
consequence since the ratio of diastereomers obtained from the two reactions is similar in
magnitude.
Substrate 625 is predicted to produce diastereomer 695 through analysis of transition
states 693 and 694. Review of transition state 693 indicates that the exo transition state exhibits
steric repulsion between the pendant aldehyde group and the chelated Lewis acid. This transition
state differs from all those discussed so far, because the Lewis acid also experiences nonbonding interactions with the tetrahydropyranyl C3 equatorial methyl.

Evaluation of exo

transition state 694, where the aldehyde approaches from the re face indicates this same steric
repulsion between the two groups in addition to that between the pendant aldehyde group and the
tetrahydropyran ring oxygen.
The endo transition state 693 alleviates two non-bonding interactions between the Lewis
acid and both the aldehyde R group and tetrahydropyran C3 methyl.

However, this endo

transition state experiences a large interaction between the Lewis acid and tetrahydropyran ring.
Contrarily, endo transition state 694 only alleviates one steric repulsion between the Lewis acid
and tetrahydropyran methyl, while developing a new, larger interaction between the Lewis acid
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and tetrahydropyran ring. For this reason transition state 694 is believed to proceed through the
endo transition state. When comparing endo model 693 and exo model 694, the accumulation of
steric effects in the 694 exo transition state most likely outweigh the large interaction present in
the 693 endo transition state between the Lewis acid and ring. Therefore exo transition state 693
is favored along with production of diastereomer 695. The similarity in energies between these
two states is indicated by the relatively low ratio of resulting diastereomers.
Scheme 3.58

Evaluation of exocyclic enol ether 624 in the carbonyl-ene reaction with ethyl glyoxylate
343 follows that of the similar trans isomer 625 (Scheme 3.59). Alternatively, diastereomer 696
is expected as the major product because hydrogen abstraction occurs from the opposite face of
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the tetrahydropyran ring. Here, the C6 axial iodomethyl group has little to no effect on the
stereoselectivity of the reaction because aldehyde approach is from the face opposite the
substituent.
Scheme 3.59

3.4 Conclusions
The carbonyl-ene reaction of 2-methylenetetrahydropyrans, with a variety of substitution
patterns about the tetrahydropyran ring, proceeded with good to excellent yields with both
activated and non-activated aldehydes. Mono-substitution at the C6, C5, and C4 positions on the
tetrahydropyran ring only produced modest selectivity of the products at best. Prediction of the
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major isomers in these systems is not straightforward from review of the corresponding
transition states, although selectivity seemed to increase as the chiral center increased in
proximity to the site of hydrogen abstraction.
The diastereoselectivity exhibited by reactions of di-substituted 2-methylenetetrahydropyrans followed the results of mono-substituted examples in that only moderate to low ratios of
products resulted. Nonetheless, evaluation of exo enol ethers 622 and 623 demonstrated that the
presence of axial substituents on the tetrahydropyran ring can cause higher product
discrimination (ratios of 1.4:1 versus upwards of 3.5:1). The product ratios of these axial
systems, which ranged from 1.7:1 to 3.5:1, seem to be based on aldehyde sterics, where the
larger the steric bulk about the carbon alpha to the carbonyl, the larger the ratio of resulting
isomers.
Alternatively, examination of enol ethers 624 and 625 demonstrates that axial influences
can be negligible, especially when these substituents are opposite the reactive tetrahydropyranyl
face. These conflicting results show the great complexity of these systems, and how selectivity
is highly substrate dependent. The assessment of enol ethers 624 and 625 confirmed, however,
that C3 substituents are capable of slight stereoinduction exhibited by the 2.1:1 ratio of products.
The compilation of these results indicates that simple substitution about the ring of 2methylenetetrahydropyrans is not likely to cause high levels of stereoinduction in the carbonylene reaction. Instead, the use of chiral catalysis may be more effective towards this end.
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3.5 Experimental
General Methods:
All air sensitive reactions were performed in oven dried glassware under an atmosphere
of argon. Reaction solvents were dried over CaH2 (benzene, dichloromethane), or
sodium/benzophenone ketyl (tetrahydrofuran, diethyl ether) and were distilled just prior to use.
All other reagents were reagent grade and purified as necessary. Analytical thin layer
chromatography was performed on EM silica gel 60 F254 glass plates (0.25 mm). Visualization
of analytical thin layer chromatography was achieved using UV absorbance (254 nm), vanillin,
and ceric ammonium molybdate stains. Melting points were recorded using an Electrothermal
melting point apparatus and are uncorrected. Flash column chromatography was performed
using SiliaFlash P60 silica gel (40-60 Ǻ) from SiliCycle, Inc. 1H NMR spectra were recorded on
a Bruker Avance DPX-300 (300 MHz) spectrometer. Chemical shifts are reported in ppm,
downfield from tetramethylsilane using residual CHCl3 as the internal standard (δ 7.27 ppm).
13

C NMR spectra were recorded on a Bruker Avance DPX-300 (75 MHz) spectrometer with

complete proton decoupling.

Chemical shifts are reported in ppm, downfield from

tetramethylsilane using residual CHCl3 as the internal standard (δ 77.0 ppm). IR spectra were
obtained with a Thermo Nicolet IR-100 spectrometer on NaCl plates. Elemental Analyses were
performed by Complete Analysis Laboratories, Inc.; Parsippany, NJ. High resolution mass
spectra were obtained using the positive ion electrospray mode on a Bruker 12 Tesla APEX-Qe
FTICR-MS with an Apollo II ion source at Old Dominion University, Norfolk, VA.
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Experimental Procedures:

Alcohol 594. Benzyl magnesium bromide 1.0 M in diethyl ether (25.0 mL, 25.0 mmol) was
added to a dried flask and stirred along with copper iodide (0.261g, 1.37 mmol). Cyclopentene
oxide 593 (1.75g, 20.8 mmol) was dissolved in diethyl ether (3.5 mL) and added via dropwise
addition to the reaction flask. The reaction mixture stirred for two hours before being quenched
with aqueous ammonium chloride (15 mL). The layers were separated and the aqueous layer
was extracted with additional diethyl ether (3 x 30 mL). The organic layers were combined, dried
over MgSO4, filtered, and concentrated in vacuo. Purification via flash column chromatography
(SiO2; hexanes:EtOAc, 4:1-2:1) yielded desired alcohol 594 as a colorless oil (2.78g, 76%).
TLC: Rf = 0.43 (hexanes:EtOAc, 2:1). 1H NMR data for this compound agreed with the known
literature values.83 1H NMR (CDCl3, 300 MHz): δ 7.24 (5H, m), 3.30 (1H, m), 3.18 (1H, dd, J =
4.1, 14.2 Hz), 2.35 (1H, dd, J = 14.1, 7.9 Hz), 1.44 (10H, m).

Ketone 595. Oxalyl chloride (2.00 mL, 23.7 mmol) was dissolved in dicholomethane (77 mL)
and cooled to -78oC. DMSO (3.59 mL, 50.5 mmol) was subsequently added via dropwise
addition over a period of fifteen minutes. The reaction mixture stirred for an additional fifteen
minutes after which alcohol 594 (2.78g, 15.8 mmol) was added in dichloromethane (13 mL).
The reaction mixture stirred for an additional thirty minutes after which triethylamine (11.0 mL,
78.9 mmol) was added by dropwise addition.

The reaction was then warmed to room

temperature and stirred for an additional hour. Water was added (100 mL). The organic and
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aqueous layers were separated and the aqueous layer was extracted with dichloromethane (3 x 70
mL). The organic layers were combined, dried over MgSO4, filtered, and concentrated in vacuo.
Purification via flash column chromatography (SiO2; hexanes:EtOAc, 5:1) yielded desired
ketone 595 as a colorless oil (2.33g, 85%) 1H NMR data for this compound agreed with the
known literature values.84

TLC: Rf = 0.76 (hexanes:EtOAc, 2:1).

1

H NMR data for this

compound agreed with the known literature values.85 1H NMR (CDCl3, 300 MHz): δ 7.24 (5H,
m), 3.16 (1H, dd, J = 13.8, 4.1 Hz), 2.55 (1H, dd, J = 13.7, 9.5 Hz), 2.36 (2H, m), 2.11 (2H, m),
1.96 (1H, m), 1.75 (1H, m), 1.58 (1H, m).

Lactone 596. mCPBA (1.03g, 4.16 mmol) and sodium bicarbonate (1.38g, 16.5 mmol) were
added to a solution of ketone 595 (0.630g, 3.62 mmol) in dichloromethane (22mL). The reaction
was stirred for 60 hours and then washed with saturated sodium bicarbonate (2 x 20 mL). The
organic and aqueous layers were separated and the aqueous layer was extracted with
dichloromethane (20 mL). The combined organic layers were dried with MgSO4, filtered, and
concentrated in vacuo. Purification via flash column chromatography (SiO2; hexanes:EtOAc
2:1) yielded the desired lactone 596 as a colorless oil (0.617g, 89%).

TLC: Rf = 0.25

(hexanes:EtOAc, 2:1). 1H NMR data for this compound agreed with the known literature
values.86 1H NMR (CDCl3, 300 MHz): δ 7.28 (5H, m), 4.50 (1H, m), 3.10 (1H, dd, J = 13.8, 5.8
Hz), 2.88 (1H, dd, J = 13.8, 7.0 Hz), 2.58 (1H, m), 2.42 (1H, m), 1.86 (3H, m), 1.53 (1H, m).
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Enol Ether 590. To a solution of lactone 596 (0.100g, 0.526 mmol) in 3 mL THF was added
Cp2TiMe2 (2.10 mL of a 0.5M solution in THF, 1.05 mmol). The resulting mixture was warmed
to reflux and stirred for 20 h in the dark. The solution was then cooled to room temperature,
concentrated in vacuo, and the resulting residue triturated with hexanes. (100 mL). The hexanes
solution was filtered through celite and concentrated again. The residue was purified via flash
chromatography (SiO2; hexanes:triethylamine, 19:1) to afford the exocyclic enol ether 590 as a
yellow oil (0.085 g, 85%). TLC: Rf = 0.70 (hexanes: EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):
δ 7.27 (5H, m), 4.34 (1H, d, J = 1.3 Hz), 4.08 (1H, d, J = 1.6 Hz), 3.85 (1H, m), 3.04 (1H, dd, J =
13.6, 6.1 Hz), 2.74 (1H, dd, J = 13.6, 7.1 Hz), 2.23 (2H, m), 1.64 (4H, m).

13

C NMR (CDCl3, 75

MHz): δ 159.9 (C), 139.5 (C), 128.9 (CH), 128.4 (CH), 126.1 (CH), 91.1 (CH2), 73.6 (CH2), 38.4
(CH2), 36.6 (CH2), 29.0 (CH2), 28.3 (CH2). IR (film): 3027, 2928, 1654 cm-1.

Aldehyde 601. Oxalyl chloride (0.0950 mL, 1.12 mmol) was dissolved in dicholomethane (3.6
mL) and cooled to -78oC. DMSO (0.170 mL, 2.40 mmol) was added to the reaction via
dropwise addition over a period of fifteen minutes. Thereafter the reaction mixture was left to
stir an additional fifteen minutes, after which alcohol 600 (0.144g, 0.749 mmol) was slowly
added as a solution in dichloromethane (0.60 mL). The reaction mixture stirred for thirty
minutes, and then triethylamine (0.530 mL, 3.75 mmol) was added via dropwise addition. The
reaction was warmed to room temperature and stirred for an additional hour. Water was added
(3 mL) and the organic and aqueous layers were separated. Aqueous layers were extracted with
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dichloromethane (3 x 10 mL). Combined organic layers were dried over MgSO4, filtered, and
concentrated in vacuo. Purification via flash column chromatography (SiO2; hexanes:EtOAc,
3:1) yielded the desired aldehyde 601 as a colorless oil (0.142g, 100%) 1H NMR data agreed
with the known literature values for this compound.14 TLC: Rf = 0.34 (hexanes:EtOAc, 2:1). 1H
NMR (300 MHz, CDCl3):  9.69 (1H, dd, J = 12.5, 1.6 Hz), 7.24 (5H, m), 4.40 (0.6H, m), 4.29
(0.4H, dt, J = 8.1, 1.7 Hz), 4.03 (1H, m), 3.66 (1H, m), 2.53 (1H, m), 2.28 (1H, m), 2.14 (1H, m),
1.92 (1H, m), 1.71 (1H, m).

Enol ether 591. To a solution of lactone 603 (0.095g, 0.499 mmol) in 3 mL THF was added
Cp2TiMe2 (2.00 mL of a 0.5M solution in THF, 0.999 mmol). The resulting mixture was warmed
to reflux and stirred for 20 h in the dark. The solution was then cooled to room temperature,
concentrated in vacuo, and the resulting residue triturated with hexanes. (100 mL). The hexanes
solution was filtered through celite and concentrated again. The residue was purified via flash
chromatography (SiO2; hexanes:triethylamine, 19:1) to afford the exocyclic enol ether 591 as a
yellow oil (0.075 g, 80%). TLC: Rf = 0.87 (hexanes: EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):
δ 7.24 (5H, m), 4.33 (1H, s), 4.07 (1H, d, J = 1.4 Hz), 4.00 (1H, ddd, J = 10.8, 4.2, 1.8 Hz), 3.43
(1H, t, J = 10.3 Hz), 2.59 (1H, dd, J = 13.5, 7.3 Hz), 2.48 (1H, dd, J = 13.5, 7.3 Hz), 2.33 (1H,
dt, J = 14.3, 4.7 Hz), 2.11 (2H,m), 1.84 (1H, m), 1.33 (1H, m).

13

C NMR (CDCL3, 75 MHz): δ

159.9 (C), 139.5 (C), 128.9 (CH), 128.4 (CH), 126.1 (CH), 91.1 (CH2), 73.6 (CH2), 38.4 (CH2),
36.6 (CH), 29.0 (CH2), 28.3 (CH2). IR (film): 3028, 2929, 1654 cm-1.
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Aldehyde 614. Oxalyl chloride (0.132 mL, 1.56 mmol) was dissolved in dicholomethane (5.1
mL) and cooled to -78oC. DMSO (0.24 mL, 3.33 mmol) was added to the reaction via dropwise
addition over a period of fifteen minutes. Thereafter the reaction mixture was left to stir an
additional fifteen minutes, after which alcohol 613 (0.200g, 1.04 mmol) was slowly added as a
solution in dichloromethane (0.83 mL). The reaction mixture stirred for thirty minutes, and then
triethylamine (0.73 mL, 5.20 mmol) was added via dropwise addition. The reaction was warmed
to room temperature and stirred for an additional hour. Water was added (3 mL) and the organic
and aqueous layers were separated. Aqueous layers were extracted with dichloromethane (3 x 10
mL). Combined organic layers were dried over MgSO4, filtered, and concentrated in vacuo.
Purification via flash column chromatography (SiO2; hexanes:EtOAc, 3:1) yielded the desired
aldehyde 614 as a colorless oil (0.146g, 73%). 1H NMR data agreed with the known literature
values for this compound.14 TLC: Rf = 0.42 (hexanes:EtOAc, 2:1). 1H NMR (300 MHz, CDCl3):
 9.78 (0.8H, d, J = 2.2 Hz), 9.55 (0.2H, d, J = 1.9 Hz), 7.25 (5H, m), 4.33 (1H, dd, J = 7.6, 2.2
Hz), 4.21 (0.8H, dt, J = 8.1, 4.7 Hz), 4.08 (0.2H, m), 3.93 (1H, m), 2.88 (2H, m), 2.46 (1H, m),
1.99 (1H, m), 1.74 (1H, m).

Enol ether 592. To a solution of lactone 615 (0.051g, 0.269 mmol) in 1.5 mL THF was added
Cp2TiMe2 (1.07 mL of a 0.5M solution in THF, 0.537 mmol). The resulting mixture was warmed
to reflux and stirred for 20 h in the dark. The solution was then cooled to room temperature,
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concentrated in vacuo, and the resulting residue triturated with hexanes. (100 mL). The hexanes
solution was filtered through celite and concentrated again. The residue was purified via flash
chromatography (SiO2; hexanes:triethylamine, 19:1) to afford the exocyclic enol ether 592 as a
yellow oil (0.043 g, 85%). TLC: Rf = 0.79 (hexanes: EtOAc, 10:1). 1H NMR (CDCl3, 300
MHz):  7.24 (5H, m), 4.34 (1H, s), 4.12 (1H, ddd, J=11.1, 4.5, 3.0 Hz), 4.04 (1H, s), 3.61 (1H,
m), 2.60 (2H, m), 2.30 (1H, m), 1.92 (1H,m), 1.54 (3H, m).

13

C NMR (CDCl3, 75 MHz):

δ159.4 (C), 139.6 (C), 129.1 (CH), 128.3 (CH), 126.1 (CH), 91.7 (CH2), 68.7 (CH2), 42.8 (CH2),
36.5 (CH), 35.6 (CH2), 31.2 (CH2). IR (film): 3067 (w), 2932 (m), 1650 (m) cm-1.

Tetrahydro-3-methyl-6-propyl-2H-pyran-2-one 627. Distilled diisopropylamine (0.27 mL,
1.94 mmol), diluted with THF (1.5 mL), was cooled to 0○C, and nBuLi (0.78mL, 1.94 mmol)
was added by dropwise addition. The reaction mixture was cooled to -78○C and stirred for 30
minutes. Octanolactone 626 (0.23g, 1.62 mmol) was dissolved in THF (1.5 mL) and added
dropwise to the solution. The reaction mixture was stirred an additional 30 minutes at which
time a mixture of MeI (0.30g, 2.10 mmol), HMPA (0.39 mL, 2.26 mmol) and THF (1 mL) were
added. The reaction was warmed to -40○C for three hours and then stirred at room temperature
overnight. The reaction mixture was washed with saturated NH4Cl and diluted with ether. The
organic layer was separated from the aqueous. The aqueous layer was extracted with ethyl
acetate (3 x 5 mL).

Organic layers were combined, dried over MgSO4, filtered, and

concentrated. Column chromatography (SiO2; 3:1, hexanes:EtOAc) afforded lactone 627 as a
colorless oil (0.170g, 67%) in a 1:1 mixture of diastereomers.

Compound identity was

determined by 1H NMR87. TLC: Rf = 0.24 (10:1, hexanes:EtOAC ) 1H NMR (CDCl3, 300 MHz):
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δ 4.30 (1H, m), 2.60 (0.6H, m), 2.45 (0.4H, m), 1.99 (2H, m), 1.55 (6H, m), 1.30 (1.2H, d, J =
7.1 Hz), 1.22 (1.8H, d, J = 6.8 Hz), 0.94 (3H, t, J = 7.1 Hz).

Tetrahydro-3-benzyl-6-propyl-2H-pyran-2-one 629.

Distilled diisopropylamine (0.27 mL,

1.94 mmol), diluted with THF (1.5 mL), was cooled to 0○C, and nBuLi (0.78mL, 1.94 mmol)
was added by dropwise addition. The reaction mixture was cooled to -78○C and stirred for 30
minutes. Octanolactone 626 (0.23g, 1.62 mmol) was dissolved in THF (1.5 ml) and added
dropwise to the solution. The reaction mixture was stirred an additional 30 minutes at which
time a mixture BnBr (0.36g, 2.10 mmol), HMPA (0.39 mL, 2.26 mmol) and THF (1 mL) were
added. The reaction was warmed to -40○C for three hours and then stirred at room temperature
overnight. The reaction mixture is washed with saturated NH4Cl and diluted with ether. The
organic layer is separated from the aqueous. The aqueous layer was extracted with ethyl acetate
(3 x 5 mL). Organic layers were combined, dried over MgSO4, filtered, and concentrated.
Column chromatography (SiO2, 30:1 hexanes/EtOAc) afforded lactone 629 as a colorless oil
(0.203g, 54%) in a 2:1 mixture of diastereomers. TLC: Rf = 0.76 (2:1, hexanes:EtOAc). 1H NMR
(CDCl3, 300 MHz): δ 7.26 (5H, m), 4.25 (1H, m), 3.41 (0.66H, dd, J= 13.6, 4.0 Hz), 3.35
(0.33H, dd, J=13.5, 4.0 Hz), 2.72 (2H, m), 1.86 (2H, m), 1.50 (6H, m), 0.93 (3H, t, J=10.2 Hz).
13

C NMR (CDCl3, 300 MHz): δ 175.2, 173.1, 139.0, 138.8, 129.1, 129.0, 128.4, 126.3 (2), 81.3,

77.7, 42.5, 40.0, 38.2, 37.6, 37.2, 36.7, 28.7, 26.3, 24.9, 24.6, 22.5, 18.2, 17.9, 13.7. IR (film):
3063, 3028, 2959, 1735, 1603 cm-1.

205

Alkene 631. Alkene 631 was made by dissolving Red-Al® (13.21g, 42.5 mmol) in THF (160
mL). The reaction mixture was cooled to -60oC, and a mixture of alkyne 638 in THF (160 mL)
was added dropwise via cannula. After stirring for six hours at -60oC, Rochelle’s salt was added
and allowed to stir for an additional hour. The organic layer and aqueous layers were separated,
and the aqueous layer was extracted with ether (3 x 80 mL). Organic layers were combined and
washed with a saturated, aqueous sodium potassium tartrate solution. Drying of the organic
layers with MgSO4 was followed by filtration, concentration, and purification by flash
chromatography (SiO2, 7:1-2:1, hexanes/ethyl acetate) to yield olefin 631 as a colorless oil
(5.49g, 94%). 1H NMR data agrees with that previously published for this compound.88 TLC: Rf
= 0.21 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz): δ 7.32 (5H, m), 5.88 (2H, m), 4.53
(2H, s), 4.15 (2H, m), 4.04 (2H, dd, J = 4.3, 1.5 Hz), 2.01 (1H, s).

Epoxide 639. Epoxide 639 was manufactured from alkene 631 (8.13g, 45.62 mmol) and 70%
mCPBA (16.87g, 68.42 mmol) by literature procedure to yield a solid white product.70 1H NMR
data for this compound agreed with the known literature values.89 TLC: Rf = 0.33
(hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz): δ 7.35 (5H, m), 4.59 (2H, d, J = 4.4 Hz),
3.96 (1H, dd, J = 12.7, 2.4 Hz), 3.79 (1H, dd, J = 11.5, 3.0 Hz), 3.67 (1H, dd, J = 12.7, 4.1 Hz),
3.55 (1H, dd, J = 11.6, 5.5 Hz), 3.26 (1H, m), 3.12 (1H, m).
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Ester 641. Freshly made carbethoxymethylene triphenylphosphorane (18.18g, 50.2 mmol) and
aldehyde 640 (8.86g, 45.6 mmol) were refluxed in benzene (225 mL) over the period of 18
hours. The reaction mixture was cooled to room temperature and concentrated. Purification by
flash column chromatography (SiO2; 8:1, hexanes:ethyl acetate) yielded ester 641 as a single
isomer with a yellow oil appearance. The 1H NMR data of this compound corresponded to that
in the literature.90 TLC: Rf = 0.31 (10:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 7.33
(5H, m), 6.67 (1H, dd, J = 15.7, 7.2 Hz), 6.16 (1H, dd, J = 15.7, 0.7 Hz), 4.59 (2H, s), 4.21 (2H,
q, J = 7.1 Hz), 3.77 (1H, dd, J = 11.6, 3.2 Hz), 3.59 (1H, dd, J = 11.6, 5.0 Hz), 3.44 (1H, dd, J =
11.7, 7.2), 3.16 (1H, m), 1.29 (3H, t, J = 7.1 Hz).

Lactone 622. Alcohol 632 (2.05g, 7.36 mmol) and 10% Pd/C (0.30g, 0.28 mmol) was diluted in
methanol (25 mL). The reaction mixture was subjected to hydrogen gas by means of an attached
balloon. The reaction was stirred vigorously for 48 h. The reaction mixture was filtered through
a pad of celit and washed with a 10% aqueous HCl solution. The organic and aqueous layers
were separated. The aqueous layers were subsequently extracted with ethyl acetate (3 x 30 mL).
Combined organic layers were dried with MgSO4, filtered, and concentrated in vacuo.
Purification via flash column chromatography (SiO2, 5:1-2:1, hexanes/ethyl acetate) yielded the
desired lactone 622 as a colorless oil (1.10g, 64%). TLC: Rf = 0.29 (2:1, hexanes:EtOAc). 1H
NMR (CDCl3, 300 MHz): δ 7.34 (5H, m), 4.59 (2H, dd, J = 29.6, 12.1 Hz), 4.07 (1H, m), 3.68
(2H, m), 2.63 (1H, ddd, J = 17.9, 6.5, 4.2 Hz), 2.49 (1H, ddd, J = 17.7, 10.6, 6.9 Hz), 2.08 (1H,
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m), 1.93 (1H, m), 1.56 (1H, m), 1.01 (3H, t, J = 6.6 Hz).

13

C NMR (CDCl3, 75 MHz): δ 137.8,

128.3, 127.6 (2), 85.1, 73.5, 69.8, 29.6, 28.7, 27.4, 17.1. IR (film): 3031, 2935, 1733 cm-1.

Enol ether 622. To a solution of lactone 633 (0.069g, 0.29 mmol) in 6 mL THF was added
Cp2TiMe2 (1.17 mL of a 0.5M solution in THF, 0.585 mmol). The resulting mixture was warmed
to reflux and stirred for 20 h in the dark. The solution was then cooled to room temperature,
concentrated in vacuo, and the resulting residue triturated with hexanes. (100 mL). The hexanes
solution was filtered through celite and concentrated again. The residue was purified via flash
chromatography (SiO2; hexanes:triethylamine, 19:1) to afford the exocyclic enol ether 622 as a
yellow oil (0.051 g, 76%). TLC: Rf = 0.91 (hexanes: EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):
δ 7.34 (5H, m), 4.62 (2H, dd, J = 35.0, 12.2 Hz), 4.38 (1H, d, J = 1.0), 4.08 (1H, d, J = 1.3 Hz),
3.67 (1H, dd, J = 10.9, 2.7 Hz), 3.61 (1H, dd, J = 10.9, 4.4 Hz), 3.39 (1H, ddd, J = 9.6, 4.3, 2.7
Hz), 2.25 (2H, m), 1.85 (2H, m), 1.29 (1H, m), 0.87 (3H, d, J = 6.5 Hz).

13

C NMR (CDCl3, 75

MHz): δ 159.3, 138.2, 128.3, 127.6, 127.5, 91.4, 79.7, 73.3, 70.3, 29.4, 29.0, 25.1, 12.7. IR
(film): 3010, 3065, 3032, 2956, 2931, 1650 cm-1.

Aldehyde 644. Epoxide 644 (0.50g, 2.57 mmol) was oxidized under Swern conditions using a
similar literature procedure.17 Oxalyl chloride (0.49g, 3.90 mmol) was dissolved in CH2Cl2 (13
mL) and cooled to -78oC. DMSO (0.64g, 8.2 mmol) was added dropwise over a period of 15
minutes. The reaction mixture was allowed to stir for an additional 15 minutes until alcohol 643
was added dropwise as a solution in CH2Cl2 (1M, 2.6 mL). After stirring for 30 minutes, Et3N
(0.64g, 228 mmol) was added dropwise, and the reaction warmed up to room temperature over
208

the period of an hour. Water was added (100 mL) and the aqueous and organic layers were
separated. The aqueous layer was back extracted with CH2Cl2 (3 x 80 mL). The organic layers
were combined, dried with MgSO4, filtered, and concentrated to yield product 644 as a yellow
oil (0.67g, 100%) which was carried on to the next step without further purification. 1H NMR
data for this compound agreed with the known literature values.91 TLC: Rf = 0.39 (2:1,
hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): 9.45 (1H, d, J = 4.8 Hz), 7.34 (5H, m), 4.57 (2H,
s), 3.81 (2H, dq, J = 11.1, 3.9 Hz), 3.47 (2H, m).

Ester 645. Formation of ester 645 (10.1g, 82%) is achieved by refluxing freshly made
carbethoxymethylene triphenylphosphorane (18.7g, 51.5 mmol)18 in benzene (125 mL) with
aldehyde 644 (9.00g, 46.8 mmol) over a period of 18 hours following a similar literature
procedure.17 The reaction mixture is cooled to room temperature and concentrated. The product
is purified via flash column chromatography (SiO2; 8:1, hexanes:ethyl acetate) to yield ester 645
as a yellow oil. 1H NMR data is consistent with that reported for ester 645.90 TLC: Rf = 0.70 (2:1
hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 7.33 (5H, m), 6.77 (1H, dd, J = 15.7, 6.6 Hz),
6.15 (1H, dd, J = 15.7, 1.0 Hz), 4.58 (2H, dd, J = 28.4, 11.9 Hz), 4.21 (2H, q, J = 7.1), 3.62 (3H,
m), 3.46 (1H, m), 1.31 (3H, t, J = 7.1 Hz).

Lactone 636. Hydrogenation of alcohol 635 (1.78g, 6.4 mmol) was accomplished by dilution in
methanol (22 mL), along with the addition of 10 % Pd/C (0.30g, 0.28 mmol). The reaction
mixture was subjected to hydrogen gas by means of an attached balloon. The reaction was
stirred vigorously for 72 h. Filtration through a pad of celite was followed by washing with a
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10% aqueous HCl solution. The organic and aqueous layers were separated. Aqueous layers
were extracted with ethyl acetate (3 x 30 mL). Combined organic layers were dried with
MgSO4, filtered, and concentrated in vacuo. Purification via flash column chromatography
(SiO2, 5:1-2:1, hexanes/ethyl acetate) yielded the desired lactone as a colorless oil (1.00g, 67%).
1

H NMR data corresponds to that of the known lactone.92 1H NMR (CDCl3, 300 MHz): δ 7.33

(5H, m), 4.55 (3H, m), 3.64 (2H, ddd, J = 24.6, 10.2, 5.5 Hz), 2.56 (2H, dt, J = 7.0, 2.4 Hz), 2.23
(1H, m), 2.01 (1H, m), 1.77 (1H, m), 0.97 (3H, d, J = 7.1 Hz).

Enol ether 623. To a solution of lactone 636 (0.64g, 2.7 mmol) in 50 mL THF was added
Cp2TiMe2 (10.9 mL of a 0.5M solution in THF, 5.5 mmol). The resulting mixture was warmed to
reflux and stirred for 20 h in the dark. The solution was then cooled to room temperature,
concentrated in vacuo, and the resulting residue triturated with hexanes. (300 mL). The hexanes
solution was filtered through celite and concentrated again. The residue was purified via flash
chromatography (SiO2; hexanes:triethylamine, 19:1) to afford the exocyclic enol ether 623 as a
yellow oil (0.44 g, 72%). TLC: Rf = 0.70 (hexanes: EtOAc, 10:1). 1H NMR (CDCl3, 300 MHz):
δ 7.33 (5H, m), 4.59 (2H, dd, J = 33.2, 12.1 Hz), 4.37 (1H, d, J = 1.0), 4.09 (1H, d, J = 0.9 Hz),
4.00 (1H, m), (1H, dd, J = 10.1, 7.0 Hz), 3.48 (1H, dd, J = 10.1, 5.1 Hz), 2.33 (1H, m), 2.16 (1H,
dt, J = 14.4, 5.4 Hz), 1.98 (1H, m), 1.79 (1H, m), 1.56 (1H, m), 0.97 (3H, d, J = 7.0 Hz).

13

C

NMR (CDCl3, 75 MHz): δ 159.3 (C), 138.2 (C), 128.3 (CH), 127.6 (CH), 127.5 (CH), 91.4
(CH2), 79.7 (CH), 73.3 (CH2), 70.3 (CH2), 29.4 (CH2), 29.0 (CH), 25.1 (CH2), 12.7 (CH3). IR
(film): 3010, 3065, 3032, 2956, 2931, 1650 cm-1.
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Ester 652. A 1.0 M solution of NaHMDS in THF (9.86 mL, 9.86 mmol) was diluted with THF
(15 mL). The reaction was cooled to -78oC and a solution of ester 651 (1.00g, 7.04 mmol) in
THF (15 mL) was added dropwise. The reaction mixture was stirred for one hour before
addition of MeI (2.19 mL, 35.2 mmol). The reaction was allowed to stir for an additional 3h
before quenching at -78oC with glacial acetic acid (4 mL). The reaction mixture was warmed to
ambient temperature before adding water (20 mL) and separating the aqueous and organic layers.
The aqueous layer was back extracted with EtOAc (3x15 mL).

The organic layers were

combined, dried with MgSO4, filtered, and concentrated.

Purification via column

chromatography (SiO2; hexanes:EtOAc, 15:1) yielded methylated ester 652 as a yellow oil (0.84
g) in 77% yield. TLC: Rf = 0.81 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): 5.77 (1H,
m), 4.99 (2H, m), 4.13 (2H, d, J = 7.2 Hz), 2.44 (1H, m), 2.06 (2H, m), 1.76 (1H, m), 1.48 (1H,
m), 1.25 (3H, t, J = 7.1 Hz), 1.14 (3H, d, J = 7.0 Hz). 13C NMR (CDCl3, 75 MHz): δ 176.7 (C),
137.9 (CH), 115.0 (CH2), 60.1 (CH2), 38.9 (CH), 32.8 (CH2), 31.3 (CH2), 17.0 (CH3), 14.2
(CH3). IR (film): 3079, 2936, 1713, 1641 cm-1.

Enol ether 624. To a solution of lactone 655 (0.022 g, 0.087 mmol) in 1.3 mL THF was added
Cp2TiMe2 (0.38 mL of a 0.5M solution in THF, 0.19 mmol). The resulting mixture was warmed
to reflux and stirred for 20 h in the dark. The solution was then cooled to room temperature,
concentrated in vacuo, and the resulting residue triturated with hexanes. (60 mL). The hexanes
solution was filtered through celite and concentrated again. The residue was purified via flash
211

chromatography (SiO2; hexanes:triethylamine, 19:1) to afford the exocyclic enol ether 624 as a
yellow oil (0.012g, 57%). TLC: Rf = 0.90 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ
4.43 (1H, s), 4.17 (1H, d, J = 0.5 Hz), 3.84 (1H, m), 3.29 (2H, ddd, J = 17.6, 10.3, 6.1 Hz), 2.39
(1H, m), 1.83 (3H, m), 1.51 (1H, m), 1.14 (3H, d, J = 6.8 Hz).

13

C NMR (CDCl3, 75 MHz): δ

163.3 (c), 91.3 (CH2), 76.7 (CH), 32.0 (CH), 28.0 (CH2), 26.7 (CH2), 18.7 (CH3), 8.4 (CH2). IR
(film): 2934, 1647 cm-1.

Enol ether 625. To a solution of lactone 656 (0.039 g, 0.153 mmol) in 2.6 mL THF was added
Cp2TiMe2 (0.61 mL of a 0.5M solution in THF, 0.31 mmol). The resulting mixture was warmed
to reflux and stirred for 20 h in the dark. The solution was then cooled to room temperature,
concentrated in vacuo, and the resulting residue triturated with hexanes. (60 mL). The hexanes
solution was filtered through celite and concentrated again. The residue was purified via flash
chromatography (SiO2; hexanes:triethylamine, 19:1) to afford the exocyclic enol ether 625 as a
yellow oil (0.010g, 25%). TLC: Rf = 0.89 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): 
4.43 (1H, s), 4.17 (1H, d, J = 0.5 Hz), 3.84 (1H, m), 3.29 (2H, ddd, J = 17.6, 10.3, 6.1 Hz), 2.39
(1H, m), 1.83 (3H, m), 1.51 (1H, m), 1.14 (3H, d, J = 6.8 Hz).

13

C NMR (CDCl3, 75 MHz): δ

163.3 (C), 91.3 (CH2), 76.7 (CH), 32.0 (CH), 28.0 (CH2), 26.7 (CH2), 18.7 (CH3), 8.4 (CH2). IR
(film): 2934, 1647 cm-1.

Alcohol 657. Enol ether 590 (0.043 g, 0.23 mmol) was placed into a flame dried flask along
with a stir bar and 0.22 mL of THF. Freshly distilled ethyl glyoxylate 343 (0.028 mL, 0.27
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mmol) was added to the reaction mixture while stirring. A 0.15 M solution of ZnCl2 in THF was
added (0.08 mL, 0.002 mmol), and the reaction mixture was allowed to stir for two hours. The
reaction mixture was concentrated in vacuo. Purification by column chromatography (SiO2;
10:1-6:1, 95% hexanes, 5% Et3N:EtOAc) yielded ene product 657 (0.065 g, 98%), a colorless
oil, as a 1.1:1 mixture of diastereomers. TLC: Rf = 0.39 (2:1, hexanes:EtOAc). 1H NMR (CDCl3,
300 MHz): δ 7.28 (5H, m), 4.60 (1H, m), 4.21 (3H, m), 4.01 (1H, m), 2.97 (2H, m), 2.79 (1H,
m), 2.46 (2H, m), 2.00 (2H, m), 1.81 (1H, m), 1.50 (1H, m), 1.28 (3H, dt, J = 7.1, 2.5 Hz).

13

C

NMR (CDCl3, 75 MHz): δ 174.1 (C), 149.7 (C), 149.2 (C), 137.8 (C), 129.4 (CH), 129.3 (CH),
128.3 (2) (CH), 126.4 (CH), 126.3 (CH), 98.3 (CH), 98.9 (CH), 98.8 (CH), 76.4 (CH), 76.3
(CH), 69.4 (CH), 68.8 (CH), 61.2 (CH2), 61.1 (CH2), 41.6 (CH2), 41.5 (CH2), 39.2 (CH2), 39.1
(CH2), 26.5 (CH2), 26.2 (CH2), 20.3 (CH2), 20.1 (CH2), 14.2 (2) (CH3). IR (film): 3511, 3064,
3028, 2924, 1735, 1680 cm-1.

Alcohol 658. Enol ether 590 (0.030g, 0.170) was placed into a flame dried flask along with a stir
bar and 0.35 mL of THF. p-Nitrobenzaldehyde 383 (0.023g, 0.15 mmol) was added to the
reaction mixture while stirring. A 0.1 M solution of ZnCl2 in THF was added (0.077 mL, 0.0080
mmol), and the reaction mixture was allowed to stir for two hours. The reaction mixture was
concentrated in vacuo. Purification by column chromatography (SiO2; 10:1-7:1, 95% hexanes,
5% Et3N:EtOAc) yielded ene product 658 (0.049, 94%), a colorless oil, as a 1:1 mixture of
diastereomers. TLC: Rf = 0.62 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 8.15 (2H,
m), 7.35 (7H, m), 4.89 (1H, dd, J=7.8, 4.4 Hz), 4.55 (0.5H, t, J=3.5 Hz), 4.48 (0.5 Hz, t, J=3.4
Hz), 4.05 (0.5H, m), 3.89 (0.5H, m), 3.03 (1H, s, br), 2.91 (2H, ddd, J=26.7, 13.5, 6.2 Hz), 2.56
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(0.5H, m), 2.35 (1.5H, m), 2.00 (2H, m), 1.86 (1H, m), 1.56 (1H, m).

13

C NMR (CDCl3, 75

MHz): δ 151.2 (C), 150.3 (C), 150.2 (C), 146.9 (C). 137.9 (C), 137.8 (C), 129.3 (2) (CH), 128.5
(2) (CH), 126.7 (CH), 126.6 (CH), 126.4 (CH), 126.2 (CH), 123.4 (CH), 123.3 (CH), 99.3 (CH),
98.9 (CH), 76.7 (CH), 71.9 (CH), 71.6 (CH), 44.1 (CH2), 43.4 (CH2), 41.7 (CH2), 41.6 (CH2),
26.8 (CH2), 26.7 (CH2), 20.2 (CH2), 20.2 (CH2). IR (film): 3339, 3064, 3029, 2920, 1678, 1603,
1520, 1345 cm-1.

Alcohol 659. Enol ether 590 (0.068g, 0.361 mmol) was placed into a flame dried flask along
with a stir bar and 0.56 mL of THF. Octyl aldehyde 495 (0.051g, 0.397 mmol) was added to the
reaction mixture while stirring. A 0.5 M solution of ZnCl2 in THF was added (0.143 mL, 0.072
mmol), and the reaction mixture was allowed to stir for 11 hours. The reaction mixture was
concentrated in vacuo. Purification by column chromatography (SiO2; 15:1-7:1, 95% hexanes,
5% Et3N:EtOAc) yielded ene product 659 (0.095g, 83%), a colorless oil, as a 1:1 mixture of
diasteromers. TLC: Rf = 0.82 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 7.26 (5H,
m), 4.55 (1H, t, J = 3.6 Hz), 4.02 (1H, m), 3.76 (1H, m), 2.60 (2H, dd, J = 7.1, 4.1 Hz), 2.31 (1H,
t, J = 3.5 Hz), 2.52 (1H, d, J = 13.8 Hz), 2.08 (3H, m), 1.77 (2H, m), 1.36 (12H, m), 0.89 (3H, t,
J = 6.6 Hz). 13C NMR (CDCl3, 75 MHz): δ 151.8 (C), 151.7 (C), 139.7 (C), 129.0 (CH). 128.3
(CH), 126.1 (CH), 97.1 (CH), 70.0 (CH), 69.9 (CH), 69.7 (CH), 69.6 (CH) 41.8 (CH2), 41.8
(CH2), 38.2 (2) (CH2), 36.8 (CH2), 33.8 (CH2), 31.8 (CH2), 29.6 (CH2), 29.3 (CH2), 26.6 (CH2),
25.7 (CH2), 22.6 (CH2), 14.1 (CH3). IR(film): 3585, 3030, 2926, 2857, 1605 cm-1.
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Alcohol 660. Enol ether 591 (0.075g, 0.371) was placed into a flame dried flask along with a stir
bar and 0.40 mL of THF. Freshly distilled ethyl glyoxylate 343 (0.049 mL, 0.478 mmol) was
added to the reaction mixture while stirring. A 0.15 M solution of ZnCl2 in THF was added
(0.136 mL, 0.020 mmol), and the reaction mixture was allowed to stir for two hours. The
reaction mixture was concentrated in vacuo. Purification by column chromatography (SiO2;
10:1-6:1, 95% hexanes, 5% Et3N:EtOAc) yielded ene product 660 (0.085g, 80%) as a colorless
oil with a dr of 1:1.3. TLC: Rf = 0.40 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 7.24
(5H, m), 4.59 (1H, ddd, J = 7.7, 4.0 Hz), 4.32 (1H, t, J = 5.3 Hz), 4.23 (2H, m), 3.96 (1H, m),
3.60 (1H, m), 3.04 (1H, dd, J = 11.9, 7.3 Hz), 2.51 (4H, m), 2.08 (2H, m), 1.76 (1H, m), 1.29
(3H, dt, J = 7.14, 0.4).

13

C NMR (CDCl3, 75 MHz): δ 174.2 (C), 174.1 (C), 149.4 (C), 149.1

(C), 139.6 (2) (C), 128.9 (CH), 128.2 (CH), 126.0 (CH), 98.3 (CH), 98.1 (CH), 69.4 (CH2), 68.9
(CH), 68.6 (CH), 61.3 (2) (CH2), 39.0 (CH2), 38.1 (CH2), 38.0 (CH2), 33.7 (CH), 33.6 (CH), 26.6
(CH2), 26.4 (CH2), 14.1 (CH3). IR (film): 3324, 3028, 2923, 1735, 1681 cm-1.

Alcohol 661. Enol ether 591 (0.040 g, 0.22 mmol) was placed into a flame dried flask along
with a stir bar and 0.40 mL of THF. p-Nitrobenzaldehyde 383 (0.030g, 0.20 mmol) was added
to the reaction mixture while stirring. A 0.1 M solution of ZnCl2 in THF was added (0.10 mL,
0.010 mmol), and the reaction mixture was allowed to stir for two hours. The reaction mixture
was concentrated in vacuo.

Purification by column chromatography (SiO2; 10:1-7:1, 95%

hexanes, 5% Et3N:EtOAc) yielded ene adduct 661 (0.059, 88%), a colorless oil, as a 1.4:1 ratio
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of diastereomers. TLC: Rf = 0.65 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 8.21
(2H, m), 7.54 (2H, m), 7.26 (5H, m), 5.00 (1H, m), 4.57 (1H, m), 4.04 (1H, m), 3.66 (1H, ddd, J
= 13.1, 10.5, 8.3 Hz), 3.07 (1H, m), 2.60 (2H, m), 2.49 (1H, m), 2.35 (1H, m), 2.10 (2H, m), 1.76
(1H, m).

13

C NMR (CDCl3, 75 MHz): δ 151.2 (C), 150.3 (C), 147.1 (C), 139.4 (C), 128.9 (CH),

128.4 (CH), 128.3 (CH), 126.4 (2) (CH), 126.2 (CH), 123.5 (CH), 98.6 (CH), 71.7 (CH), 71.6
(CH), 69.9 (CH2), 69.8 (CH2), 44.1 (CH2), 44.0 (CH2), 38.2 (CH2), 33.7 (CH), 26.5 (CH2). IR
(film): 3547, 3081, 3026, 2918, 1679, 1603, 1519, 1346 cm-1.

Alcohol 662. Enol ether 591 (0.045g, 0.239 mmol) was placed into a flame dried flask along
with a stir bar and 0.18 mL of THF. Octyl aldehyde 495 (0.031g, 0.239 mmol) was added to the
reaction mixture while stirring. A 0.16 M solution of ZnCl2 in THF was added (0.30 mL, 0.048
mmol), and the reaction mixture was allowed to stir for 11 hours. The reaction mixture was
concentrated in vacuo. Purification by column chromatography (SiO2; 15:1-7:1, 95% hexanes,
5% Et3N:EtOAc) yielded ene product 100 (0.060, 80%), a colorless oil, as a 1.3:1 mixture of
diastereomers. TLC: Rf = 0.87 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 7.26 (5H,
m), 4.55 (1H, t, J = 3.6 Hz), 4.02 (1H, m), 3.76 (1H, m), 3.64 (1H, m), 2.60 (2H, dd, J = 7.1, 4.1
Hz), 2.31 (1H, t, J = 3.5 Hz), 2.52 (1H, d, J = 13.8 Hz), 2.08 (3H, m), 1.77 (1H, m), 1.36 (12H,
m), 0.89 (3H, t, J = 6.6 Hz).

13

C NMR (CDCl3, 75 MHz): δ 151.8 (C), 151.7 (C), 139.7 (C),

129.0 (CH). 128.3 (CH), 126.1 (CH), 97.1 (CH), 70.0 (CH2), 69.9 (CH2), 69.7 (CH), 69.6 (CH)
41.8 (CH2), 41.8 (CH2), 38.2 (2) (CH2), 36.8 (CH2), 33.8 (CH), 31.8 (CH2), 29.6 (CH2), 29.3
(CH2), 26.6 (CH2), 25.7 (CH2), 22.6 (CH2), 14.1 (CH3). IR (film): 3501, 3028, 2926, 2855, 1678
cm-1.
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Alcohol 663. Enol ether 592 (0.020 g, 0.11 mmol) was placed into a flame dried flask along
with a stir bar and 0.21 mL of THF. Freshly distilled ethyl glyoxylate 343 (0.011 mL, 0.12
mmol) was added to the reaction mixture while stirring. A 0.07 M solution of ZnCl2 in THF was
added (0.08 mL, 0.005 mmol), and the reaction mixture was allowed to stir for two hours. The
reaction mixture was concentrated in vacuo. Purification by column chromatography (SiO2; 8:15:1, 95% hexanes, 5% Et3N:EtOAc) yielded ene product 663 (0.030 g, 100%) as a colorless oil
with a dr of 2.4:1. TLC: Rf = 0.59 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 7.23
(5H, m), 4.54 (1H, d, J = 2.3 Hz), 4.32 (1H, m), 4.23 (2H, dq, J = 7.1, 1.7 Hz), 4.03 (1H, m),
3.90 (1H, m), 2.97 (1H, dd, J = 7.3, 2.5 Hz), 2.54 (5H, m), 1.79 (1H, m), 1.56 (1H, m), (3H, dt, J
= 7.1, 4.6 Hz).

13

C NMR (CDCl3, 75 MHz): δ 174.1 (C), 149.5 (C), 140.0 (C), 129.0 (CH),

128.3 (CH), 126.0 (CH), 103.8 (CH), 103.7 (CH), 68.9 (CH), 65.0 (CH2), 64.9 (CH2), 61.4
(CH2), 42.8 (CH2), 39.4 (CH2), 39.3 (CH2), 32.8 (CH), 32.7 (CH), 28.3 (CH2), 28.2 (CH2), 14.2
(CH3). IR (film): 3475, 3062, 3027, 2928, 1734, 1674 cm-1.

Alcohol 664. Enol ether 592 (0.010g, 0.053) was placed into a flame dried flask along with a stir
bar and 0.65 mL of THF. p-Nitrobenzaldehyde 383 (0.007g, 0.048 mmol) was added to the
reaction mixture while stirring. A 0.1 M solution of ZnCl2 in THF was added (0.071 mL, 0.0020
mmol), and the reaction mixture was allowed to stir for two hours. The reaction mixture was
concentrated in vacuo. Purification by column chromatography (SiO2; 10:1-7:1, 95% hexanes,
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5% Et3N:EtOAc) yielded ene product 664 (0.015, 92%), a colorless oil, as a 2.6:1 ratio of
diastereomers. TLC: Rf = 0.62 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 8.21 (2H,
d, J=8.8 Hz), 7.53 (2H, d, J=8.4 Hz), 7.26 (3H, m), 7.12 (2H, m), 4.98 (1H, m), 4.48 (1H, m),
4.10 (1H, m), 3.95 (1H, m), 3.07 (0.19H, s), 3.00 (0.81H, s), 2.58 (2H, m), 2.47 (2H, m), 2.33
(1H, m), 1.82 (1H, m), 1.56 (1H, m).

13

C NMR (CDCl3, 75 MHz): δ 151.2 (C), 150.3 (C), 147.1

(C), 139.7 (C), 139.6 (C), 129.0 (CH), 128.3 (CH), 126.4 (CH), 126.1 (CH), 123.5 (CH), 103.9
(2) (CH), 71.6 (CH), 71.6 (CH), 65.2 (CH2), 65.1 (CH2), 44.4 (CH2), 44.3 (CH2), 42.7 (CH2),
32.6 (CH), 32.5 (CH), 28.3 (CH2), 28.2 (CH2). IR (film): 3498, 3027, 2923, 1673, 1603, 1520,
1346 cm-1.

Alcohol 665. Enol ether 592 (0.022g, 0.117) was placed into a flame dried flask along with a stir
bar and 0.11 mL of THF. Octyl aldehyde 495 (0.016g, 0.129 mmol) was added to the reaction
mixture while stirring. A 0.73 M solution of ZnCl2 in THF was added (0.03 mL, 0.023 mmol),
and the reaction mixture was allowed to stir for 11 hours. The reaction mixture was concentrated
in vacuo.

Purification by column chromatography (SiO2; 20:1-10:1, 95% hexanes, 5%

Et3N:EtOAc) yielded ene product 665 (0.028, 76%), a colorless oil, as a 2.4:1 ratio of
diastereomers. TLC: Rf = 0.81 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 7.24 (5H,
m), 4.50 (1H, s), 4.06 (1H, m), 3.94 (1H, m), 3.74 (1H, m), 2.57 (2H, m), 2.30 (2H, m), 2.04
(1H, m), 1.80 (1H, m), 1.37 (13H, m), 0.89 (3H, t, J = 6.6 Hz)

13

C NMR (CDCl3, 75 MHz): δ

151.8 (C), 140.0 (C), 129.0 (CH), 128.3 (CH), 126.0 (CH), 102.7 (CH), 69.6 (CH), 65.0 (CH2),
64.9 (CH2), 43.0 (CH2), 42.9 (CH2), 42.1 (CH2), 42.0 (CH2), 36.8 (CH2), 32.7 (CH2), 31.8 (CH),
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29.6 (CH2), 29.3 (CH2), 28.4 (CH2), 25.7 (CH2), 22.7 (CH2), 14.1 (CH3) IR (film): 3028, 2928,
1670, 1603 cm-1.

Alcohol 678. Enol ether 622 (0.023 g, 0.10 mmol) was placed into a flame dried flask along
with a stir bar and 0.20 mL of THF. Freshly distilled ethyl glyoxylate 343 (0.012 mL, 0.12
mmol) was added to the reaction mixture while stirring. A 0.15 M solution of ZnCl2 in THF was
added (0.03 mL, 0.004 mmol), and the reaction mixture was allowed to stir for two hours. The
reaction mixture was concentrated in vacuo. Purification by column chromatography (SiO2; 9:15:1, 95% hexanes, 5% Et3N:EtOAc) yielded ene adduct 678 (0.033 g, 100%) as a colorless oil
with a dr of 1.3:1. TLC: Rf = 0.54 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 7.32
(5H, m), 4.61 (3H, m), 4.35 (1H, m), 4.21 (2H, m), 3.65 (3H, m), 3.25 (1H, ddd, J = 11.6, 7.5
Hz), 2.50 (2H, m), 2.05 (1H, dt, J = 16.6, 5.0), 1.91 (1H, m), 1.70 (1H, m), 1.28 (3H, dt, J = 7.1,
1.5 Hz), 0.95 (3H, dd, J = 6.6, 4.4 Hz).

13

C NMR (CDCl3, 75 MHz): δ 174.1 (C), 149.1 (C),

148.4 (C), 138.1 (C), 128.3 (CH), 127.8 (CH), 127.7 (CH), 127.6 (CH), 98.3 (2) (CH), 79.8
(CH), 79.5 (CH), 73.3 (CH2), 70.2 (CH2), 70.1 (CH2), 69.4 (CH), 69.0 (CH), 61.2 (2) (CH2), 38.9
(CH2), 28.4 (CH), 28.0 (CH), 27.6 (CH2), 27.3 (CH2), 17.6 (CH3), 17.4 (CH3), 14.2 (CH3). IR
(film): 3496, 3065, 3031, 2959, 1736, 1683 cm-1.

Alcohol 679. Enol ether 622 (0.015 g, 0.065 mmol) was placed into a flame dried flask along
with a stir bar and 0.21 mL of THF. p-Nitrobenzaldehyde 383 (0.008 g, 0.054 mmol) was added
to the reaction mixture while stirring. A 0.18 M solution of ZnCl2 in THF was added (0.015 mL,
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0.003 mmol), and the reaction mixture was allowed to stir for two hours. The reaction mixture
was concentrated in vacuo.

Purification by column chromatography (SiO2; 10:1-8:1, 95%

hexanes, 5% Et3N:EtOAc) yielded ene adduct 679 (0.019 g, 94%), a colorless oil, as a 1.4:1 ratio
of diastereomers. TLC: Rf = 0.55 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 8.18
(2H, dd, J = 8.9, 2.2 Hz), 7.54 (2H, d, J = 7.8 Hz), 7.34 (5H, m), 5.01 (1H, m), 4.61 (2H, dd, J =
16.4, 12.3 Hz), 4.52 (1H, dd, J = 4.4, 2.9 Hz), 3.66 (3H, m), 3.54 (1H, br s), 2.54 (1H, dd, J =
14.2, 2.9 Hz), 2.37 (1H, m), 2.02 (1H, dt, J = 16.6, 5.1 Hz), 1.89 (1H, m), 1.67 (1H, m), 0.95
(3H, t, J = 7.1 Hz).

13

C NMR (CDCl3, 75 MHz): δ 151.4 (C), 149.7 (C), 149.3 (C), 147.0 (C),

137.9 (C), 128.4 (CH), 127.7 (CH), 126.5 (CH), 123.4 (CH), 98.4 (CH), 79.9 (CH), 79.6 (CH),
73.5 (CH2), 73.4 (CH2), 72.1 (CH), 71.7 (CH), 70.1 (CH2), 70.0 (CH2), 43.6 (CH2), 43.5 (CH2),
28.2 (CH2), 28.0 (CH2), 27.5 (2) (CH), 17.5 (CH3), 17.4 (CH3). IR (film): 3503, 3124, 3066,
2915, 1682, 1603, 1519, 1346 cm-1.

Alcohol 680. Enol ether 622 (0.0230g, 0.09980) was placed into a flame dried flask along with a
stir bar and 0.20 mL of THF. Octyl aldehyde 495 (0.0110g, 0.083 mmol) was added to the
reaction mixture while stirring. A 0.13 M solution of ZnCl2 in THF was added (0.126 mL,
0.0166 mmol), and the reaction mixture was allowed to stir for eleven hours. The reaction
mixture was concentrated in vacuo. Purification by column chromatography (SiO2; 20:1-5:1,
95% hexanes, 5% Et3N:ethyl acetate) yielded ene product 680 (0.0171g, 57%), a colorless oil as
a mixture of diastereomers. TLC: Rf = 0.84 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz):
δ 7.32 (5H, m), 4.58 (3H, m), 3.63 (2H, d, J = 4.1 Hz), 3.72 (2H, m), 2.67 (1H, dd, J = 35.9, 3.4
Hz), 2.28 (1H, d, J = 14.1 Hz), 2.07 (2H, m), 1.92 (1H, m), 1.70 (1H, m), 1.33 (12H, m), 0.92
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(6H, m). 13C NMR (CDCl3, 75 MHz): δ 151.2 (C), 150.9 (C), 128.4 (CH), 127.7 (CH), 127.6
(CH), 97.1 (CH), 97.0 (CH), 79.7 (CH), 79.5 (CH), 73.4 (2) (CH2), 70.3 (CH), 70.3 (CH2), 70.0
(CH), 41.6 (2) (CH2), 36.8 (2) (CH2), 36.6 (CH2), 31.8 (CH2), 29.7 (CH2), 29.3 (CH2), 28.2
(CH2), 28.1 (CH2), 27.6 (CH), 25.8 (CH2), 22.7 (CH2), 17.6 (CH3), 17.5 (CH3), 14.1 (CH3). IR
(film): 3528, 3033, 2956, 1681, 1603 cm-1.

Alcohol 681. Enol ether 623 (0.0230g, 0.0998) was placed into a flame dried flask along with a
stir bar and 0.20 mL of THF. Freshly distilled ethyl glyoxylate 343 (0.0122 mL, 0.120 mmol)
was added to the reaction mixture while stirring. A 0.15 M solution of ZnCl2 in THF was added
(0.0300 mL, 0.00415 mmol), and the reaction mixture was allowed to stir for two hours. The
reaction mixture was concentrated in vacuo. Purification by column chromatography (SiO2;
10:1-5:1, 95% hexanes, 5% Et3N:ethyl acetate) yielded ene product 681 (0.0320g, 97%) as a
colorless oil with a dr of 2.6:1. TLC: Rf = 0.47 (2:1, hexanes:EtOAc).

1

H NMR (CDCl3, 300

MHz): δ 7.33 (5H, m), 4.60 (3H, m), 4.36 (1H, m), 4.21 (2H, dq, J = 7.2, 2.3 Hz), 4.12 (1H, m),
3.62 (1H, m), 3.46 (1H, m), 3.39 (1H, d, J = 8.0 Hz), 2.38 (3H, m), 2.05 (1H, m), 1.64 (1H, m),
1.28 (3H, t, J = 7.1 Hz), 0.89 (3H, dd, J = 7.0, 2.1 Hz). 13C NMR (CDCl3, 75 MHz): δ 174.0 (C),
148.0 (C), 138.0 (C), 128.4 (CH), 127.8 (CH), 127.7 (2) (CH), 97.9 (CH), 97.7 (CH), 76.9 (CH),
73.3 (CH2), 73.2 (CH2), 69.8 (CH2) 69.3 (CH) 69.2 (CH), 68.7 (CH2) 61.3 (CH2), 61.2 (CH2),
38.8 (CH2), 28.4 (CH2), 27.9 (CH2), 27.3 (CH), 27.1 (CH3), 14.2 (CH3). IR (film): 3473, 3066,
2924, 1735, 1676 cm-1.
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Alcohol 682. Enol ether 623 (0.0230g, 0.0998) was placed into a flame dried flask along with a
stir bar and 0.20 mL of THF. p-Nitrobenzaldehyde 383 (0.0120g, 0.084 mmol) was added to the
reaction mixture while stirring. A 0.18 M solution of ZnCl2 in THF was added (0.0233 mL,
0.0040 mmol), and the reaction mixture was allowed to stir for two hours. The reaction mixture
was concentrated in vacuo.

Purification by column chromatography (SiO2; 10:1-5:1, 95%

hexanes, 5% Et3N:ethyl acetate) yielded ene product 682 (0.0300g, 100%) as a colorless oil with
a dr of 3.5:1. TLC: Rf = 0.47 (2:1, hexanes:EtOAc). 1H NMR (CDCl3, 300 MHz): δ 8.19 (2H, d,
J = 8.8 Hz), 7.54 (2H, d, J = 8.3 Hz), 7.24 (5H, m), 5.01 (1H, m), 4.56 (3H, m), 4.14 (1H, m),
3.66 (1H, m), 3.48 (1H, dd, J = 10.2, 4.0 Hz), 2.30 (4H, m), 1.66 (1H, m), 0.88 (3H, d, J = 6.9
Hz). 13C NMR (CDCl3, 75 MHz): δ 151.5 (C), 148.9 (C), 147.0 (C), 137.7 (C), 128.5 (CH),
128.3 (CH), 127.8 (2) (CH), 126.4 (CH), 123.5 (CH), 98.2 (CH), 77.2 (CH), 79.9 (CH), 73.3
(CH2), 71.2 (CH), 69.0 (CH2), 43.7 (CH2), 28.0 (CH2), 27.5 (CH), 14.3 (CH3). IR (film): 3421,
3066, 2964, 1603, 1519, 1345 cm-1.

Alcohol 683. Enol ether 623 (0.0180g, 0.0770) was placed into a flame dried flask along with a
stir bar and 0.15 mL of THF. Octyl aldehyde 495 (0.0090g, 0.0640 mmol) was added to the
reaction mixture while stirring. A 0.18 M solution of ZnCl2 in THF was added (0.0184 mL,
0.0030 mmol), and the reaction mixture was allowed to stir for eleven hours. The reaction
mixture was concentrated in vacuo. Purification by column chromatography (SiO2; 10:1-5:1,
95% hexanes, 5% Et3N:ethyl acetate) yielded ene product 683 (0.017g, 74%) as a colorless oil
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with a 1.7:1 mixture of diastereomers. TLC: Rf = 0.69 (2:1, hexanes:EtOAc).

1

H NMR (CDCl3,

300 MHz): δ 7.32 (5H, m), 4.57 (3H, m), 4.13 (1H, m), 3.78 (1H, m), 3.63 (1H, m), 3.48 (1H,
m), 2.68 (1H, br s), 2.27 (2H, m), 2.07 (2H, m), 1.68 (1H, m), 1.23 (12H, m), 1.04 (3H, t, J=7.2
Hz), 0.93 (3H,m).

13

C NMR (CDCl3, 75 MHz): δ 150.8 (C), 150.3 (C), 138.0 (C), 137.9 (C),

128.4 (CH), 127.7 (3) (CH), 96.7 (CH), 96.5 (CH), 76.8 (CH), 73.4 (CH2), 73.3 (CH2), 70.6
(CH), 69.7 (CH), 69.4 (CH2), 69.2 (CH2), 41.6 (2) (CH2), 36.8 (2) (CH2), 31.8 (CH2), 29.6
(CH2), 29.3 (CH2), 28.2 (CH2), 28.1 (CH2), 27.4 (CH), 27.3 (CH), 25.7 (CH2), 22.7 (CH2), 14.2
(CH2), (CH3) 14.1 (CH3), 13.8 (CH3). IR (film): 3498, 3032, 2927, 2856, 1677 cm-1.

Alcohol 684. Enol ether 624 (0.030g, 0.119 mmol) was placed into a flame dried flask along
with a stir bar and 0.238 mL of THF. Freshly distilled ethyl glyoxylate 343 (0.013 mL, 0.131
mmol) was added to the reaction mixture while stirring. A 0.10 M solution of ZnCl2 in THF was
added (0.06 mL, 0.006 mmol), and the reaction mixture was allowed to stir for two hours. The
reaction mixture was concentrated in vacuo. Purification by column chromatography (SiO2;
10:1-5:1, 95% hexanes, 5% Et3N:ethyl acetate) yielded the colorless oil ene product 684 (0.025g,
60%) as a 1:2 mixture of diastereomers. TLC: Rf = 0.51 (2:1, hexanes:EtOAc).

1

H NMR

(CDCl3, 300 MHz): δ 4.39 (1H, m), 4.22 (2H, m), 3.78 (0.33H, m), 3.67 (0.67H, m), 3.25 (2H,
m), 3.18 (0.33H, d, J = 7.9 Hz), 3.00 (0.66H, d, J = 7.2 Hz), 2.64 (2H, m), 2.02 (3H, m), 1.71
(1H, m), 1.61 (3H, s), 1.30 (3H, dt, J = 7.1, 1.6 Hz). 13C NMR (CDCl3, 75 MHz): δ 174.4 (C),
142.8 (C), 105.8 (C), 74.3 (CH), 73.4 (CH), 69.6 (CH), 69.3 (CH), 61.3 (CH2), 34.7 (2) (CH2),
27.8 (2) (CH2), 26.4 (CH2), 26.2 (CH2), 17.5 (CH3), 14.2 (CH3), 8.7 (CH2), 8.2 (CH2). IR (film):
3610, 2981, 2923, 1734, 1689 cm-1.
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Alcohol 684. Enol ether 625 (0.007g, 0.039 mmol) was placed into a flame dried flask along
with a stir bar and 0.078 mL of THF. Freshly distilled ethyl glyoxylate 343 (0.004 mL, 0.044
mmol) was added to the reaction mixture while stirring. A 0.065 M solution of ZnCl2 in THF
was added (0.03 mL, 0.002 mmol), and the reaction mixture was allowed to stir for two hours.
The reaction mixture was concentrated in vacuo. Purification by column chromatography (SiO2;
10:1-5:1, 95% hexanes, 5% Et3N:ethyl acetate) yielded the colorless oil ene product 684 (0.005g,
51%) as a 2:1 mixture of diastereomers. TLC: Rf = 0.51 (2:1, hexanes:EtOAc). 1H NMR
(CDCl3, 300 MHz): δ 4.39 (1H, m), 4.22 (2H, m), 3.78 (0.67H, m), 3.67 (0.33H, m), 3.25 (2H,
m), 3.18 (0.67H, d, J = 7.9 Hz), 3.00 (0.33H, d, J = 7.2 Hz), 2.64 (2H, m), 2.02 (3H, m), 1.71
(1H, m), 1.61 (3H, s), 1.30 (3H, dt, J = 7.1, 1.6 Hz). 13C NMR (CDCl3, 75 MHz): δ 174.4 (C),
142.8 (C), 105.8 (C), 74.3 (CH), 73.4 (CH), 69.6 (CH), 69.3 (CH), 61.3 (CH2), 34.7 (2) (CH2),
27.8 (2) (CH2), 26.4 (CH2), 26.2 (CH2), 17.5 (CH3), 14.2 (CH3), 8.7 (CH2), 8.2 (CH2). IR (film):
3610, 2981, 2923, 1734, 1689 cm-1.
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Chapter 4: Formation of Pyrans and Trioxadispiroketals via a Bi-Directional CarbonylEne Approach
4.1 Overview
In light of the recent research concerning the formation of dihydropyranyl ketides via
carbonyl-ene reactions of 2-methylenetetrahydropyrans, our focus shifted towards determining
the efficacy of a bi-directional approach toward pyran and subsequently trioxadispiroketal
synthesis. Such 2,6--hydroxypyrans may be utilized as advanced synthetic intermediates for
natural product synthesis, namely complex trioxadispiroketal systems. This chapter will review
trioxadisprioketals including those natural products, which contain such moieties, the chemical
aspects of spiroketal systems, previous approaches to trioxadispiroketal synthesis, and our route
toward their synthesis.
Herein is described a novel route toward the manufacture of 2,6--hydroxypyrans via two
successive carbonyl-ene reactions (Scheme 4.1). 6-Iodomethylene-2-methylenetetrahydropyran
302 is coupled with enophiles to yield -hydroxydihydropyrans 303.

Subsequent

dehydrohalogenation and secondary coupling of the newly formed 2-methylenedihydropyran to
an activated aldehyde yields substituted bis--hydroxypyrans 304. The use of these pyranyl
intermediates as bis-spiroketal precursors is also discussed.
Scheme 4.1
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4.2 Background and Significance
Tetrahydropyran and spiroketal functionalities are prevalent in many biologically active
natural products, and for this reason their construction is of particular interest to synthetic
organic chemists. This current work focuses on the synthesis of 2,6-substituted pyranyl ketides
and trioxadispiroketals using our recently discovered carbonyl-ene chemistry of 2-methylenetetrahydropyrans (Scheme 4.2) via a bi-directional approach. The pyranyl ketides produced
(Scheme 4.1) have potential as synthetic precursors to tetrahydropyranyl ketides and spiroketals
via reduction or acid-catalyzed ketalization, respectively.
Scheme 4.2

The importance that bis--oxygenated tetrahydropyran and trioxadispiroketal moieties
have in chemistry is demonstrated by their existence in medically significant, biologically active,
natural products. Trioxadispiroketals are especially interesting to synthetic chemists because of
their complexity. Anomeric effects, hydrogen bonding, and chelation can all play a role in their
stereochemical outcome. Many organic synthetic groups have devised syntheses towards natural
products containing complex trioxadispiroketals. Interest in spiroketals and trioxadispiroketal
systems has even sparked enough interest to warrant the publication of reviews pertaining to
them.1 This portion of the chapter will examine these topics in detail while also reviewing initial
studies toward spiroketal synthesis from exo enol ethers via a carbonyl-ene approach.
Bis--Hydroxy-Tetrahydropyran and Trioxadispiroketal-Containing Natural Products
Natural products that contain tetrahydropyranyl ketides, spiroketals or a combination of
the two are popular synthetic targets both due to their structural challenge and interesting
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biological activities. Symbiospirol A, cyanolide A, and the spongistatins (Figure 4.1) all contain
a bis--oxygenated tetrahydropyran which could theoretically be constructed through carbonyl
ene chemistry.
Figure 4.1

Symbiospirol A (702) was isolated from cultured symbiotic dinoflagellate Symbiodinium
sp., a single-celled algae, collected from the marine flatworm Amphiscolops sp. off the shore of
Okinawa, Japan.2 Interest in this natural product stems from its demonstrated PKC inhibition,
which lends to its potential as an inflammation-suppression drug. The structure of symbiospirol
was elucidated, and some of its relative stereochemistry was determined. However, a portion of
the relative and absolute stereochemistry has yet to be resolved. Symbiospirol (702) is a 67linear carbon chain compound that contains a 2,6-,’-dihydroxy tetrahydropyran ring.
Cyanolide A (703) was recently isolated from Lyngbya bouillonii, a cyanobacterium
native to coral off of Papua New Guinea.3 Cyanolide A (703) is a dimeric, 16-membered
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macrocycle that contains two bis--oxygenated tetrahydropyrans and two pendant xylose
residues. Cyanolide A (703) has proven to be a molluscicidal agent against Biomphalaria
glabrata, a snail that carries the parasites responsible for schistosomiasis infection. Roughly 200
million people are currently infected, making schistosomiasis one of the most prevalent
worldwide parasitic infections. By eradicating the parasite at the point of snail infection, the
reproductive cycle will halt, effectively eliminating parasitic transmission to humans.

The

absolute configuration was tentatively assigned based on the natural D-configuration of the
xylose residues and was recently confirmed by total synthesis.4
The spongistatins (704, 705, 706) were isolated from several marine sponges and
identified by the Pettit and Kobayashi groups concurrently.5,6 These compounds show potent
cytotoxic effects. The highly substitiuted macrocyclic lactone consists of two -keto-(6,6)spiroketals along with a bis-tetrahydropyranyl unit. Absolute configuration of this complex
molecule was finally determined after total synthesis of spongistatin 1 by the Evans group.7
Spongistatin 1 has shown the highest toxicity toward cancer cell lines including L1210
murine leukemia cells with IC50 values of 20 pM., kangaroo rat kidney PtK1 cells, posessing IC50
values of 3.6 M, and has shown inhibition toward the glutamate-induced polymerization of
purified tubulin (IC50 values of 3.6 M).8 Thus spongistatin 1 shows similar or more potent
toxicity than known antimitotic agents such as colchicines, dolastatin 10, vinblastine, and
halichondrin B. Use of spongistatin to treat leukemia cell lines has proven to be more effective
against long-term survival of cancer cells than 8 out of 10 clinically used cytotoxic drugs due to
its XIAP degradation effects.9 Spongistatin 1 also acts as a mitosis and microtube assembly
inhibitor. By binding to tubulin, spongistatin 1 prevents cell growth by blocking tubulin receptor
sites toward GTP and vinblastine.
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Examples of trioxadispiroketals are more limited, but many of the natural products
containing these functional groups are bioactive and include examples such as salinomycin,
spirolide A, pinnatoxin A, spirastrellolide A and their derivatives (Figures 4.2-4.4). The
salinomycin family of natural products, salinomycin (707) narasin (708), norboritomycin A and
B (709, 710), CP 44,661 (711), and antibiotic X-14766A (712), are all examples of bioactive
(6,6,5)-trioxadispiroketal units (Figure 4.2). Isolated from Streptomyces albus, salinomycin (707)
Figure 4.2

contains a (6,6,5)-trioxaspirodiketal

at its core and two pendant, functionalized

tetrahydropyranyl rings. This natural product acts as a potent anticoccidial, and as such has been
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marketed by Procoxacin as an antibacterial and coccidiostat within the poultry industry to
improve overall animal health and production.10
Narasin (708) only differs from salinomycin by the presence of a C4 methyl group. The
alteration in structure is slight and as such Narasin effectively has the same properties as
Salinomycin. This natural product is marketed by Elanco animal health as Monteban 45® and is
likewise used as a coccidiostat in chickens.
Norboritomycins A and B (709, 710), CP 44,161 (711), and antibiotic X-14766A (712)
are all similar in core structure to salinomycin (707), but differ in that a salicylic acid
chromophore and tetrahydrofuran ring reside off the trioxadispiroketal. The norboritomycins
were isolated from streptomyces noboritoensis and their absolute configuration was determined
by X-ray crystallography.11

The norboritomycins exhibit biological activity against gram-

positive bacteria and Eimeria teriella (chicken coccidiosis).
CP 44,161 (711) is produced from Dactylosporangium, and was isolated in 1978.12 Much
like the properties of the other members of the salinomycin family of natural products, CP
44,161 is a polyether antibiotic with coccidiostat properties. Futhermore this compound has
demonstrated broad anti-viral activities against the varicella zoster and herpes viruses.13
Antibiotic X-14766A (712) was isolated from a fermented culture of streptomyces
malachitofuscus subsp. Downeyi, which is a soil organism native to North America.14

This

natural product demonstrates wide application in agriculture with activities against gram-positive
bacteria and protazoa.

This compound can be administered in many ways to treat swine

dysentery and ketosis or to increase feed utilization in ruminants or swine. Many members
within the salinomycin family of natural products are medically significant even with their
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diverse sidechains and functionality.

This fact lends argument to the importance of the

trioxadispiroketal as a key component towards their bioactivity.
The pinnatoxins (713-716), pteriatoxins (717, 718), and spirolides (719, 720) all posses
very similar, potent toxicity (Figure 4.3). All three types of natural products were isolated from
Figure 4.3

Okinawain shellfish, Pinna attenuata,15 Petria penguin,16 and Mytilus edulis and Placopecten
magellanicus,17 respectively. These natural products are Ca2+ channel activators, and are one of
the principal causes for food poisoning resulting from shellfish ingestion. The pinnatoxins have
additionally demonstrated cytotoxicity against murine leukemia cell lines.

18

Both their high

toxicity and interesting structure are cause for organic synthetic interest.
The pinnatoxins and pteriatoxins are very similar structurally, containing a 20-membered
macrocyclic core which possesses 14 chiral centers, a (6,5,6)-trioxaspirodiketal, and 5,6 bicyclo-,
and 6,7-azaspiro-rings. The pteriatoxins 717 and 718 differ only in that they contain a sulfide
side chain. The spirolides also exist as a 20-membered macrocycle, but rather contain a (5,5,6)bis-spiroketal core.
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Of recent interest to many research groups, are efforts toward the synthesis of the
spirastrellolides (Figure 4.4). Spirastrellolide A (721) was isolated in 2003 from the Caribbean
Figure 4.4

marine sponge Spirastrella coccinea, after which structure revision and comparison to a
spirastrellolide B analog led to elucidation of the absolute configuration (376).19 Spirastrellolide
A is a 38-membered macrolide that possesses 21 stereocenters, a cis-fused tetrahydropyran ring
(A), a [6,6]-spiroketal (BC rings), a [5,6,6]-bis spiroketal (DEF rings), and a skipped-(E/Z)-diene
side chain. Synthetic interest is based not only on spirastrellolide’s complex structure, but also
on its interesting biological activity.
Spirastrellolide A (376) has been demonstrated to be a potent and selective inhibitor of
Ser/Thr protein phosphatase 2A. This activity causes cells to prematurely enter into mitosis,
leading to cell death, and thus spirastrellolide A has potential as an anticancer agent or as a
treatment for neurological disorders. Clinical development of spirastrellolide A (376) could
therefore act as an alternative to cancer treatments like Taxol, which effect tubulin
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polymerization. Full clinical testing of spirastrellolide is currently problematic due to the low
yield of isolated material from natural sources.
The structure of spirastrellolide A published initially lacked the F-ring of the
trioxadispiroketal moiety, the C28 chlorine, and much of the relative stereochemistry found in the
compound. Work published in 2004 demonstrated the presence of the trioxadispiroketal moiety
in spirastrellolide A, after acetylation of a methyl ester derivative did not result in incorporation
at the C35 or C38 alcohols in proposed structure 721. Much of the relative stereochemistry was
also determined at this time, along with the discovery of the C28 chloro substituent. Relative
configurations were determined within three segments (C3-C7, C9-C24, and C27-C38), however,
the stereochemical relationships between segments, the configuration of the C46 stereocenter, and
the absolute stereochemistry were not discovered until additional analysis of spirastrellolide B
furnished further insight.
Spirastrellolide B (722), isolated in 2007, has been instrumental in determining the
absolute configuration of the macrolide core. X-ray diffraction analysis of the methyl ester
derivative of compound 722 yielded the absolute stereochemistry of this compound. Since the
NMR data of spirastrellolide B closely resembled that of A, it was deduced that the absolute
stereochemistry was the same for both isomers. Shortly thereafter five other spirastrellolide
macrolides (C-G) were isolated and identified from the same sponge.20 The main structural
difference between the spirastrellolide members is the presence or absence of chlorine at C4 and
C28, and the presence or absence of an olefin within the B ring.
Many of the trioxadispiroketal-containing natural products isolated from nature possess
interesting and potent biological activities. The use of these compounds in medicine is well
founded, however limited natural supplies often require synthetic methods for their production
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and sale. Routes toward the trioxadispiroketal portions of these natural products is reviewed in
detail later in this introduction, however to fully understand the research the chemistry and
conformational aspects of spiroketals must be examined.
Conformational Aspects of Trioxadispiroketals
In order to develop new methodologies towards trioxadispiroketal synthesis, it is
imperative to understand their chemical nature. Trioxadispiroketal characteristics resemble that
of spiroketals, however, making conformational predictions is difficult due to their added
structural complexity. The conformations of spiroketals are generally governed by the following
factors: anomeric effects, steric influences, and intramolecular hydrogen bonding or chelation. If
these factors combine, conformational predictions can be made with some confidence. When
one of these preferences is compromised, conformational predictions become complicated.
The anomeric effect, first discovered by Lemieux,21 is a phenomenon whereby
electronegative groups at C2 prefer the axial orientation on tetrahydropyranyl rings.

This

preference opposes what is seen in cyclohexane systems where sterically driven equatorial
conformations are favored to avoid 1,3-diaxial interactions and gauche interactions within the
ring. Exactly what influences give rise to the anomeric effect and to what degree each contributes
is under debate. The observed thermodynamic stability derived from the anomeric effect is
currently reasoned in several different ways: minimization of electrostatic repulsions between
electron pairs of the ring oxygen and the exocyclic C-O bond,22 reduction of the molecule’s
overall dipole moment, and increases in hyperconjugative effects.23
The repulsion of syn-axial electron pairs is otherwise known as the “rabbit-ear effect.”24
This disfavored effect involves unshared electrons on nonadjacent atoms residing parallel to one
another. These high energy conformations are disfavored due to repulsion experienced by the
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electric dipoles on the lone pairs. When a lone pair-containing substituent is positioned axially,
rabbit ear effects are minimized, as opposed to equatorial positions. Table 4.1 illustrates this
point.25
Table 4.1: Rabbit-Ear Effects Associated with Tetrahydropyranyl Ring Conformations

When the oxygen substituent is axial, rabbit-ear effects are minimized, and a maximum
of one set of electron pair repulsions results within the system (entries 1-3). Syn axial electron
repulsion is further minimized by a within-the-plane arrangement of the pendant ether group to
the ring (entry 1). The conformation that brings the pendant ether group towards the inside of
the chair is highly unstable due to steric interactions with the ring (entry 3).

When the

substituent is held equatorially, either one (entries 4 and 5) or two rabbit-ear effects (entry 6) are
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experienced. In each of these conformations there is at least one electronic interaction between
the tetrahydropyranyl ring oxygen and the oxygen held equatorially on the ring.
The minimization of rabbit-ear effects on tetrahydropyranyl ring systems therefore favors
conformations where lone-pair bearing substituents adjacent to the ring oxygen are positioned
axially. Furthermore when an electron-withdrawing substituent is held axially, the overall dipole
moment of the molecule is reduced, which favors its formation in nonpolar solvents. Although
these two factors contribute to the anomeric effect, hyperconjugative effects are thought to have
greater influence over the ring conformation.
Hyperconjugative effects, described by Altona, arise from a n-* donation of electrons,23
and includes both an exo and endo component. The exo anomeric effect relates to the exocyclic
substituent’s ability to donate electrons from its lone pair into the * orbital of the ring oxygen.
Maximum stabilization occurs when both orbitals are in a synperiplanar arrangement to one
another (Figure 4.5). The exo anomeric effect transpires when the substituent is located at either
axial (728) or equatorial (729) positions.26
Figure 4.5

The endo anomeric effect relates to the donation of the endocyclic oxygen’s lone pair into
the * orbital of the exocyclic C-O bond (730). This effect can only occur when the substituent
is axial. The exo and endo anomeric effects exist in competition with one another, and as the
electronegativity of the exo substituent increases, the endo anomeric effect is of greatest
influence. Since the endo anomeric effect is greatest in rings with electronegative anomeric
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substituents, such as oxygen in the case of spiroketals, this phenomenon helps to govern the
conformation of spiroketal rings, with axial heteroatom substitution preferred.27 The anomeric
effect, influenced by rabbit-ear effects, molecular dipoles, and hyperconjugative effects, has a
profound influence on the stability of spiroketals and highly influences their favored
conformations.
The most stable spiroketal conformation is one that maximizes anomeric effects while
also minimizing non-bonding interactions.

For the unsymmetrically substituted spiroketal

system 731 there are four possible chair conformations where conformation 731a is favored
(Scheme 4.3). Both ring oxygens are axially positioned with respect to the other ring in this
conformation. This orientation gives rise to two anomeric effects. Steric interactions are
Scheme 4.3
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concurrently minimized with both A and B substituents equatorial.28 The relative energies of
each conformation are listed for each conformation along with the associated anomeric effects
and non-bonding interactions.
By inverting ring A, the oxygen within the B ring is now equatorial to the A ring. Thus
only one anomeric effect exists in conformation 721c, found between the endocyclic B oxygen
and the oxygen held axially to ring B. This conformation also exhibits non-bonding interactions
including one gauche pentane, two gauche butane, and more notably one syn-butyl ether
interaction.
Inversion of the B ring in conformer 721a gives rise to conformation 721b, which is
energetically equivalent to conformer 721c. Again only one anomeric effect occurs due to one of
the oxygens being placed equatorially. Both the reduced anomeric stabilization coupled with the
increase in non-bonding interactions makes these conformations considerably less stable (ca. 4.4
Kcal/mol) than conformer 721a. Inversion of both the A and B rings gives rise to conformer
721d, which has no anomeric stabilization effects and two highly unfavorable syn-pentane
interactions. This conformer is by far the least stable (ca. 9.8 Kcal/mol) of the four. Therefore a
spiroketal of this type will favor conformation 721a due to its high stability. These general
principals of increased anomeric stabilization and decreased steric interactions can be
extrapolated to similar spiroketal systems which possess substitution at other positions.
Hydrogen-bonding and chelation also contribute to spiroketal stability in specific cases.
Hydrogen-bonding is prevalent in tetrahydropyranyl systems containing axial alcohols along
with axial C-O spiro bonds. However intramolecular hydrogen-bonding has only been shown to
influence spiroketal conformations in aprotic solvents. Ireland demonstrated the formation of
spiroketals which possess hydrogen-bonding in work reported toward the synthesis of monesin
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(Scheme 4.4).29 Spiroketalization of precursor 722, produced spiroketal 723 as a mixture of four
diastereomers. A single spiroisomer could be obtained upon debenzylation and subsequent
Scheme 4.4

equilibration of isomers 723 using pyridinium p-toluenesulfonate (ppts).

Although ring

conformation 724 benefits from stabilizing intramolecular hydrogen-bonding between the axial
alcohol and the oxygen of the furan ring, it also possesses anomeric stabilization whereas the
other chair isomer would not. Nonetheless the existence of a hydrogen bond was established by
a sharp O-H absorption at 3560 cm-1 in the IR spectrum. Similarly, Walba’s synthetic work
toward monesin confirmed that hydrogen bonding exists in a similar intermediate, 725, via X-ray
crystallography.30 While these studies show the existence of hydrogen-bonding in spiroketal
systems, they do not conclusively demonstrate how this stabilizing force directs conformational
preferences.
Intramolecular hydrogen bonding is significantly affected by the solvent used in the
equilibration process. These effects were demonstrated in Schreiber’s work toward the synthesis
of talaromycins A and B.31 Deprotection and cyclization of acetal 726 led to a mixture of
spiroketal products, the ratio of which is dependent on the spiroketalization conditions, as
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demonstrated in Table 4.2. In many cases (entries 2-6), conditions are used that give rise to a
thermodynamic ratio of products. The kinetic ratio of products is shown in entries 1a-c, whereby
spiroketals 729 and 730 are formed in only slight excess. The use of polar solvents, which act as
Table 4.2: Cyclization Conditions for Spiroketal Formation

hydrogen bond acceptors, favored formation of spiroketals 729 and 730 (entries 4, 5 and 6). Use
of non-polar, aprotic solvents produced spiroketals 727 and 728 as the major isomers (entries 2
and 3). These results can be explained as follows: In non-polar, aprotic solvents like CH2Cl2
(entries 2 and 3), the axial alcohol can readily form an intramolecular hydrogen-bond to the
tetrahydropyranyl ring oxygen, and acts to stabilize that conformation, giving rise to 727 and 728
as the major spiroketal isomers. However, when polar solvents like DMSO are used (entries 4-6)
that are capable of making intermolecular hydrogen bonds, the alcohol instead readily hydrogen246

bonds with the solvent. The alcohol substituent resides equatorially in these cases to avoid 1,3diaxial interactions.
Non-intramolecularly hydrogen-bonded spiroketal isomers were favored in the synthesis
of 1,7-dioxaspiro[5,5]undecanes (Scheme 4.5) using solvents containing protic species.32 Acid
Scheme 4.5

catalyzed cyclization of dihydropyran 731 in polar protic solvent produced isomers 732 and 733,
19:1 respectively, favoring the equatorial alcohol spiroketal isomer. These results favor those
published by Mori,33 which demonstrate the greater stability of spiroketal 732. When spiroketal
733 was subjected to protic conditions (Scheme 4.6) of acid in methanol, a mixture of spiroketals
732 and 733 resulted as a 88:7 mixture. Although the product ratios differ slightly, in both cases
spiroketal 732 is preferred.
Scheme 4.6

Bis-diaxial diol 734 was also isomerized to the all-equatorial isomer 735 using dilute
acidic conditions. From these examples we can infer that generally equatorial alcohols are
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favored on a steric basis, however, in some cases intramolecular hydrogen bonding can control
spiroketal conformation, especially in non-polar, aprotic solvents.
Chelation effects also effect spiroketal conformation. Descotes has shown spiroketal 53
to isomerize to spiroketal 54 under Lewis acidic conditions, by epimerizing the carbon  to the
spirocenter (Scheme 4.7).34 Bidentate chelation of a Lewis acid to the tetrahydropyranyl oxygen
Scheme 4.7

and alcohol substituent favors formation of isomer 738 over 736, where bidentate chelation is not
possible. Under similar conditions, tricyclic spiroketal 739 readily isomerizes to the more stable,
bidentate-chelated spiroketal 740 (>20:1, 740:739) (Scheme 4.8).35 Likewise, spiroketal 741
isomerizes to spiroketal 742 (5:1, 742:741).
Scheme 4.8

Chelation controlled spiroketalization has been used to drive kinetic product ratio toward
the thermodynamic product. Dithiane 743 was deprotected and partially cyclized to produce both
ketone 744 and spiroketals 745 and 746 in a 1:3 ratio respectively (Scheme 4.9).36 Secondary
subjection of ketone 744 to acidic conditions successfully produced spiroketals 745 and 746 as a
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1:6 ratio of isomers. The favored spiroketal isomer produced in these cases (745) was not that
which was desired (746).

Fortunately, subjection of spiroketal isomer 745 to magnesium

trifluoroacetate resulted in isomerization to spiroketal 746, due to the favorable, stabilizing
bidentate chelation that occurs between the Lewis acid, the tetrahydrofuranyl oxygen, and the
pendant tetrahydropyranyl oxygen under these conditions.
Scheme 4.9

Similarly, Williams also demonstrated that the ratio of isomers formed from the
spiroketalization of 1--hydroxy-1-methoxy-tetrahydropyrans is highly dependent upon reaction
conditions (Scheme 4.10).37 For example, subjection of tetrahydropyran 747 to both kinetic and
thermodynamic conditions resulted in a 3.3:1 ratio of spiroketals, favoring isomer 748.
Alternatively, the reaction of the same substrate with Lewis acidic conditions preferentially
afforded the opposite isomer 749 in a 5:95 ratio. Not only is the opposite isomer produced, but
in much greater selectivity. This is due to the favorable bis-chelation that occurs between the
magnesium trifluoroacetate, the tetrahydrofuranyl oxygen, and the axial MEM ether.
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Scheme 4.10

Epimerization of stereocenters  to the spirocenter has also been used in natural product
synthesis. Evans took advantage of this phenomenon in his syntheses toward calcimycin
(Scheme 4.11). 38 Upon functional group deprotection, advanced intermediate 750 was cyclized
and equilibrated to afford the most stable conformers 751. Since the  carbon of spiroketal
intermediate 750 is epimerizable under acidic conditions, the stereochemistry of the methyl
substituent at C15 need not be set prior to spiroketalization. The methyl group epimerizes upon
ring-opening of the dihydropyran to the corresponding ketone. Thus the thermodynamic product
results from a process of cyclization, ring-opening, and subsequent cyclization.

Here the

orientation of groups about the spiro framework is controlled rather than the actual conformation
Scheme 4.11

.
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of the spiroketal itself. By recognizing the epimerizability of these centers, both researchers
were able to simplify their synthetic approach to calcimycin. In setting fewer stereocenters prior
to cyclization, the efficiency of this sequence was increased. Therefore Nakahara adopted a very
similar approach to calcimycin that capitalized from this simplification.39
Thermodynamic equilibration to form the most stable spiroketal conformer has been
similarly used in the synthesis of invictrolide. Both Hoye40 and Schreiber41 cyclized
intermediates 752 and 754 respectively to form advanced synthetic intermediates of this natural
product (Scheme 4.12).

In both cases a mixture of diastereomers was thermodynamically

cyclized under acidic conditions to afford bis-equatorial spiroketals 753 and 755 as the major
isomers. Here, none of the C5-C7 axial-equatorial products were formed due to the high energy
syn pentane steric interaction associated with that conformation. The ratio of isomers 755 to 756
is representative of the energetic difference between these two conformations where the C3
methyl group prefers an equatorial position. Only a trace of the axial-axial isomer 757 was
detected.
Scheme 4.12

Previous work has shown that anomeric effects, non-bonding interactions, hydrogenbonding, chelation control, and epimerization of centers adjacent to the spirocenter play an
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important role in the stabilization and conformational preferences of spiroketals. While the study
of trioxadispiroketal systems has not specifically been reported, the properties of simple
spiroketals can be projected onto these double spiroketal systems. The factors that control
thermodynamic spiroketalization are important to consider when designing syntheses of
spiroketal-containing natural products. Many investigators use these stabilizing traits to their
advantage when carrying out natural product synthesis.

Application of these principles to

trioxadispiroketal synthesis is discussed below.
Trioxadispiroketal Syntheses
The synthesis of trioxadispiroketals is more challenging than the manufacture of simple
spiroketals due to increasing steric interactions and the greater difficulty in predicting the
thermodynamic preferences of a complex three-ring system. Exactly which stabilizing effects
will govern the manufacture of one conformer or diastereomer over another is based on the
substituents in the ring system. Therefore the synthesis of trioxadispiroketals must be carefully
evaluated on a case by case basis.
When working toward the manufacture of natural product-based bis-spiroketals, the
thermodynamic isomer is typically that desired. For this reason, acid catalyzed cyclization of a
ketone or similar moieties is a viable route. Other methods used include oxidative cyclization
and Norrish type II cleavage. These methods have been used for the synthesis of (5,5,5), (5,6,5),
(6,5,6), (6,6,6), and (5,6,6)-trioxadispiroketal systems.
Synthesis of 1,6,8-trioxadispiro[4.1.4.2]tridecanes
The synthesis of a trioxadispiroketal was first reported in 1963 by Ponomarev and
Markushina (Scheme 4.13).42 Their approach to the 1,6,8-trioxadispiro[4.1.4.2]tridecane ring
system involved electrolytic alkoxylation of furan 760 using a nickel cathode and carbon anode.
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Furan 73 was constructed by acid promoted acrolein addition to furan 758, followed by carbonyl
reduction. The (5,5,5)-trans-bis-spiroketal diastereomer 761 was selectively formed, due to the
low overall molecular dipole moment experience by this compound compared to all other
possible isomers. This example proves interesting as the spiroketal system was directly formed
from an aromatically stabilized furan precursor, and this required relatively strong conditions.
These conditions, however, may not be accessible for every laboratory.
Scheme 4.13

Cohen designed the synthesis of 5,5,5-bis-spiroketals 764 and 765 through the
consecutive addition/cyclization of an organocerium reagent to succinic anhydride 762 (Scheme
4.14).43

Addition of Cerium 3-ceriopropoxide 766 to succinic anhydride, followed by an acidic

workup provided spirolactone 763 in 72% yield. Subsequent addition of a second equivalent of
Scheme 4.14

the cerium reagent 766 yielded spiroketals 764 and 765 as a 20:1 mixture of diastereomers.
Under thermodynamic conditions a 6:1 ratio of diastereomers was realized.
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The requisite

organocerium reagent was readily prepared by addition of LDBB to 3,3-dimethyloxetane
followed by treatment with CeCl3.44 The use of organocerium reagents is superior to other
organometallics in this application. For example, addition of similar organolithium reagents to
succinic anhydride gave only a 13% yield of lactone product 763.

Overall this sequence

provides a rapid, highly convergent preparation of the 5,5,5-bis-spiroketal core, though yields are
variable in other systems.
1,6,8-Trioxadispiro[4.1.4.3]tetradecane Synthesis
(5,6,5)-Trioxadispiroketal systems were studied by Descotes, who applied Norrish type II
reactions toward their synthesis (Scheme 4.15).45 Dihydropyran 767 was combined with alcohol
768 under acid catalysis to form ketal 769. Subsequent photolysis of tetrahydropyran 769 and
cyclization of the resulting diradical yielded spiroketal 770 as a mixture of isomers that were
carried forward together.

Transketalization of spiroketal 770 with alcohol 768 provided

spiroketals 771 and 772, which were separated and individually irradiated to form the
trioxadispiroketal products (773-778). Irradiation of spiroketal 771 yielded products 773-776.
Likewise treatment of spiroketal 772 produced products 776-778.
Norrish type II conditions provided kinetic cyclization products, and resulted in poor
diastereomer product mixtures. Note that bis-spiroketals 773, 775, and 777 adopt a twist boatlike conformation for two reasons; this conformation maximizes stabilizing anomeric effects
while decreasing unfavorable 1,3-diaxial interactions. This work demonstrated the success in
using Norrish type II cyclization strategy toward bis-spiroketal synthesis although poor product
mixtures result.
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Synthesis of 1,7,9-trioxadispiro[5.1.5.3]hexadecanes
(6,6,6)-Trioxadispiroketal systems have been synthesized using both oxidative
cyclization with hypoiodite (Scheme 4.16) and acid catalyzed cyclization. Alcohol 781 was
prepared by nucleophilic addition of allyltributyltin reagent 780 to the oxonium ion generated
Scheme 4.15
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from the advanced spiroketal intermediate 779.46 Subsequent deprotection provided alcohol 781
in moderated yield. This alcohol was then oxidatively cyclized by irradiation in an iodobenzene
diacetate solution containing iodine to kinetically form trioxadispiroketals 782 and 783 as a 1:1.3
kinetic ratio of products. The poor product ratio, minimally favors formation of anomerically
stabilized bis-spiroketal 783.
Scheme 4.16

Brimble employed acid catalyzed cyclization to synthesize phenylsulfonyl bis-spiroketals
787 and 788 from 3,4-dihydropyran 306 (Scheme 4.17).47 Sulfone 784 was synthesized from
Scheme 4.17
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dihydropyran 306 over 2 steps in 28% yield. This intermediate was subsequently deprotonated
and added to -valerolactone to provide keto alcohol 785 that lies in equilibrium with cyclic
hemiacetal 786.

Direct cyclization of the mixture under acidic conditions provided bis-

spiroketals 787 and 788 as a 1:1 mixture of cis and trans diastereomers in 57% yield over two
steps. These isomers were then individually reduced to provide bis-spiroketals 788 and 790.
The poor diastereomeric ratio is the result of the two products having similar stabilities.
Although in theory the cis isomer is stabilized by four anomeric effects, the trans isomer benefits
from a more favorable overall dipole moment (Figure 4.6).
Figure 4.6

McGarvey synthesized unsubstituted (6,6,6)-bis-spiroketal systems by acid catalyzed
cyclization in an attempt to both improve yield as compared to the Brimble synthesis while also
studying the relative stabilities of the cis and trans isomers.48

McGarvey devised three

approaches to this system. The first synthetic approach involved addition of propanedithiol to
3,4-dihydropyran 306 to create dithiane 791 (Scheme 4.18). Addition of two equivalents of the
deprotonated dithiane 791 to 1,3-dibromopropane afforded diol 792 after alcohol deprotection.
Removal of dithiane protecting groups and Lewis acid catalyzed cyclization yielded cis and
trans-bis-spiroketals 789 and 790 (1:1.7-1:2.1) in 32% and 28% yields respectively. The yields
for this synthetic pathway are far greater than Brimbles (1.6%). The trans diastereomer was
produced in excess of the cis due to the lesser overall dipole moment in that molecule, although
cis diastereomer 789 benefits more from anomeric effects.
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Scheme 4.18

The second approach to this system by the same group involved preparation from
substrates where asymmetry could be more easily introduced into the bis-spiroketal (Scheme
4.19). Alkylation of keto ester 793 followed by Krapcho decarboxylation gave ketone 794.49
Subsequent addition of organolithium 795 to ketone 794 yielded alcohol 796. Elimination was
followed by oxidative cleavage and acid catalyzed deprotection-cyclization to afford spiroketals
Scheme 4.19

789 and 790. The overall yield of this process was relatively low (3.3%), and therefore led to an
alternate approach of these bis-spiroketal products where asymmetry could be easily introduced
(Scheme 4.20).
McGarvey’s third approach provided the desired spiroketals in good overall yield (32%).
The carbon skeleton of the trioxadispiroketal was constructed through 1,3-dipolar addition of a
nitrile. Monoprotection, and oxidation of 1,5-pentanediol 798 was followed by conversion to .
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Oxime 799. 1,3-dipolar addition of nitrile oxide 799 to olefin 800 yielded isoxazoline 801.
Reductive cleavage of the N-O bond was followed by elimination of the mesylated hydroxyketone Subsequent hydrogenation of the olefin afforded ketone 802. Acid cyclization
with PPTS yielded spiroketals 789 and 790 (1:2.1) in an overall yield of 32%.
The work of Brimble and McGarvey demonstrates the success of acid catalyzed
cyclization toward trioxadispiroketal synthesis, although these (6,6,6)-systems provide little
Scheme 4.20

diastereoselective preference. McGarvey studied these trioxadispiroketals further to examine
their conformations and determine what relative energy difference exists between the two
isomers. Subjection of each bis-spiroketal to thermodynamic conditions resulted in favored
production of the trans isomer, where the ratio of isomers was slightly based on solvent effects
(Table 4.3). The use of non-polar solvents resulted in spiroketal ratios clearly favoring the trans
isomer. Alternatively, use of polar solvents like DMSO provided lower ratios presumably by
stabilizing the molecular dipole experienced by the cis-isomer.
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Table 4.3: Isomerization of 1,7,9-Trioxadispiro[5.1.5.3]hexadecanes in Different Solvents

Analysis of these ratios indicate that the relative energy difference between the two
conformations is between 0.3-0.7 kcal/mol favoring the trans isomer. NMR studies of both
isomers indicated that the central ring adopts a twist-boat conformation (Figure 4.7). This
conformation allows for maximization of anomeric effects while concurrently alleviating both
steric and dipole-dipole interactions. As a result, the trans isomer benefits from 4 anomeric
effects, although favorable bond angles are compromised. On the other hand, the cis isomer
Figure 4.7

gives up one of the anomeric stabilizations to alleviate the dipole-dipole interaction it
experiences. Overall the trans isomer is slightly preferred. These results indicate that anomeric
effects cannot solely be studied for the evaluation of isomeric preference in trioxadispiroketals.
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Unlike simple spiroketals, clearly dipole-dipole interactions play a critical role in the
conformation preference of bis-spiroketals.
1,7,9-trioxadispiro[5.1.5.2]pentadecane Synthesis
6,5,6-Trioxadispiroketal systems have been prepared en route to the synthesis of
pinnatoxin 713 (Figure 3).50 Double anomeric effects and reduction of sterics stabilize the bisspiroketal present in the pinnatoxins, making thermodynamic cyclization a viable ring-closing
technique (Figure 4.8).
Figure 4.8

Murai’s group was the first to synthesize the bis-spiroketal portion of the pinnatoxins as outlined
in Scheme 4.21.51 The key intermediates, sulfone 804 and aldehyde 806 were each prepared in
six steps from the alcohols 803 and 805 respectively. Deprotection of the sulfone 804 and
addition to the aldehyde 806 then gave the hydroxyl sulfone derivative 807. Swern oxidation,
desulfonation, and oxidation of the alkyne yielded trione 808, which upon acid catalyzed
cyclization produced the desired spirocyclic pinnatoxin core 809 in good yield. The major
diasteomer formed exhibits anomeric stabilization between the tetrahydrofuran ring and both
tetrahydropyranyl rings. This coupled with the equatorial arrangement of substituents makes this
conformer the most stable and therefore the major isomer isolated. Dipole-dipole interactions
are minimized in this system as compared to the [6,6,6]-bis-spiroketal because of the placement
of polar substituents, thus increasing the yield of cis isomer formed.
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Scheme 4.21

Figure 4.9

Minor diastereomers of bis-spiroketal 809 formed from this process could be reequilibrated such that bis-spiroketal 809 was ultimately obrained in 86% yield. Addition of
methyllithium to the remaining ketone moiety installed the needed methyl group
stereoselectively from the less hindered, bottom face. The Murai synthesis achieved formation
of the pinnatoxin trioxadispiroketal in 12 steps and 16% overall yield. The route benefits from
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the convergent approach and used thermodynamic spiroketalization to produce the desired bisspiroketal core stereoselectively.
The second synthesis of the pinnatoxin trioxadispiroketal was achieved by Hirama
(Scheme 4.22).52

Alkylation of the -keto ester 812 with allyl choride 811 was followed by

saponification and decarboxylation to yield ester 813. Diol deprotection and reduction of the
ester led to acetal 814, which was produced in 64% yield from ketone 813. Acetal 814 was, in
turn, converted to spiroketal precursor 815 in 6 steps and 40% yield. With acetal 815 in hand,
cyclization to the desired trioxadispiroketal was possible under aqueous acidic conditions over a
48-hour period. The desired spiroketal 816 was produced as the major product (74%), with other
isomers formed in 12% yield. These isomers were then re-subjected to the reaction conditions to
afford the desired spiroketal. Hirama’s synthesis provided the pinnatoxin bis-spiroketal core in
17% overall yield in 13 consecutive steps, similar to the results obtained by the Murai.
Scheme 4.22

A third approach to the pinnatoxin trioxadispiroketal system was reported by the Kishi
group as described in their total synthesis of pinnotoxin A (Scheme 4.23).53

Advanced

intermediates 817 and 818 were combined through use of transmetallation to yield alcohol 819 as
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Scheme 4.23

a mixture of diastereomers which were carried on together.

Sharpless asymmetric

dihydroxylation and subsequent Swern oxidation resulted in formation of dione 820, which after
acid induced cyclization with camphorsulfonic acid, afforded both the desired bis-spiroketal
structure 821 along with the C19 epimer 822. Interestingly, subjection of bis-spiroketal 822 to
silylation conditions epimerized the stereocenter back to the desired configuration to provide
silyl-protected bis-spiroketsl 823.

Alternatively, spiroketal 821 would epimerize to bis-

spiroketal 822 in the presence of magnesium bromide. Once the tertiary alcohol was converted
to the silyl ether, causing it to be configurationally stable, subsequent chemical transformations
were carried out without compromising the stereochemical integrity of the bis-spiroketal. Thus
the core of pinnatoxin A was produced in 12% overall yield through 13 reported linear steps,
which is a slightly lower yield than the Murai and Hirama syntheses. The trioxadispiroketal core
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was then further manipulated and transformed into pinnatoxin A to provide the first reported
total synthesis of this natural product.
Synthesis of 1,6,8-Trioxadispiro[4.1.5.3]pentadecanes
Approaches to (5,6,6)-bis-spiroketals include synthetic work towards both salinomycin
707 (Figure 4.2) and spirastrellolide A 376 (Figure 4.4) natural products. Several groups have
worked towards synthesizing members of the salinomycin family of antibiotics due to their high
molecular complexity and bioactivity. Model studies toward the synthesis of the salinomycins
were performed by Perron,54 Kocienski,55 and Baker.56 Perron created the trioxadispiroketal
moiety by oxidation and cyclization of functionalized furan 136 (Scheme 4.24). Oxidation and
Scheme 4.24

rearrangement of furan 136 using NBS yielded spiroketal 137 as an equilibrium mixture of
isomers, which were carried on together. Desilylation and acid-induced kinetic spiroketalization
produced bis-spiroketals 827 and 828 in 90% yield, which could then be successfully separated.
Subsequent reduction of the individual isomers proceeded in good yield from the more
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accessible bottom face. Overall, this synthesis provided the desired bis-spiroketals 829 and 830
in 36% overall yield from furan in 5 steps.
Kocienski developed an alternate approach to this spiroketal system in which
methoxyallene 831 was metallated and carboxylated to yield intermediate allene 832 (Scheme
4.25).57 Sulfuric acid catalyzed cyclization led to butenolide 833. Subjection of the butenolide
to hydrofluoric acid effected hydrolysis and secondary cyclization to give spirocyclic butenolide
834, which was added to lithiated dihydrofuran 835 to afford the bis-dihydrofuran intermediate
836. Cyclization with camphor sulfonic acid yielded the desired trioxadispiroketals 827 and 828
in a 1:1 mixture in an overall yield of 15% from methoxyallene 831. Although this synthesis of
the (6,6,5)-trioxadispiroketal model system is lower yielding than the route involving furan, it
provides as an alternative entry to bis-spiroketal production by utilizing butenolides as
intermediary structures.
Scheme 4.25

Baker approached the salinomycin ring system by two routes, which diverged from a
common intermediate 839 (Scheme 4.26).56 The first route employed oxidative cyclization to
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Scheme 4.26

manufacture the three-ring system, while the second path utilized acidic conditions.
Intermediate 839 was synthesized by addition of the lithium acetylide 838 to -valerolactone 837
followed by various functional group manipulations, which included non-stereoselective
epoxidation. To form the olefin-containing trioxadispiroketal 841, alkyne 839 was partially
reduced to the corresponding cis-olefin, the epoxide was opened, and acid catalyzed ring closing
by irradiation in an iodobenzene diacetate solution containing iodine formed the first spirocenter
840.

Oxidative cyclization then gave the bis-spiroketal 841.

The isomer formed was

consequently that which is believed to experience the most stabilization due to anomeric effects.
The corresponding saturated trioxadispiroketal 843 was also prepared from intermediate
839. Desilyation, full alkyne reduction, and oxidation yielded spiroketal precursor 842, which
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was transformed under acid catalyzed conditions into the single trioxadispiroketal product 843,
though the stereochemistry about the tetrahydrofuran-tetrahydropyran spirocenter was not
assigned. This work demonstrated the creation of bis-spiroketals from intermediates derived
from alkyne addition into lactones. This same methodology was later used by Brimble towards
the total synthesis of epi-17-deoxy-(O-8)-salinomycin,58 however late stage synthetic challenges
caused this route to be abandoned.
Suarez utilized two subsequent hypervalent iodine oxidation-cyclizations toward the
synthesis of (5R,7S,13S)-13-methoxy-1,6,8-trioxadispiro[4.1.5.3]pentadecane (Scheme 4.27).59
Diol 845 was prepared from readily available tri-O-acetyl-D-glucal 844 in 61% yield over 6
steps.60

Selective tosylation of the primary alcohol followed by displacement with allyl

magnesium bromide and methylation of the remaining secondary alcohol led to alkene 846.
Hydroboration of the newly formed olefin resulted in tetrahydropyran 847a, which is in
equilibrium with conformer 847b. Efforts to cyclize the diol version of this tetrahydropyran to
Scheme 4.27
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form the bis-spiroketal were unsuccessful. It is proposed that the 5,6-spiroketal forms first, and
the steric bulk of this spirocenter hinders hydrogen abstraction and thus formation of the second
spirocenter.61 Therefore stepwise cyclization was necessitated. Conformers 847a and 847b both
give rise to spiroketal 848 which benefits from maximization of anomeric effects in spite of the
axial orientation of the methoxy group. Protecting group modification is followed by a second
cyclization using iodobenzene diacetate-iodine to afford trioxadispiroketals 849 and 850 (58%
and 20% yields respectively).
Brimble used a similar methodology to form the saturated (5,6,6)-bis-spiroketal systems
854 and 855 (Scheme 4.28).62

An allyl side chain was introduced to spiroketal 851 via

stereocontrolled nucleophilic addition of allyltributyltin.63 The allyl-substituted spiroketal was
formed by Lewis acid-catalyzed oxonium ion generation, followed by nucleophilic addition of
allyltributyltin to the carbonium ion intermediate. Hydroboration of spiroketal 852 was followed
by treatment with iodobenzene diacetate and iodine to yield the cis (854) and trans (855)
trioxadispiroketals in a 1.5:1 mixture respectively, favoring the isomer experiencing double
anomeric effects. The oxidative cyclization conditions caused both rings to open, resulting in the
mixture of isomers observed for this reaction.
Scheme 4.28
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The first total synthesis of salinomycin was published by Kishi and involved umpolung
coupling along with acid catalyzed trioxadispiroketal ring formation (Scheme 4.29).64 The
carbon skeleton was constructed by combining advanced aldehyde intermediate 856 with
dithiane 857.

Alcohol deprotection and separation of the C20 isomers yielded bis-

tetrahydropyran intermediate 858 in 85% yield. Removal of the dithiane and acid catalyzed
cyclization of the resulting ketone gave acetal 859. The newly formed tetrahydrofuran ring,
containing an alkyne, was reduced to the corresponding cis olefin, and then selectively converted
into the trioxadispiroketal 860 isomer. This work was the first to demonstrate the feasibility of
alkyne cyclization to form bis-spiroketals.
Scheme 4.29

The bis-spiroketal formed is a C17 epimer of the naturally occurring salinomycin and
narisin, however, isomerization to the correct isomer readily occurs in a late stage synthesis.
Although it is not precisely known, it is assumed that the free C20 hydroxy substituent is key in
creating the correct natural product stereochemistry. In fact there exist so many substituents off
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of the trioxadispiroketal ring system of salinomycin that minimization of steric interactions
rather than maximization of anomeric effects generally directs formation of the major isomer.
Yonemitsu’s formal synthesis of salinomycin is similar to the Kishi approach. In this
case the carbon skeleton is forged by addition of an alkyne nucleophile 862 to aldehyde 861
(Scheme 4.30).65 Manganese dioxide oxidation was followed by acid catalyzed cyclization to
Scheme 4.30

form the tetrahydropyran ring of intermediate 864. Protecting group manipulation and alkyne
reduction led to the trioxadispiroketal precursor.

Like Kishi, Yonemitsu cyclized the bis-

tetrahydropyranyl tetrahydrofuran ring system with acetic acid, which produced three
trioxadispiroketal isomers (1.8:1.4:1.0) about the C13 and C17 stereocenters. Subsequent
oxidation of the isomer mixture produced bis-spiroketals 865. Protecting group manipulations
and re-subjection of the mixture to acidic conditions led to formation of trioxadispiroketal 866 as
a single isomer. This work represented a formal synthesis of salinomycin.
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Brown’s synthesis of salinomycin was based on the Perron model study,66 whereby the
trioxadispiroketal is constructed by oxidation and cyclization of the corresponding furan
(Scheme 4.31).67 Furan 869 was synthesized from aldehyde 867 in three steps: addition, partial
Scheme 4.31

reduction of alkyne, and acid promoted aromatization. Furan 869 was subsequently metallated
and added to lactone 870 to yield ketone 871. Diol deprotection, oxidative rearrangement, and
thermodynamic equilibration of the 2-acyl furan provided trioxadispiroketal 872 as the major
isomer along with the C21 epimer, in a 3:1 ratio respectively. The major trioxadispiroketal
formed, 872, is epimeric to salinomycin at the C17 and C21 stereocenters. As in the Kishi66 case,
late stage isomerization of the bis-spiroketal under acidic conditions successfully led to the
natural product after a number of manipulations.
Spirastrellolide A 376 (Figure 4.4) is a trioxadispiroketal-containing natural product that
has sparked more recent interest. A number of groups have worked toward the synthesis of this
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natural product including Hsung,68 Debrabander,69 Smith,70 Phillips,71 and Chandrasekhar.72
Few, however, have tackled the trioxadispiroketal-containing northern fragment. The Paterson,73
Forsythe,74 and Fürstner75 groups have all reported efforts towards this end.
Stabilization of the trioxadispiroketal unit of spirastrellolide A is derived from two
factors, a double anomeric effect, whereby all the ring oxygens are oriented axially to one
another, and minimization of steric interactions, arising from an all equatorial arrangement of
substituents. Therefore the conformation of the three-ring system is easy to predict, as Figure
4.10 illustrates, and thermodynamic spiroketalization processes can be expected to produce the
Figure 4.10

desired outcome. Most researchers took advantage of this observation in approaches to the bisspiroketal unit of spirastrellolide. Though all three research groups set the C36 stereocenter prior
to spiroketalization, in theory the stereochemistry at that position can be set by epimerization
under thermodynamic conditions. One problem that these groups faced toward the synthesis of
this fragment was the tetrahydrofuran’s propensity toward elimination. In addition, research
groups at that time had to design synthetic routes compatible with the unknown relative
stereochemistry between the C3-C7, C9-C24, and C27-C38 stereoclusters.
Paterson first published work towards the synthesis of the trioxadispiroketal moiety or
“northern fragment” of spirastrellolide A in 2005.76 The Paterson synthesis of the fragment
developed in three iterations, where each successive approach either improved the overall yield
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or the scaleability of the process for application to the total synthesis. The general approach by
Paterson is summarized in Scheme 4.32.

The trioxadispiroketal is formed from the acid

catalyzed cyclization of a multi-oxygenated substrate created from the Sharpless asymmetric
dihydroxylation of precursor 875.

These three routes differed mainly in the sequence of

dihydroxylation with other synthetic steps, the final route employing this oxidation in the last
step. The carbon skeleton of the bis-spiroketal precursor was formed from either aldol or
Horner-Wadsworth-Emmons addition of substrates with functionalities like chloride 876 and
aldehyde 877.
Scheme 4.32

The original Paterson route is outlined in Scheme 4.33 and features the Horner-WadsworthEmmons reaction of a bicyclic aldehyde 884 to prepare the spiroketal backbone. Manufacture of
phosphonate 880 began from known aldehyde 878. Oehlschlager-Brown chloroallylation and
methylation of the resulting alcohol afforded olefin 879 in > 95% ee.77 This efficient method for
the challenging introduction of chlorine was used in all of Paterson’s syntheses of
Spirastrellolide A. Sharpless asymmetric dihydroxylation78 of olefin 879 was followed by diol
protection, silyl ether cleavage, and subsequent Swern oxidation to afford the corresponding
aldehyde. Subsequent addition of lithiated methylene phosphonate and oxidation with DessMartin periodionane gave the -ketophosphonate 880 thereafter.
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Scheme 4.33

The synthesis of intermediate 884 began with a cross-metathesis of olefins 881 and 882
using Grubbs second generation catalyst.79 The resulting (E)-olefin was subjected to asymmetric
dihydroxylation (97:3 dr) with concomitant cyclization to form the corresponding 5-membered
lactone selectively. Protection of the secondary alcohol, removal of the benzyl-protecting group,
and subsequent oxidation yielded an aldehyde that was transformed stereoselectively into alcohol
173 after Brown crotylation (95:5 dr).80 Oxidation of the newly formed alcohol, acid catalyzed
cyclization, and oxidative cleavage of the terminal olefin yielded desired aldehyde 884.
Phosphonate 880 was deprotonated with barium hydroxide and coupled with aldehyde
884 via a Horner-Wadsworth-Emmons reaction.
problematic.

Reduction of the resulting olefin was

Use of typical reduction conditions on the newly formed olefin, such as
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hydrogenation over catalytic palladium on carbon, led to decomposition products. Therefore
conjugate reduction conditions with Stryker’s reagent,81 were employed for the formation of
cyclization precursor 885. From here, effective spiroketalization of ketone 885 was dependent
on the choice of catalyst. Treatment of ketone 885 with Dowex resin yielded the desired
trioxadispiroketal 886 in 40% yield, while use of stronger acids, such as CSA, resulted in
formation of furan 887.
Paterson designed a second synthesis toward the northern fragment of spirastellolide A in
hopes of alleviating the formation of furan 887 (Scheme 4.34).75b The redesigned synthesis
reversed the direction of acetalization from ring F  FED to ED  FED, while also
Scheme 4.34
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performing a late stage hydroxylation of the C26,27 olefin, thus eliminating the need for acetonide
deprotection. The synthesis began with the coupling of aldehyde 888 and malonic acid 889 via a
deconjugative Knoevenagel condensation to form the E-(,)-unsaturated ester 890.82

This

method proved to be more efficient for the synthesis of ester 890 than the corresponding crossmetathesis used in the first generation synthesis. Lactone 891 was then prepared from ester 890
through a route similar to that in the first synthesis. Brown crotylation of lactone 891, protection
of the newly formed alcohol, and oxidative cleavage of the olefin yielded aldehyde 892.
Phosphonate 183 was prepared in a manner similar to that described in the first Paterson
route, except that the dihydroxylation of the terminal olefin was deferred until later in the
synthesis. Silyl ether cleavage of olefin 879, an intermediate formed in the first generation
synthesis, was followed by oxidation, phosphonate addition, and subsequent oxidation to yield
phosphonate 893. Phosphonate 893 and aldehyde 892 were coupled in a Horner-WadsworthEmmons reaction and reduced by Stryker’s reagent. Removal of the TES-group was then
followed by Dess Martin oxidation to provide the corresponding ketone.

Asymmetric

dihydroxylation of the terminal double bond was accompanied by cyclization of the D ring to
afford tetrahydropyran 894. Subsequent silyl cleavage and concomitant cyclization resulted in
the formation of the desired trioxadispiroketal 895 along with a C35 epimer 896. Efforts to
recycle epimer 896 resulted in elimination. The formation of the undesired epimer along with
the inability to scale up this process led Paterson to adopt yet a third approach toward the
trioxadispiroketal system (Scheme 4.35-4.36).
The final approach toward the northern fragment features an asymmetric aldol reaction to
assemble key fragments as well as late stage bis-hydroxylation. The manufacture of aldehyde
189 began from a previously synthesized intermediate, the ester 180 (Scheme 4.35).
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Manipulation of this intermediate to give the corresponding aldehyde was followed by an aldol
reaction with ketone 187 to form the anti-aldol adduct 188 stereoselectively. Alcohol protection,
reduction, and oxidative cleavage of the resulting diol then afforded aldehyde 189.
Scheme 4.35

Formation of requisite chloroketone was again achieved by Oehlschlager-Brown
chloroallylation, followed by subsequent formation of the methyl ether (d.r. > 95:5, 92% ee)
(Scheme 4.36). Ketone 191 was converted to the kinetic dicyclohexylboron enolate and added to
Scheme 4.36
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aldehyde 189 to form the aldol condensation product 192 upon elimination of the secondary
alcohol. Conjugate reduction of the resulting enone using Stryker’s reagent, silyl ether cleavage,
and Swern oxidation gave the linear precursor 193 for spiroketalization.
A bis-asymmetric Sharpless epoxidation of 893, the key step of the synthesis, afforded
the partially cyclized intermediate 894, which after treatment with PPTS gave the desired
trioxadispiroketal 895 along with other isomers. Use of PPTS for this cyclization was essential
because stronger acids such as CSA or HCl again resulted in competitive furan formation.
Because the spiroketal isomers were unstable to chromatography, they were converted to the
corresponding triethylsilyl ethers prior to purification. Separation of the TES-protected bisspiroketal 196 from other isomers was then successful. These minor isomers were successfully
recycled by re-subjection to PPTS and subsequent TES-diol protection to afford bis-spiroketal
896. After one recycle, trioxadispiroketal 896 was formed in 65% from ketone 893.
Paterson’s final synthesis of the northern fragment differed from his first two in several
ways.

The lactone moiety used to set the stereochemistry at C37 and C38 in the first two

syntheses was avoided in the third generation fo reduce the incidence of furan formation. The
new method also used reactions that were scaleable, a feature essential for the total synthesis of
this large and complex molecule. Additionally, the asymmetric dihydroxylation and subsequent
cyclization were performed concurrently, and at a late stage in the synthesis. This modification
resulted in an efficient and elegant end to the trioxadispiroketal core. Overall the best Paterson
synthesis of spirastrellolide A (route 3) was realized over 16 linear steps in a reported 18% yield.
Unfortunately this process required that unwanted bis-spiroketal isomers be recycled to
maximize the overall yield of the northern spirastrellolide fragment.
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Forsyth was one of the first authors to report work toward the DEF ring system of
spirastrellolide A.77 This approach included a chelation-controlled Mukiyama aldol reaction, a
Nozaki-Hiyama-Kishi83 coupling to assemble key fragments, and a thermodynamic bisintramolecular hetero-Michael addition (Scheme 4.37). Synthesis of the trioxadispiroketal began
Scheme 4.37

with a selective Mukiyama aldol coupling between ketone 897 and aldehyde 898 (20:1 dr)
(Scheme 4.38). Protecting group manipulations of the aldol adduct 899 then yielded the ketone
900, which was converted to the alkynyl iodide 901. Nozaki-Hiyama-Kishi coupling of this
iodide with aldehyde 902 and subsequent oxidation gave ketone 903.84 Removal of the TESprotecting groups gave the linear backbone 904, which was poised for spirocyclization.
Cyclization of alcohol 904 was initiated under base-catalyzed conditions, followed by
treatment with CSA. The resulting ketone 906 was highly unstable, however, and was therefore
reduced to the more stable corresponding alcohol 907, which proved to be less labile. The
introduction of the C28 chlorine substituent, present on spirastrellolide A, was intended through
selective -keto chlorination of the spirocyclic ketone, which was no longer possibile. Therefore
the sequence was modified so as to introduce the chlorine at an early stage in the synthesis.
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Scheme 4.38

It is interesting to note that spirocyclization of alkyne 904 under acidic conditions was
problematic, and resulted in elimination of the C37 oxygen functionality regardless of the
protecting groups utilized. Activation of alkyne 904 using metal salts such as AgOTf led to one
of two results; a competing single hetero-Michael addition and -elimination or no reaction at all
(Scheme 4.39). So after base catalyzed spiroketalization to form spiroketal intermediate 905,
Scheme 4.39
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CSA was used to induce the second cyclization to form the unstable bis-spiroketal 906 that was
then reduced to the alcohol.
Forsyth’s second attempt toward the trioxadispiroketal of spirastrellolide A involved
installation of the chlorine substituent at an early stage (Scheme 4.40). Though incorporation of
Scheme 4.40

this functionality into the linear precursor 911 was straightforward, the presence of the chlorine
substituent during spiroketalization led to either elimination product 912 in the presence of acid
or epoxide-containing spiroketal 913 with base.

While a successful synthesis of the

spirastrellolide A spiroketal was not realized, Forsyth demonstrated that the double
intramolecular hetero-Michael addition was an effective method for manufacture of DEF analogs
of spirastrellolide A that lack a chlorinated substituent.
Fürstner’s synthesis of C27-C38 of spirastrellolide A differed from those of Paterson and
Forsyth in that kinetic rather than thermodynamic spiroketalization conditions were used to form
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the trioxadispiroketal.78 Fürstner anticipated spirocyclization of a ketoisoxazoline 931 to form
the bis-spiroketal moiety 932 (Scheme 4.41). The synthesis of the ketoisoxazoline 931 was in
turn envisioned through the umpolung coupling of isoxazoline 925 with nitrile 930. Model
studies on a simpler substrate suggested that thermo spirocyclization would result in unwanted
byproducts. This work demonstrated that thermodynamic spiroketalization of the 2-isoxazoline
914 resuted in aromatization to give furan 915 upon extensive equilibration (Scheme 4.41).
Scheme 4.41

Direct cyclization of isoxazoline 914 provided either furan 915 or spiroketal 916,
depending on the availability of the C31 alcohol toward immediate cyclization. When the C31
alcohol is unprotected, spirocylization occurs cleanly to give the EF ring system 916. However,
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when the C31 alcohol is TES-protected, aromatization is favored resulting in formation of furan
915. Presumably, aromatization occurred to avoid the transannular strain that develops within
the tetrahydrofuran system due to the all-cis configuration. Likewise, acid catalyzed cyclization
of the extended diketone 917 in which all alcohols that are participating in the spirocyclization
are protected, led solely to the bis-furan byproduct 918. These model studies showed that furan
byproduct formation occurs when the C31 alcohol is unavailable towards cyclization. To avoid
furan formation, the synthesis of spirastrellolide A was carefully planned around proper
protecting group cleavage to promote spiroketal formation and avoid production of furan
byproducts through equilibration.
Fürstner’s forward synthesis is outlined in Schemes 4.42 and 4.43. Key steps include
[1,3]-dipolar cycloaddition, umpolung coupling, and kinetic spiroketalization. The synthesis of
isoxozoline 923 was initiated from monoprotected diol 919 (Scheme 4.42). Diol 919 was
Scheme 4.42

284

converted to oxime 920 by oxidation and reaction with ammonium hydroxide.

The

corresponding nitrile oxide 921 reacts with enantiopure allylic alcohol 925 to give isoxazoline
922 in 76% yield.

The Kanamasa85 protocol selectively formed the desired stereoisomer

exclusively. The preparation of isoxazoline 923 was completed by selective iodination of the
primary alcohol and protection of the secondary alcohol as the TES ether. This intermediate was
later used for preparation of the linear spirocyclization precursor.

The allylic alcohol used in

the [3+2] dipolar cycloaddition was prepared by addition of dimethylsulfonium methylide to
epoxide 924, which was readily available by hydrolytic kinetic resolution.
The preparation of bis-spiroketal 932 was then completed as shown in Scheme 4.43. Like
Paterson, Fürstner began this sequence from chloroether 879, which was synthesized in two steps
from aldehyde 878 (Scheme 4.33). Asymmetric dihydroxylation, followed by selective
Scheme 4.43
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tosylation of the primary alcohol afforded the terminal epoxide 926 upon treatment with base.
Subsequent homologation with dimethylsulfonium methylide gave the allylic alcohol 927. This
transformation was not a trivial due to the potential for competing chloride displacement. In the
end, the desired allylic alcohol was prepared in four steps and 57% yield from chloride 879.
Protecting group manipulations and subsequent oxidation then provided aldehyde 928.
At this point an umpolung coupling was envisioned between aldehyde 928 and iodide
923. After conversion of aldehyde 928 to dithiane 929, deprotonation under a number of
different conditions proved difficult. Therefore, this substrate was abandoned and aldehyde 928
was converted instead to cyanohydrin 930. This intermediate could be effectively deprotonated
with LDA and subsequently alkylated with iodide 923 to give the linear cyclization precursor.
Cleavage of the isoxazoline moiety, global deprotection, and subsequent, kinetic cyclization (in
the presence of PPTS) provided the desired trioxadispiroketal 932 along with two other isomers
(4.1:1.7:1 dr respectively). No furan-containing products were isolated.
This sequence effectively produced the DEF-ring system of spirastrellolide A in a highly
convergent manner. The desired bis-spiroketal was formed in 15 linear steps and 11% overall
yield from aldehyde 878.

This approach differed from those previous in both the use of

isoxazoline intermediates and a kinetic spiroketalization process. The trioxadispiroketal thus
prepared was later used by Fürstner in the synthesis of spirastrellolide G.86
More recently Brimble devised a synthesis for the northern fragment of spirastrellolide B,
which differs from spirastrellolide A in that it does not contain a chlorine at C28.87 This lack of
functionality results in a somewhat simplified synthesis compared to the previous work toward
spirastrellolide A. Brimble’s strategy involved formation of the carbon skeleton 946 through a
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series of dithiane couplings (Scheme 4.44). The final spiroketalization was achieved in the
presence of HgCl2 under thermodynamic conditions.
Scheme 4.44

Dithiane 937 was prepared in six steps from the known allyl alcohol 933 (Scheme 4.45).
Sharpless asymmetric epoxidation, regioselective ring-opening with trimethyl-aluminum, 88 and
oxidative cleavage of the 1,2-diol produced aldehyde 935. Formation of the dithiane 936 and
protecting group manipulations subsequently yielded dithiane 937.
Scheme 4.45

The synthesis of epoxide 939 also began from allyl alcohol 933 (Scheme 4.46). Alkene
933 was transformed into diol 938 by conversion of the alcohol to the corresponding chloride
and Sharpless dihydroxylation.

Intramolecular epoxidation followed by protection of the
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remaining secondary alcohol as the ethoxymethyl (EOM) ether gave the enantiomerically
enriched epoxide 939 in 78% overall yield.
Scheme 4.46

The third intermediate, dithiane 943 was prepared in four steps from triol 941, which is
readily available from D-(+)-ribonic acid -lactone 940 (Scheme 4.47).89 In this sequence triol
941 was transformed to epoxide 942 by conversion of the primary alcohol to the substituted
sulfone, which underwent internal displacement by the adjacent free alcohol, and protection of
the remaining hydroxyl group. In turn this compound was transformed to dithiane 943 after
addition of lithiated 1,3-dithiane and methyl ether formation.
Scheme 4.47

With the three key intermediates in hand, unit coupling began with deprotonation of
dithiane 937 followed by addition of epoxide 939 (Scheme 4.48). Protection of the resulting
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secondary alcohol 944, deprotection of the primary silyl ether, and TPAP oxidation then yielded
aldehyde 945, which was combined with the deprotonated dithiane 943 to give alcohol 946.
Acidic cleavage of the EOM groups gave an intermediate triol which after subsequent dithiane
removal and concomitant cyclization yielded the bis-spiroketal 947 as a single diastereomer.
Conversion of this compound to the DEF-ring of spirastrellolide B was then achieved through a
modified Barton deoxygenation at C32. Overall, the bis-spiroketal portion of spirastrellolide B
was prepared in 15 steps from the known allyl alcohol 933 in 5.7 % yield. This process
benefited from use of the same starting material for two of the three required intermediates and
used simple dithiane couplings to construct the carbon skeleton of the bis-spiroketal 948.
Scheme 4.48
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In general, the preparation of trioxadispiroketals involves acid catalyzed/promoted
cyclizations of multioxygenated precursers. Such methods have been used towards the synthesis
of trioxadisprioketal portions of the pinnatoxins, salinomycins, and spirastrellolides as well as for
the preparation of (5,5,5)- and (6,6,6)-bis-spiroketal systems. Although less popular, Norrish
type II cleavage and oxidative cyclization with hypoiodite have also been used successfully in
the synthesis of (5,6,5)-trioxadispiroketals, and (5,6,6)- and (6,6,6)-bis-spiroketal systems
respectively. Use of thermodynamic spiroketalization conditions yields predominantly the most
stable isomers, which typically match the stereochemistry found in the natural product targets.
Unlike previous groups, we envisioned the synthesis of trioxadispiroketal systems from the acid
catalyzed spiroketalization of pyran precursors derived from the two directional carbonyl ene
reaction of exocyclic enol ethers.
4.3 Results and Discussion
Carbonyl-Ene Approach to the Synthesis of Trioxadispiroketals
Our approach to bis--hydroxypyran and trioxadispiroketal synthesis builds from our
success with the carbonyl-ene reaction of 2-methylenetetrahydropyrans and various enophiles as
was discussed in Chapter 3 (Scheme 3.1).90 The C27-C38 bis-spiroketal of the spirastrellolides,
for example, was anticipated through the thermodynamic acid catalyzed cyclization of pyran
950 (Scheme 4.49).

Pyran 950 could be synthesized by the two-directional carbonyl-ene

reaction of aldehydes 343 and 953 with the bis-enol ether equivalent 952. The spiroketal
backbone 950 is anticipated through the carbonyl-ene reaction of the less reactive aldehyde 953
followed by elimination of the iodide and ene reaction of the newly generated enol ether with
ethyl glyoxylate 343. The reaction with ethyl glyoxylate 343 is predicted to yield stereoenriched pyran 950 based on the chirality transfer studies outlined in Chapter 3. This step could
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also be facilitated with chiral Lewis acid. Cyclization is predicted to yield spiroketal 949 where
the C29, C31, C34, and C35 stereocenters are controlled by thermodynamic equilibration.
Scheme 4.49

Previous work in our lab has demonstrated the feasibility of controlling the
stereochemistry at C29 by equilibration (Scheme 4.50).91
Scheme 4.50

When a 1:1 mixture of dihydropyrans 954 was subjected to aqueous hydrochloric acid in
THF, the (6,6)-spiroketals 955 and 956 were formed in excellent yield as a 3:2 ratio of
stereoisomers (Scheme 4.48). Upon chromagraphic separation, the individual isomers were
291

resubjected to acid in refluxing THF (Scheme 4.51). In both cases, spiroketals 955 and 956 were
obtained in a 6:1 ratio. Application of the equilibration conditions to both isomers demonstrated
Scheme 4.51

that Spiroketal 955 is lower in energy and thus the thermodynamic product.

While both

spiroketals 955 and 956 benefit from double anomeric stabilization and equatorial orientation of
the propyl side chain, spiroketal 955 is further stabilized by the equatorial orientation of the
hydroxy group. As previously discussed, free alcohols on spirocyclic systems typically prefer to
be equatorial when cyclized under thermodynamic conditions in polar solvent. In these cases,
the alcohol hydrogen-bonds preferentially to solvent rather than to the oxygen in the
tetrahydropyran ring, increasing its effective steric bulk and preference for an equatorial
orientation (Scheme 4.5 and 4.6). The conditions used for equilibration in this case involved
dilute HCl in refluxing aqueous THF, which is unlikely to work for bis-spiroketalization of the
labile pyran precursors. Instead equilibration of these systems could be carried out at room
temperature over longer reaction times.
A mechanism for the interconversion of spiroketal 956 to 955 is shown in Scheme 4.52.
This sequence has been previously proposed independently by both Smith92 and Mori in their
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work toward the taleromycins.93

Acid catalyzed ring-opening of spiroketal 956 results in

formation of the oxonium ion 957, which after double bond isomerization yields the enocyclic
Scheme 4.52

enol ether 958. Protonation of the C4 hydroxyl group and loss of water then provides the
conjugated oxonium intermediate 959. A Michael-type addition of water from the opposite face
(960) and spiroketalization then provides the thermodynamic spiroketal 954.
A second (6,6)-spiroketal was prepared successfully using the carbonyl-ene
/thermodynamic spiroketalization sequence to control the stereochemistry at C3 (Scheme 4.53).
Scheme 4.53
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This system more closely resembles that of the DE portion of the spirastrellolide northern
fragment. By this method, 2-methylenetetrahydropyran 2 was combined with chiral aldehyde
259, to provide ene adduct 960, which was not purified, but treated directly with protic acid to
give spiroketals 962 and 963. Again, under thermodynamic conditions the equatorial hydroxy
isomer 963 predominates.
Successive carbonyl-ene/spirocyclization reactions have also been demonstrated for the
synthesis of (6,5)-spiroketal 264, a system similar in structure to the EF spiroketal of
spirastrellolide (Scheme 4.54).97

Dihydropyran 589 was formed as a 1:1 mixture of

diastereomers by reaction of the corresponding exocyclic enol ether 588 and ethyl glyoxylate
343 (Scheme 3.37). Upon treatment with acid, dihydropyran 589 cyclized to spiroketals 964 and
965 in a 2:1 ratio after 24 hours. In this case, the isomer most similar to the EF ring system of
spirastrellolide A was favored. The bias for this selectivity is not known.
Scheme 4.54

The successful preparation and equilibration of substituted (6,6)- and (6,5)-spiroketals
using the carbonyl-ene/spirocyclization pathway described above support the use of this method
in the preparation of the DEF-bis-spiroketal present in the northern fragment of the
spirastrellolides. In particular, we sought to apply a two-directional carbonyl-ene methodology
towards formation of bis--hydroxy pyrans, which in turn could be converted to
trioxadispiroketals like that found in the spirastrellolides.
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Synthesis of Bis--Hydroxypyrans

To achieve a synthesis of trioxadispiroketals, we first sought methods to create bis-hydroxypyrans, their envisioned precursors.

The preparation of bis--hydroxypyrans is

anticipated in a three-step sequence from 6-iodomethyane-2-methylenetetrahydropyran 302
(Scheme 4.55). After the carbonyl-ene reaction between enol ether 302 and an aldehyde, base
promoted elimination of the iodine results in compound 966, which contains both endo and exo
enol ethers. Prior work in the lab suggests the exocyclic enol ethers are more reactive than the
endo, so therefore the second carbonyl-ene reaction is anticipated to react exclusively with the
exo olefin to give the desired bis--hydroxylated pyran 304.
Scheme 4.55

Efforts in this area began with the synthesis of the bis enol ether equivalent 302 from 5hexen-1-ol as shown in Scheme 4.56. Jones oxidation94 of the primary alcohol resulted in
Scheme 4.56
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quantitative conversion to carboxylic acid 967.

Iodo-lactonization under slightly basic

conditions afforded lactone 968. Petasis olefination of lactone 968 then yielded enol ether 302 in
good yield.
With enol ether 302 in hand, the next step was to explore the feasibility and limitations of
the coupling methodology for the synthesis of bis--hydroxypyrans. The first step in this
sequence involved the carbonyl-ene reaction of exocyclic enol ether 302 with various enophiles.
The results of these reactions are summarized in Table 4.4.
As shown, the reactivity of enol ether 302 varied with the structure of the carbonyl
coupling partner. The reaction with ethyl glyoxylate 343 (Table 4.4, entry 1) produced the ene
adduct 969 in good yield after 2 hours. Due to the inherent reactivity of this aldehyde, only 5
mole % of ZnCl2 is required to catalyze this reaction in a short period of time. The carbonyl-ene
reaction proved slower with non-activated aldehydes 972, 973, and 975 (entries 3, 4, and 5) and
thus required higher catalyst loading and longer reaction times compared to the glyoxylate
example. Similar results were obtained with the activated ketone 369 (entry 2). Nonetheless
these substrates provided the desired ene products in good to excellent yields.
The carbonyl-ene reaction of exocyclic enol ether 302 was also compatible with activated
ketone enophiles (Table 4.4, entry 2). Ethyl pyruvate 369 was combined with the enol ether to
give ene adduct 970 in 66% yield. Although activated, the increased sterics inherent in the
ketone slow the reaction, resulting in the need for longer reaction times and higher catalyst
loading than the similar glyoxylate example (entry 1).
As with earlier work,97 the presence of a substituent at C6 on the enol ether had no
influence on the stereoselectivity of the carbonyl-ene reaction. A 1:1 mixture of diastereomeric
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products resulted for entres 1-4. Ene adduct 975 was produced as a mixture of 4 diastereomers
In these circumstances, diastereoselectivity is of little consequence as one of the stereocenters
will ultimately be destroyed in the next reaction.
Table 4.4: Carbonyl-Ene Reactions of 6-Iodomethyane-2-Methylenetetrahydropyran

Ethyl glyoxylate 343, octylaldehyde 495, and ethyl pyruvate 369 are available from
commercial sources, whereas aldehydes 971 and 97497 were prepared in a few synthetic steps
from commercially available materials. Aldehyde 971 was prepared from the corresponding diol
in two steps (Scheme 4.57). Mono-protection of diol 976 gave alcohol 977 in quantitative yield
by known conditions.95 Swern oxidation of this substrate96 efficiently afforded aldehyde 971 in
86% yield.
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Scheme 4.57

Aldehyde 974 was prepared from ester 978 in two steps (Scheme 4.58). Silyl protection
of both hydroxyls provided silyl ether 977 in 83% yield. Partial reduction of the ester moiety
upon treatment with di-iso-butylaluminum hydride97 then provided aldehyde 974 in high yield.
Scheme 4.58

After carbonyl-ene reactions were successfully performed on the iodinated substrate 302,
elimination to the corresponding exocyclic enol ethers was effected. Two methods for the
conversion of the iodomethyl group to an exocylic enol ether were explored. The first focused
on the reaction with silver fluoride in pyridine and provided enol ether 976 in 77% yield
(Scheme 4.59). A second method was explored that would be compatible with silyl-protected
substrates:

DBU facilitated elimination.

Not only did these reaction conditions work on

silylated substrates (Table 4.5, entries 3 and 5), but also produced enol ether 976 (entry 1) in
higher yield (93%). For these reasons, the DBU elimination was the preferred method of
Scheme 4.59
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dehydrohalogenation.

In all cases, the elimination of iodine proceeded smoothly to provide

desired exocyclic enol ethers in good to excellent yields.
Table 4.5: DBU Elimination of Carbonyl-Ene Adducts

Upon formation of the second exocyclic enol ether the stage was set to explore the final
phase of the synthesis. The newly formed enol ethers were subjected to a second carbonyl-ene
reaction to afford the bis--hydroxy pyrans (Tables 4.6-4.8). The carbonyl-ene reaction of these
2-methylenedihydropyrans with ethyl glyoxylate was first evaluated (Table 4.6). As before,
ethyl glyoxylate proved to be an excellent substrate, and generally provided bis--hydroxypyrans
in good to excellent yields as 1:1 mixtures of diastereomers. These reactions proceeded in the
presence of 5% ZnCl2 after a relatively short reaction time. The presence of glyoxylate polymer
as a byproduct in these reactions made purification of the fairly polar product difficult by
chromatography. Therefore two equivalents of the enol ether were used for each equivalent of
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ethyl glyoxylate to avoid polymer formation.

The excess enol ether was quantitatively

recoverable in all cases, without any observed double bond isomerization.
Table 4.6: Ene Reactions of 2-Methylenedihydropyrans with Ethyl Glyoxylate

Enol ether 985 was prepared from enol ether 980 by oxidation with Dess-Martin
Periodinane (Scheme 4.60). The purpose of this oxidation was to simplify the product mixture
that would result from the second carbonyl-ene reaction. If enol ether 980 were used in the
reaction, up to four diastereomers could result.
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Scheme 4.60

Reactions of the same 2-methylenedihydropyrans with p-nitrobenzaldehyde, a relatively
activated aldehyde, produced only low yields of the desired products when treated with 5 mol%
ZnCl2 over 48 hours (Table 4.7, entry 1). Rather, longer reaction times and equimolar amounts
Table 4.7: Ene Reactions of 2-Methylenedihydropyrans with p-Nitrobenzaldehyde
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of zinc chloride were required to obtain adequate product yields. It is not entirely unexpected
that lower yields are associated with the carbonyl-ene reactions of less activated enophile
components because the presence of the endocyclic double bond is expected to reduce
reactivity.98
Along these lines, the carbonyl-ene reaction of 2-methylenedihydropyrans with nonactivated aldehydes did not provide any of the desired products (Table 4.8). Trials combining
enol ether 978 and silyl ether aldehyde 971 with various amounts of ZnCl2, ranging from 20 to
100 mol % (entries 1-3), resulted in consumption of the starting enol ether, without production of
the desired pyrans. Likewise, ene reactions using benzaldehyde 479 as the enophile did not yield
the desired dihydroxypyran (entry 4).
Table 4.8: Carbonyl-Ene reaction of Aliphatic Aldehydes with 2-Methylenedihydropyrans
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As these results show, the carbonyl-ene reaction of 2-methylenedihydropyrans generally
proceeds in moderate to high yields when activated aldehydes are used. This is not the case with
non-activated aldehydes. These substrates give none of the anticipated ene adducts even in the
presence of equimolar amounts of ZnCl2.

The reactions of 2-methylenedihydropyrans are

therefore limited by the type of enophile that can be coupled under these conditions. As noted
above the internal double bond present in these enol ethers draws electron density away from the
dihydropyran oxygen.

Thus these types of enol ethers are not as reactive as their

tetrahydropyranyl equivalents because the internal oxygen is less capable of donating electrons
to the reactive, exocyclic olefin. In order to overcome the limitations of this reaction, two
options were considered: use of a stronger Lewis acid to facilitate aldehyde activation or
reduction of the endocyclic enol ether prior to elimination. Because exo enol ether substrates are
such labile compounds, the later route was examined.
In an effort to prepare a more reactive substrate for the bi-directional carbonyl-ene
reaction with non-activated enophiles, the synthesis of enol ether 995 was attempted (Scheme
4.61). By reducing the dihydropyran double bond, we hoped to avoid the charge delocalization
Scheme 4.61

experienced by the ring oxygen in the 2-methylenedihydropyran intermediates, and thus make a
more reactive enol ether. Thus, dihydropyran 979 was treated with triethylsilane in the presence
of BF3-OEt2 to give the 2,6-disubstituted tetrahydropyran as a 1:1 mixture of diastereomers.
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Oxidation of secondary alcohol 991 was then performed using Dess-Martin periodinane in order
to simplify the product mixture. A single ketone diastereomer 992 was isolated.
Reduction of dihydropyran 979 is expected to give the cis-2,6-tetrahydropyran on both
stereoelectronic99 and steric grounds. The oxonium ion intermediate formed in this reaction is
expected to adopt a half-chair conformation.

The two possible conformations of this

intermediate are either oxonium ion 993 or 994, the latter of which is lower in energy (Scheme
4.62). Axial attack of the nucleophile is favored on stereoelectronic grounds where the reaction
Scheme 4.62

proceeds through a chair transition-state. In contrast, equatorial attack proceeds through a higher
energy boat transition state and in the absence of competing steric effects, will be disfavored.
Axial addition to intermediate 993 is disfavored due to steric interactions between the
approaching nucleophile and the pseudoaxial iodomethyl group at C6. Therefore, it is expected
that the cis stereoisomer predominates based on axial attack of hydride on the low energy
conformer 994. The nOe studies on ketone 992 are consistent with this expectation. Irradiation
of Ha led to the strong enhancement of the Hb resonance and likewise, irradiation of Hb caused
enhancement of Ha (Figure 4.11).

304

Figure 4.11

With the desired tetrahydropyran ring in hand, dehydrohalogenation of iodide 992 was
subsequently attempted in order to prepare the corresponding exocyclic enol ether 995 (Scheme
4.63). Upon treatment with DBU only recovered iodide 992 was obtained albeit in 23% yield.
No other identifiable products were isolated, and TLC of the crude reaction mixture showed only
the spot corresponding to the unreacted starting material. When silver fluoride was used to effect
elimination, iodide 992 was completely consumed, but none of the desired enol ether 995 was
isolated.

1

H NMR and TLC of the crude reaction mixture did not show the presence of any

decernible compounds. In light of these difficulties, focus shifted to the synthesis of bisspiroketals from bis--hydroxypyrans.
Scheme 4.63

Progress Toward Trioxadispiroketal Synthesis
With the development of an effective route to bis-b-hydroxypyrans the next stage was the
application of this chemistry for the synthesis of trioxadispiroketals. The interest in synthesizing
bis--hydroxypyrans lies partially in the manufacture of bis-spiroketal units like those seen in the
northern fragment of the spirastrellolides.
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Work toward the synthesis of a (5,6,6)-trioxadispiroketal system akin to the northern
fragment of the spirastrellolides, was attempted previously in the lab.97 The spirocyclization of
-hydroxy--keto-pyran 986 proved difficult (Scheme 4.64).

The two-step desilyation and

cyclization of this pyran was attempted for the synthesis of (5, 6, 6)-trioxadispiroketal 996.
Subjection of pyran 986 to TBAF and subsequent treatment of the crude mixture with PPTS did
not provide the desired spiroketal product nor was the starting pyran recovered.
Scheme 4.64

The inability to cyclize pyran 986 prompted the study of spirocyclization conditions that
are conducive to these sensitive bis--oxygenated pyran substrates. Spirocyclization studies
began with bis--hydroxypyran 983 (Scheme 4.65). In theory this pyran should spiroketalize
into the same (5,6,6)-trioxadispiroketal ring system as bis-spiroketal 996, but is made in fewer
synthetic steps.

Direct treatment with hydrofluoric acid should deprotect and concurrently

cyclized the pyran to form trioxadispiroketal 998.

Under these conditions however, no

discernable products were obtained, although all starting material was consumed. As both
Paterson100 and Forsyth101 had observed decomposition in the presence of strong acid in related
systems, we sought milder acidic conditions.

Therefore a second, two-step approach was

explored for the synthesis of the bis-spiroketal 998. Silyl deprotection with tetrabutylammonium
fluoride yielded the triol 997 in good yield. This triol was carried on crude to the next reaction.
Spiroketalization was then attempted under mildly acidic conditions.
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Scheme 4.65

Treatment of triol 997 with PPTS showed complete consumption of starting material after
eighteen hours at room temperature. The reaction progress was carefully monitored by TLC
throughout the experiment, though no distinct product spots emerged.

1

H NMR of the crude

reaction mixture did not show the presence of any identifiable compounds.
Earlier work in our lab demonstrated the feasibility of using an ester nucleophile directly
for the preparation of spiroketals 964 and 965 using HCl (scheme 4.54). The direct, acid
catalyzed cyclization of diester pyran 981 was thus attempted in an effort to prepare the (5,6,5)
bis-spiroketal 999 (Scheme 4.66). Application of these same acidic conditions to pyran 981 did
not have the same result. The TLC of the reaction showed disappearance of the pyran, with no
other spot emerging, even with use of polar solvent systems. The 1H NMR of the crude residue
did not show any apparent products.
Scheme 4.66
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In a second approach to trioxadispiroketal 999, the ester groups were reduced prior to
cyclization (Scheme 4.67) Thus, diester 981 was treated with LiAlH4 to give the presumed
tetrahydroxy-intermediate 1000 that was not isolated, but subjected immediately to aqueous
acidic workup.

Again TLC of the reaction mixture showed disappearance of the starting

material, without the emergence of any new spots, even with polar solvents. The tetrahydroxy
intermediate, if formed, would be highly polar and would most likely be lost in the aqueous
workup. The same could be true of any spiroketal systems formed if they proved to be polar
enough, although TLC of the aqueous layers did not show the presence of any organic
compounds.
Scheme 4.67

The failure to prepare the bis-spiroketals directly from the bis--hydroxypyrans may be
due to the inherent sensitivity of these systems. These concerns led us to explore an alternative,
stepwise approach for trioxadispiroketal synthesis. It is anticipated that the original sequence for
bis-b-hydroxy-dienol ethers 966 (Scheme 4.55) could be intercepted such that formation of the
first spiroketal system (BC) (Scheme 4.68) precedes elimination to generate the new exocyclic
enol ether. Potential advantage of this approach over direct cyclization is that bis-spiroketals
derived from two non-activated aldehydes may now be available because reactivity of exo enol
ether 1003 is not attenuated by the presence of an endo enol ether.
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Scheme 4.68

Efforts focused on the synthesis of the (6,6,6)-bis-spiroketal 1004 (n = 1) (Scheme 4.69).
The carbonyl-ene reaction of enol ether 302 with aldehyde 971 (Scheme 4.69) very efficiently
provided ene adduct 972 in the presence of 20 mol% ZnCl2. Silyl deprotection afforded diol
1005, which was carried on crude to the next reaction. Acid catalyzed cyclization with PPTS
Scheme 4.69

yielded spiroketals 1006 and 1007 as a 1:1 mixture of diastereomers. These diastereomers were
separated by flash column chromatography and carried on individually as described below.
As the spiroketalization was conducted under thermodynamic conditions, formation of
the most stable carbon framework was expected. This framework should contain an equatorial
iodomethyl group and would benefit from double anomeric stabilization. For this reason the
resulting diastereomers 1006 and 1007 were presumed to differ only in the stereochemistry of the
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secondary alcohol. The identity of the individual isomers was confirmed on the basis of 1H
NMR coupling constants.
The stereochemistry for each isomer was determined by evaluating the coupling
constants for the hydrogen at C4 (Hb) (Figure 4.12). In each case the angles between the proton.
Figure 4.12

at this position and those at adjacent positions are assumed to be similar, thereby simplifying the
resonance pattern. Compound 1006 possesses an axial alcohol, and therefore both Jba and Jbc are
expected to be small. Since the magnitude of these coupling constants should be similar, the H4
resonance should appear as a narrow triplet in the 1H NMR. An equatorial orientation of Hb is
expected to exhibit small-small coupling patterns. Conversely, compound 1007, which has an
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equitorial alcohol, it is expected Jb’a to be large and Jb’c to be small. Therefore the C4 proton
peak in the 1H NMR is expected to appear as a doublet of doublets.
Examination of the relevant portions of the 1H NMRs show that the peaks are somewhat
in agreement with these expectations. Spiroketal 1006 shows a narrow peak at 4.08 ppm. This
peak overlaps slightly with a peak associated with C10 at 4.14 ppm. This peak is not the narrow
triplet expected, due to non-equivalent coupling constants associated with the adjacent protons.
Nonetheless this peak is narrower than that associated with spiroketal 1007. Likewise the peak
representing Hb’ in compound 1007 is not the expected doublet of doublets, but does represent
the presence of a larger coupling constant.
With spiroketals 1006 and 1007 in hand, attention was turned to the formation of
exocyclic enol ether 1003 (Scheme 4.70). Two methods were evaluated: the base-induced
elimination of iodine under conditions previously established for the preparation of bis-enol
pyrans 976-980 (cf. Table 4.5) and internal elimination of a selenoxide.
Scheme 4.70

Elimination was first attempted on iodide 1006.

Treatment with DBU proved

unsuccessful and resulted only in 62% recovery of starting material (Table 4.9, entry 1).
Elimination was also attempted with silver fluoride both at room temperature (entry 2) and 65 oC
(entry 3). At room temperature only the starting iodide was isolated in 86%. Since the reactivity
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Table 4.9

was low, higher temperatures were applied to the same reaction, but only the starting iodide was
isolated in 31% or the iodide was replaced by fluorine (26%).

The difficulty observed in

eliminating the iodide may be due to steric hindrance. The proximal stereocenter may block
access of the base to the C10 hydrogen, thereby impeding the formation of the double bond. The
difficulties experienced with these reactions prompted an approach involving internal
elimination.
In a second approach, iodide 1007 was converted to the selenoxide 1010 (Scheme 4.71).
We anticipated that elimination of the selenoxide might work better for this system since the
Scheme 4.71
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reaction is intramolecular. In practice, iodide 1006 was treated with diphenyl selenide and
sodium borohydride to give the selenide 1009 in 87% yield.102 This compound was subsequently
oxidized to selenoxide 1010,

103

which upon workup, was directly subjected to elimination

conditions without further purification. Several solvents were used to facilitate the elimination
including tetrahydrofuran, dihydropyran, and dimethylsulfide (Table 4.10, entries 1-3).104 None
of the desired exocyclic enol ether 1011 was formed in either THF or DHP though a trace
amount of this product 1011 was detected by 1H NMR using dimethylsulfide as solvent. The
small quantities of material produced precluded further pursuit of this sequence.
Table 4.10

4.4 Conclusions
We have demonstrated a facile approach to the preparation of bis--hydroxypyrans
through two-directional carbonyl-ene reactions of exocyclic enol ethers.

The use of an

iodomethyl derivative as the bis-exo enol ether equivalent facilitates this process and allows for
the preparation of non-symmetrical systems. The initial ene reaction in the sequence proceeds
cleanly in the presence of 5 mol% ZnCl2. The intermediate 6-methylene-dihydropyran prepared
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is more stable than expected, though participates in the carbonyl-ene reactions of activated
enophiles in good to excellent yields in the presence of 20 mol% ZnCl2. The reaction of the bisenol ether with unactivated aldehydes was more troublesome and was not observed even in the
presence of equimolar amounts of ZnCl2. Use of stronger Lewis acids may overcome this
difficulty and allow us to further broaden the substrate scope. Overall, this method represents an
efficient method for the formation of bis-b-hydroxypyrans, compounds that may prove useful for
the preparation of tetrahydropyran-containing natural products.
The current data suggests that the synthesis of trioxadispiroketals from bis--hydroxy
precursors is non-trivial. The inability to produce these complex systems from these pyran
precursors is most likely due to their sensitivity. Further examination of the reaction conditions
will be required to effect trioxadispiroketal formation. This truly would be a unique method for
bis-spiroketal construction. Advantages of this method include its highly convergent nature and
potential ease with which a number of different spiroketals could be formed from a common
intermediate. The formation of these bis-spiroketals is of high interest due to their presence in
interesting, biologically active metabolites.
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4.5 Experimentals
General Methods
All air sensitive reactions were performed in oven dried glassware under an atmosphere
of argon. Reaction solvents were dried over CaH2 (benzene, dichloromethane), or
sodium/benzophenone ketyl (tetrahydrofuran, diethyl ether) and were distilled just prior to use.
All other reagents were reagent grade and purified as necessary. Analytical thin layer
chromatography was performed on EM silica gel 60 F254 glass plates (0.25 mm). Visualization
of analytical thin layer chromatography was achieved using UV absorbance (254 nm) and ceric
ammonium molybdate stain. Melting points were recorded using an Electrothermal melting
point apparatus and are uncorrected.

Flash column chromatography was performed using

SiliaFlash P60 silica gel (40-60 Ǻ) from SiliCycle, Inc.
Bruker Avance DPX-300 (300 MHz) spectrometer.

1

H NMR spectra were recorded on a

Chemical shifts are reported in ppm,

downfield from tetramethylsilane using residual CHCl3 as the internal standard (δ 7.27 ppm).
13

C NMR spectra were recorded on a Bruker Avance DPX-300 (75 MHz) spectrometer with

complete proton decoupling.

Chemical shifts are reported in ppm, downfield from

tetramethylsilane using residual CHCl3 as the internal standard (δ 77.0 ppm). IR spectra were
obtained with a Thermo Nicolet IR-100 spectrometer on NaCl plates. Elemental Analyses were
performed by Complete Analysis Laboratories, Inc.; Parsippany, NJ. High resolution mass
spectra were obtained using the positive ion electrospray mode on a Bruker 12 Tesla APEX-Qe
FTICR-MS with an Apollo II ion source at Old Dominion University, Norfolk, VA.
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Experimental Procedures

Lactone 968. To a solution of iodine (26.0g, 0.315 mol) and NaHCO3 (16.0g, 62.9 mmol) in
acetonitrile (175 mL) was added carboxylic acid 967 (4.00g, 31.5 mmol). The reaction was
stirred at room temperature for 24 hours. The reaction mixture was then diluted with EtOAc (50
mL) and washed with a saturated sodium thiosulfate solution (40 mL). The organic and aqueous
layers were separated, and the aqueous layer was extracted with EtOAc (3 x 40 mL). The
organic layers were combined and dried over MgSO4, filtered, and concentrated in vacuo. The
residue was purified by flash chromatography (SiO2; hexanes:EtOAc, 5:1-4:1) to afford
tetrahydropyran 968 (6.55g, 82%) as a yellow oil. 1H NMR data for this compound agreed with
the known literature values.105 TLC: Rf = 0.23 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300
MHz): m), 3.33 (2H, m), 2.58 (1H, m), 2.45 (1H, m), 2.16 (1H, m), 1.91 (2H, m),
1.62 (1H, m).

Enol ether 302. To a solution of lactone 968 (0.75g, 3.13 mmol) in THF (42 mL) was added
dimethyl titanocene ( 12.5 mL of a 0.5M solution in THF, 6.26 mmol) in the dark. The reaction
mixture was heated to reflux and stirred in the dark for 24 h. After cooling to room temperature,
solvent was removed in vacuo to approximately half the volume. The residue was diluted with
hexanes (500 mL) and filtered through Celite. The solvent was removed in vacuo and the
resulting crude residue was purified by flash chromatography using deactivated silica gel (SiO2;
316

hexanes:Et3N, 95%:5%) to afford enol ether 302 (0.56 mg, 76%) as a yellow liquid. TLC: Rf =
0.67 (hexanes:EtOAc, 10:1). 1H NMR (CDCl3, 300 MHz):  4.37 (1H, d, J = 1.2 Hz), 4.09 (1H,
d, J = 1.5 Hz), 3.58 (1H, m), 3.24 (2H, dd, J = 5.7, 1.2 Hz), 2.15 (2H, m), 1.69 (4H, m).

13

C

NMR (CDCl3, 75 MHz):  159.3 (C), 92.4 (CH2), 77.6 (CH), 30.1 (CH2), 28.5 (CH2), 21.9
(CH2), 9.1 (CH2). IR (film): 2946, 2868, 1652, 1252 cm-1. HRMS (ESI) Calcd for C7H11IO
([M+Na]+): 498.9601, found 498.9613.

Dihydropyran 969: Ethyl glyoxylate (0.12 mL, 1.19 mmol) was added to a solution of enol
ether 302 (235 mg, 0.992 mmol) in dry THF (1.7 mL) followed by 0.30 mL of a freshly prepared
solution of ZnCl2 (22.4 mg/mL, 0.049 mmol) in dry THF. The reaction was stirred at room
temperature for 2 h. The solvent was removed in vacuo and the residue was purified by flash
chromatograpy (SiO2; hexanes:EtOAc, 10:1) to afford dihydropyran 969 (281 mg, 84%) as a
yellow oil with a diastereomeric ratio of 1:1. TLC: Rf = 0.34 (hexanes:EtOAc, 3:1). 1H NMR
(CDCl3, 300 MHz):  4.61 (1H, q, J = 3.7 Hz), 4.35 (1H, m), 4.24 (2H, q, J = 7.1 Hz), 3.87
(0.5H, m), 3.77 (0.5H, m), 3.27 (2H, m), 3.09 (0.5H, br s), 2.98 (0.5H, br s), 2.50 (2H, m), 2.04
(3H, m), 1.67 (1H, m), 1.30 (1.5H, t, J = 7.1 Hz), 1.30 (1.5H, t, J = 7.1 Hz). 13C NMR (CDCl3,
75 MHz):  174.2 (C), 174.0 (C), 149.3 (C), 149.0 (C), 99.0 (2) (CH), 74.8 (CH), 74.0 (CH),
68.9 (CH), 68.6 (CH), 61.4 (CH2), 38.9 (2) (CH2), 27.0 (CH2), 26.9 (CH2), 19.7 (CH2), 19.5
(CH2), 14.3 (CH3), 14.2 (CH3), 8.4 (CH2), 7.8 (CH2). IR (film): 3494, 2926, 1735, 1681, cm-1.
HRMS (ESI) Calcd for C11H17IO4 ([M+Na]+): 363.0064, found 363.0066.
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Dihydropyran 970: Ethyl pyruvate (77 mg, 0.67 mmol) was added to a solution of enol ether
302 (140 mg, 0.556 mmol) in dry THF (0.1 mL) followed by 1.0 mL of a freshly prepared
solution of ZnCl2 (15 mg/mL, 0.11 mmol) in dry THF. The reaction was stirred at room
temperature for 24 h. The solvent was removed in vacuo and the residue was purified by flash
chromatograpy (SiO2; hexanes:EtOAc, 10:1) to afford dihydropyran 970 (142 mg, 66%) as a
yellow oil with a diastereomeric ratio of 1:1. TLC: Rf = 0.65 (hexanes:EtOAc, 2:1). 1H NMR
(CDCl3, 300 MHz):  4.59 (1H, m), 4.22 (2H, m), 3.87 (0.5H, m), 3.75 (0.5H, br s), 3.68 (0.5H,
m), 3.51 (0.5H, br s), 3.25 (2H, m), 2.57 (1H, m), 2.37 (1H, m), 2.01 (3H, m), 1.64 (1H, m), 1.44
(3H, d, J = 3.1 Hz), 1.31 (3H, m).

13

C NMR (CDCl3, 75 MHz):  175.8 (C), 175.5 (C), 149.9

(C), 149.5 (C), 99.5 (CH), 99.4 (CH), 75.1 (CH), 74.4 (CH), 73.9 (CH), 73.8 (CH), 61.4 (2)
(CH2), 44.9 (2) (CH2), 27.0 (2) (CH2), 25.7 (CH3), 25.6 (CH3), 19.9 (CH2), 19.6 (CH2), 14.3 (2)
(CH3), 8.7 (CH2), 7.6 (CH2). IR (film): 3526, 3066, 2980, 1731, 1679 cm-1. HRMS (ESI) Calcd
for C12H19IO4 ([M+Na]+): 377.0220, found 377.0224.

Dihydropyran 972: Aldehyde 971 (296 mg, 0.95 mmol) was added to a flask containing enol
ether 1 (188 mg, 0.79 mmol) followed by 1.58 mL of a freshly prepared solution of ZnCl2 ( 13
mg/mL, mmol) in dry THF. The reaction was stirred at room temperature for 24 h. The solvent
was removed in vacuo and the residue was purified by flash chromatograpy (SiO2;
hexanes:EtOAc, 20:1) to afford dihydropyran 972 (428 mg, 99%) as a yellow oil with a
diastereomeric ratio of 1:1. TLC: Rf = 0.75 (hexanes:EtOAc, 3:1). 1H NMR (CDCl3, 300 MHz):
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 7.72 (4H, m), 7.42 (6H, m), 4.58 (1H, t, J = 3.6 Hz), 4.13 (1H, m), 3.88 (2H, q, J = 5.8 Hz),
3.86 (2H, m), 3.28 (2H, dd, J = 5.8, 2.5 Hz), 3.18 (1H, s), 2.25 (2H, d, J = 6.1 Hz), 2.03 (2H, m),
1.75 (2H, q, J = 5.9 Hz), 1.67 (2H, m), 1.07 (9H, s).

13

C NMR (CDCl3, 75 MHz):  151.3 (C),

135.5 (CH), 134.8 (CH), 133.4 (C), 133.3 (C), 129.7 (CH), 129.6 (CH), 127.7 (CH), 97.7 (C),
97.6 (C), 74.4 (CH), 74.3 (CH), 68.8 (CH), 62.6 (CH2), 62.5 (CH2), 41.9 (CH2), 38.4 (2) (CH2),
27.2 (CH2), 27.1 (CH2), 26.8 (CH3), 26.5 (CH3), 19.7 (CH2), 19.1 (C), 8.5 (CH2), 8.4 (CH2). IR
(film): 3433, 3069, 3047, 2929, 2855, 1676 cm-1.

HRMS (ESI) Calcd for C26H35IO3Si

([M+Na]+): 573.1292, found 573.1282.

Dihydropyran 973: Octyl aldehyde (340 mg, 2.66 mmol) was added to a solution of enol ether
302 (562 mg, 2.21 mmol) in dry THF (1.7 mL) followed by 2.7 mL of a freshly prepared
solution of ZnCl2 (22.4 mg/mL, 0.44 mmol) in dry THF. The reaction was stirred at room
temperature for 11 h. The solvent was removed in vacuo and the residue was purified by flash
chromatograpy (SiO2; hexanes:EtOAc, 20:1) to afford dihydropyran 973 (695 mg, 82%) as a
yellow oil with a diastereomeric ratio of 1:1. TLC: Rf = 0.71 (hexanes:EtOAc, 2:1).1H NMR
(CDCl3, 300 MHz):  4.57 (1H, m), 3.84 (2H, m), 3.30 (2H, m), 2.47 (1H, dd, J = 27.9, 3.6 Hz),
2.27 (1H, m), 2.04 (4H, m), 1.66 (2H, m), 1.37 (10H, m), 0.88 (3H, t, J = 6.7 Hz).

13

C NMR

(CDCl3, 75 MHz):  151.7 (C), 97.9 (CH), 97.7 (CH), 74.5 (CH), 70.2 (CH), 70.1 (CH), 41.7
(CH2), 36.8 (2) (CH2), 31.8 (CH2), 29.6 (CH2), 29.3 (CH2), 27.3 (CH2), 27.2 (CH2), 25.7 (CH2),
25.6 (CH2), 22.6 (CH2), 19.8 (CH2), 19.7 (CH2), 14.1 (CH3), 8.5 (CH2), 8.4 (CH2). IR (film):
3500, 3063, 2927, 2853, 1679 cm-1. HRMS (ESI) Calcd for C15H27IO2 ([M+Na]+): 389.0948,
found 389.0954.
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Dihydropyran 975: Aldehyde 974 ( 93.1 mg, 0.160 mmol) was added to a solution of enol ether
302 (45.6 mg, 0.192 mmol) in dry THF (0.13 mL) followed by 0.19 mL of a freshly prepared
solution of ZnCl2 (22.4 mg/mL, 0.032 mmol) in dry THF. The reaction was stirred at room
temperature for 24 h. The solvent was removed in vacuo and the residue was purified by flash
chromatograpy (SiO2; hexanes, 100%) to afford dihydropyran 975 (100.3 mg, 76%) as a yellow
oil with a diastereomeric ratio of 2.7:2.7:1:1. TLC: Rf = 0.54 (hexanes:EtOAc, 5:1). 1H NMR
(CDCl3, 300 MHz):  7.45 (20H, m), 4.50 (0.24H, m), 4.44 (0.76H, m), 4.05 (2H, m), 3.74 (1H,
m), 3.59 (2H, m), 3.21 (2H, dd, J = 5.6, 2.5 Hz), 2.86 (0.24H, dd, J = 6.6, 3.2 Hz), 2.70 (0.74H,
dd, J = 6.0, 3.9 Hz), 1.86 (8H, m), 1.03 (6.6H, s), 1.02 (2.4H, s), 0.99 (6.6H, s), 0.98 (2.4H, s).
13

C NMR (CDCl3, 75 MHz):  151.2 (3) (C), 135.9 (CH), 135.7 (CH), 135.5 (3) (CH), 134.0 (C),

133.8 (C), 133.5 (C), 133.3 (C), 129.6 (CH), 129.5 (CH), 129.4 (CH), 127.5 (2) (CH), 127.4 (2)
(CH), 97.7 (CH), 97.6 (CH), 77.2 (CH), 74.2 (2) (CH), 72.3 (CH), 67.1 (CH2), 66.9 (CH), 41.8
(CH2), 41.7 (CH2), 40.8 (CH2), 27.0 (CH3), 26.8 (CH3), 19.6 (CH2), 19.5 (CH2), 19.2 (CH2), 19.1
(CH2), 8.4 (CH2), 8.3 (CH2). IR (film): 3369, 3071, 2965, 2861, 1679, 1112 cm-1. HRMS (ESI)
Calcd for C43H55IO4Si2 ([M+Na]+): 841.2576, found 841.2565.

Dihydropyran 976: DBU (0.382 mL, 2.56 mmol) was added to a solution of iodide 969 (87 mg,
0.256 mmol) in benzene (4.7 mL). The reaction was heated to 65C for a period of 24 h.
Thereafter the reaction was cooled to room temperature, diluted with diethyl ether (50 mL) and
filtered through celite. Column chromatography (SiO2; hexanes:EtOAc, 10:1) yielded enol ether
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976 (50 mg, 93%) as a colorless oil. TLC: Rf = 0.42 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3,
300 MHz):  4.77 (1H, t, J = 4.0 Hz), 4.39 (1H, s), 4.35 (1H, m), 4.24 (2H, q, J = 7.1 Hz), 4.05
(1H, d, J = 0.8 Hz), 2.92 (1H, d, J = 6.7 Hz), 2.52 (2H, dq, J = 14.5, 4.6 Hz), 2.36 (2H, t, J = 6.6
Hz, 2.09 (2H, q, J = 6.5 Hz), 1.30 (3H, dt, J = 7.1, 0.4 Hz).

13

C NMR (CDCl3, 75 MHz):  174.2

(C), 156.0 (C), 147.6 (C), 99.8 (CH), 89.9 (CH2), 68.2 (CH), 61.5 (CH2), 38.6 (CH2), 25.6 (CH2),
20.3 (CH2), 14.1 (CH3). IR (film): 3489, 2980, 2931, 1732, 1691, 1652 cm-1. HRMS (ESI)
Calcd for C11H16O4 ([M+Na]+): 235.0938, found 235.0938.

Dihydropyran 977: DBU (0.55 mL, 3.66 mmol) was added to a solution of iodide 970 (142 mg,
0.366 mmol) in benzene (7 mL). The reaction was heated to 65C for a period of 24 h.
Thereafter the reaction was cooled to room temperature, diluted with diethyl ether (50 mL) and
filtered through celite. Column chromatography (SiO2; hexanes:EtOAc, 10:1) yielded enol ether
977 (87 mg, 92%) as a colorless oil. TLC: Rf = 0.64 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3,
300 MHz):  4.73 (1H, t, J = 4.2 Hz), 4.33 (1H, s), 4.19 (2H, q, J = 7.1 Hz), 4.02 (1H, d, J = 0.8
Hz), 3.38 (1H, s), 2.60 (1H, d, J = 13.9 Hz), 2.33 (3H, m), 2.06 (2H, m), 1.42 (3H, s), 1.28 (3H,
t, J = 7.2 Hz).

13

C NMR (CDCl3, 75 MHz):  175.8 (C), 155.9 (C), 148.1 (C), 100.3 (CH), 89.9

(CH2), 73.3 (C), 61.5 (CH2), 44.6 (CH2), 25.6 (CH3), 25.5 (CH2), 20.3 (CH2), 14.1 (CH3). IR
(film): 3529, 3118, 3067, 2982, 1732, 1686, 1654 cm-1. HRMS (ESI) Calcd for C12H18O4
([M+Na]+): 249.1097, found 249.1095.
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Dihydropyran 978: DBU (0.17 mL, 1.12 mmol) was added to a solution of iodide 972 (112 mg,
0.112 mmol) in benzene (2 mL). The reaction was heated to 65C for a period of 24 h.
Thereafter the reaction was cooled to room temperature, diluted with diethyl ether (50 mL) and
filtered through celite. Column chromatography (SiO2; hexanes:EtOAc, 20:1) yielded enol ether
978 (48 mg, 100%) as a colorless oil. TLC: Rf = 0.81 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3,
300 MHz):  7.70 (4H, m), 7.43 (6H, m), 4.75 (1H, t, J = 4.1 Hz), 4.34 (1H, s), 4.16 (1H, m),
4.07 (1H, s), 3.88 (2H, m), 3.12 (1H, br s), 2.39 (2H, t, J = 6.6 Hz), 2.29 (2H, m), 2.12 (2H, m),
1.76 (4H, m), 1.08 (9H, s).

13

C NMR (CDCl3, 75 MHz):  156.4 (C), 149.9 (C), 135.5 (CH),

133.3 (C), 129.7 (CH), 127.7 (CH), 98.6 (CH), 89.8 (CH2), 68.7 (CH), 62.8 (CH2), 41.6 (CH2),
38.2 (CH2), 26.8 (CH3), 25.8 (CH2), 20.4 (CH2), 19.1 (C). IR (film): 3500, 3071, 3050, 2931,
2857, 1687, 1652 cm-1.

HRMS (ESI) Calcd for C26H34O3Si ([M+Na]+): 445.2170, found

445.2169.

Dihydropyran 979: DBU (0.44 mL, 2.96 mmol) was added to a solution of iodide 973 (113 mg,
0.296 mmol) in benzene (5.5 mL). The reaction was heated to 65C for a period of 24 h.
Thereafter the reaction was cooled to room temperature, diluted with diethyl ether (50 mL) and
filtered through celite. Column chromatography (SiO2; hexanes:EtOAc, 20:1) yielded enol ether
979 (75 mg, 80%) as a colorless oil. TLC: Rf = 0.73 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3,
300 MHz):  4.74 (1H, t, J = 4.2 Hz), 4.44 (1H, s), 4.09 (1H, d, J = 0.9 Hz), 3.82 (1H, m), 2.39
(2H, t, J = 6.6 Hz), 2.30 (1H, m), 2.12 (3H, m), 1.43 (2H, m), 1.29 (10H, s), 0.89 (3H, t, J = 6.8
Hz).

13

C NMR (CDCl3, 75 MHz):  156.2 (C), 150.1 (C), 98.8 (CH), 90.0 (CH2), 69.3 (CH),

41.5 (CH2), 36.7 (CH2), 31.8 (CH2), 29.6 (CH2), 29.2 (CH2), 25.7 (CH2), 25.6 (CH2), 22.6 (CH2),
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20.3 (CH2), 14.1 (CH3). IR (film): 3449, 3116, 2955, 2854, 1686, 1654 cm-1. HRMS (ESI)
Calcd for C15H26O2 ([M+Na]+): 261.1825, found 261.1825.

Dihydropyran 980: DBU (0.24 mL, 1.59 mmol) was added to a solution of iodide 975 (130 mg,
0.159 mmol) in benzene (3.5 mL). The reaction was heated to 65C for a period of 24 h.
Thereafter the reaction was cooled to room temperature, diluted with diethyl ether (20 mL) and
filtered through celite. Column chromatography (SiO2; hexanes:EtOAc, 50:1) yielded enol ether
980 (97 mg, 89%) as a yellow oil. TLC: Rf = 0.58 (hexanes:EtOAc, 5:1). 1H NMR (CDCl3, 300
MHz):  7.46 (20H, m), 4.64 (1H, m), 4.38 (1H, s), 4.04 (1H, s), 4.02 (2H, m), 3.56 (2H, m),
2.77 (0.14H, d, J = 2.8 Hz), 2.57 (0.86H, d, J = 3.5 Hz), 2.33 (2H, t, J = 6.7 Hz), 2.12 (4H, m),
1.79 (2H, m), 1.02 (7.7H, s), 1.01 (1.3H, s), 0.98 (7.7H, s), 0.96 (1.3H, s).

13

C NMR (CDCl3, 75

MHz):  156.2, 149.8, 135.9, 135.8, 135.7 (2), 135.5 (2), 135.4 (2), 133.9, 133.6, 133.3 (2),
133.2 (2), 129.7, 129.6, 129.5, 127.6, 127.5 (3), 127.4 (2), 98.6, 98.3, 89.9, 89.7, 77.4, 72.3, 72.0,
67.2, 66.7, 65.8, 42.1, 41.7, 40.8, 40.1, 26.9, 26.8, 25.8, 25.7, 20.3, 19.2, 19.1 (3).

IR (film):

3570, 3071, 2930, 2857, 1686, 1651, 1112 cm-1. HRMS (ESI) Calcd for C43H54O4Si2 ([M+Na]+):
713.3453, found 713.3437.

Ketone 985: To a solution of alcohol 980 (10.5 mg, 0.015 mmol) in CH2Cl2 (1.0 mL) was added
Dess-Martin periodinane (7.4 mg, 0.017 mmol) at room temperature. The reaction stirred for 30
min and was then diluted with diethyl ether (5 mL), filtered through a pad of celite, and
concentrated in vacuo.

The crude residue was purified by flash chromatography using
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deactivated silica gel (SiO2; hexanes:EtOAc, 100:1) to afford dihydropyran 985 (7.2 mg, 69%) as
a yellow oil. TLC: Rf = 0.66 (hexanes:EtOAc, 5:1). 1H NMR (CDCl3, 300 MHz):  7.47 (20H,
m), 4.65 (1H, t, J = 4.2 Hz), 4.38 (1H, s), 4.33 (2H, m), 4.04 (1H, s), 3.57 (2H, m), 2.93 (2H, s),
2.80 (2H, m), 2.33 (2H, t, J = 6.5 Hz), 2.07 (2H, q, J = 6.1 Hz), 1.00 (9H,s), 0.99 (9H, s).

13

C

NMR (CDCl3, 75 MHz):  205.1, 155.9, 146.5, 135.9, 135.7, 135.5 (2), 133.9, 133.6, 133.3 (2),
129.6, 129.5 (2), 129.4, 127.5 (2), 127.4, 100.3, 90.3, 70.0, 67.0, 48.6, 45.9, 26.9, 26.8, 25.4,
20.4, 19.2 (2).

IR (film): 3072, 2932, 2858, 1721, 1682 cm-1.

HRMS (ESI) Calcd for

C43H52O4Si2 ([M+Na]+): 711.3296, found 711.3290.

Pyran 981: Ethyl glyoxylate (40 mg, 0.188 mmol) was added to a solution of enol ether 976 (40
mg, 0.188 mmol) in dry THF (0.05 mL) followed by 0.13 mL of a freshly prepared solution of
ZnCl2 (15 mg/mL, 0.018 mmol) in dry THF. The reaction was stirred at room temperature for 2
h. The solvent was removed in vacuo and the residue was purified by flash chromatograpy (SiO2;
hexanes:EtOAc, 3:1-1:1) to afford pyran 981 (25 mg, 89%) as a yellow oil. TLC: Rf = 0.11
(hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  4.61 (2H, m), 4.30 (6H, m), 3.63 (2H, br
s), 2.69 (2H, s), 2.46 (4H, m), 1.32 (6H, m). 13C NMR (CDCl3, 75 MHz):  174.1 (C), 174.0 (C),
146.9 (C), 146.0 (C), 98.9 (2) (CH), 68.6 (CH), 68.5 (CH), 61.6 (2) (CH2), 38.5 (CH2), 38.3
(CH2), 21.0 (CH2), 20.9 (CH2), 14.2 (2) (CH3). IR (film): 3464, 3067, 2983, 1739, 1674 cm-1.
HRMS (ESI) Calcd for C15H22O7 ([M+Na]+): 377.1258, found 377.1266.
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Pyran 982: Ethyl glyoxylate (0.0071 mL, 70 mmol) was added to a solution of enol ether 977
(0.020 mg, 77 mmol) in dry THF (0.10 mL) followed by 0.054 mL of a freshly prepared solution
of ZnCl2 (20 mg/mL, 0.003 mmol) in dry THF. The reaction was stirred at room temperature for
2 h. The solvent was removed in vacuo and the residue was purified by flash chromatograpy
(SiO2; hexanes:EtOAc, 3:1-1:1) to afford pyran 982 (20 mg, 80 %) as a yellow oil. TLC: Rf =
0.25 (hexanes:EtOAc, 2:1).

1

H NMR (CDCl3, 300 MHz):  4.59 (2H, m), 4.27 (1H, m), 4.25

(2H, q, J = 7.1 Hz), 3.68 (1H, br d, J = 26.6 Hz), 2.68 (2H, s), 2.33 (2H, m), 1.44 (3H, d, J = 2.4
Hz), 1.30 (6H, tt, J = 7.1, 0.8 Hz).

13

C NMR (CDCl3, 75 MHz):  175.9 (C), 173.9 (C), 147.2

(C), 147.1 (3 (C), 99.5 (CH), 99.3 (CH), 98.6 (CH), 77.2 (C), 74.0 (CH2), 73.7 (CH2), 68.9 (CH),
68.8 (CH), 61.6 (CH2), 44.2 (CH2), 44.1 (CH2), 38.5 (CH2), 38.3 (CH2), 29.7 (CH), 25.9 (CH3),
25.7 (CH3), 21.0 (CH2), 20.9 (CH2), 14.2 (CH3). IR (film): 3258, 2982, 2851, 1734, 1672 cm-1.
HRMS (ESI) Calcd for C16H24O7 ([M+Na]+): 351.1414, found 351.1417.

Pyran 983: Ethyl glyoxylate (68 mg, 0.665 mmol) was added to a solution of enol ether 978
(200 mg, 0.732 mmol) in dry THF (1.0 mL) followed by 0.50 mL of a freshly prepared solution
of ZnCl2 (10 mg/mL, 0.033 mmol) in dry THF. The reaction was stirred at room temperature for
2 h. The solvent was removed in vacuo and the residue was purified by flash chromatograpy
(SiO2; hexanes:EtOAc, 3:1-1:1) to afford pyran 983 (230 mg, 70%) as a yellow oil. TLC: Rf =
0.30 (hexanes:EtOAc, 2:1).

1

H NMR (CDCl3, 300 MHz):  7.69 (4H, m), 7.42 (6H, m), 4.62

(1H, m), 4.58 (1H, m), 4.33 (1H, m), 4.24 (2H, m), 4.10 (1H, m), 3.86 (2H, m), 3.31 (1H, br s),
3.06 (1H, br s), 2.70 (2H, s), 2.55 (1H, dd, J = 14.5, 4.5 Hz), 2.41 (1H, dd, J = 14.5, 6.9 Hz),
2.20 (2H, d, J = 6.4 Hz), 1.74 (2H, q, J = 5.8 Hz), 1.29 (3H, dt, J = 7.1, 2.6), 1.06 (9H, s). 13C
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NMR (CDCl3, 75 MHz):  174.1 (C), 148.8 (C), 148.6 (C), 146.8 (C), 135.5 (CH), 133.2 (C),
133.1 (C), 129.7 (CH), 127.7 (CH), 98.9 (2) (CH), 97.9 (CH), 97.7 (CH), 68.8 (CH), 68.5 (CH),
68.4 (CH), 68.3 (CH), 62.7 (CH2), 61.6 (CH2), 41.4 (CH2), 38.5 (CH2), 38.2 (2) (CH2), 26.8
(CH3), 21.0 (CH2), 19.1 (C), 14.2 (CH3). IR (film): 3483, 3071, 2931, 2857, 1736, 1672 cm-1.
HRMS (ESI) Calcd for C30H40O6Si ([M+Na]+): 547.2486, found 547.2484.

Pyran 984: Ethyl glyoxylate (7 mg, 0.067 mmol) was added to a solution of enol ether 979 (34
mg, 0.134 mmol) in dry THF (0.11 mL) followed by 0.018 mL of a freshly prepared solution of
ZnCl2 (23 mg/mL, 0.003 mmol) in dry THF. The reaction was stirred at room temperature for 2
h. The solvent was removed in vacuo and the residue was purified by flash chromatograpy (SiO2;
hexanes:EtOAc, 3:1-1:1) to afford pyran 984 (22 mg, 92%) as a yellow oil. TLC: Rf = 0.36
(hexanes:EtOAc, 2:1).

1

H NMR (CDCl3, 300 MHz):  4.63 (1H, m), 4.58 (1H, m), 4.34 (1H,

dd, J = 6.9, 4.4 Hz), 4.25 (2H, m), 3.78 (1H, m), 2.70 (2H, s), 2.49 (2H, m), 2.21 (1H, m), 2.03
(1H, m), 1.44 (2H, m), 1.27 (10H, m), 0.88 (3H, t, J = 6.8 Hz). 13C NMR (CDCl3, 75 MHz): 
174.2 (C), 149.0 (C), 148.8 (C), 146.9 (C), 146.8 (C), 99.0 (CH), 98.0 (CH), 97.8 (CH), 69.5
(CH), 69.3 (CH), 68.5 (CH), 68.4 (CH), 61.7 (CH), 45.1 (CH2), 41.3 (CH2), 38.3 (2) (CH2), 36.9
(CH2), 36.8 (CH2), 31.8 (CH2), 29.6 (CH2), 29.2 (CH2), 25.7 (CH2), 22.6 (CH2), 21.0 (CH2), 14.2
(CH3), 14.1 (CH3), 8.8 (CH3). IR (film): 3499, 2928, 2856, 1737, 1673 cm-1. HRMS (ESI)
Calcd for C19H32O5 ([M+Na]+): 363.2142, found 363.2142.

326

Pyran 986: Ethyl glyoxylate (8 L, 0.78 mmol) was added to a solution of enol ether 343 (7.0
mg, 0.010 mmol) in dry THF (50 L) followed by 20 L of a freshly prepared solution of ZnCl2
(13.8 mg/mL, 0.002 mmol) in dry THF. The reaction was stirred at room temperature for 2 h.
The solvent was removed in vacuo and the residue was purified by flash chromatograpy (SiO2;
hexanes:EtOAc, 3:1-1:1) to afford pyran 986 (8.0 mg, 99 %) as a yellow oil. TLC: Rf = 0.23
(hexanes:EtOAc, 5:1). 1H NMR (CDCl3, 300 MHz):  7.48 (20H, m), 5.02 (1H, t, J = 4.2 Hz),
4.63 (1H, m), 4.49 (1H, m), 4.33 (1H, m), 4.24 (2H, m), 4.19 (2H, m), 3.57 (2H, m), 2.69 (5H,
m), 2.88 (2H, s), 1.25 (3H, t, J = 7.1 Hz), 1.02 (9H, s), 1.02 (9H,s). 13C NMR (CDCl3, 75 MHz):
 205.0, 198.1, 174.1, 174.0, 146.8 (2), 145.2 (2), 135.9, 136.8, 135.7, 135.6, 135.5 (3), 134.0,
133.9, 133.6 (2), 133.4 (2), 133.3 (3), 129.6, 129.5 (3), 127.6, 127.5 (3), 127.4, 99.7, 98.7, 71.0
(2), 70.2 (2), 67.9 (2), 67.1 (2), 49.4, 48.3, 46.1 (2), 45.9, 38.4, 38.3, 26.9, 26.8, 22.3, 22.2, 21.4,
21.0, 19.2 (3), 17.5, 14.2, 14.1. IR (film): 3514, 3072, 2932, 2858, 1732, 1603, 1112 cm-1.
HRMS (ESI) Calcd for C47H58O7Si2 ([M+Na]+): 813.3613, found 813.3617.

Pyran 987: p-Nitrobenzaldehyde (20.6 mg, 0.136 mmol) was added to enol ether 976 (24.0 mg,
0.114 mmol). 0.23 mL of a freshly prepared solution of ZnCl2 (67.8 mg/mL, 0.114 mmol) in dry
THF was added to the reaction flask. The reaction was stirred at room temperature for 48 h. The
solvent was removed in vacuo and the residue was purified by flash chromatograpy (SiO2;
hexanes:EtOAc, 3:1-1:1) to afford pyran 987 (31.6 mg, 77%) as a yellow oil. TLC: Rf = 0.33
(hexanes:EtOAc, 1:1). 1H NMR (CDCl3, 300 MHz):  8.19 (2H, d, J = 9.2 Hz), 7.55 (2H, d, J =
9.2 Hz), 5.04 (1H, m), 4.63 (1H, m), 4.56 (1H, m), 4.33 (1H, m), 4.26 (2H, q, J = 7.4 Hz), 2.67
(2H, m), 2.42 (6H, m), 1.30 (3H, t, J = 7.0 Hz). 13C NMR (CDCl3, 75 MHz):  151.2 (C), 148.6
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(C), 147.6 (C), 147.1 (C), 135.5 (CH), 132.9 (C), 129.8 (CH), 127.8 (CH), 126.4 (2) (CH), 123.5
(CH), 99.2 (CH), 99.1 (CH), 98.0 (CH), 97.9 (CH), 70.9 (CH), 70.7 (CH), 69.4 (CH), 69.2 (CH),
63.0 (CH2), 45.1 (CH2), 43.7 (CH2), 43.6 (CH2), 41.3 (CH2), 38.0 (CH2), 26.8 (CH3), 20.9 (CH2),
19.0 (C). IR (film): 3396, 3072, 2931, 2858, 1717, 1603, 1522, 1346 cm-1. HRMS (ESI) Calcd
for C18H21NO7 ([M+Na]+): 386.1210, found 386.1211.

Pyran 988: p-Nitrobenzaldehyde (23 mg, 0.152 mmol) was added to a solution of enol ether 977
(33 mg, 0.127 mmol) in dry THF (0.08 mL) followed by 0.17 mL of a freshly prepared solution
of ZnCl2 (100 mg/mL, 0.127 mmol) in dry THF. The reaction was stirred at room temperature
for 48 h. The solvent was removed in vacuo and the residue was purified by flash chromatograpy
(SiO2; hexanes:EtOAc, 3:1-1:1) to afford pyran 988 (28 mg, 54%) as a yellow oil. TLC: Rf =
0.20 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  8.21 (2H, d, J = 8.6 Hz), 7.57 (2H,
dd, J = 8.8, 1.7 Hz), 5.01 (1H, m), 4.62 (1H, m), 4.56 (0.5H, m), 4.53 (0.5H, m), 4.27 (2H, m),
3.59 (0.5H, br s), 3.47 (1H, br s), 3.36 (0.5H, d, J = 3.5 Hz), 2.69 (2H, s), 2.60 (1H, dd, J = 14.4,
5.1 Hz), 2.43 (3H, m), 1.47 (3H, d, J = 1.8 Hz), 1.34 (3H, t, J = 7.2 Hz). 13C NMR (CDCl3, 75
MHz):  176.3 (C), 176.2 (C), 151.2 (C), 151.1 (C), 147.9 (C), 147.5 (C), 147.0 (C), 126.4 (CH),
129.4 (CH), 123.5 (2) (CH), 99.7 (2) (CH), 99.0 (CH), 98.8 (CH), 73.9 (C), 73.8 (C), 71.3 (CH),
71.1 (CH), 61.9 (2) (CH2), 43.8 (CH2), 43.7 (CH2), 43.5 (CH2), 43.4 (CH2), 26.1 (CH3), 25.9
(CH3), 20.9 (CH2), 14.2 (CH3). IR (film): 3466, 3126, 2984, 2838, 1718, 1604, 1520, 1347 cm-1.
HRMS (ESI) Calcd for C19H23NO7 ([M+Na]+): 400.1367, found 400.1367.
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Pyran 989: p-Nitrobenzaldehyde (25 mg, 0.167 mmol) was added to a solution of enol ether 977
(59 mg, 0.139 mmol) in dry THF (0.178 mL) followed by 0.1 mL of a freshly prepared solution
of ZnCl2 (210 mg/mL, 0.139 mmol) in dry THF. The reaction was stirred at room temperature
for 48 h. The solvent was removed in vacuo and the residue was purified by flash chromatograpy
(SiO2; hexanes:EtOAc, 3:1-1:1) to afford pyran 989 (40 mg, 51%) as a yellow oil. TLC: Rf =
0.33 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  8.20 (2H, d, J = 8.7), 7.68 (4H, m),
7.55 (2H, d, J = 8.7 Hz), 7.41 (6H, m), 5.02 (1H, m), 4.60 (2H, m), 4.17 (1H, m), 3.88 (2H, m),
3.48 (1H, m), 3.29 (1H, m), 2.70 (2H, d, J = 2.9 Hz), 2.47 (2H, m), 2.25 (2H, d, J = 6.1 Hz), 1.69
(2H, m), 1.06 (9H, s). 13C NMR (CDCl3, 75 MHz):  151.2 (C), 148.6 (C), 147.6 (C), 147.1 (C),
135.5 (CH), 132.9 (C), 129.8 (CH), 127.8 (CH), 126.4 (2) (CH), 123.5 (CH), 99.2 (CH), 99.1
(CH), 98.0 (CH), 97.9 (CH), 70.9 (CH), 70.7 (CH), 69.4 (CH), 69.2 (CH), 63.0 (CH2), 45.1
(CH2), 43.7 (CH2), 43.6 (CH2), 41.3 (CH2), 38.0 (CH2), 26.8 (CH3), 20.9 (CH2), 19.0 (C). IR
(film): 3396, 3072, 2931, 2858, 1717, 1603, 1522, 1346 cm-1.

HRMS (ESI) Calcd for

C33H39NO6Si ([M+Na]+): 596.2439, found 596.2437.

Pyran 990: p-Nitrobenzaldehyde (50 mg, 0.33 mmol) was added to a solution of enol ether 979
(70 mg, 0.276 mmol) in dry THF (0.1 mL) followed by 0.39 mL of a freshly prepared solution of
ZnCl2 (96 mg/mL, 0.276 mmol) in dry THF. The reaction was stirred at room temperature for 48
h. The solvent was removed in vacuo and the residue was purified by flash chromatograpy (SiO2;
hexanes:EtOAc, 3:1-1:1) to afford pyran 990 (59 mg, 53%) as a yellow oil. TLC: Rf = 0.32
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(hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  8.19 (2H, d, J = 8.7 Hz), 7.53 (2H, d, J =
8.5 Hz), 4.98 (1H, m), 4.57 (2H, m), 3.75 (1H, m), 2.68 (2H, s), 2.40 (2H, m), 2.24 (1H, d, J =
14.5 Hz), 2.08 (1H, m), 1.45 (2H, m), 1.27 (10H, s), 10.77 (3H, t, J = 7.0 Hz). 13C NMR (CDCl3,
75 MHz):  151.1 (C), 151.0 (C), 148.7 (C), 147.5 (C), 147.4 (C), 147.1 (C), 126.4 (2) (CH),
123.5 (CH), 99.2 (CH), 98.1 (2) (CH), 71.0 (CH), 70.9 (CH), 69.7 (2) (CH), 43.5 (2) (CH2), 41.1
(CH2), 41.0 (CH2), 37.0 (CH2), 36.9 (CH2), 31.8 (CH2), 29.6 (CH2), 29.2 (CH2), 25.6 (CH2), 22.6
(CH2), 20.9 (CH2), 14.1. IR (film): 3401, 3080, 2928, 2856, 1603, 1521, 1346 cm-1. HRMS
(ESI) Calcd for C22H31NO5 ([M+Na]+): 412.2094, found 412.2094.

Tetrahydropyran 991: To a solution of iodide 979 (301mg, 0.79 mmol) in dichloromethane (1.3
mL) was added triethylsilane (0.10 mL, 0.796 mmol). The reaction mixture was cooled to –78oC
and BF3-EtO2 (0.405 mL, 2.54 mmol) was added.

The reaction was warmed to room

temperature overnight and concentrated in vacuo. The resulting liquid was purified by flash
column chromatography (SiO2; hexanes:EtOAc, 5:1) to afford pyran 991 (193 mg, 64 %) as a
yellow oil. TLC: Rf = 0.73 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  3.93 (1H, m),
3.71 (1H, m), 3.38 (1H, m), 3.17 (2H, m), 2.88 (1H, br s), 1.53 (20 H, m), 0.88 (3H, t, J = 6.7
Hz).

13

C NMR (CDCl3, 75 MHz):  77.3 (CH), 76.2 (CH), 68.8 (CH), 41.7 (CH2), 37.1 (CH2),

31.8 (CH2), 31.2 (CH2), 30.7 (CH2), 29.6 (CH2), 29.3 (CH2), 25.9 (CH2), 23.2 (CH2), 22.6 (CH2),
14.1 (CH3), 10.1 (CH2). IR (film): 3512, 2928, 2855 cm-1.
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Tetrahydropyran 992: To a solution of tetrahydropyran 991 (30mg, 0.078 mmol) in
dicholoromethane (0.35 mL) was added Dess-Martin Periodinane (40 mg, 0.090mmol) and
NaHCO3 (10 mg, 0.26 mmol) at room temperature. The reaction stirred for 3 hr and was then
diluted with diethyl ether (10 mL), filtered through a pad of celite, and concentrated in vacuo.
The crude residue was purified by flash chromatography using deactivated silica gel (SiO2;
hexanes:EtOAc, 20:1) to afford tetrahydropyran 992 (19 mg, 66%) as a colorless oil. TLC: Rf =
0.63 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  3.82 (1H, m), 3.36 (1H, m), 3.13
(2H, m), 2.69 (1H, dd, J = 15.1, 7.9 Hz), 2.51 (2H, q, J = 7.4 Hz), 2.39 (1H, dd, J = 15.1, 4.8
Hz), 1.83 (2H, m), 1.59 (4H, m), 1.26 (10H, m), 0.88 (3H, t, J = 6.7 Hz).

13

C NMR (CDCl3, 75

MHz):  209.9 (C), 77.0 (CH), 75.0 (CH), 49.1 (CH2), 44.2 (CH2), 31.7 (CH2), 31.0 (2) (CH2),
29.1 (2) (CH2), 23.5 (CH2), 23.0 (CH2), 22.6 (CH2), 14.1 (CH3), 9.6 (CH2). IR (film): 2927,
2853, 1709 cm-1.

Triol 998: TBAF (0.49mL of a 1M solution, 0.048 mmol) was added to a solution of silyl ether
983 ( 0.025g, 0.048 mmol) in THF (0.5 mL) . The reaction was stirred for two hours at room
temperature after which the reaction mixture was concentrated and run through a plug of silica
(SiO2; 2:1 (hexanes: EtOAc) – 10% MeOH in EtOAc). The crude residue was isolated as a
yellow oil in 71% yield (0.010g) and quickly subjected to the next reaction.

TLC: Rf = 0.09

(hexanes:EtOAc, 1:1). 1H NMR (CDCl3, 300 MHz):  4.62 (2H, m), 4.36 (1H, m), 4.27 (2H,
dq, J = 7.2, 0.9 Hz), 4.08 (1H, t, J = 6.9 Hz), 3.87 (2H, m), 2.70 (2H, s), 2.64-2.38 (2H, m), 2.29
(2H, m), 1.73 (2H, m), 1.41 (3H, t, J = 7.1 Hz).
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Diol 1006: TBAF (0.184mL of a 1M solution, 0.184 mmol) was added to a solution of silyl
ether 972 (0.100g, 0.182 mmol) in THF (1.9 mL).

The reaction was stirred for two hours at

room temperature after which the reaction mixture was concentrated and run through a plug of
silica (SiO2; 2:1 (hexanes: EtOAc) – 10% MeOH in EtOAc). The crude residue was isolated as a
yellow oil in 72% yield (0.041g) and quickly subjected to the next reaction.

TLC: Rf = 0.11

(hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  4.61 (1H, m), 4.10 (1H, m), 3.87 (3H, m),
3.32 (2H, m), 2.97 (1H, d, J = 3.1 Hz), 2.90 (1H, d, J = 3.1 Hz), 2.66 (1H, m), 2.24 (2H, m), 2.04
(3H, m), 1.72 (2H, m).

Spiroketals 1006 and 1007: TBAF (0.184 mL) was added to a solution of dihydropyran 1005
dissolved in THF (1.9 mL). The reaction was stirred for two hours at room temperature. The
solution was concentrated and subjected to the next reaction. PPTS (2 mg, 0.009 mmol) was
added to the concentrate, which was diluted with CH2Cl2 (1.0 mL). The reaction was stirred at
room temperature overnight and concentrated afterwards.

Purification via column

chromatography (SiO2; hexanes:EtOAc, 9:1-2:1) afforded spiroketal 1006 (14 mg) and spiroketal
1007 (14 mg), colorless oils, as a 1:1 mixture of separable diastereomers. Spiroketal 1006: TLC:
Rf = 0.22 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  4.25 (1H, m), 3.87 (1H, ddd, J
= 12.8, 11.4, 2.3 Hz), 3.68 (2H, m), 3.20 (1H, dd, J = 10.2, 3.7 Hz), 3.10 (1H, dd, J = 10.2, 8.9
Hz), 2.05 (1H, ddd, J = 12.4, 4.7, 2.1 Hz), 1.85 (3H, m), 1.60 (3H, m), 1.45 (1H, dq, J = 13.2, 4.9

332

Hz), 1.34 (1H, dd, J = 12.4, 11.2), 1.19 (1H, ddq, J = 12.4, 4.7, 1.5 Hz). 13C NMR (CDCl3, 75
MHz):  98.4 (C), 69.3 (CH), 64.1 (CH), 59.1 (CH2), 45.0 (CH2), 35.0 (CH2), 34.6 (CH2), 30.8
(CH2), 18.6 (CH2), 9.8 (CH2). IR (film): 3394, 2943, 1090 cm-1. Spiroketal 1007: TLC: Rf =
0.46 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  4.15 (1H, dt, J = 12.1, 3.3 Hz), 4.05
(1H, m), 3.79 (1H, m), 3.64 (1H, m), 3.22 (1H, dd, J = 10.4, 2.9 Hz), 3.08 (1H, dd, J = 10.2, 10.1
Hz), 1.88 (2H, m), 1.76 (3H, m), 1.67 (1H, dd, J = 14.3, 2.9 Hz), 1.56 (2H, m), 1.41 (1H, dt, J =
13.5, 4.7 Hz), 1.21 (1H, m). 13C NMR (CDCl3, 75 MHz):  98.4 (C), 70.4 (CH), 64.3 (CH), 55.5
(CH2), 40.2 (CH2), 34.7 (CH2), 32.0 (CH2), 30.7 (CH2), 18.2 (CH2), 9.3 (CH2). IR (film): 3524,
2940, 1081 cm-1.

Fluoride 1006b: To a solution of spiroketal 1006 (0.072g, 0.231 mmol) in pyridine (3 mL) was
added AgF (0.088g, 0.692 mmol). The reaction was stirred at 65oC for 24 hours in the dark. The
reaction mixture was concentrated in vacuo and purified by column chromatography (SiO2;
hexanes:EtOAc, 6:1-2:1), which afforded the fluoride (12 mg, 26%) as a colorless oil. TLC: Rf =
0.18 (hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  4.41 (1H, d, J = 3.5 Hz), 4.27 (1H, d
J = 3.5 Hz), 4.16 (1H, m), 3.85 (1H, m), 3.67 (2H, m), 2.06 (1H, m), 1.90 (1H, m), 1.74-1.25
(8H, m).

Spiroketal 1009: Iodide 1007 was dissolved in ethanol and THF (5:3, 2.5 mL) and cooled to
0oC. Diphenylselenide (38 mg, 0.123 mmol) and sodium borohydride (8 mg, 0.224 mmol) were
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added to the reation mixture. The reaction was allowed to warm to room temperature overnight
after which it was concentrated in vacuo.

Purification via column chromatography (SiO2;

hexanes:EtOAc, 15:1-8:1) afforded spiroketal 1009 (33 mg, 87%) as a colorless oil. TLC: Rf =
0.50 (hexanes:EtOAc, 2:1).

1

H NMR (CDCl3, 300 MHz):  7.50 (2H, m), 7.25 (3H, m), 4.19

(1H, d, J = 10.8 Hz), 4.02 (2H, m), 3.81 (1H, m), 3.81 (1H, m), 3.54 (1H, dd, J = 11.6, 4.9 Hz),
3.08 (1H, dd, J = 12.5, 3.6 Hz), 2.89 (1H, dd, J = 12.5, 9.8 Hz), 1.73 (8H, m), 1.34 (2H, m). 13C
NMR (CDCl3, 75 MHz):  132.2 (CH), 130.1 (C), 129.1 (CH), 126.8 (CH), 98.1 (C), 68.7 (CH),
64.3 (CH), 55.2 (CH2), 40.3 (CH2), 34.7 (CH2), 33.5 (CH2), 32.0 (CH2), 31.0 (CH2), 18.2 (CH2).
IR (film): 3505, 3056, 2937, 2878, 1655 cm-1.

Spiroketal 1010: Spiroketal 1009 was dissolved in a mixture of methanol and dionized water
(6:1, 1.5 mL). To this solution was added NaHCO3 (9 mg, 0.106 mmol) and NaIO4 (27 mg,
0.126 mmol). The reaction was stirred at room temperature for four hours after which a white
precipitate formed. Methanol was evaporated and the resulting liquid was partitioned between
dichloromethane (10 mL) and water (5 mL). The two layers were separated and the water layer
was extracted using dichloromethane (3 x 15 mL). The organic layers were combined, dried
over MgSO4, filtered, and concentrated in vacuo. The resulting solid white product (34 mg,
100%) was used without further purification in the reaction sequence.

TLC: Rf = 0.26

(hexanes:EtOAc, 2:1). 1H NMR (CDCl3, 300 MHz):  7.74 (2H, m), 7.50 (3H, m), 4.29 (2H, m),
4.06 (1H, m), 3.70 (1H, m), 2.92 (2H, m), 2.05-1.29 (10H, m).
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Appendix 1
Selected Spectral Data for Chapter 2: Three-Component Coupling
Reactions of 2-Methylenetetrahydropyrans
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Selected Spectral Data for Chapter 3: Carbonyl-Ene Reactions of
Substituted Exocyclic Enol Ethers
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